0000878526-22-000026.txt : 20220225 0000878526-22-000026.hdr.sgml : 20220225 20220225160302 ACCESSION NUMBER: 0000878526-22-000026 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 111 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220225 DATE AS OF CHANGE: 20220225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NATUS MEDICAL INC CENTRAL INDEX KEY: 0000878526 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 770154833 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-33001 FILM NUMBER: 22679774 BUSINESS ADDRESS: STREET 1: 3150 PLEASANT VIEW ROAD CITY: MIDDLETON STATE: WI ZIP: 53562 BUSINESS PHONE: 6088298500 MAIL ADDRESS: STREET 1: 3150 PLEASANT VIEW ROAD CITY: MIDDLETON STATE: WI ZIP: 53562 10-K 1 ntus-20211231.htm 10-K ntus-20211231
false2021FY00008785265,2716,2130.0010.001120,000,000120,000,00034,225,68233,911,70334,225,68233,911,7030.0010.00110,000,00010,000,000————P3Y25.02.71.50.50.41234http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentNethttp://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentNetP1Yhttp://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent18,53135.2537,06235.2521212100008785262021-01-012021-12-3100008785262021-06-30iso4217:USD00008785262022-02-18xbrli:shares0000878526us-gaap:AllowanceForCreditLossMember2020-12-310000878526us-gaap:AllowanceForCreditLossMember2021-01-012021-12-310000878526us-gaap:AllowanceForCreditLossMember2021-12-310000878526us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2020-12-310000878526us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2021-01-012021-12-310000878526us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2021-12-310000878526us-gaap:WarrantyReservesMember2020-12-310000878526us-gaap:WarrantyReservesMember2021-01-012021-12-310000878526us-gaap:WarrantyReservesMember2021-12-310000878526us-gaap:AllowanceForCreditLossMember2019-12-310000878526us-gaap:AllowanceForCreditLossMember2020-01-012020-12-310000878526us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2019-12-310000878526us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2020-01-012020-12-310000878526us-gaap:WarrantyReservesMember2019-12-310000878526us-gaap:WarrantyReservesMember2020-01-012020-12-310000878526us-gaap:AllowanceForCreditLossMember2018-12-310000878526us-gaap:AllowanceForCreditLossMember2019-01-012019-12-310000878526us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2018-12-310000878526us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2019-01-012019-12-310000878526us-gaap:WarrantyReservesMember2018-12-310000878526us-gaap:WarrantyReservesMember2019-01-012019-12-3100008785262021-12-3100008785262020-12-31iso4217:USDxbrli:shares00008785262020-01-012020-12-3100008785262019-01-012019-12-310000878526us-gaap:CommonStockMember2018-12-310000878526us-gaap:RetainedEarningsMember2018-12-310000878526us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-3100008785262018-12-310000878526srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:RetainedEarningsMember2019-01-012019-12-310000878526us-gaap:AccumulatedOtherComprehensiveIncomeMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-01-012019-12-310000878526srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-01-012019-12-310000878526us-gaap:CommonStockMember2019-01-012019-12-310000878526us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-12-310000878526us-gaap:RetainedEarningsMember2019-01-012019-12-310000878526us-gaap:CommonStockMember2019-12-310000878526us-gaap:RetainedEarningsMember2019-12-310000878526us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-3100008785262019-12-310000878526us-gaap:CommonStockMember2020-01-012020-12-310000878526us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310000878526us-gaap:RetainedEarningsMember2020-01-012020-12-310000878526us-gaap:CommonStockMember2020-12-310000878526us-gaap:RetainedEarningsMember2020-12-310000878526us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000878526us-gaap:CommonStockMember2021-01-012021-12-310000878526us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-310000878526us-gaap:RetainedEarningsMember2021-01-012021-12-310000878526us-gaap:CommonStockMember2021-12-310000878526us-gaap:RetainedEarningsMember2021-12-310000878526us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000878526srt:MinimumMember2021-01-012021-12-310000878526srt:MaximumMember2021-01-012021-12-31ntus:strategicBusinessUnitntus:operating_segmentntus:reporting_unit00008785262020-01-010000878526us-gaap:EmployeeStockOptionMember2021-01-012021-12-310000878526ntus:EmployeesMemberus-gaap:RestrictedStockMember2021-01-012021-12-310000878526srt:ExecutiveOfficerMemberus-gaap:RestrictedStockMember2021-01-012021-12-310000878526us-gaap:ShareBasedCompensationAwardTrancheTwoMembersrt:ExecutiveOfficerMemberus-gaap:RestrictedStockMember2021-01-012021-12-31xbrli:pure0000878526us-gaap:ShareBasedCompensationAwardTrancheTwoMembersrt:DirectorMemberus-gaap:RestrictedStockMember2021-01-012021-12-310000878526ntus:MarketStockUnitMemberntus:EmployeesMember2021-01-012021-12-310000878526srt:MinimumMemberus-gaap:FurnitureAndFixturesMember2021-01-012021-12-310000878526srt:MaximumMemberus-gaap:FurnitureAndFixturesMember2021-01-012021-12-310000878526srt:MinimumMemberus-gaap:BuildingMember2021-01-012021-12-310000878526srt:MaximumMemberus-gaap:BuildingMember2021-01-012021-12-310000878526us-gaap:ComputerEquipmentMember2021-01-012021-12-310000878526srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-04-012021-06-300000878526us-gaap:UnbilledRevenuesMember2020-12-310000878526us-gaap:UnbilledRevenuesMember2021-01-012021-12-310000878526us-gaap:UnbilledRevenuesMember2021-12-3100008785262019-01-012021-12-3100008785262020-01-012021-12-3100008785262021-01-012021-12-3100008785262022-01-012021-12-3100008785262023-01-012021-12-310000878526us-gaap:LandMember2021-12-310000878526us-gaap:LandMember2020-12-310000878526us-gaap:BuildingMember2021-12-310000878526us-gaap:BuildingMember2020-12-310000878526us-gaap:LeaseholdsAndLeaseholdImprovementsMember2021-12-310000878526us-gaap:LeaseholdsAndLeaseholdImprovementsMember2020-12-310000878526us-gaap:FurnitureAndFixturesMember2021-12-310000878526us-gaap:FurnitureAndFixturesMember2020-12-310000878526us-gaap:ComputerEquipmentMember2021-12-310000878526us-gaap:ComputerEquipmentMember2020-12-310000878526ntus:DemonstrationAndLoanedEquipmentMember2021-12-310000878526ntus:DemonstrationAndLoanedEquipmentMember2020-12-310000878526us-gaap:DevelopedTechnologyRightsMember2021-12-310000878526us-gaap:DevelopedTechnologyRightsMember2020-12-310000878526us-gaap:CustomerRelationshipsMember2021-12-310000878526us-gaap:CustomerRelationshipsMember2020-12-310000878526us-gaap:TradeNamesMember2021-12-310000878526us-gaap:TradeNamesMember2020-12-310000878526us-gaap:SoftwareDevelopmentMember2021-12-310000878526us-gaap:SoftwareDevelopmentMember2020-12-310000878526us-gaap:PatentsMember2021-12-310000878526us-gaap:PatentsMember2020-12-310000878526us-gaap:ServiceAgreementsMember2021-12-310000878526us-gaap:ServiceAgreementsMember2020-12-310000878526us-gaap:IntellectualPropertyMember2021-12-310000878526us-gaap:IntellectualPropertyMember2020-12-310000878526us-gaap:DevelopedTechnologyRightsMember2021-01-012021-12-310000878526us-gaap:PatentsMember2021-01-012021-12-310000878526us-gaap:CustomerRelationshipsMember2021-01-012021-12-310000878526us-gaap:TradeNamesMember2021-01-012021-12-310000878526us-gaap:ComputerSoftwareIntangibleAssetMember2021-01-012021-12-310000878526us-gaap:ServiceAgreementsMember2021-01-012021-12-3100008785262020-07-012020-09-300000878526us-gaap:CostOfSalesMember2020-07-012020-09-300000878526us-gaap:OperatingExpenseMember2020-07-012020-09-300000878526us-gaap:DevelopedTechnologyRightsMember2020-01-012020-12-310000878526us-gaap:DevelopedTechnologyRightsMember2019-01-012019-12-310000878526us-gaap:CustomerRelationshipsMember2020-01-012020-12-310000878526us-gaap:CustomerRelationshipsMember2019-01-012019-12-310000878526us-gaap:TradeNamesMember2020-01-012020-12-310000878526us-gaap:TradeNamesMember2019-01-012019-12-310000878526us-gaap:IntellectualPropertyMember2019-12-310000878526us-gaap:SoftwareDevelopmentMember2021-01-012021-12-310000878526us-gaap:SoftwareDevelopmentMember2020-01-012020-12-310000878526us-gaap:SoftwareDevelopmentMember2019-01-012019-12-310000878526us-gaap:PatentsMember2020-01-012020-12-310000878526us-gaap:PatentsMember2019-01-012019-12-310000878526us-gaap:ServiceAgreementsMember2020-01-012020-12-310000878526us-gaap:ServiceAgreementsMember2019-01-012019-12-310000878526us-gaap:GeneralAndAdministrativeExpenseMember2021-01-012021-12-310000878526us-gaap:GeneralAndAdministrativeExpenseMember2020-01-012020-12-310000878526us-gaap:GeneralAndAdministrativeExpenseMember2019-01-012019-12-310000878526srt:MinimumMember2021-12-310000878526srt:MaximumMember2021-12-310000878526us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2019-12-310000878526srt:MaximumMemberntus:CreditAgreementMemberntus:CitibankNationalAssociationMember2021-12-310000878526srt:MinimumMemberntus:CreditAgreementMemberntus:CitibankNationalAssociationMember2021-12-310000878526srt:MinimumMemberntus:CreditAgreementMemberus-gaap:LondonInterbankOfferedRateLIBORMemberntus:CitibankNationalAssociationMember2021-01-012021-12-310000878526srt:MaximumMemberntus:CreditAgreementMemberus-gaap:LondonInterbankOfferedRateLIBORMemberntus:CitibankNationalAssociationMember2021-01-012021-12-310000878526us-gaap:CostOfSalesMember2021-01-012021-12-310000878526us-gaap:CostOfSalesMember2020-01-012020-12-310000878526us-gaap:CostOfSalesMember2019-01-012019-12-310000878526us-gaap:SellingAndMarketingExpenseMember2021-01-012021-12-310000878526us-gaap:SellingAndMarketingExpenseMember2020-01-012020-12-310000878526us-gaap:SellingAndMarketingExpenseMember2019-01-012019-12-310000878526us-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-12-310000878526us-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-12-310000878526us-gaap:ResearchAndDevelopmentExpenseMember2019-01-012019-12-310000878526us-gaap:EmployeeStockOptionMembersrt:DirectorMember2021-01-012021-12-310000878526us-gaap:EmployeeStockOptionMember2021-12-310000878526us-gaap:RestrictedStockMember2021-12-310000878526us-gaap:RestrictedStockMember2020-12-310000878526us-gaap:RestrictedStockMember2021-01-012021-12-310000878526us-gaap:RestrictedStockMember2020-01-012020-12-310000878526us-gaap:RestrictedStockMember2019-01-012019-12-310000878526us-gaap:RestrictedStockMember2019-12-310000878526us-gaap:RestrictedStockUnitsRSUMember2020-12-310000878526us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-310000878526us-gaap:RestrictedStockUnitsRSUMember2021-12-310000878526us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-12-310000878526us-gaap:RestrictedStockUnitsRSUMember2019-01-012019-12-310000878526us-gaap:RestrictedStockUnitsRSUMember2019-12-310000878526us-gaap:EmployeeStockMember2021-12-310000878526us-gaap:EmployeeStockMember2021-01-012021-12-310000878526us-gaap:StateAndLocalJurisdictionMember2021-12-310000878526srt:MinimumMemberus-gaap:DomesticCountryMember2021-01-012021-12-310000878526us-gaap:ResearchMemberus-gaap:StateAndLocalJurisdictionMember2021-12-310000878526us-gaap:ForeignCountryMember2021-12-310000878526country:FR2021-12-310000878526country:DK2021-12-310000878526country:CA2021-12-310000878526country:CN2021-12-310000878526country:DE2021-12-310000878526srt:MinimumMemberus-gaap:ForeignCountryMember2021-01-012021-12-310000878526ntus:IncomeTaxProvisionMember2021-01-012021-12-31ntus:Segment0000878526country:US2021-01-012021-12-310000878526country:US2020-01-012020-12-310000878526country:US2019-01-012019-12-310000878526us-gaap:NonUsMember2021-01-012021-12-310000878526us-gaap:NonUsMember2020-01-012020-12-310000878526us-gaap:NonUsMember2019-01-012019-12-310000878526ntus:NeurologyProductsMemberntus:DevicesAndSystemsMember2021-01-012021-12-310000878526ntus:NeurologyProductsMemberntus:DevicesAndSystemsMember2020-01-012020-12-310000878526ntus:NeurologyProductsMemberntus:DevicesAndSystemsMember2019-01-012019-12-310000878526ntus:SuppliesMemberntus:NeurologyProductsMember2021-01-012021-12-310000878526ntus:SuppliesMemberntus:NeurologyProductsMember2020-01-012020-12-310000878526ntus:SuppliesMemberntus:NeurologyProductsMember2019-01-012019-12-310000878526ntus:ServicesMemberntus:NeurologyProductsMember2021-01-012021-12-310000878526ntus:ServicesMemberntus:NeurologyProductsMember2020-01-012020-12-310000878526ntus:ServicesMemberntus:NeurologyProductsMember2019-01-012019-12-310000878526ntus:NeurologyProductsMember2021-01-012021-12-310000878526ntus:NeurologyProductsMember2020-01-012020-12-310000878526ntus:NeurologyProductsMember2019-01-012019-12-310000878526ntus:DevicesAndSystemsMemberntus:NewbornCareProductsMember2021-01-012021-12-310000878526ntus:DevicesAndSystemsMemberntus:NewbornCareProductsMember2020-01-012020-12-310000878526ntus:DevicesAndSystemsMemberntus:NewbornCareProductsMember2019-01-012019-12-310000878526ntus:SuppliesMemberntus:NewbornCareProductsMember2021-01-012021-12-310000878526ntus:SuppliesMemberntus:NewbornCareProductsMember2020-01-012020-12-310000878526ntus:SuppliesMemberntus:NewbornCareProductsMember2019-01-012019-12-310000878526ntus:ServicesMemberntus:NewbornCareProductsMember2021-01-012021-12-310000878526ntus:ServicesMemberntus:NewbornCareProductsMember2020-01-012020-12-310000878526ntus:ServicesMemberntus:NewbornCareProductsMember2019-01-012019-12-310000878526ntus:NewbornCareProductsMember2021-01-012021-12-310000878526ntus:NewbornCareProductsMember2020-01-012020-12-310000878526ntus:NewbornCareProductsMember2019-01-012019-12-310000878526ntus:DevicesAndSystemsMemberntus:OtometricsProductsMember2021-01-012021-12-310000878526ntus:DevicesAndSystemsMemberntus:OtometricsProductsMember2020-01-012020-12-310000878526ntus:DevicesAndSystemsMemberntus:OtometricsProductsMember2019-01-012019-12-310000878526ntus:SuppliesMemberntus:OtometricsProductsMember2021-01-012021-12-310000878526ntus:SuppliesMemberntus:OtometricsProductsMember2020-01-012020-12-310000878526ntus:SuppliesMemberntus:OtometricsProductsMember2019-01-012019-12-310000878526ntus:OtometricsProductsMember2021-01-012021-12-310000878526ntus:OtometricsProductsMember2020-01-012020-12-310000878526ntus:OtometricsProductsMember2019-01-012019-12-310000878526country:US2021-12-310000878526country:US2020-12-310000878526country:IE2021-12-310000878526country:IE2020-12-310000878526country:CA2020-12-310000878526country:DK2020-12-310000878526ntus:ForeignCountriesMember2021-12-310000878526ntus:ForeignCountriesMember2020-12-310000878526country:CAus-gaap:LandMember2021-07-012021-09-300000878526us-gaap:BuildingMembercountry:GB2021-07-012021-09-300000878526ntus:MedixMedicalDevicesSRLMember2019-04-022019-04-020000878526ntus:MedixMedicalDevicesSRLMember2019-04-020000878526ntus:MedixMedicalDevicesSRLMember2021-04-012021-06-300000878526ntus:MedixMedicalDevicesSRLMember2021-03-3100008785262021-04-012021-06-300000878526ntus:MedixMedicalDevicesSRLMember2019-08-02
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
☒ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2021
or
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission file number: 000-33001
 
 NATUS MEDICAL INCORPORATED
(Exact name of registrant as specified in its charter)
Delaware 77-0154833
(State or other jurisdiction of
incorporation or organization)		 (I.R.S. Employer
Identification Number)
3150 Pleasant View Road, Middleton, WI 53562
(Address of principal executive offices) (Zip Code)
(608) 829-8500
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.001 par value per shareNTUSThe Nasdaq Stock Market LLC
(The Nasdaq Global Select Market)
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  ☒    No  ☐
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  ☐    No  ☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒  No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
Large Accelerated Filer ☒Accelerated filer ☐
Non-accelerated filer
☐

Smaller reporting company☐
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ 
Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared and issued its audit report.☒
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  ☐    No  ☒
As of June 30, 2021, the last business day of Registrant’s most recently completed second fiscal quarter, there were 34,132,106 shares of Registrant’s common stock outstanding, and the aggregate market value of such shares held by non-affiliates of Registrant (based upon the closing sale price of such shares on the Nasdaq Global Select Market on June 30, 2021) was $886,752,114. Shares of Registrant’s common stock held by each executive officer and director and by each entity that owns 5% or more of Registrant’s outstanding common stock have been excluded in that such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes.
On February 18, 2022, the registrant had 34,408,154 shares of its common stock outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Certain portions of the Registrant's Definitive Proxy Statement for the 2022 Annual Meeting of Stockholders or an amendment to this Annual Report on Form 10-K, to be filed with the Securities and Exchange Commission, are incorporated by reference into Part III of this Annual Report on Form 10-K.
Auditor Data Elements
Auditor Name: KPMG LLP        Auditor Location: San Francisco, CA        Auditor Firm ID: 185


NATUS MEDICAL INCORPORATED
ANNUAL REPORT ON FORM 10-K
TABLE OF CONTENTS
ITEM 1.
ITEM 1A.
ITEM 1B.
ITEM 2.
ITEM 3.
ITEM 4.
ITEM 5.
ITEM 6.
ITEM 7.
ITEM 7A.
ITEM 8.
ITEM 9.
ITEM 9A.
ITEM 10.
ITEM 11.
ITEM 12.
ITEM 13.
ITEM 14.
ITEM 15.
ITEM 16.


PART I 
ITEM 1.    Business
This Annual Report on Form 10-K (this “Annual Report”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 about Natus® Medical Incorporated (“Natus,” “we,” “us,” or “our”). These statements include, among other things, statements concerning our expectations, beliefs, plans, intentions, future operations, financial condition and prospects, and business strategies. The words “may,” “will,” “continue,” “estimate,” “project,” “intend,” “believe,” “expect,” “anticipate,” and other similar expressions generally identify forward-looking statements. Forward-looking statements in this Item 1 include, but are not limited to, statements regarding the effectiveness and advantages of our products, factors relating to demand for and economic advantages of our products, our plan to develop and acquire additional technologies, products or businesses, our marketing, technology enhancement, and product development strategies, our ability to complete all of our backlog orders, and the anticipated timing and effect of the implementation of our new organizational structure.
Forward-looking statements are not guarantees of future performance and are subject to substantial risks and uncertainties that could cause our actual results to differ materially from those that we predicted in the forward-looking statements. Investors should carefully review the information contained under the caption “Risk Factors” contained in Item 1A for a description of risks and uncertainties that could cause actual results to differ from those that we predicted. All forward-looking statements are based on information available to us on the date hereof, and we assume no obligation to update forward-looking statements, except as required by Federal Securities laws.
Natus® and other trademarks of ours appearing in this report are the intellectual property of Natus Medical Incorporated or one of its subsidiaries.
Overview
Natus provides innovative healthcare solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.
Our broad product portfolio represents a heritage of innovation and leadership. Natus brands have been setting the standard for patient care for over eighty (80) years. Our products are trusted by medical professionals in university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and other sites around the world. Improving quality of human life is at the core of our business.
We use our clinical expertise to support our customers' evolving needs with advanced products, continuing education and outstanding technical service. 
Natus provides product solutions for three end markets: Neuro, Newborn Care and Hearing & Balance.
Markets
Neuro — Includes products and services that provide diagnostic, therapeutic and surgical solutions in neurodiagnostics, neurocritical care and neurosurgery. Neuro's comprehensive neurodiagnostic solutions include electroencephalography (“EEG”) and long-term monitoring (“LTM”), Intensive Care Unit (“ICU”) monitoring, electromyography (“EMG”), sleep analysis or polysomnography (“PSG”), and intraoperative monitoring (“IOM”). These solutions enhance the diagnosis of neurological conditions such as epilepsy, sleep disorders and neuromuscular diseases.
Our neurocritical care solutions include management of traumatic brain injury by continuous monitoring of intracranial pressure (“ICP”) and cerebrospinal fluid (“CSF”) drainage, as well as cranial access kits for entry into the cranium. Our neurosurgical solutions such as valves, shunts and related treatment solutions for procedures involving hydrocephalus, in addition to newly launched subdural electrodes for functional brain mapping. Neuro represents approximately 60% of total revenues.
Newborn Care — Includes products and services for newborn care including hearing screening, brain monitoring, eye imaging, jaundice management, live video streaming and various disposable newborn care supplies. These solutions provide important screening, diagnostic and treatment options for newborns in both the neonatal intensive care unit (“NICU”) and well-baby nursery. Newborn Care represents approximately 22% of total revenues.
Hearing & Balance — The Hearing portfolio includes products for hearing assessment and diagnostics, and hearing aid fitting, including computer-based audiological, otoneurologic and vestibular instrumentation for hearing care professionals. Our Balance portfolio provides diagnosis and assessment of vestibular and balance disorders. These solutions have a complete product and brand portfolio known for its sophisticated design technology in the hearing and balance assessment markets. Hearing & Balance represents approximately 18% of total revenues.
Neuro
1
Our Neuro portfolio is comprised of a comprehensive line of neurodiagnostic, neurocritical care, and neurosurgical products that are used by healthcare practitioners in the diagnosis and monitoring of neurological disorders. The environments in which these products are used include outpatient private practice facilities and inpatient hospital environments. Our products can be used throughout the continuum of care through diagnostic procedures and monitoring of patients during admissions, surgery, in post-operative care, and in intensive care units. Our Neuro products and services include:
Neurodiagnostic
•Electroencephalography — Equipment, supplies and services used to monitor and visually display the electrical activity generated by the brain and other key physiological signals for both diagnosis and monitoring of neurological disorders in the hospital, research laboratory, clinician office and patient’s home.
•Electromyography — Equipment and supplies used to measure electrical activity in nerves, muscles, and critical pathways includes EMG, nerve conduction and evoked potential functionality.
•Polysomnography — Equipment and supplies used to measure a variety of respiratory and physiologic functions to assist in the diagnosis and monitoring of sleep disorders, such as insomnia and obstructive sleep apnea.
•Intraoperative monitoring — Equipment and supplies used to monitor the functional integrity of certain neural structures (i.e. nerves, spinal cord and parts of the brain) during surgery. The goal of IOM is to provide real time guidance to the surgeon and anesthesiologist, which will reduce the risk to the patient during surgery.
Neurocritical Care
•Intracranial pressure monitoring and external ventricular drainage — Equipment and catheters used to monitor pressure in the cranium/brain and catheters to drain cerebrospinal fluid from the brain to aid in traumatic brain injury cases and hydrocephalus.
•Cranial access kits — Convenient, pre-packaged sterile sets containing all necessary components for entry into the cranium, to monitor intracranial pressure and provide temporary drainage of CSF.
Neurosurgery
•Shunts — Shunts are used to manage the drainage of cerebrospinal fluid from the brain to maintain appropriate levels of CSF when treating hydrocephalus.
•Subdural electrodes — Subdural electrodes are designed to integrate seamlessly with the Natus EEG equipment, simplifying the set up for functional brain mapping with minimal connections and cables.
Diagnostic EEG and Long-term Monitoring
We design, manufacture, and market a full line of instruments and supplies used to help diagnose the presence of seizure disorders and epilepsy, look for causes of confusion, evaluate head injuries, tumors, infections, degenerative diseases, and metabolic disturbances that affect the brain; and assist in surgical planning. This type of testing is also done to diagnose brain death in comatose patients. These systems and instruments work by detecting, amplifying, and recording the brain’s electrical impulses, as well as other physiological signals needed to support clinical findings. Routine clinical EEG recording is done by placing electrodes on a patient’s scalp over various areas of the brain to record and detect patterns of activity and specific types of electrical events. EEG technologists perform the tests, and neurologists, neurophysiologists and epileptologists review and interpret the results.
Routine outpatient clinical EEG testing is performed in hospital neurology laboratories, private physician offices, and in ambulatory settings such as the patient’s home, providing physicians with a clinical assessment of a patient’s condition. Long-term inpatient monitoring of EEG and video to monitor behavior (LTM) is used to determine complex treatment plans, and for patients with seizures that do not respond to conventional therapeutic approaches, surgical solutions may be appropriate. Patients suffering from severe head trauma and other acute conditions that may affect the brain are monitored in ICUs. In addition, research facilities use EEG equipment to conduct research on humans and laboratory animals.
Diagnostic Electroencephalograph Monitoring Product Lines
Our EEG diagnostic monitoring product lines for neurology consist of signal amplifiers, workstations to capture and store synchronized video and EEG data, and proprietary software. These products are typically used as part of an EEG “system” by the neurology/neurophysiology department of a hospital or clinic to assist in the diagnosis and monitoring of neurological conditions.
•NeuroWorks®; Nicolet®One.    Our EEG Systems include a broad range of products, from software licenses and ambulatory monitoring systems to advanced laboratory systems with multiple capabilities for EEG, ICU monitoring,
2
long-term monitoring of up to 256 channels, as well as nursing stations to monitor patients and physician review stations with quantitative EEG analysis capabilities.
•Stellate/Gotman Spike and Seizure; NicoletOne Trends.    Our proprietary spike and seizure detection algorithm detects, summarizes, and reports EEG events that save health-care professionals' time by increasing the speed and accuracy of interpretation. NicoletOne Trends provides a comprehensive set of EEG analysis algorithms that are used to generate compressed trends of large amounts of data to assist in the clinical evaluation and data review process.
•Proprietary Signal Amplifiers.    Our proprietary signal amplifiers function as the interface between the patient and the computer. The headbox connects electrodes attached to the patient’s head to our EEG monitoring systems.
•Nicolet Cortical Stimulator.    This product is our proprietary device that provides cortical stimulation to the brain during functional brain mapping either before or during surgery to help the surgeon protect the eloquent parts of the brain (parts of the brain that control speech, motor and sensory functionality). The device can be used as a standalone unit or with the fully integrated NicoletOne or NeuroWorks software that supports control of the device from the software, automated mapping and comprehensive report generation.
•Supplies.    We also manufacture and market a full line of proprietary EEG electrodes and other supplies used in the electroencephalography field.
Electrodiagnostic Monitoring
Our electrodiagnostic systems include electromyography (EMG), nerve conduction (“NCS”), and evoked potential (“EP”) functionality. EMG and NCS involve the measurement of electrical activity of muscles and nerves both at rest and during contraction. Measuring the electrical activity in muscles and nerves can help diagnose diseases of the peripheral, central nervous system or musculature system. An electromyogram is performed to determine if there is any disease present that affects muscle tissue, nerves, or the junctions between nerve and muscle (neuromuscular junctions). An electromyogram can also be used to diagnose the cause of weakness, paralysis, and muscle twitching, and is also used as a primary diagnosis for carpal tunnel syndrome, which is the most frequently encountered peripheral compressive neuropathy. EMG is also used for clinical applications of Botox to relieve muscle spasm and pain. We market both the clinical system and the needles used for these procedures.
Evoked brain potentials are elicited in response to a stimulus. These evoked potentials can come from the sensory pathways (such as hearing and visual) or from the motor pathways. An examination tests the integrity of these pathways including the associated area of the brain. Sophisticated amplifiers are required to recognize and average evoked potential EMG and NCS signals.
Electrodiagnostic Product Lines
•Dantec Keypoint®.    The Dantec Keypoint G-4 and Focus EMG and EP family of products features amplifiers, stimulators, and strong signal quality. The Keypoint G4 is used for advanced neurodiagnostic applications such as single fiber EMG, visual and auditory evoked potentials, and in routine nerve conduction studies. The Keypoint Focus system is also available in a portable laptop configuration.
•Dantec Clavis.    The Dantec Clavis device is a hand-held EMG stimulation device that provides muscle and nerve localization information to assist with medication and Botox injections. In conjunction with the Bo-ject® or Myoject hypodermic needle and electrodes, physicians can better localize the site of the injection.
•Nicolet EDX® family.    A hardware platform of amplifiers, base control units, stimulators and hand-held probes that are sold with Nicolet brand proprietary software. These mid- to high-end systems have full functionality, strong signal quality, and flexibility. They include EMG, NCS, EP’s, IOM and advanced data analysis features.
•Natus UltraPro.    With a newly globally launched hardware and software system, this entry level product with add on capabilities offers high quality data collection using the UltraPro S100 amplifier and the proprietary Natus Elite software.
•Supplies.    We also manufacture and market a full line of proprietary EMG needles and other supplies used in the electrodiagnostic field.
Diagnostic Polysomnography Monitoring
Polysomnography (“PSG”), which involves the analysis of respiratory patterns, brain electrical activity and other physiological data, has proven critical for the diagnosis and treatment of sleep-related diseases such as apnea, insomnia, and narcolepsy. A full polysomnographic sleep study entails a whole-night recording of brain electrical activity, muscle movement, airflow, respiratory effort, oxygen levels, electrical activity of the heart, and other parameters. In some studies, patients are
3
fitted with treatment devices using Positive Airway Pressure technology (“PAP”) during the sleep study and the proper settings for the treatment devices are determined. In many cases, the sleep study is performed in the patient’s home.
Diagnostic PSG Monitoring Product Lines
We market dedicated diagnostic PSG monitoring products that can be used individually or as part of a networked system for overnight sleep studies to assist in the diagnosis of sleep disorders. Additionally, we offer products that are specifically designed to be used in the patient’s home. Some of our EEG systems described above can also be configured to perform diagnostic PSG monitoring. These products include software licenses, ambulatory monitoring systems, and laboratory systems that combine multiple capabilities, including EEG monitoring, physician review stations, and quantitative PSG analysis capabilities.
•Embla REMlogic, Sandman®; and Xltek SleepWorks®.    Our diagnostic PSG systems capture and store all data digitally. The systems enable users to specify rules and personal preferences to be used during analysis, summarizing the results graphically and incorporating them in detailed reports.
•Proprietary Amplifiers.    Our data acquisition systems incorporate recent developments in superior amplifiers for sleep analysis. Our amplifiers are used in both hospitals and stand-alone clinics. In addition to exceptional signal quality, headboxes include various tools such as built-in oximeters and controls to allow the user to start and stop a study or perform electrode impedance testing either at the patient’s bedside or from the monitoring room.
•Supplies.    We also market a broad line of supplies, disposable products and accessories for the PSG laboratory including the XactTrace® respiratory monitoring belts.
Intraoperative Monitoring
Intraoperative monitoring (“IOM”) is the use of electrophysiological methods such as EEG, EMG, and evoked potentials to monitor the functional integrity of certain neural structures (i.e. nerves, spinal cord and parts of the brain) during surgery. The purpose of IOM is to reduce the risk to the patient’s nervous system, and/or to provide functional guidance to the surgeon and anesthesiologist during surgery.
Diagnostic IOM Product Lines
The Nicolet EDX combo systems are used in IOM applications where a smaller number of channels is sufficient. This approach is primarily followed in international markets that utilize the integrated system approach that allows for the use of the system in EMG clinical applications as well as in IOM applications.
Neurocritical Care Products
Intracranial pressure and temperature provide insight into the health of the brain, especially in patients experiencing a traumatic brain injury, other traumatic, ischemic or hemorrhagic incidents, or a major neurosurgical procedure. A small hole is drilled into the cranium to allow insertion of a catheter that contains a pressure/temperature or pressure only transducer that allows continuous monitoring of brain temperature and/or pressure.
•Camino® ICP Monitor. The Camino ICP Monitor is a compact, portable device that provides tools for continuously determining and monitoring intracranial pressure and intracranial temperature. It has a touch screen interface, physiological alarms, and can output data to either a patient bedside monitor or to remote media types via a USB drive. These systems are used in the intensive care unit (ICU) environment.
•Camino Catheters. Camino catheters use either fiber optic or strain gauge technology to measure either pressure and temperature or just pressure. Camino catheters measure their respective values at the tip of the catheter, which eliminates the need for a fluid-filled system that uses an external transducer to measure pressure. The Camino Flex Ventricular Intracranial Pressure Monitoring Kit has a catheter that allows both the measurement of ICP and CSF drainage.
•Natus EDS 3®. The EDS 3 is a CSF External Drainage System used to manage increased ICP by safely eliminating CSF from the ventricles of the brain or lumbar spine. This drainage can be performed continuously or intermittently. Clinical conditions that may require its use include trauma, stroke or an expansile lesion.
•Cranial Access Kits. Cranial Access Kits are convenient procedural kits that include all the instrumentation and items needed to access the subarachnoid space or the lateral ventricles of the brain. The kit is intended to be used with an external drainage and monitoring system in selected patients to reduce intracranial pressure, to provide temporary drainage of CSF, and to monitor ICP. The kit is a convenient, pre-packaged sterile set containing all necessary components for entry into the cranium and is available with or without drugs and with a variety of drill bits and instrumentation.
Neurosurgical Products
4
Brain surgery is performed to place shunts in the brain to help drain excess CSF either into the body for reabsorption to help treat hydrocephalus or to place subdural electrodes for functional brain mapping.
•Shunts. Shunts are used in the operating room to provide solutions for hydrocephalus or brain trauma. Shunts are used to manage the drainage of cerebrospinal fluid from the brain to maintain appropriate levels of CSF when treating hydrocephalus.
•XactTrode™ Subdural Electrodes. Subdural strip and grid electrodes are used for epilepsy surgical monitoring and brain mapping. The XactTrode portfolio of electrodes are designed to integrate seamlessly with Natus amplifiers and provide increased patient comfort with fewer connections and cables.
Newborn Care
Our newborn care products and services are used by healthcare practitioners in the diagnosis and treatment of common medical ailments in newborn care. Our products are organized in eight modalities and include:
•Newborn Hearing Screening — Products used to screen hearing in newborns.
•Jaundice Management — Products used to treat jaundice, the single largest cause for hospital readmission of newborns in the U.S.
•Newborn Brain Injury — Products used to diagnose the severity of brain injury, monitor the effectiveness of drug therapies, detect seizure activity and monitor general neurological status.
•Eye Imaging — Systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging.
•Essentials — Products used in the everyday operation of NICU and well-baby nursery department within the hospital environment.
•NICVIEW® — Live streaming video for families with babies in the NICU that enables family members and approved friends to see the new baby, 24/7, from anywhere in the world - from any Internet connected device, within a secured environment.
Newborn Hearing Screening
Hearing impairment is the most common treatable chronic disorder in newborns, affecting as many as five babies out of every 1,000 newborns. It is estimated that 20,000 hearing-impaired babies are born in the United States (“U.S.”) every year, and as many as 60,000 more in the rest of the developed world. Until the introduction of newborn hearing screening programs, screening was generally performed only on those newborns that had identifiable risk factors for hearing impairment. However, screening only those newborns with risk factors for hearing impairment overlooks approximately half of newborns with some level of hearing impairment.
Early identification of hearing impairment and early intervention has been shown to improve language development significantly. Undetected hearing impairment often results in the failure to learn, process spoken language, and speak.
Newborn Hearing Screening Techniques
The two traditional technologies used to screen newborns and infants for hearing impairment are auditory brainstem response and otoacoustic emissions.
Auditory brainstem response (“ABR”).    ABR technology is the most accurate and comprehensive method for screening and diagnosing hearing impairment. ABR technology is based on detecting the brain’s electrical impulses resulting from a specific auditory stimulus.
Otoacoustic emission (“OAE”).    OAEs are sounds created by the active biomechanical processes within the sensory cells of the cochlea. They occur both spontaneously and in response to acoustic stimuli. OAE screening uses a probe placed in the ear canal to deliver auditory stimuli and to measure the response of the sensory cells with a sensitive microphone.
Newborn Hearing Screening Product Lines
Our newborn hearing screening product lines consist of the ALGO®, ABaer®, AuDX®, and Echo-Screen® newborn hearing screeners. These hearing screening products utilize proprietary signal detection technologies to provide accurate and non-invasive hearing screening for newborns and are designed to detect hearing loss at 30 or 35 dB nHL or higher. Each of these devices is designed to generate a PASS or REFER result.
•ALGO® 5 and 3i Newborn Hearing Screeners.    These Automated Auditory Brainstem Responses (“AABR”®) devices deliver thousands of soft audible clicks to the newborn’s ears through sound cables and disposable earphones connected to the instrument. Each click elicits an identifiable brain wave, which is detected by disposable
5
electrodes placed on the head of the child and analyzed by the screening device. These devices use our proprietary AABR signal detection algorithm.
•ALGO® 7i.    The ALGO® 7i continues the Natus tradition of advancing standards in patient care, combining industry-leading performance with enhanced usability and taking AABR hearing screening to the next level. The ALGO 7i incorporates proven ALGO AABR® technology. The icon-driven interface intuitively guides users through each step of the screening process.
•ABaer Newborn Hearing Screener.    The ABaer, which is a PC-based newborn hearing screening device, offers a combination of AABR, OAE, and diagnostic ABR technologies in one system.
•Echo-Screen.    Our hand-held Echo-Screen products provide a choice or combination of proprietary ABR and OAE technologies that can also be used for children through adults. The Echo-Screen III device is a compact, multi-modality handheld hearing screener that is tightly integrated with audible Lite Hearing Screening Data Management.
Hearing Screening Supply Products
For infection control, accuracy, and ease of use, the supply products used with our newborn hearing screening devices are designed as single-use, disposable products. Each screening supply product is designed for a specific hearing screening technology.
•ABR Screening Supply Kits.    Each ABR screen is carried out with single-use earphones and electrodes, which are alcohol and latex-free. The adhesives used in these supply products are specially formulated for use on the sensitive skin of newborns. To meet the needs of our customers we offer a variety of packaging options. Echo-Screen and ABaer offer the choice of either an earphone or use of ear tips for perform ABR screening.
•OAE Supply Products.    Each OAE screen is carried out with single-use ear tips that are supplied in a variety of sizes and packaging options.
Jaundice Management
The American Academy of Pediatrics estimates that each year 60% of the approximately three and a half million newborns in the U.S. become jaundiced. According to the Journal of the American Medical Association, neonatal jaundice is the single largest cause for hospital readmission of newborns in the U.S., and accounts for approximately 50% of readmissions. Because of the serious consequences of hyperbilirubinemia, the American Academy of Pediatrics recommends that all newborns be closely monitored for jaundice and that phototherapy is the standard of care for the treatment of hyperbilirubinemia. The guidelines further recommend that all nurseries have the necessary equipment to provide intensive phototherapy, and specifically recommend the use of the “blue” light as incorporated into our neoBLUE® products.
Jaundice Management Products
•neoBLUE Product Family.    This product line consists of our neoBLUE Overhead, neoBLUE Compact and neoBLUE blanket devices, which utilize light emitting diodes (“LEDs”) to generate a high-intensity, narrow spectrum of blue light that is clinically proven to be most effective in the treatment of newborn jaundice. Our neoBLUE phototherapy devices emit significantly less ultraviolet light and heat than conventional phototherapy devices, reducing the risk of skin damage and dehydration for infants undergoing treatment. Because of the high intensity of these lights, the treatment time associated with phototherapy is reduced.
Newborn Brain Injury
For many years, newborn infants admitted to the NICU of a hospital have been routinely monitored for heart activity, temperature, respiration, oxygen saturation, and blood pressure. Recently it has also been considered important to monitor brain activity. A cerebral function monitor, utilizing amplitude-integrated EEGs (“aEEGs”), is a device for monitoring background neurological activity. Our simplified aEEG devices, introduced over ten years ago, are designed to be simple for use by nurses and neonatologists.
Newborn Brain Injury Products
Our newborn brain injury products record and display parameters that the neonatologist uses to assess and monitor neurological status in the newborn. These devices continuously monitor and record brain activity, aiding in the detection and treatment of hypoxic-ischemic encephalopathy (“HIE”), and seizures. The devices also monitor the effects of drugs and other therapies on brain activity and improve the accuracy of newborn neurological assessments. They are used with electrodes attached to the head of the newborn to acquire an EEG signal that is then filtered, compressed, and displayed graphically on the
6
device or as a hardcopy printout. The monitors have touch screens for easy navigation and onscreen keyboards for data entry at the bedside.
•Olympic Brainz Monitor.    The Olympic Brainz Monitor is our latest generation Cerebral Function Monitor. The device can be used in single-channel, two-channel or three-channel modes to continuously monitor and record brain activity.
Eye Imaging
Our RetCam® devices incorporate a camera combined with proprietary imaging software that are used to diagnose and monitor a range of ophthalmic maladies in premature infants. RetCam specializes in NICU ophthalmic imaging used in the detection of retinopathy of prematurity (“ROP”) and Retinoblastoma (“RB”) in newborns. ROP and RB are diseases of the retina that must be detected very early after birth and treated immediately, so the RetCam diagnostic camera is a fundamental tool in preventing vision loss and total blindness in infants.
Eye Imaging Products
RetCam images assist physicians in the evaluation of pediatric ocular disease, which have preserved the vision in thousands of infants. Each of the RetCam systems deliver objective and interpretable detail, allow image comparison over time, enable remote consultations, and provide reliable and defensible medico-legal documentation.
•RetCam Envision. The RetCam Envision is a contact type wide-field fundus ophthalmic imaging system used for general ophthalmic, imaging including retinal, corneal, and external imaging. Photo documentation of pediatric ocular diseases, including ROP, are included. The RetCam Envision brings patented Light Shaping Technology that delivers uniform illumination and focus throughout the entire 130 degree field of view.
•RetCam 3. Full-featured imaging systems with a range of interchangeable lenses, Fluorescein Angiography module option.
•RetCam Shuttle. Laptop-based system with a smaller cart and dual wheel casters for improved transportability.
•RetCam Portable. Laptop-based version in a case for maximum portability.
•RetCam DataLink. Cloud-based image review solution that enables anytime, anywhere access to time sensitive image data for rapid review and interpretation. DataLink enables seamless integration with electronic medical records enabling capturing orders, image review and sharing results.
Essentials
The Newborn Care Essentials products include such items as: Biliband® eye protectors, MiniMuffs® noise attenuators, NeatNick® heal lancets, Olympic Circumstraint, Olympic Papoose Boards, Olympic Smart Scales®, OraSwab, Save the Gonads x-ray protection devices and SugarPlum glucose lancets.
Live Video Streaming
Live video streaming offers parents and families secured access to a live video stream of their baby. For hospitals, the system offers a step into family centered care.
Live Video Steaming Products
NICVIEW 2 is a user-friendly, web-based video systems for real-time streaming on any online device via a standard downloadable app. Password-protected access ensures parents can view only their own child, with end-to-end encryption and SSL authentication. The video stream can be turned on/off and repositioned at will, so that NICU staff remain in control of the care process at all times.
Hearing & Balance
Our Hearing & Balance product portfolio provides hearing diagnostic, hearing aid fitting and balance instrumentation and software solutions to hearing and balance care professionals worldwide. For more than 50 years, we have helped hearing and balance care professionals succeed in improving the quality of life for their clients and patients by delivering expert knowledge, reliable solutions and services and trusted partnerships. We will continue this tradition and legacy as we develop, manufacture and market computer-based audiological, otoneurologic and vestibular instrumentation in the future.
    Our solutions portfolio covers key application areas within hearing assessment, hearing screening, hearing instrument fitting and balance assessment. Many of our hearing and balance care solutions have set precedent within the hearing care industry and are used by thousands of clinicians around the world.
As an independent provider of hearing care diagnostic solutions, we work closely with leading hearing aid manufacturers to develop new solutions within hearing assessment and hearing aid fitting.
7
Hearing Assessment
From otoacoustic emissions (OAE) and immittance screening to advanced audiological testing and 3D digital ear scanning, we offer a wide range of flexible devices and PC-based solutions that are designed to screen, test and assess patients of all ages. Our hearing assessment solutions offer a range of functionality to support basic audiometric testing to advanced tinnitus and pediatric hearing assessment. Our hearing care solutions help streamline the hearing screening and assessment process making it easier and convenient for the professional and the patient. We also manufacture and market a broad line of supplies and disposable products and accessories for hearing assessment.
Hearing Instrument Fitting and Verification
Hearing fitting solutions help professionals manage the entire hearing aid fitting process - from fitting and verifying the hearing aid to patient counseling and follow up. Used by hearing aid dispensers, audiologists and clinicians around the world, our fitting solutions support otoscopy, audiometry, hearing aid testing and programming, fitting and verification with wireless design and binaural fitting capability. Our fitting solutions are PC-based and supported by integrated audiometric software that helps to streamline the fitting process for greater efficiency and patient satisfaction. We also manufacturer and market a broad line of supplies and disposable products and accessories for hearing instrument fitting and verification.
3D Digital Ear Scanning
Hearing assessment solutions include the breakthrough 3D digital ear scanning solutions Otoscan® that gives hearing care professionals innovative ways to attract and convert more clients while delivering customized hearing care in an efficient way. Otoscan enables hearing care professionals to make digital impressions for custom in-the-ear pieces such as earmolds and hearing aids. The scanner solution applies breakthrough technology to transform images of the ear into 3D digital files that are uploaded to the cloud service, Otocloud®, for immediate use in production of custom products, delivering significant efficiency and quality gains in the production of hearing aids. Otocloud is a web-based portal supported by a dedicated Microsoft Azure server domain.
Balance Assessment
Professionals who evaluate patients with balance disorders use our vestibular diagnostic and ENG/VNG (electronystagmography/videonystagmography) systems and services. These solutions are used by audiologists, otolaryngologists, otologists and neurologists for identifying auditory and vestibular abnormalities. Our balance care solutions are compact and include the world's first portable, gold standard video head impulse test (“vHIT”) and offer modular functionality to support vHIT, video frenzel, positional, oculomotor and SHIMP (suppression head impulse) testing. We also manufacture and market a broad line of supplies, disposable face cushions, and accessories for balance assessment.

Segment and Geographic Information
We determine our reportable segments by first identifying our operating segments, and then by assessing whether any components of these segments constitute a business for which discrete financial information is available and where segment management regularly reviews the operating results of that component. Prior to 2019, our operating segments were based on three strategic business units. Since then, we transitioned from an operating structure of three strategic business units to a single, unified company with globally led operational teams in Sales and Marketing, Manufacturing, Research and Development, Quality, and General and Administrative functions.
We operate as one operating segment and one reportable segment, which provides healthcare products, and services focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. Financial information is reviewed on a consolidated basis for purposes of making operating decisions and assessing financial performance. Consolidated financial information is accompanied by disaggregated information about revenues by end market and geographic region. We do not assess the performance of our end markets or geographic regions on measures of profit or loss, or asset-based metrics. We have disclosed the revenues for each of our end markets and geographic regions to provide the reader of the financial statements transparency into our operations.
Information regarding our revenues and long-lived assets in the U.S. and in countries outside the U.S. is contained in Note 19—Segment, Customer and Geographic Information of our Consolidated Financial Statements included in this report and is incorporated in this section by this reference.
Revenue by Product Market and Product Category
8
For the years ended December 31, 2021, 2020 and 2019, revenue from our product markets as a percent of total revenue was approximately as follows:
 Year Ended December 31,
 202120202019
Neuro60 %57 %58 %
Newborn Care22 %25 %22 %
Hearing & Balance18 %18 %20 %
Total100 %100 %100 %
We also look at revenue as either being generated from sales of Devices and Systems, which are generally non-recurring, or related Supplies and Services, which are generally recurring. The products that are attributable to these categories are described above. Revenue from Devices and Systems, Supplies and Services as a percent of total revenue for the years ending December 31, 2021, 2020 and 2019 is as follows:
 Year Ended December 31,
 202120202019
Devices and Systems75 %73 %74 %
Supplies22 %23 %22 %
Services3 %4 %4 %
Total100 %100 %100 %
In 2021, 2020 and 2019, no single end-user customer comprised more than 10% of our revenue.
Backlog
In general, we do not manufacture our products against a backlog of orders and do not consider backlog to be a significant indicator of the level of annual future sales activity. Production and inventory levels are based on the level of incoming orders as well as projections of future demand. Therefore, we believe that backlog information is not meaningful to understanding our overall business and should not be considered a reliable indicator of our ability to achieve any particular level of revenue or financial performance.
Marketing and Sales
Marketing
Our marketing strategies differ by product market, incorporating market dynamics, trends and competition in the positioning, promotion and pricing of each product. The value proposition that we communicate is focused on the quality, clinical performance, and customer benefit. We invest in educating our customers worldwide about our products through trade conferences and direct presentations to healthcare professionals.
Domestic Direct and Distributor Sales
We sell our products in North America primarily through a direct sales organization. We believe this direct sales organization allows us to maintain a higher level of customer service and satisfaction than would otherwise be possible by other distribution methods. We also sell certain products under private label and distribution arrangements.
For the years ended December 31, 2021, 2020 and 2019, domestic revenue as a percent of total revenue was approximately as follows:
 Year Ended December 31,
 202120202019
Domestic revenue60.4 %60.7 %59.0 %
9
International Direct and Distributor Sales
We sell some of our products outside the U.S. through direct sales channels in Australia, Canada, China, Denmark, France, Germany, Italy, the Netherlands, New Zealand, the Nordics (Finland, Sweden, Norway), Spain, and the United Kingdom; we sell other products in those regions and into more than 100 other countries through a distributor sales channel.
    For the years ended December 31, 2021, 2020 and 2019, international revenue as a percent of total revenue was approximately as follows:
 Year Ended December 31,
 202120202019
International revenue39.6 %39.3 %41.0 %
We sell products to our distributors under substantially the same terms as sales through our direct sales channels. Terms of sales to international distributors are generally “ex works,” where title and risk of loss are assumed by the distributor at the shipping point. Distributors are generally given exclusive rights in their territories to purchase products from Natus and to resell to end users or sub-distributors in their respective markets. Our distributors typically perform marketing, sales, and technical support functions in their respective markets. Each distributor may sell Natus products to their customer directly, via other distributors or resellers, or both. We actively train our distributors in product marketing, selling, and technical service techniques.
Seasonality in Revenue
We experience seasonality in our revenue. Demand for our products is historically higher in the second half of the year compared to the first. Our seasonality results from the purchasing habits of our hospital-based customers, whose purchases are often governed by calendar year budgets.
Group Purchasing Organizations
More than 90% of the hospitals in the U.S. are members of group purchasing organizations (“GPO”s), which negotiate volume purchase agreements for member hospitals, group practices, and other clinics.
For the years ended December 31, 2021, 2020 and 2019, revenue from direct purchases under a GPO contract as a percent of total revenue was approximately as follows:
 Year Ended December 31,
 202120202019
Direct purchases by GPO members23.6 %22.5 %18.7 %

Third-Party Reimbursement
In the U.S., healthcare providers generally rely on third-party payors, including private health insurance plans, federal Medicare, state Medicaid, and managed care organizations, to reimburse all or part of the cost of the procedures they perform. Third-party payors can affect the pricing or the relative attractiveness of our products by regulating the maximum amount of reimbursement these payors provide for services utilizing our products.
Customer Service and Support
We generally provide a one-year warranty on our medical device and system products. We also sell extended service agreements on our medical device and system products. Service, repair, and calibration services for our domestic customers are provided by Company-owned service centers and our field service specialists. Service for international customers is provided by a combination of Company-owned facilities and vendors on a contract basis.
Manufacturing
We procure a significant portion of the components used in our products from other manufacturers; however, we perform final assembly, testing, and packaging of many of the devices ourselves to control quality and manufacturing efficiency and we are the manufacturer of record. We also use contract manufacturers to manufacture some of our disposable supply and medical device products. We perform regular quality assessments of these contract manufacturers, which include on-site quality audits.
We purchase materials and components from qualified suppliers that are subject to our quality specifications and inspections. We conduct quality audits of our key suppliers, several of which are experienced in the supply of components to manufacturers of finished medical devices or supplies for use with medical devices. Most of our purchased components are available from more than one supplier.
10
Our manufacturing, service, and repair facilities are subject to periodic inspection by local and foreign regulatory authorities. Our quality assurance system is subject to regulation by the U.S. Food and Drug Administration (“FDA”) and other government agencies. We are required to conduct our product design, testing, manufacturing, and control activities in conformance with the FDA’s quality system regulations and to maintain our documentation of these activities in a prescribed manner. In addition, our production facilities have received International Organization for Standardization (“ISO”) 13485 certification. ISO 13485 certification standards for quality operations have been developed to ensure that medical device companies meet the standards of quality on a worldwide basis. We have also received the EC Certificate pursuant to the European Union Medical Device Directive 93/42/EEC, which allows us to place a CE mark on our products.
Research and Development
We are committed to introducing new products and supporting current product offerings in our markets through a combination of internal as well as external efforts that are consistent with our corporate strategy.
Internal product development capabilities.    We believe the ability to develop innovative products is essential to providing our customers with new product offerings. We plan to leverage our core technologies by introducing product line extensions as well as new product offerings.
Partnerships that complement our expertise. We continue to seek strategic partners in order to develop products that may not otherwise be available to us. By taking advantage of our core competencies, we believe that we can bring acquired or distributed products to market in an efficient manner and leverage our distribution channels.
New opportunities through technology acquisition. We continue to evaluate new, emerging, and complementary technologies in order to identify new product opportunities. With our knowledge of our current markets, we believe that we can effectively develop acquired technologies into successful new products.
Proprietary Rights
We protect our intellectual property through a combination of patent, copyright, trade secret, and trademark laws. We attempt to protect our intellectual property rights by filing patent applications for new features and products we develop. We enter into confidentiality or license agreements with our employees, consultants, and corporate partners, and seek to control access to our intellectual property, distribution channels, documentation, and other proprietary information. However, we believe that these measures afford only limited protection.
The intellectual rights to some of the original patents for technology incorporated into our products are now in the public domain. However, we do not consider these patents, or any currently viable patent or related group of patents, to be of such importance that their expiration or termination would materially affect our business.
We capitalize the cost of purchased technology and intellectual property, as well as certain costs incurred in obtaining patent rights, and amortize these costs over the estimated economic lives of the related assets.
We have numerous registered trademarks and service marks. Our marks are pending or registered trademarks in the United States and several foreign countries. We intend to file for additional trademarks to strengthen our trademark rights, but we cannot be certain that our trademark applications will result in registration or that our trademarks will be enforceable.
Competition
We sell our products in competitive and rapidly evolving markets. We face competition from other companies in all of our product lines. Our competitors range from small privately-held companies to multinational corporations and their product offerings vary in scope and breadth. We do not believe that any single competitor is dominant in any of our product lines.
We derive a significant portion of our revenue from the sale of disposable supplies that are used with our medical devices. In the U.S., we sell our supply products in a mature market and we expect that our products could face increasing competition, including competitors offering lower prices, which could have an adverse effect on our revenue and profit margins.
We believe the principal factors that will draw clinicians and other buyers to our products, include:
•The clinical performance of our products including the level of specificity, sensitivity, and reliability of the product;
•Time required to obtain results with the product, such as to test for or treat a clinical condition;
•Relative ease of use of the product;
•Our level of expertise in these fields which produces the depth and breadth of the products features;
•Quality of customer support for the product;
•Internet connectivity and cyber-security of the product;
11
•Frequency of product updates;
•Extent of third-party reimbursement of the cost of the product or procedure;
•Extent to which the products conform to standard of care guidelines; and
•Price of the product.
We believe that our primary competitive strength relates to the clinical functionality and reliability of our products.
Government Regulation
FDA’s Premarket Clearance and Approval Requirements
Unless an exemption applies, the medical devices we sell in the United States, must first receive one of the following types of FDA premarket review authorizations under the Food, Drug, and Cosmetics Act, as amended:
•Clearance via Section 510(k); or
•Premarket approval via Section 515 if the FDA has determined that the medical device in question poses a greater risk of injury.
FDA review-time goal for 510(k) applications are 90 days, but clearance may take longer. The process of obtaining premarket approval via Section 515 is much more costly, lengthy, and uncertain. FDA review-time goal for premarket approval applications are 320 days, but approval may take longer. We cannot be sure that the FDA will ever grant either 510(k) clearance or premarket approval for any product we propose to market in the United States.
The FDA decides whether a device must undergo either the 510(k) clearance or premarket approval process based upon statutory criteria. These criteria include the level of risk that the FDA perceives to be associated with the device and a determination of whether the product is a type of device that is substantially equivalent to devices that are already legally marketed. The FDA places devices deemed to pose relatively less risk in either Class I or Class II, which requires the manufacturer to submit a premarket notification requesting 510(k) clearance, unless an exemption applies. The premarket notification under Section 510(k) must demonstrate that the proposed device is substantially equivalent in intended use and in safety and effectiveness to a previously cleared 510(k) device or a device that was in commercial distribution before May 28, 1976 for which the FDA has not yet called for the submission of premarket approval applications.
The FDA places devices deemed to pose the greatest risk, such as life-sustaining, life-supporting or implantable devices, or devices deemed to be not substantially equivalent to a predicate device, in its Class III classification. The FDA requires these devices to undergo the premarket approval process via Section 515 in which the manufacturer must prove the safety and effectiveness of the device. A premarket approval application must provide extensive pre-clinical and clinical trial data.
The FDA may require results of clinical trials in support of a 510(k) submission and generally requires clinical trial results for a premarket approval application. In order to conduct a clinical trial on a significant-risk device, the FDA requires manufacturers to apply for and obtain, in advance, an investigational-device exemption. The investigational-device exemption application must be supported by appropriate data, such as animal and laboratory testing results. If the FDA and the Institutional Review Boards at the clinical trial sites approve the investigational-device exemption application for a significant-risk device, the manufacturer may begin the clinical trial. An investigational-device exemption approval provides for a specified clinical protocol, including the number of patients and study sites. If the manufacturer deems the product a non-significant risk device, the product will be eligible for more abbreviated investigational-device exemption requirements. If the Institutional Review Boards at the clinical trial sites concur with the non-significant risk determination, the manufacturer may begin the clinical trial.
Most of our products have been cleared by the FDA as Class II devices.
FDA Regulation
Numerous FDA regulatory requirements apply to our products. These requirements include:
•FDA quality system regulations which require manufacturers to create, implement, and follow design, testing, control, documentation, and other quality assurance procedures;
•Medical device reporting regulations, which require that manufacturers report to the FDA certain types of adverse and other events involving their products; and
•FDA general prohibitions against promoting products for unapproved uses.
Class II and III devices may also be subject to special controls applied to them, such as performance standards, post-market surveillance, patient registries, and FDA guidelines that may not apply to Class I devices. We believe we are in
12
compliance with applicable FDA guidelines, but we could be required to change our compliance activities or be subject to other special controls if the FDA changes existing regulations or adopts new requirements.
We are subject to inspection and market surveillance by the FDA to determine compliance with regulatory requirements. If the FDA finds that we have failed to adequately comply, the FDA can institute a wide variety of enforcement actions, including:
•Issuance of a Form 483 citation;
•Fines, injunctions, and civil penalties;
•Recall or seizure of our products;
•Issuance of public notices or warnings;
•Imposition of operating restrictions, partial suspension, or total shutdown of production;
•Refusal of our requests for 510(k) clearance or pre-market approval of new products;
•Withdrawal of 510(k) clearance or pre-market approval already granted; or
•Criminal prosecution.
The FDA also has the authority to require us to repair or replace any misbranded or adulterated medical device manufactured or distributed by us.
Other Regulations
We also must comply with numerous additional federal, state, and local laws relating to matters such as safe working conditions, manufacturing practices, environmental protection, biohazards, fire hazard control, and hazardous substance disposal. We believe we are currently in compliance with such regulations.
Countries outside of the U.S. regulate medical devices in a manner similar to that of the FDA. Our manufacturing facilities are subject to audit and have been certified to be ISO 13485:2016, Medical Device Directive 93/42/EEC, and MDSAP compliant, which allows us to sell our products in Europe, Canada, and other territories around the world. All of our manufacturing facilities are subject to inspection by our notified bodies or other competent authorities, and in some cases without advance notice. We plan to seek approval to sell our products in additional countries, while maintaining our current approvals. The time and cost of obtaining new, and maintaining existing, market authorizations from countries outside of North America, and the requirements for licensing products in these countries may differ significantly from FDA requirements.
In 2017, the European Union (“EU”) adopted the EU Medical Device Regulation (Council Regulations 2017/745) which imposes stricter requirements for the marketing and sale of medical devices, including new quality system and post-market surveillance requirements. The regulation has a three-year implementation period that has now been extended to May 2021 and will replace the existing directives on medical devices in the EU. After May 2021, medical devices marketed in the EU require certification according to these new requirements, except that devices with valid CE certificates, issued pursuant to the Medical Device Directive before May 2021, may be placed on the market until 2024. Complying with this new regulation requires us to incur significant costs on product design history file transition. Failure to meet the requirements of the regulation could adversely impact our business in the European Union and other countries that utilize or rely on European Union requirements for medical device registrations.
Human Capital
Overview
Our Natus Pledge to our Teammates is to create a safe and secure (physical, psychological, financial, and social) environment where each Teammate feels they belong and have the resources and training to respond to the needs of our customers, the quality of life to grow as a person and professional, and time for family, health, and their community.
Workforce Demographics
As of December 31, 2021, we are a workforce of approximately 1,400 full-time Teammates, with about 50% of our Teammates located outside the United States.
We are organized by function, which breaks down as follows: Commercial with 692 Teammates (including Sales, Service & Marketing), Manufacturing Operations with 252 Teammates, Engineering with 173 Teammates, General and Administrative with 177 Teammates and Quality and Regulatory Affairs with 104 Teammates.
Our gender distribution of our Teammates is 34% women and 66% men. Our Teammates' average length of service is 8 years.
13
We experienced an increase in voluntary turnover in 2021 due to the effects of the global pandemic and other related factors, including more competitive demand for talent, low unemployment in core locations, increasing compensation expectations and more retirements than in previous years.
We formalized a flexible and remote work policy in 2021 to support our Teammates safety and well-being. Managers and Teammates were given tools, training and support to make a smooth transition to a more flexible work environment. Today our workforce is 28% flexible, 42% fully remote and 30% on-site as required by their role and/or preference. We believe this transition also opens additional and more diverse talent recruitment opportunities for Natus.
Teammate Engagement
We conduct a semi-annual engagement survey to collect feedback from our Teammates. In 2021, our engagement actions were focused on increasing communications, collaboration across our diverse and global organization, recognition and employee development.
Teammate feedback is also gathered through a variety of focus groups, onboarding and exit surveys and a diverse culture council to help support, retain and attract Teammates. We recognize that a culture of inclusion makes us stronger. Providing appropriate forums where Teammates globally can share ideas and feedback is an important component of our diversity and inclusion efforts.
We believe building a culture of appreciation starts with a simple thank you and acknowledgments, so we started a Peer Appreciation channel which has had hundreds of our Teammates recognizing one another from across the company, across the globe, across teams and functions.
Diversity, Inclusion and Belonging
Our commitment to a diverse and inclusive environment seeks to ensure our global teammates feel a sense of belonging, helping us to produce innovative products that serve our diverse customers and their patients. We know a diverse workforce also strengthens our ability to attract and retain talent who want to grow a career where their perspective is valued and encouraged.
We have an outreach program to recruit and promote our job opportunities to a broad range of organizations and hundreds of job boards with the intent of developing a diverse pool of qualified candidates.
We are committed to providing a work environment free of discrimination or harassment of any kind, supported by policies, training and communication. We have an open and robust support system for Teammates to address any issues, concerns or complaints. We provide management escalation paths, Human Resources support systems and a confidential ethics hotline that is monitored by the Corporate Compliance Officer and the Board of Directors. As part of our onboarding process, all Teammates must go through training on Natus Policies & Procedures and attest to our company Code of Conduct which outlines the standards for appropriate conduct and behavior.
Continuous learning and Development
We provide internal training to Teammates globally through our online learning platforms. In addition to our extensive quality and business process training, we provide comprehensive training resources to Teammates including an on-demand online learning system with over 7,000 courses to support skill building in a wide variety of areas from business, technical, leadership/management to personal productivity and wellness. Our Teammates each took an average of 20 hours of training in 2021.
Total rewards
Our global Total Rewards Philosophy is to establish and maintain total compensation programs that include competitive cash compensation for Teammates in all geographical regions where we operate, short and long-term incentives and comprehensive global health and welfare benefits that meet the varying needs of our Teammates. We added new mental, physical, family and financial wellness resources for Teammates in 2021 to cover a wide variety of personal needs and situations.
All Teammates (except those on commission) are eligible to participate in the corporate bonus program. Payment of the bonus is dependent upon financial and operating goals that our Teammates drive throughout the year.
In 2021, 95% of our Teammates received a merit salary increase based on performance. Our average salary increase was 3% with 6% of our population receiving a merit increase greater than 5%.
Health and safety
Protecting the safety, health, and well-being of our Teammates around the world is a key priority. Throughout the COVID-19 pandemic, we have remained focused on the health and safety of our Teammates by implementing new safety
14
protocols, providing personal protective equipment, increasing cleaning procedures and requiring the wearing of masks globally. In addition, we trained Teammates and increased communications, reconfigured our facilities to add space for physical distancing, implemented remote work where possible and enhanced our IT systems to facilitate working from home and improved cybersecurity.
We mandated the COVID-19 vaccine where permissible. We also anticipated the need for virus testing kits early on and secured a supply for our manufacturing sites and provided Teammates and their families with an onsite COVID-19 vaccination clinic at our largest manufacturing site.
Technology
Our HR Technology Roadmap was accelerated with more Teammates working remotely. In 2021, we implemented various technology enhancements like automation, standardization and increased security features to improve access, enhance the online experience and reduce risk in a globally distributed and often remote workforce.
Executives
The following table lists our executive officers and their ages as of February 25, 2022: 
NameAgePosition(s)
Thomas J. Sullivan58 President and Chief Executive Officer
B. Drew Davies56 Executive Vice President and Chief Financial Officer
D. Christopher Chung, M.D.
58 Vice President of Quality, Regulatory Affairs and Chief Medical Officer
Austin F. Noll, III
55 Executive Vice President and Chief Commercial Officer
Thomas J. Sullivan began serving as Chief Executive Officer on December 27, 2021, and has served as a member of the Board of Directors since February 2019. Prior to joining Natus, Mr. Sullivan was the President & Chief Executive Officer of Spectrum Plastics Group, a medical device global contract manufacturer. In earlier roles, he led multiple public and privately owned medical device companies including A&E Medical, Symmetry Surgical, and Symmetry Medical. In addition, Mr. Sullivan held numerous executive roles at Johnson & Johnson (“J&J”) from 1990 to 2011 including President of J&J Medical Products Canada and the U.S. Orthopedics division. Mr. Sullivan graduated as a Palmer Scholar from The Wharton School at the University of Pennsylvania in 1991 where he earned an MBA in Strategic Management and Information Technology. He also holds a Bachelor of Science magna cum laude in Applied Mathematics and Computer Science from the University of Pittsburgh. Mr. Sullivan has earned the National Association of Corporate Directors (NACD) Directorship Certification.
B. Drew Davies joined Natus as Executive Vice President and Chief Financial Officer in October 2018. Mr. Davies most recently served as Executive Vice President and Chief Financial Officer of Extreme Networks since June 2016. Before joining Natus, Mr. Davies served as Vice President and Corporate Controller at Marvell Semiconductor Inc. from December 2015 until May 2016. Prior to that, Mr. Davies was the Senior Vice President, Corporate Controller at Spansion, Inc. from August 2012 to December 2015. Prior to Spansion, Mr. Davies was Corporate Controller at Intersil Corporation from April 2009 to August 2012, and served as Operations Controller from March 2008 to April 2009. Mr. Davies also served as Chief Financial Officer of Nanoconduction, Inc. from March 2007 to March 2008, Director of Finance and Administration for STATSChipPac from September 1999 to March 2007, held various finance roles at Micron Custom Manufacturing Services from November 1992 to September 1999. Mr. Davies holds a Master of Business Administration degree from Santa Clara University and a Bachelor of Science, Business Accounting degree from the University of Idaho.
D. Christopher Chung, joined Natus in 2000 as the Medical Director. He has also served as Vice President of R&D and most recently since 2011 as Vice President Medical Affairs, Quality and Regulatory. From 2000 to 2007, Dr. Chung also served as a Pediatric Hospitalist at the California Pacific Medical Center in San Francisco providing patient care in the Neonatal Intensive Care Unit and Newborn Nursery. From 1997 to 2000, Dr. Chung trained as a pediatric resident at Boston Children’s Hospital and Harvard Medical School. From 1986 to 1993, Dr. Chung worked as an R&D engineer at Nellcor Incorporated, a medical device company that pioneered the development of pulse oximetry. Dr. Chung holds a Bachelor of Arts degree in Computer Mathematics from the University of Pennsylvania and a Doctor of Medicine degree from the Medical College of Pennsylvania-Hahnemann University School of Medicine. He is board certified in Pediatrics and is a Fellow of the American Academy of Pediatrics. Dr. Chung has also been awarded nine U.S. Patents in the medical device field.
Austin F. Noll, III currently Chief Commercial Officer, joined Natus in August 2012 as the Vice President and General Manager, Neuro. Prior to joining Natus, Mr. Noll served as the President and CEO of Simpirica Spine, a California-based start-up company that developed and commercialized a novel device for spinal stabilization. Prior to joining Simpirica Spine, Mr. Noll served as the President and CEO of NeoGuide Systems, a medical robotics company acquired by Intuitive Surgical. Prior to joining NeoGuide Systems, Mr. Noll held numerous management positions at Medtronic over a 13-year period, where he served as the Vice President and General Manager of the Powered Surgical Solutions and the Neurosurgery businesses.
15
Before Medtronic, he held sales positions at C.R. Bard and Baxter Healthcare. He received a Bachelor of Science degree in Business Administration from Miami University and a Master of Business Administration degree from the University of Michigan.
Other Information
Natus was incorporated in California in May 1987 and reincorporated in Delaware in August 2000.
We maintain corporate offices at 3150 Pleasant View Road, Middleton, WI 53562. Our telephone number is (608) 829-8500. We maintain a corporate website at www.natus.com. References to our website address do not constitute incorporation by reference of the information contained on the website, and the information contained on the website is not part of this document.
We make available, free of charge on our corporate website, copies of our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, Proxy Statements, and all amendments to these reports, as soon as reasonably practicable after such material is electronically filed with or furnished to the Securities and Exchange Commission pursuant to Section 13(a) or 15(d) of the Securities Exchange Act. We also show detail about stock trading by corporate insiders by providing access to SEC Forms 3, 4 and 5. This information may also be obtained from the SEC’s on-line database, which is located at www.sec.gov. Our common stock is traded on the Nasdaq Stock Market under the symbol “NTUS”.

Item 1A.    Risk Factors
Risks Related to the COVID-19 Pandemic
Our business has been and may continue to be negatively affected by the ongoing COVID-19 pandemic and any future outbreaks of disease.
Our operations and financial performance have and continue to be significantly affected by the ongoing global COVID-19 pandemic and the resulting volatility and uncertainty it has caused in the U.S. and international markets. Over the course of fiscal year 2021, national, state and local authorities have continued to recommend social distancing, vaccinations, wearing masks, and quarantining when individuals are feeling ill or recovering from the effects of COVID-19 in an effort to mitigate the spread of COVID-19. However, this virus has had adverse impacts on the U.S. and foreign economies of uncertain severity and duration and has and may continue to negatively impact our ongoing operations, including our revenue, manufacturing and supply chain. Spikes in the transmission of COVID-19 and other variant strains of the virus may lead to renewed or expanded shutdowns, curfews or other isolation measures and may result in further restriction on, and decreased demand for, elective medical procedures, which may adversely affect our business operations, financial position or consolidated cash flows.
In addition, we have experienced and may continue to see disruption and delays in parts of our direct and indirect supply chain. We have made investments in inventory to help mitigate against further potential supply chain interruptions. These investments include increased inventory and firm purchase orders beyond our typical timeframe in order to secure capacity at our key suppliers. We have experienced, and may continue to experience, increased costs as a result of excess inventory, which in turn has resulted, and may continue to result, in lower gross margins. In addition, our inventory management systems and related supply chain visibility tools were not designed to forecast manage supply of our products and product components under these unprecedented pandemic conditions, and as a result our forecasts could be inaccurate or our supply decisions could be incorrect. We may experience restricted stock availability or delays or difficulty sourcing certain products in the future, which could negatively impact us.
As a result of the ongoing COVID-19 pandemic, much of our workforce continues to operate under a temporary remote working model, which may result in us experiencing lower work efficiency and productivity, which in turn may adversely affect our business. As our employees work from home and access our systems remotely, we may be subject to heightened security and privacy risks, including the risks of cyberattacks and privacy incidents. Additionally, we have a number of employees who continue to work in our facilities or perform services at our customers' facilities who may be subject to heightened risks for COVID-19 exposure thus potentially impacting their health and future worker compensation claims against us. We may also be subject to lawsuits from employees and others exposed to COVID-19 at our facilities, which could involve large demands and substantial defense costs. Our cyber liability, professional liability, and commercial general liability insurance may not cover all claims against us. Furthermore, if any of our employees are unable to perform his or her duties for a period of time, including as the result of illness, our results of operations or financial condition could be adversely affected. Finally, the widespread pandemic has caused and is expected to continue to cause significant disruption of global financial markets, which may reduce or impair our ability to access capital, or access capital on terms that would be consistent with our expectations.
16
We cannot estimate the length or severity of the COVID-19 pandemic, including the potential for further mutation and the long-term efficacy of vaccines, or the related response, including the length of time it may take for normal economic and operating conditions to resume or the extent to which the disruption may materially impact our business, consolidated financial position, consolidated results of operations or consolidated cash flows. To the extent the COVID-19 pandemic continues to adversely affect our business, it may also have the effect of heightening many of the other risks described here within.
As we allow our employees more flexibility, our organizational culture may be subject to more complexity due to managing employees working at remote locations, working at our office locations, and working in a hybrid workforce model.
Our culture is a key contributor to our success as an organization. While we have begun voluntary phased re-openings in our offices in accordance with guidance provided by government agencies, a significant portion of our workforce have been working remotely and have continued to work in more remote and hybrid work environments. Although many of our employees can effectively perform their responsibilities while working remotely, some work is not well-suited for remote work, and that work may not be completed as efficiently as if it were performed on site. A long-term continuation of these restrictions could, among other things, negatively impact employee morale and productivity. Any failure to preserve our culture could harm our future success, including our ability to retain and recruit personnel, innovate and operate effectively and execute on our business strategy.
Risks Related to Our Manufacturing and Supply Chain
The ability of suppliers to deliver parts, components and manufacturing equipment to our manufacturing facilities, and our ability to manufacture without disruption, could affect our global business performance.
We source components and materials to manufacture our products from a limited number of suppliers, resulting in our product supply being subject to such suppliers' lead times, volume constraints and increasing costs. We have experienced, and may continue to experience, extended lead times and product unavailability due to factory disruptions or closures as well as delays and unanticipated costs associated with the supply of our products, including expedite fees and air freight charges to mitigate delays in product supply, particularly in light of the COVID-19 pandemic. We also expect continued shortages and/or delay of critical components and related services as a result of growing demand in the industry or other sectors. For example, the global semiconductor supply shortages have resulted, and may continue to result, in lower availability, longer lead times, increased prices for such components and increased competition for logistics services. Our supply chain operations span several geographies globally, and we are heavily dependent upon third party logistics and transportation services to deliver our products to customers. We have experienced, and expect to continue to experience, increased competition for and disruptions in logistics and transportation services due to transportation backlogs and labor shortages, which have resulted in longer lead times, increased prices, and surcharges and increased investments in critical components and higher overall costs to manage our supply chain logistics. Extended lead times and shortages could impair our ability to meet our customers' requirements, require us to pay higher prices or incur expedite fees, which would harm our business and negatively impact our gross margin and results of operations.
Adverse economic conditions in markets in which we operate may harm our business.
Unfavorable changes in U.S. and international economic environments may adversely affect our business and financial results. Concerns over the economic stability, the level of U.S. national debt, currency fluctuations and volatility, the growth of economies, unemployment, the availability and cost of credit, inflation levels, trade relations, energy costs and geopolitical uncertainty have contributed to increased volatility in the global economy and markets. During challenging economic times, and in tight credit markets, our customers may delay or reduce capital expenditures. This could result in reductions in sales of our products, longer sales cycles, difficulties in collection of accounts receivable, slower adoption of new technologies, and increased price competition, all of which could impact our results of operations and financial condition. In addition, if these factors are present they will cause us to be more cautious in evaluating potential acquisition opportunities, which could hinder our ability to grow through acquisition while conditions continue.
In addition, we are susceptible to risks related to natural disasters and the COVID-19 pandemic. In particular, the spread of COVID-19 globally could adversely affect our operations, including our manufacturing and supply chain, sales and marketing, and product development efforts depending on the availability of parts and potentially longer lead times. Our direct and indirect supply chain relies on manufacturing at, and transportation of products and materials to and from, facilities located throughout the world, and is accordingly subject to disruption or product contamination. Additionally, our results of operations could be adversely affected to the extent that COVID-19 or any other epidemic harms our business or the economy in general either globally or in any region in which we do business. The extent to which COVID-19 will continue to affect our operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the outbreak, the emergence of new variants, the efficacy of vaccines and other treatments, new information that may emerge concerning the severity of COVID-19 and the actions to contain COVID-19 or treat its impact, among others, and could have an adverse effect on our business and financial condition.
17
Further, the U.S. federal government has called for, or enacted, substantial changes to healthcare, trade, fiscal, and tax policies, which may include changes to existing trade agreements and may have a significant impact on our operations. We cannot predict the impact, if any, that these changes could have on our business. If economic conditions worsen or new legislation is passed related to the healthcare system, trade, fiscal or tax policies, customer demand may not materialize to levels we require to achieve our anticipated financial results, which could have a material adverse effect on our business, financial condition and results of operations.
Uncertain credit markets and concerns regarding the availability of credit could impact consumer and customer demand for our products, as well as our ability to manage normal commercial relationships with our customers, suppliers and creditors, including financial institutions. If the current situation deteriorates, our business could be negatively affected by factors such as reduced demand for our products resulting from a slow‑down or volatility in the general economy, supplier or customer disruptions and/or temporary interruptions in our ability to conduct day‑to‑day transactions through our financial intermediaries involving the payment to or collection of funds from our customers, vendors and suppliers.
If we lose our relationship with any supplier of key product components or our relationship with a supplier deteriorates or key components are not available in sufficient quantities, our manufacturing could be delayed and our business could suffer.
We contract with third parties for the supply of some of the components used in our products and the production of our disposable products. Some of our suppliers are not obligated to continue to supply us. We have relatively few sources of supply for some of the components used in our products and in some cases we rely entirely on sole-source suppliers. In addition, the lead-time involved in the manufacturing of some of these components can be lengthy and unpredictable. If our suppliers become unwilling or unable to supply us with components meeting our requirements, it might be difficult to establish additional or replacement suppliers in a timely manner, or at all. This would cause our product sales to be disrupted and our revenue and operating results to suffer.
Replacement or alternative sources might not be readily obtainable due to regulatory requirements and other factors applicable to our manufacturing operations. Incorporation of components from a new supplier into our products may require a new or supplemental filing with applicable regulatory authorities and clearance or approval of the filing before we could resume product sales. This process may take a substantial period of time, and we may not be able to obtain the necessary regulatory clearance or approval. This could create supply disruptions that would harm our product sales and operating results.
Because we rely on distributors or sub-distributors to sell our products in most of our markets outside of the United States, our revenue could decline if our existing distributors reduce the volume of purchases from us, or if our relationship with any of these distributors is terminated.
We currently rely on our distributors or sub-distributors for a majority of our sales outside the United States. Some distributors also assist us with regulatory approvals and education of clinicians and government agencies. Our contracts with our distributors or sub-distributors do not assure us significant minimum purchase volume. If a contract with a distributor or sub-distributor is terminated for cause or by us for convenience, the distributor or sub-distributor will have no obligation to purchase products from us. We intend to continue our efforts to increase our sales in Europe, Asia, and other developed markets throughout the world. If we fail to sell our products through our international distributors, we would experience a decline in revenue unless we begin to sell our products directly in those markets. We may not be able to attract new international distributors to market our products effectively or provide timely and cost-effective customer support and service. Even if we are successful in selling our products through new distributors, the rate of growth of our revenue could be harmed if our existing distributors do not continue to sell a large dollar volume of our products. None of our existing distributors are obligated to continue selling our products.
We may be subject to foreign laws governing our relationships with our international distributors. These laws may require us to make payments to our distributors if we terminate our relationship for any reason, including for cause. Some countries require termination payments under local law or legislation that may require us to pay to terminate our contractual relationship with the distributor. Any required payments could adversely affect our operating results.
We have substantial international operations which are subject to numerous risks; if our international operations are not successful, our business will be adversely affected.
In 2021, approximately 39.6% of our sales were made outside the United States. We plan to expand our international sales and marketing efforts to increase sales of our products in foreign countries. We may not realize corresponding growth in revenue from growth in international unit sales, due to the lower average selling prices we receive on sales outside of the United States. Even if we are able to successfully expand our international selling efforts, we cannot be certain that we will be able to create or increase demand for our products outside of the United States. Our international operations are subject to other risks, which include:
18
•The ongoing COVID-19 pandemic, which has caused disruptions in our and our distributors', vendors' and customers' respective operations, and any future outbreak of a contagious disease;
•Impact of possible recessions in economies outside the United States;
•Political and economic instability, including instability related to war and terrorist attacks and to political and diplomatic matters;
•Adverse changes in tariffs and trade protection measures;
•Difficulty in obtaining and maintaining foreign regulatory approval and complying with foreign regulations, including the EU Medical Device Regulations;
•Contractual provisions governed by foreign law, such as local law rights to sales commissions by terminated distributors;
•Decreased healthcare spending by foreign governments that would reduce international demand for our products;
•Strengthening of the U.S. dollar relative to foreign currencies that could make our products less competitive because slightly less than half of our international sales are denominated in U.S. dollars;
•Changes in capital and exchange controls affecting international trade;
•Greater difficulty in accounts receivable collection and longer collection periods;
•Difficulties of staffing and managing foreign operations;
•Reduced protection for intellectual property rights in some countries and potentially conflicting intellectual property rights of third parties under the laws of various foreign jurisdictions;
•Attitudes by clinicians, and cost reimbursement policies, towards use of disposable supplies that are potentially unfavorable to our business;
•Complying with U.S. regulations that apply to international operations, including trade laws, the U.S. Foreign Corrupt Practices Act, and anti-boycott laws, as well as international laws such as the U.K. Bribery Act;
•Loss of business through government tenders that are held annually in many cases; and
•Potentially negative consequences from changes in tax laws, including legislative changes concerning taxation of income earned outside of the United States.
Risks Related to Our Business and Operations
We depend upon key employees in a competitive market for skilled personnel, and, without retaining our existing employees and recruiting additional employees, we may not be able to grow or maintain profitability.
Our products and technologies are complex, and we depend substantially on the continued service of our senior management team. The loss of any of our key employees could adversely affect our business and slow our product development process. Our future success will depend, in part, on the continued service of our key management personnel, software engineers, and other research and development employees, and our ability to identify, hire, and retain additional personnel, including customer service, marketing, and sales staff. Demand for these skilled employees in our industry is very competitive due to the limited number of people available with the necessary technical skills and understanding of our product technologies. We may be unable to attract and retain personnel necessary for the development of our business.
We previously identified a material weakness in our internal control over financial reporting in a prior period, and if we fail to maintain proper and effective internal control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act in the future, the accuracy and timeliness of our financial reporting may be adversely affected.
The Sarbanes-Oxley Act requires, among other things, that we assess the effectiveness of our internal control over financial reporting annually and disclosure controls and procedures quarterly. In particular, we must perform system and process evaluation and testing of our internal control over financial reporting to allow management to report on, and our independent registered public accounting firm to attest to, the effectiveness of our internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act.
During the fourth quarter of 2019, we identified errors as part of closing our books and concluded that certain deficiencies existed in the Company’s internal control over financial reporting. Specifically, we did not have controls designed to identify and properly account for certain research and development activities related to an arrangement with a third party. Additionally, insufficient training provided to a new control operator and the design of one of our controls over payroll accounts contributed to an error in the period end accrual. The Company has concluded that these deficiencies could have resulted in a material misstatement of the consolidated financial statements that would not have been prevented or detected on a timely basis, and as such, these control deficiencies resulted in a material weakness in our internal control over financial reporting. We have made substantive changes to enhance our design of controls to identify and assess contracts that include research and development and to confirm the accuracy of the payroll accruals. Process updates focused on material weakness remediation were implemented early in 2020 and operated throughout the year. After completing the necessary year-end testing of the enhanced procedures, we concluded that the previously identified material weakness is remediated as of December 31, 2020. However, our current efforts to maintain an effective control environment may not be sufficient to prevent future material
19
weaknesses or significant deficiencies from occurring or to promptly remediate any such future material weaknesses or significant deficiencies.
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements will not be prevented or detected on a timely basis. Controls and Procedures-Management’s Report on Internal Control Over Financial Reporting. The existence of this material weakness and of any other ineffective controls over our financial reporting could result in one or more of the following:
•Revision of previously filed financial statements;
•Failure to meet our reporting obligations;
•Loss of investor confidence; and
•Negative impact on the trading price of our common stock.
If other material weaknesses are identified in the future or we are not able to comply with the requirements of Section 404 in a timely manner, we may be unable to accurately report our consolidated financial results, or report them within the timeframes required by the SEC, we could receive an adverse opinion regarding our controls from our independent registered accounting firm and we could be subject to investigations or sanctions by regulatory authorities, which would require additional financial and management resources, and the market price of our stock could decline.
The United Kingdom's withdrawal from the European Union may have a negative effect on global economic conditions, financial markets and our business and operations.
The U.K. exited from the European Union on January 31, 2020 (often referred to as “Brexit”). On December 24, 2020, the U.K. and the European Union entered into a trade and cooperation agreement (the “Trade and Cooperation Agreement”), which was provisionally applied as of January 1, 2021 and entered into force on May 1, 2021 following ratification by the EU. While the economic integration does not reach the level that existed during the time the U.K. was a member state of the European Union, the Trade and Cooperation Agreement sets out preferential arrangements in areas such as trade in goods and in services, digital trade and intellectual property. Negotiations between the U.K. and the European Union are expected to continue in relation to the relationship between the U.K. and the European Union in certain other areas which are not covered by the Trade and Cooperation Agreement. The long-term effects of Brexit will depend on the effects of the implementation and application of the Trade and Cooperation Agreement and any other relevant agreements between the U.K. and the European Union. It is still unclear what terms, if any, may be agreed within the U.K. and between the U.K. and other countries on many aspects of fiscal policy, cross-border trade and international relations, both in the final outcome and for any transitional period. The withdrawal of the U.K. from the European Union could potentially disrupt the free movement of goods, services and people between the U.K. and the European Union, including in Ireland where we have significant manufacturing operations, undermine bilateral cooperation in key geographic areas and significantly disrupt trade between the U.K. and the European Union or other nations as the U.K. pursues independent trade relations. In addition, Brexit could lead to legal uncertainty and potentially divergent national laws and regulations as the U.K. determines which European Union laws to replace or replicate. Because this is an unprecedented event, it is unclear what long-term economic, financial, trade and legal implications Brexit would have and how it would affect the regulation applicable to our business globally and in the region. Any of these developments, along with any political, economic and regulatory changes that may occur, could cause political and economic uncertainty in Europe and internationally and harm our business and financial results. The impact on Natus from Brexit will depend, in part, on the application of the Trade and Cooperation Agreement and the outcome of other tariff, trade, regulatory and other negotiations. Although we have not observed a material financial impact or identified any trends or potential changes to critical accounting estimates as a result of Brexit at this time we will continue to assess the impact of Brexit on our business and operations, and on accounting and reporting considerations. The effects of Brexit and the application of the Trade and Cooperation Agreement could adversely affect our business, financial condition or future results.
Our operating results may suffer because of our exposure to foreign currency exchange rate fluctuations.
Substantially all of our sales contracts with our U.S. based customers provide for payment in U.S. dollars. With the exception of our Canadian operations, substantially all of the revenue and expenses of our foreign subsidiaries are denominated in the applicable foreign currency for the countries in which they operate. In the past, we have executed only limited foreign currency contracts to hedge these currency risks. Our future revenue and expenses may be subject to volatility due to exchange rate fluctuations that could result in foreign exchange gains and losses associated with foreign currency transactions and the translation of assets and liabilities denominated in foreign currencies.
Substantially all our sales from our U.S. operations to our international distributors provide for payment in U.S. dollars. A strengthening of the U.S. dollar relative to other foreign currencies could increase the effective cost of our products to our
20
international distributors as their functional currency is typically not the U.S. dollar. This could have a potential adverse effect on our ability to increase or maintain average selling prices of our products to our foreign-based customers.
The interest rates on our revolving credit facility are priced using a spread over LIBOR.
LIBOR, the London interbank offered rate, is the basic rate of interest used in lending between banks on the London interbank market and is widely used as a reference for setting the interest rate on loans globally. We typically use LIBOR as a reference rate in our term loans such that the interest due to our creditors pursuant to a term loan extended to us is calculated using LIBOR. Most of our term loan agreements contain a stated minimum value for LIBOR.
Our credit facility permits interest on the outstanding principal balance to be calculated based on LIBOR. On July 27, 2017, the U.K. Financial Conduct Authority (the "FCA") announced that it will no longer require banks to submit rates for the calculation of LIBOR after June 2023, and the U.S. Federal Reserve and the Bank of England have begun publishing a Secured Overnight Funding Rate ("SOFR"), which is currently intended to serve as alternative reference rate to LIBOR. SOFR significantly differs from LIBOR, both in the actual rate and how it is calculated, and therefore is it unclear whether and when markets will adopt this rate as a widely accepted replacement for LIBOR. During the third quarter of 2020, we amended the terms of our credit facility to permit a transition of the reference rate from LIBOR upon the expiration of LIBOR or an earlier election by the parties to the credit facility. At this time, it is not possible to predict the effect of any such changes, any establishment of alternative reference rates or any other reforms to LIBOR that may be implemented in the United Kingdom or elsewhere. Actions in the meantime, by the FCA, other regulators, or law enforcement agencies are expected to influence the method by which LIBOR is calculated. At this time, it is not possible to predict the effect of any such changes or any other reforms to LIBOR that may be enacted in the U.K. or elsewhere. Uncertainty as to the nature of such potential changes, alternative reference rates or other reforms may adversely affect our indebtedness that bear interest at a floating rate determined by reference to LIBOR.
Future changes in technology or market conditions could result in adjustments to our recorded asset balance for intangible assets, including goodwill, resulting in additional charges that could significantly impact our operating results.
Our balance sheet includes significant intangible assets, including goodwill and other acquired intangible assets. The determination of related estimated useful lives and whether these assets are impaired involves significant judgment. Our ability to accurately predict future cash flows related to these intangible assets might be hindered by events over which we have no control. Due to the highly competitive nature of the medical device industry, new technologies could impair the value of our intangible assets if they create market conditions that adversely affect the competitiveness of our products. Further, declines in our market capitalization may be an indicator that our intangible assets or goodwill carrying values exceed their fair values which could lead to potential impairment charges that could impact our operating results.
We have experienced seasonality in the sale of our products.
We experience seasonality in our revenue. For example, our sales typically decline from the second half of our fiscal year to the first half of the fiscal year, due to patterns in the capital budgeting and purchasing cycles of our customers, many of which are government agencies, and the compensation arrangements of our direct sales employees, as those arrangements are tied to calendar-year sales plans. We anticipate that we will continue to experience seasonal fluctuations, which may lead to fluctuations in our quarterly operating results. We believe that you should not rely on our results of operations for interim periods as an indication of our expected results in any future period.
We make regular changes to our information systems that could disrupt our business and our financial results.
We continuously improve and plan to continue to improve our information systems to support the form, functionality, and scale of our business. These types of transitions frequently prove disruptive to the underlying business of an enterprise and may cause us to incur higher costs than we anticipate. Failure to manage a smooth transition to the new systems and the ongoing operations and support of the new systems could materially harm our business operations.
Risks Related to Growth and Competition
Our operating results may decline if we do not succeed in developing, acquiring, and marketing additional products or improving our existing products.
We intend to develop additional products and technologies, including enhancements of existing products, for the screening, detection, treatment, monitoring and tracking of common medical ailments. Developing new products and improving our existing products to meet the needs of current and future customers requires significant investments in research and development. Healthcare products typically receive regulatory approval based on data obtained in controlled clinical trials, which can be time consuming and expensive. Unfavorable or inconsistent clinical data from existing or future clinical trials may adversely affect our ability to secure marketing authorization for certain products. Furthermore, all results, even positive ones, are subject to the interpretation of FDA and other regulatory agencies. If we fail to sell new products, update existing products,
21
or timely react to changes in technology, our operating results may decline as our existing products reach the end of their commercial life cycles.
Demand for some of our products depends on the capital spending policies of our customers, and changes in these policies could harm our business.
A majority of customers for our products are hospitals, physician offices, and clinics. Many factors, including public policy spending provisions, available resources, and economic cycles have a significant effect on the capital spending policies of these entities and the amount that they can spend on our equipment products. If budget resources limit the capital spending of our customers, they will be unlikely to either purchase any new equipment from us or upgrade to any of our newer equipment products. Lack of liquidity in credit markets and uncertainty about future economic conditions can have an adverse effect on the spending patterns of our customers. These factors can have a significant adverse effect on the demand for our products.
Our business results depend on our ability to successfully manage ongoing strategic initiatives and business transformation to drive growth and achieve cost savings and operating efficiency.
Our financial goals assume a level of growth and increased productivity. If we are unable to deliver these expected improvements, or continue to invest in business growth, or if the volume and nature of change require additional resources, our business operations and financial results could be materially and adversely impacted. Our ability to successfully manage and execute these initiatives and realize the related profitability improvement in the amounts and at the times anticipated is important to our business success. Any failure to do so, which could result from our inability to successfully execute organizational change and business transformation plans, changes in global or regional economic conditions, competition, changes in the industries in which we compete, unanticipated costs or charges, loss of key personnel and other factors described herein, could have a material adverse effect on our businesses, financial condition and results of operations.
At previous points in our past, our growth has depended substantially on the completion of acquisitions and we may not be able to complete or successfully capitalize on acquisitions of the same nature or relative size in the future to support a similar level of growth.
The acquisitions that we have completed have contributed to our growth in prior years. We have expended considerable effort in seeking to identify attractive acquisition candidates, and ultimately, to negotiate mutually agreeable acquisition terms. The market for attractive acquisitions is competitive and others with different strategic objectives or greater financial resources than we have may be better positioned than we are to acquire desirable targets. Further, we may not be able to negotiate acquisition terms with target companies that will allow us to achieve acceptable financial returns from the transaction.
If completed, the success of any acquisitions will depend, in part, on our ability to successfully combine and integrate the acquired business into our businesses and realize the anticipated benefits, including synergies, from the transaction. The integration of any acquired businesses may result in material challenges, including: the diversion of management's attention from ongoing business concerns and performance shortfalls at one or both of the companies; maintaining employee morale and retaining key management, sales and other employees; retaining existing business and operational relationships; the possibility of faulty assumptions underlying expectations regarding the integration process; consolidating corporate and administrative infrastructures and eliminating duplicative operations; unanticipated issues in integrating information technology, communications and other systems; and unforeseen costs, expenses and liabilities (including litigation related liabilities) associated with such acquisition.
If we fail in our efforts to educate clinicians, government agency personnel, and third-party payors about the effectiveness of our products, we may not achieve future sales growth.
It is critical to the success of our sales efforts that we educate a sufficient number of clinicians, hospital administrators, and government agencies about our products and the costs and benefits of their use. The commercial success of our products depends upon clinician, government agency, and other third-party payor confidence in the economic and clinical benefits of our products as well as their comfort with the efficacy, reliability, sensitivity, and specificity of our products. We believe that clinicians will not use our products unless they determine, based on published peer-reviewed journal articles and experience, that our products provide an accurate and cost-effective alternative to other means of testing or treatment. Our customers may choose to use competitive products, which may be less expensive or may provide faster results than our devices. Clinicians are traditionally slow to adopt new products, testing practices and clinical treatments, partly because of perceived liability risks and the uncertainty of third-party reimbursement. If clinicians, government agencies and hospital administrators do not adopt our products, we may not maintain profitability. Factors that may adversely affect the medical community’s acceptance of our products include:
•Publication of clinical study results that demonstrate a lack of efficacy or cost-effectiveness of our products;
•Changing governmental and physician group guidelines;
•Actual or perceived performance, quality, price, and total cost of ownership deficiencies of our products relative to other competitive products;
22
•Our ability to maintain and enhance our existing relationships and to form new relationships with leading physicians, physician organizations, hospitals, state laboratory personnel, and third-party payors;
•Changes in federal, state and third-party payor reimbursement policies for our products; and
•Repeal of laws requiring universal newborn hearing screening and metabolic screening.
Sales to members under group purchasing agreements and sales to high volume purchasers may reduce our average selling prices, which could reduce our operating margins.
We have entered and expect in the future to enter into agreements with customers who purchase a high volume of our products. Our agreements with these customers may contain discounts from our normal selling prices and other special pricing considerations, which could cause our operating margins to decline. In addition, we have entered into agreements to sell our products to members of GPOs, which negotiate volume purchase prices for medical devices and supplies for member hospitals, group practices and other clinics. While we make sales directly to GPO members, the GPO members receive volume discounts from our normal selling price and may receive other special pricing considerations from us. Sales to members of all GPOs accounted for approximately 23.6%, 22.5% and 18.7% of our total revenue during 2021, 2020 and 2019, respectively. Certain other existing customers may be members of GPOs with which we do not have agreements. If we enter into agreements with new GPOs and some of our existing customers begin purchasing our products through those GPOs, our operating margins could decline.
Consolidation in the healthcare industry could have an adverse effect on our revenues and results of operations.
Many healthcare industry companies, including our customers and competitors, are consolidating to create new companies with greater market power. As the healthcare industry consolidates, competition to provide goods and services to our customers could become more intense. Our customers may try to use their market power to negotiate price concessions and our competitors may utilize their size and broad product lines to offer cheaper alternatives to our products. If we are forced to reduce our prices because of consolidation in the healthcare industry, our revenues would decrease and our consolidated earnings, financial condition, or cash flow would suffer.
Our markets are very competitive and in the United States we sell certain of our products in a mature market.
We face competition from other companies in all our product lines. Our competitors range from small privately held companies to multinational corporations and their product offerings vary in scope and breadth. We do not believe that any single competitor is dominant in any of our product lines.
The markets for certain of our products in the United States, including the newborn hearing screening, EMG, and EEG monitoring markets, are mature and we are unlikely to see significant growth for such products in the United States. The market for newborn care products is affected by birthrates, and a declining U.S. birthrate has adversely affected our operating results in recent periods. In the United States we derive a significant portion of our revenue from the sale of disposable supplies. Our disposable supply products could face increasing competition, including competitors offering lower prices, which could have an adverse effect on our revenue and margins.
Our competitors may have certain competitive advantages, which include the ability to devote greater resources to the development, promotion, and sale of their products. Consequently, we may need to increase our efforts, and related expenses for research and development, marketing, and selling to maintain or improve our position.
We expect recurring sales to our existing customers to generate much of our revenue in the future, and if our existing customers do not continue to purchase products from us, our revenue may decline.
If healthcare providers are not adequately reimbursed for procedures conducted with our devices or supplies, or if reimbursement policies change adversely, we may not be successful marketing and selling our products or technologies.
Clinicians, hospitals, and government agencies are unlikely to purchase our products if they are not adequately reimbursed for the procedures conducted with our devices or supplies. Unless a sufficient amount of conclusive, peer-reviewed clinical data about our products has been published, third-party payors, including insurance companies and government agencies, may refuse to provide reimbursement. Furthermore, even if reimbursement is provided, it may not be adequate to fully compensate the clinicians or hospitals. Some third-party payors may impose restrictions on the procedures for which they will provide reimbursement. If healthcare providers cannot obtain sufficient reimbursement from third-party payors for our products or the screenings conducted with our products, we may not achieve significant market acceptance of our products. Acceptance of our products in international markets will depend upon the availability of adequate reimbursement or funding within prevailing healthcare payment systems. Reimbursement, funding, and healthcare payment systems vary significantly by country. We may not obtain approvals for reimbursement in a timely manner or at all.
Adverse changes in reimbursement policies in general could harm our business. We are unable to predict changes in the reimbursement methods used by third-party healthcare payors, particularly those in countries and regions outside the United States. For example, some payors are moving toward a managed care system in which providers contract to provide
23
comprehensive healthcare for a fixed cost per person. In a managed care system, the cost of our products may not be incorporated into the overall payment for patient care or there may not be adequate reimbursement for our products separate from reimbursement for other procedures.
Risks Related to Our Compliance and Regulatory Environment
An interruption in or breach of security of our information or manufacturing systems, including the occurrence of a cyber-incident or a vulnerability in our cybersecurity, or disclosure of private patient health information, may result in a loss of business or damage to our reputation.
We rely on communications, information and manufacturing systems to conduct our business. Any failure, interruption or cyber incident affecting these systems could result in failures or disruptions in our customer relationship management or product manufacturing. Similarly, there can be no assurance that our third-party collaborators, distributors and other contractors and consultants will be successful in protecting our data that is stored on their systems. A cyber incident is an intentional attack or an unintentional event that can include an unauthorized actor gaining access to our systems to disrupt operations, corrupt data, or steal confidential information. In October 2021, we identified a cyber incident that resulted in the unauthorized access to certain personal data, including the personal data of certain of our current and former employees. We are not aware of any evidence that any patient data was accessed, and the breach has not materially impacted our operations. However, the occurrence of any future failures, interruptions or cyber incidents could result in a loss of customer business or reputation and have a material effect on our business, financial condition, results of operations and cash flows. In addition, our products are used in customer networks transmitting a range of sensitive information and any actual or perceived exposure of our products used in customer networks to malicious software or cyber-attacks could adversely affect our business and results of operations.
In the course of performing our business we obtain, from time to time, confidential patient health information. For example, we may learn patient names and be exposed to confidential patient health information when we provide training on our products to our customers’ staff. Complying with federal and state privacy and security requirements imposes compliance related costs, subjects us to potential regulatory audits, and may restrict our business operations. These various laws may be subject to varying interpretations by courts and government agencies creating potentially complex compliance issues for our business. If we were to violate any of our legal obligations to safeguard any confidential patient health information or protected health information against improper use and disclosure, we could lose customers and be exposed to liability, and our reputation and business could be harmed. Concerns or allegations about our practices with regard to the privacy or security of personal health information or other privacy-related matters, even if unfounded, could damage our reputation and harm our business.
We are also subject to new U.S. laws as well as laws and regulations in foreign countries covering data privacy and other protection of health and employee information that may be more onerous than previous corresponding U.S. laws. These laws and regulations impose technical and organizational measures to ensure the security of personal data and may require that we notify regulatory agencies, individuals or the public about any data security breaches. In particular, in the United States, the California Consumer Privacy Act of 2018 (“CCPA”) imposes a private right of action with damages of up to $750 per person in the event of certain data breaches. Other states are considering similar laws. As these laws and regulations develop in the United States and we expand our international operations, we may be required to expend significant time and resources to put in place additional mechanisms to ensure compliance with multiple cybersecurity laws. Failure to comply with these laws may result in significant fines and other administrative penalties and harm our business, and could expose us to significant civil damages.
The FDA has issued guidance advising manufacturers to take cybersecurity risks into account in product design for connected medical devices and systems, to assure that appropriate safeguards are in place to reduce the risk of unauthorized access or modification to medical devices that contain software and reduce the risk of introducing threats into hospital systems that are connected to such devices. The FDA also issued guidance on post market management of cyber security in medical devices. Compliance with these requirements may require changes in business practices, complicate our operations, and add complexity and additional management and oversight needs. They also may complicate our clinical research activities, as well as product offerings that involve transmission or use of clinical data. Failure to comply with these laws could result in vulnerabilities that would make us susceptible to hackers and other cyber attacks, as well as fines or administrative penalties that, if imposed, would harm our business.
Our ability to market and sell products depends upon receipt of domestic and foreign regulatory clearances of our products and successful inspections of our manufacturing operations. Our failure to obtain or maintain regulatory compliance could negatively affect our business.
Our products and manufacturing operations are subject to extensive regulation in the United States by the FDA and by similar regulatory agencies in other countries. Our products are classified as medical devices. Medical devices are subject to extensive regulation by the FDA pursuant to regulations that are wide ranging and govern, among other things: design and development; manufacturing and testing; labeling; storage and record keeping; advertising, promotion, marketing, sales distribution and export; and surveillance and reporting of deaths or serious injuries.
24
Unless an exemption applies, each medical device that we propose to market in the United States must first receive one of the following types of FDA premarket review authorizations:
•Clearance via Section 510(k) of the Food, Drug, and Cosmetics Act of 1938, as amended; or
•Premarket approval via Section 515 of the Food, Drug, and Cosmetics Act if the FDA has determined that the medical device in question poses a greater risk of injury.
The FDA will clear marketing of a medical device through the 510(k) process if it is demonstrated that the new product is substantially equivalent to other 510(k)-cleared products. The premarket approval application process is much more costly, lengthy and uncertain than the 510(k) process, and must be supported by extensive data from preclinical studies and human clinical trials. The FDA may not grant either 510(k) clearance or premarket approval for any product we propose to market. Further, any modification to a 510(k)-cleared device that could significantly affect its safety or effectiveness, or that would constitute a major change in its intended use, design or manufacture, requires a new 510(k) clearance or, possibly, approval of a premarket approval application. The FDA requires every manufacturer to make this determination in terms of the classification of the modification, but the FDA may review any manufacturer’s decision at any time. If the FDA requires us to seek 510(k) clearance or premarket approval for modification of a previously cleared product for which we have concluded that new clearances or approvals are unnecessary, we may be required to cease marketing or to recall the modified product until we obtain clearance or approval, and we may be subject to significant regulatory fines or penalties. Further, our products could be subject to recall if the FDA determines, for any reason, that our products are not safe or effective.
Delays in receipt of, or failure to receive, clearances or approvals, the loss of previously received clearances or approvals, or the failure to comply with existing or future regulatory requirements could adversely impact our operating results. If the FDA finds that we have failed to comply with these requirements, the FDA can institute a wide variety of enforcement actions, ranging from a public warning letter to more severe sanctions such as:
•Fines, injunctions and civil penalties;
•Recall or seizure of our products;
•Issuance of public notices or warnings;
•Imposition of operating restrictions, partial suspension, or total shutdown of production;
•Refusal of our requests for Section 510(k) clearance or premarket approval of new products;
•Withdrawal of Section 510(k) clearance or premarket approvals already granted;
•Criminal prosecution;
•Domestic regulation of our products and manufacturing operations, other than that which is administered by the FDA, includes the Environmental Protection Act, the Occupational Safety and Health Act, and state and local counterparts to these Acts; or
Foreign governments and regulatory authorities have, and may continue to, propose and implement regulations that apply to our products and operations. Penalties for regulatory non-compliance could be severe, including fines and revocation or suspension of a company's business license, mandatory price reductions, and criminal sanctions. Future laws and regulations may have a material adverse effect on our business.
Our business would be harmed if regulatory authorities determine that we have failed to comply with applicable regulations governing the manufacture of our products and/or if we are subject to enforcement actions such as seizure, injunction, fines or criminal prosecution.
We and our suppliers are required to demonstrate and maintain compliance with the FDA’s Quality System Regulation. The Quality System Regulation sets forth the FDA’s requirements for good manufacturing practices of medical devices and includes requirements for, among other things, the design, testing, production processes, controls, quality assurance, labeling, packaging, storage and shipping of such products. In addition, we and our suppliers must engage in extensive recordkeeping and reporting and must make available our manufacturing facility and records for periodic unscheduled inspections by federal, state and foreign agencies, including the FDA. We cannot assure you that we and our suppliers are or will continue to be in full compliance with the Quality System Regulation, nor that we will not encounter any manufacturing difficulties.
A failure by us or our third party suppliers and manufacturers to comply with applicable regulations or to adequately respond to any future compliance issues raised by the FDA or regulatory agencies in other countries that we are subject to could result in sanctions being imposed on us, including, among other things, fines, injunctions, civil penalties, failure of regulatory authorities to grant marketing approval of our products, delays, suspension or withdrawal of approvals, seizures or recalls of products and manufacturing restrictions, any of which could harm our business.
If we deliver products with defects, we may incur costs to repair and, possibly, recall that product and market acceptance of our products may decrease.
The manufacturing and marketing of our products involve an inherent risk of our delivering a defective product or products that do not otherwise perform as we expect. We may incur substantial expense to repair any such products and may
25
determine to recall such a product, even if not required to do so under applicable regulations. Any such recall would be time consuming and expensive, diverting management's attention and resources. Product defects or recalls may adversely affect our customers’ acceptance of the recalled and other of our products.
If we fail to comply with healthcare regulations, we could face substantial penalties and our business, operations and financial condition could be adversely affected.
We could be subject to healthcare fraud regulation and enforcement by both the federal government and the states in which we conduct our business. The laws that may affect our ability to operate include: (i) the federal healthcare programs Anti-Kickback Law, which prohibits, among other things, persons from knowingly and willfully soliciting, receiving, offering or paying remuneration, directly or indirectly, in exchange for or to induce either the referral of an individual for, or the purchase, order or recommendation of, any good or service for which payment may be made under federal healthcare programs such as Medicare or Medicaid, (ii) federal false claims laws which prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, claims for payment from Medicare, Medicaid, or other third-party payors that are false or fraudulent, and which may apply to entities like us which provide coding and billing advice to customers, and/or (iii) state law equivalents of each of the above federal laws, such as anti-kickback and false claims laws which may apply to items or services reimbursed by any third-party payor, including commercial insurers, many of which differ from their federal counterparts in significant ways, thus complicating compliance efforts.
If our operations are found to be in violation of any of the laws described above or any other governmental regulations that apply to us, we may be subject to penalties, including civil and criminal penalties, damages, fines and the curtailment or restructuring of our operations. Any penalties, damages, fines, curtailment or restructuring of our operations could adversely affect our ability to operate our business and our financial results. The risk of our being found in violation of these laws is increased by the fact that their provisions are open to a variety of interpretations. Any action against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management’s attention from the operation of our business.
Our business may suffer if we are required to revise our labeling or promotional materials, or if regulatory authorities take an enforcement action against us for promoting off-label use of our products.
We are prohibited by the FDA from promoting or advertising our medical device products for uses not within the scope of our clearances or approvals, or from making unsupported promotional claims about the benefits of our products. If the FDA determines that our claims are outside the scope of our clearances, or are unsupported, it could require us to revise our promotional claims or take enforcement action against us. If we were subject to such an action by the FDA, our sales could be delayed, our revenue could decline, and our reputation among clinicians could be harmed. Likewise, if we acquire new products, either through the purchase of products, technology assets, or businesses, that are subsequently deemed to have inadequate supporting data, we may be required to (i) obtain adequate data, which could be costly and impede our ability to market these products, or (ii) modify the labeling on these products, which could impair their marketability, as described above.
We are subject to data privacy laws and our failure to comply with them may require us to make significant changes to our products or incur penalties or other liabilities.
Our business relies on the secure electronic transmission, storage and hosting of sensitive information, including personally identifiable information (“PII”), personal health information, financial information, intellectual property and other sensitive information related to our customers and workforce. The collection, maintenance, protection, use, transmission, disclosure and disposal of certain personal information and the security of medical devices are regulated at the U.S. federal and state, international and industry levels. U.S. federal and state laws, such as the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”), protect the confidentiality of certain patient health information, including patient medical records, and restrict the use and disclosure of patient health information. We sign business associate agreements with certain customers for which we perform services as business associates under HIPAA, and therefore we are directly subject to certain provisions of HIPAA that are applicable to business associates. Noncompliance with laws and regulations relating to privacy and security of personal information, including HIPAA, or with contractual obligations under any business associate agreement may lead to significant fines, civil and criminal penalties, or liabilities.  We also may be required to report breaches of protected health information that we experience. The U.S. Department of Health and Human Services (“HHS”), audits the compliance of business associates and enforces HIPAA privacy and security standards. HHS enforcement activity has become more significant over the last few years and HHS has signaled its intent to continue this trend.
In addition to the regulation of personal health information, a number of states have also adopted laws and regulations that may affect our privacy and data security practices for other kinds of PII, such as state laws that govern the use, disclosure and protection of personal information, such as social security numbers, or that are designed to protect credit card account data. State consumer protection laws, including the CCPA, which became effective on January 1, 2020, may also establish privacy and security standards for use and management of PII, including information related to customers, suppliers and care providers. The CCPA provides individuals certain rights regarding the collection or processing of personal data related to California
26
residents, which may restrict our ability to use personal data, of California residents. Failure to comply with the CCPA could result in penalties of up to $7,500 per violation. Moreover, a new privacy law, the California Privacy Rights Act (“CPRA”) was approved by ballot initiative during the November 3, 2020 general election. Effective starting on January 1, 2023, the CPRA imposes additional obligations on companies covered by the legislation and will significantly modify the CCPA, including by expanding consumers' rights with respect to certain sensitive personal information. The CPRA also creates a new state agency that will be vested with authority to implement and enforce the CCPA and the CPRA. The effects of the CCPA and the CPRA are potentially significant and may require us to modify our data collection or processing practices and policies and to incur substantial costs and expenses to comply and increase our potential exposure to regulatory enforcement and/or litigation. Additionally, the Federal Trade Commission, and many state attorneys general are interpreting federal and state consumer protection laws to impose standards for the online collection, use, dissemination, and security of data. The burdens imposed by the CCPA and other similar laws that have been or may be enacted at the federal and state level may require us to modify our data processing practices and policies and to incur substantial expenditures in order to comply.
Outside the United States, we are impacted by the privacy and data security requirements at the international, national, and regional level, and on an industry specific basis. We serve customers across the globe. Legal requirements in these countries relating to the collection, storage, handling and transfer of personal data and potentially intellectual property continue to evolve with increasingly strict enforcement regimes. More privacy and security laws and regulations are being adopted, and more are being enforced, with potential for significant financial penalties. In the European Union, increasingly stringent data protection and privacy rules that will have substantial impact on the use of patient data across the healthcare industry became effective in May 2018. The European Union General Data Protection Regulation (“GDPR”) applies uniformly across the European Union and to businesses in other countries that target European Union residents and includes, among other things, a requirement for prompt notice of data breaches to data subjects and supervisory authorities in certain circumstances and significant fines for non-compliance. The GDPR also requires companies processing personal data of individuals, including employees, residing in the European Union to comply with European Union privacy and data protection rules. Other international jurisdictions have issued privacy laws that mirror many of the requirements of GDPR. As we expand our international operations, we may be required to expend significant time and resources to put in place additional mechanisms to ensure compliance with multiple data privacy laws. Failure to comply with these laws may result in significant fines and other administrative penalties and harm our business.
Compliance with these laws and regulations may require significant additional costs or changes in our business, which could adversely affect our results of operations or financial condition. Noncompliance with these laws and regulations could result in the imposition of fines and penalties or could result in significant civil and other liabilities. Additionally, the restrictions imposed by these laws and regulations may limit the use and adoption of our products, reduce overall demand for our products, require us to modify our data handling practices and impose additional costs and burdens.
Healthcare reforms, changes in healthcare policies, and changes to third-party reimbursements for our products may affect demand for our products.
    Uncertainty in the U.S. healthcare system may influence the way our customers spend on medical devices, supplies, and services in the future. Future rulemakings could affect rebates, prices, or the rate of price increase for healthcare products and services. Cost-containing measures implemented by healthcare providers worldwide could harm our profitability. If we fail to effectively react to healthcare reforms, our business may be adversely affected.
Regulations related to “conflict minerals” may force us to incur additional expenses, may result in damage to our business reputation and may adversely impact our ability to conduct our business.
The Dodd‑Frank Wall Street Reform and Consumer Protection Act and the rules promulgated by the SEC thereunder require companies, including Natus, to disclose the existence in their products of certain metals, known as “conflict minerals,” which are metals mined from the Democratic Republic of the Congo and adjoining countries. These rules require investigative efforts, which has and will continue to cause us to incur associated costs, could adversely affect the sourcing, availability and pricing of minerals used in our products and may cause reputational harm if we determine that certain of our components contain such conflict minerals or if we are unable to alter our processes or sources of supply to avoid using such materials, all of which could adversely impact sales of our products and results of operations.
If guidelines mandating universal newborn hearing screening do not continue to develop in foreign countries and governments do not mandate testing of all newborns as we anticipate, or if those guidelines have a long phase-in period, our sales of newborn hearing screening products may not achieve the revenue growth we have achieved in the past.
We estimate that approximately 95% of the children born in the United States are currently being tested for hearing impairment prior to discharge from the hospital. To date, there has been only limited adoption of newborn hearing screening prior to hospital discharge by foreign governments, and when newborn hearing screening programs are enacted by foreign governments there can be a phase-in period spanning several years. The widespread adoption of guidelines depends, in part, on our ability to educate foreign government agencies, neonatologists, pediatricians, third-party payors, and hospital administrators
27
about the benefits of universal newborn hearing screening as well as the use of our products to perform the screening and monitoring. Our revenue from our newborn hearing screening product lines may not grow if foreign governments do not require universal newborn hearing screening prior to hospital discharge, if physicians or hospitals are slow to comply with those guidelines, or if governments provide for a lengthy phase-in period for compliance.
As a result of increased scrutiny and reporting requirements from customers, shareholders, investors, and government agencies related to environmental, social, and governance (“ESG”) compliance objectives, our organization may be subject to reputational harm and/or monetary impact for any ESG non-compliance or slow progression to ESG compliance.
Organizations are being challenged with a heightened focus related to current and rapidly evolving corporate ESG-related initiatives by its customers, vendors, shareholders, investors, and governmental agencies. Compliance with ESG objectives and expectations may require us to incur additional and ongoing costs and resources, which may have an adverse effect on our business, financial condition and results of operations. Certain influential institutional investors are increasing their focus on ESG practices and are placing importance on the implications and social cost of their investments. If our ESG practices do not meet the standards set by these stockholders, they may choose not to invest in our common stock or if our peer companies outperform us in their ESG initiatives, potential or current investors may elect to invest with our competitors instead. If our organization's ESG practices do not meet or are slow to comply with ESG-imposed standards by interested parties, then our reputation, stock price, growth, employee retention, and customers' and vendors' willingness to do business with us may be negatively impacted for non-compliance or delay in compliance.
If we don’t have a diverse and inclusive environment where our global teammates feel a sense of belonging it may impede our ability to produce innovative products through diversity of perspectives, serve our diverse customers/patients and attract, develop and retain diverse and talented teammates.
Our organization is committed to supporting an environment where we create a sense of safety, respect and belonging where diverse perspectives are valued and encouraged regardless of race, gender association, sexual orientation, age, religion, ethnic origin, national origin and any unique characteristics. There can be no assurances that our initiatives to foster and create a sense of belonging and fair treatment with a diverse workforce will be successful. A failure to adopt or maintain competitive policies and practices that enhance our workplace culture, such as those related to diversity and inclusion, could adversely impact our ability to attract, develop and retain teammates, cause us reputation harm and negatively affect our operations and financial results.

Risks Related to our Intellectual Property and Potential Litigation
We may not be able to preserve the value of our intellectual property because we may not be able to protect access to it or we may lose our intellectual property rights due to expiration of our licenses or patents.
If we fail to protect our intellectual property rights or if our intellectual property rights do not adequately cover the technology we employ, other medical device companies could sell products with features similar to ours, and this could reduce demand for or perceived value of our products. We protect our intellectual property through a combination of patent, copyright, trade secret and trademark laws. Despite our efforts to protect our proprietary rights, others may attempt to copy or otherwise improperly obtain and use our products or technology. Policing unauthorized use of our technology is difficult and expensive, and we cannot be certain that the steps we have taken will prevent misappropriation. Our means of protecting our proprietary rights may be inadequate. Enforcing our intellectual property rights could be costly and time consuming and may divert our management’s attention and resources. Failing to enforce our intellectual property rights could also result in the loss of those rights.
Our financial results may suffer if we were subject to a protracted infringement or products liability litigation.
The medical technology industry is characterized by a substantial amount of litigation and related administrative proceedings regarding patents and intellectual property rights. We expect that medical screening and diagnostic products may become increasingly subject to third-party infringement claims as the number of competitors in our industry grows and the functionality of products overlap. Third parties such as individuals, educational institutions, or other medical device companies may claim that we infringe their intellectual property rights. Any claims, with or without merit, could have any of the following negative consequences:
•Result in costly litigation and damage awards;
•Divert our management’s attention and resources;
•Cause product shipment delays or suspensions; or
•Require us to seek to enter into royalty or licensing agreements.
From time to time, we may be subject to cases based on third-party patent infringement claims. A successful claim of infringement against us from any current or future claim could result in a substantial damage award and materially harm our
28
financial condition. Our failure or inability to license the infringed or similar technology, or design and build non-infringing products, could prevent us from selling our products and adversely affect our business and financial results.
We may also find it necessary to bring infringement actions against third parties to seek to protect our intellectual property rights. Litigation of this nature, even if successful, is often expensive and disruptive of our management’s attention, and in any event may not lead to a successful result relative to the resources dedicated to any such litigation.
In addition, the sale and use of our products could lead to the filing of a product liability claim by someone claiming to have been injured using one of our products or claiming that one of our products failed to perform properly. A product liability claim could result in substantial damages and be costly and time consuming to defend, either of which could materially harm our business reputation or financial condition. Our product liability insurance may not protect our assets from financial impact of defending a product liability claim. Any product liability claim brought against us, with or without merit, could increase our product liability insurance rates or prevent us from securing any coverage in the future.
We license intellectual property rights from third parties and would be adversely affected if our licensors do not appropriately defend their proprietary rights or if we breach any of the agreements under which we license commercialization rights to products or technology from others.
We license rights from third parties for products and technology that are important to our business. If our licensors are unsuccessful in asserting and defending their proprietary rights, including patent rights and trade secrets, we may lose the competitive advantages we have through selling products that we license from third parties. Additionally, if it is found that our licensors infringe on the proprietary rights of others, we may be prohibited from marketing our existing products that incorporate those proprietary rights. Under our licenses, we are subject to commercialization and development, sublicensing, royalty, insurance, and other obligations. If we fail to comply with any of these requirements, or otherwise breach a license agreement, the licensor may have the right to terminate the license in whole or to terminate the exclusive nature of the license.

ITEM 1B.    Unresolved Staff Comments.
None.
ITEM 2.    Properties
Our corporate headquarters is located in Middleton, Wisconsin, in a facility covering 121,000 square feet pursuant to a lease that expires in April 2024.
We also utilize the following properties:
Company-owned Facilities:
•62,400 square feet in Gort, Ireland, utilized substantially for manufacturing; and
•40,000 square feet in Oakville, Ontario, Canada, primarily utilized for research and development and technical support.
Leased Facilities:
Following is a listing of our most significant leased properties; we have a number of smaller facilities under lease in various countries where we operate.
•55,400 square feet in Taastrup, Denmark, pursuant to a lease with the option to terminate with six months-notice beginning January 2022, that is utilized for manufacturing, research and development, marketing and sales, and general and administrative;
•38,300 square feet in San Diego, California, pursuant to a lease that expires in June 2022, that is utilized substantially for manufacturing; and
•25,100 square feet in Schaumburg, Illinois, pursuant to a lease that expires in November 2026, that is utilized substantially for marketing and sales.
•8,200 square feet in Pleasanton, California, our previous headquarters, pursuant to a lease that expires in January 2025, that is utilized substantially for administrative services.
ITEM 3.    Legal Proceedings
We may from time to time become a party to various legal proceedings or claims that arise in the ordinary course of business. We are not currently involved in any legal or administrative proceedings that we believe are likely to have a material
29
effect on our business, financial condition, or results of operations, although we cannot be assured of the outcome of such matters.

ITEM 4.    Mine Safety Disclosures
The disclosure required by this item is not applicable.

PART II
ITEM 5.    Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Our common stock trades on the Nasdaq Global Select Market under the symbol “NTUS”. The following table sets forth, for the periods indicated, the high and low sale price per share of our common stock, as reported on the Nasdaq Global Select Market. 
HighLow
Fiscal Year Ended December 31, 2021:
Fourth Quarter$28.65 $21.87 
Third Quarter27.54 22.54 
Second Quarter29.70 24.97 
First Quarter27.97 19.93 
Fiscal Year Ended December 31, 2020:
Fourth Quarter$21.98 $16.60 
Third Quarter22.99 16.38 
Second Quarter26.97 20.25 
First Quarter34.67 18.91 
As of February 18, 2022, there were 34,408,154 shares of our common stock issued and outstanding and held by approximately 118 stockholders of record. We estimate that there are approximately 13,770 beneficial owners of our common stock.
Dividends
We have never declared or paid cash dividends on our capital stock and do not anticipate paying any cash dividends in the foreseeable future.
Stock Performance Graph
The following information of Part II Item 5 is being furnished and shall not be deemed to be “soliciting material” or to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, nor will it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that we specifically incorporate such information by reference thereto.
The following graph shows a comparison, from January 1, 2016 through December 31, 2021, of cumulative total return for our common stock, the Nasdaq Composite Index and the Standard & Poor’s 500 Health Care Equipment Index. Such returns are based on historical results and are not intended to suggest future performance. Data for the Nasdaq Composite Index and the Standard & Poor’s 500 Health Care Equipment Index assumes reinvestment of dividends.
30
ntus-20211231_g1.jpg
 
201620172018201920202021
Natus Medical IncorporatedReturn %— 9.77 (10.92)(3.06)(39.25)18.41 
Cum $100.00 109.77 97.78 94.79 57.58 68.19 
NASDAQ Composite-Total ReturnsReturn %— 29.64 (2.84)36.69 44.92 22.18 
Cum $100.00 129.64 125.96 172.18 249.51 304.85 
S&P 500 Health Care Equipment IndexReturn %— 30.90 16.24 29.32 17.63 19.35 
Cum $100.00 130.90 152.15 196.77 231.46 276.26 

Purchases of Equity Securities by the Issuer

In December 2019, the Board of Directors approved a share repurchase program, which authorized the repurchase from time to time of up to a maximum of $50.0 million of our outstanding common stock. The program expired on December 12, 2021.

ITEM 6.    [Reserved]
Not applicable

31
ITEM 7.    Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) should be read in conjunction with the Consolidated Financial Statements and the accompanying footnotes. MD&A includes the following sections:
Business
We are a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.
Year 2021 Overview
Our consolidated revenue increased by $57.8 million for the year ended December 31, 2021 compared to the year ended December 31, 2020. This increase was driven by an increase in demand for our Neuro and Hearing and Balance products as a result of the recovery from the impact of the COVID-19 global pandemic.
Net income was $13.2 million, or $0.39 per share in the year ended December 31, 2021, compared with net loss of $16.6 million, or $0.49 per share in the prior year. This increase in income was primarily driven by higher revenue resulting from the recovery of the impact of the COVID-19 pandemic on global demand for our products, a more profitable mix of revenue and impairment of intangibles related to end of sale products in 2020, not repeating to the same level in 2021. This was partly offset by an increase in operating expenses as we returned closer to more normal operating levels of the business related to the impact of the COVID-19 global pandemic. We generated cash flow from operations of $64.0 million.
COVID-19 Update
Healthcare providers and patients continue to depend on our products and services every day. Our team members and partners are continuing to maintain our supply chain, manufacturing and delivery of our products and services. The health and welfare of our employees, our customers and our partners remain our top priority as we continue our business operations.
We have implemented safeguards in our facilities to protect team members, including social distancing practices, work from home and other measures consistent with specific regulatory requirements and guidance from health authorities. As an essential supplier of healthcare products and services, all of our manufacturing, engineering, sales and customer support functions remain fully operational and will continue to support customers with vital supplies, service and equipment. Supply chain delays and constraints have impacted our ability to ship products in the last few quarters. We are working with our suppliers to reduce constraints by providing forecasts further into the future and closely monitoring and communicating changes in the forecast, however we remain uncertain of when the supply chain will stabilize.
Impact to our supply chain
Many of our materials are single source and require lengthy qualification periods. Disruptions in our supply chain could negatively impact our ability to produce and supply our finished products. We continue to experience some extended lead times and delays in receiving supplies and finished goods which impacted revenue this period. We are working closely with our suppliers to manage orders and proactively resolve delays in the materials we require to meet our demand.
Liquidity
In the first quarter of 2020 we drew $60.0 million on our credit line as a precaution to ensure we have the necessary capital to continue to reliably serve our customers during an extended period of uncertainty. During the third quarter of 2020 we amended our Credit Agreement which extended the maturity date of the original agreement from September 23, 2021 to September 25, 2023, reduced the aggregate revolving credit facility from $225.0 million to $150.0 million, and amended certain covenants. During 2021, we repaid the full outstanding debt balance under our Credit Agreement and continued to maintain a strong cash position ending the period with $75.6 million in cash.
While we believe that we have sufficient liquidity to operate the Company for the foreseeable future, we are evaluating additional measures we could take to further enhance our liquidity position should negative economic conditions deteriorate for an extended period of time.
Impact to fair-value of intangible assets
We have reviewed the assets on our balance sheet, particularly goodwill and significant intangible assets for indications of impairment related to COVID-19 and determined that there are no indicators of impairment at this time. The values of these assets are particularly sensitive to our market cap and the long term value of their cash flows. If these conditions change
32
significantly, we may need to record an impairment to their value. However, any impairment charges would not require the use of cash and are excluded from the calculation of our debt covenants and therefore would not affect our ability to borrow under our existing credit line.
Government Grants
Various government programs have been established to provide financial relief for businesses affected by COVID-19 including the Canada Emergency Wage Subsidy (“CEWS”) and Canada Emergency Rent Subsidy (“CERS”) under the COVID-19 Economic Response Plan in Canada. We received $4.1 million for payroll subsidies under CEWS and CERS for the year ended December 31, 2021. Our policy is to account for these subsidies in the same manner as an offset to the expense they relate to in the period in which we are reasonably assured to receive payment. For the year ended December 31, 2021 we recognized reductions of $0.5 million in cost of sales, $1.7 million in marketing and selling expense, $1.7 million in research and development expense, and $0.2 million in general and administrative expense in the condensed consolidated statement of operations for these subsidies.
Travel restrictions and use of online technology
The global Natus team is geographically diverse with multiple small locations and hundreds of employees that typically work from home in normal circumstances. We use the latest collaboration technology and have been able to transition to a company-wide work from home model without major interruption. Our manufacturing, distribution and field service operations require physical presence of certain employees as their work requires them to handle our products. In these cases, we have made adjustments to shift size and schedule and limited access to these groups by non-related employees. Our field service technicians are following our customers' requirements for distancing practices but continue to provide service where needed.
Travel restrictions have forced most customer and external partner collaboration to online technology. Using this technology has enabled us to continue operations without incident. However, in-person customer engagement as well as physical presence in laboratory settings is returning and becoming more frequent.
Critical Accounting Estimates
We prepare our financial statements in accordance with accounting principles generally accepted in the United States of America (“GAAP”). In so doing, we must often make estimates and use assumptions that can be subjective and, consequently, our actual results could differ from those estimates. For any given individual estimate or assumption we make, there may also be other estimates or assumptions that are reasonable. Our estimates are based on our historical experience and a variety of other assumptions that we believe to be reasonable under the circumstances. We evaluate our estimates, assumptions, and judgements on a regular basis.
We believe that the following critical accounting estimates require the use of significant assumptions and judgments to have a full understanding of our financial statements. By their nature, these estimates and judgements are subject to an inherent degree of uncertainty. The use of different estimates, assumptions, and judgments could have a material effect on the reported amounts of assets, liabilities, revenue, expenses, and related disclosures as of the date of the financial statements and during the reporting period.
Inventory Valuation
Inventories are carried at the lower of cost or net realizable value, with cost being determined using the first-in, first-out method. The carrying value of our inventory is reduced for any difference between cost and estimated net realizable value of the inventory. We determine net realizable value by evaluating ending inventories for excess quantities, obsolescence, and other factors that could impact our ability to consume inventory for its intended use. The estimate for inventory valuation includes significant assumptions that have a high degree of subjectivity. For example, our evaluation includes an analysis of historical sales by product including judgements with respect to projections of future demand by product and qualitative analysis of obsolescence by product based on expectations from operations. Adjustments to the value of inventory establish a new cost basis and are considered permanent even if circumstances later suggest that increased carrying amounts are recoverable. If demand is higher than expected, we may sell inventory that had previously been written down.
33
Results of Operations
The following table sets forth for the periods indicated selected consolidated statement of income data as a percentage of total revenue. Our historical operating results are not necessarily indicative of the results for any future period.
 
Percent of Revenue
Years Ended December 31,
202120202019
Revenue100.0 %100.0 %100.0 %
Cost of revenue40.8 %44.7 %39.7 %
Intangibles amortization1.4 %3.2 %1.4 %
Gross profit57.8 %52.1 %58.9 %
Operating expenses:
Marketing and selling24.5 %25.8 %26.1 %
Research and development11.9 %14.7 %11.9 %
General and administrative11.1 %11.8 %12.0 %
Intangibles amortization3.6 %3.7 %3.1 %
Restructuring1.6 %0.9 %9.0 %
Total operating expenses52.8 %56.9 %62.1 %
Income (loss) from operations5.0 %(4.9)%(3.2)%
Other expense, net
(0.9)%(0.5)%(1.1)%
Income (loss) before provision (benefit) for income tax4.1 %(5.3)%(4.3)%
Provision (benefit) for income tax expense1.3 %(1.3)%(1.1)%
Net income (loss)2.8 %(4.0)%(3.2)%
Comparison of 2021 and 2020
Revenue 
 Years ended December 31,
 20212020Change
Neuro
Devices and Systems$220,929 $179,464 23 %
Supplies63,838 56,275 13 %
Total Neuro Revenue284,767 235,739 21 %
Newborn Care
Devices and Systems55,174 52,284 6 %
Supplies33,710 36,174 (7)%
Services16,139 16,566 (3)%
Total Newborn Care Revenue105,023 105,024 — %
Hearing & Balance
Devices and Systems$78,652 $70,738 11 %
Supplies4,996 4,183 19 %
Total Hearing & Balance Revenue83,648 74,921 12 %
Total Revenue$473,438 $415,684 14 %
For the year ended December 31, 2021, Neuro revenue increased by 21% compared to the prior year. Devices and Systems revenue increased by 23% and Supplies revenue increased by 13% compared to the prior year primarily due to the recovery from the impact of the global COVID-19 pandemic, as non-emergent procedures were halted in 2020.
For the year ended December 31, 2021, Newborn Care revenue remained flat compared to the prior year. Devices and Systems revenue increased by 6% due primarily to the recovery from the impact of the global COVID-19 pandemic, particularly in our Hearing Screening business. Supplies revenue decreased 7% compared to the prior year primarily due to
34
lower Hearing Screening supplies shipments, mostly due to production and supply chain constraints. Services revenue decreased by 3% compared to the prior year due to lower revenue from our Newborn Care business.
For the year ended December 31, 2021, Hearing & Balance revenue increased 12% compared to the prior year. Devices and Systems revenue increased by 11% compared to the prior year, particularly in our Hearing Assessment and Fitting businesses. Supplies revenue increased by 19% compared to the prior year, particularly in our Fitting business. The increases are primarily due to the recovery from the impact of the global COVID-19 pandemic, as non-emergent procedures were halted in 2020.
Cost of Revenue and Gross Profit
 Years ended December 31,
 20212020
Revenue$473,438 $415,684 
Cost of revenue193,015 185,912 
Intangibles amortization6,743 13,241 
Gross profit273,680 216,531 
Gross profit percentage57.8 %52.1 %
For the year ended December 31, 2021, our gross profit as a percentage of sales increased by 5.7% compared to the prior year. This increase was primarily attributable to higher revenue resulting from a partial recovery from the impact of the COVID-19 pandemic, a more profitable mix of product shipments, lower inventory scrap and lower amortization relating to an impairment of a product line during 2020.
Operating Costs
 Years ended December 31,
 20212020
Marketing and selling$116,014 $107,282 
Percentage of revenue24.5 %25.8 %
Research and development$56,306 $61,296 
Percentage of revenue11.9 %14.7 %
General and administrative$52,753 $49,113 
Percentage of revenue11.1 %11.8 %
Intangibles amortization$17,129 $15,224 
Percentage of revenue3.6 %3.7 %
Restructuring$7,699 $3,809 
Percentage of revenue1.6 %0.9 %
Marketing and Selling
Marketing and selling expenses increased during the year ended December 31, 2021 as compared to the prior year. The increase in expenses is mainly attributable to higher expenses as we moved towards more normal operating levels of the business, as compared to the impact of COVID-19, in the prior year which caused increases in travel expense, tradeshow and other events, payroll, commissions, and service expenses.
Research and Development
Research and development expenses decreased during the year ended December 31, 2021 compared to the prior year. The decrease relates to lower project spend for Medical Device Regulation compliance, consulting and testing, and remediation partly offset by increased spending on new product development.
General and Administrative
General and administrative expenses increased during the year ended December 31, 2021 compared to the prior year. This increase was due to more normal operating levels of the business as we recover from the impact of the global COVID-19 pandemic, resulting in increases in payroll expenses and outside services.
35
Intangibles Amortization
Intangibles amortization increased for the year ended December 31, 2021 compared to the prior year due to an intangible impairment of $2.0 million relating to the Babybe acquisition.
Restructuring
Restructuring costs increased during the year ended December 31, 2021 compared to the prior year. This increase was driven by costs of approximately $6.9 million associated with the Company’s executive management transition, which were primarily comprised of accelerated vesting of stock compensation, severance expense, and sign-on bonus.
Other Income (Expense), net
Other income (expense), net consists of interest income, interest expense, net currency exchange gains and losses, and other miscellaneous income and expense. We reported other expense, net of $4.4 million in the year ended December 31, 2021, compared to $1.9 million in the prior year. We reported $2.0 million of foreign currency exchange losses in the year ended December 31, 2021 versus $2.0 million of foreign currency gains in the prior year. Interest expense was $1.9 million in the year ended December 31, 2021 compared to $3.7 million in the prior year. The reduction in interest expense was driven by accelerated payments on and full repayment of our outstanding third-party bank debt. Other miscellaneous income and expense consisted primarily of a loss on our equity method investment of $0.6 million in the year December 31, 2021.
Provision for Income Tax
The effective tax rate (“ETR”) for the year ended December 31, 2021 was 31.9% as compared to 24.7% for the prior year. Significant items that impact the effective tax rate are the change in geographic mix of income and adjustments and reversals of uncertain tax positions.

For discussion of the year ended December 31, 2020 compared to the year ended December 31, 2019, please refer to Part II, Item 7 “Management's Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2020.

Liquidity and Capital Resources
Liquidity is our ability to generate sufficient cash flows from operating activities to meet our obligations and commitments. In addition, liquidity includes the ability to obtain appropriate financing and to raise capital. Therefore, liquidity cannot be considered separately from capital resources that consist of our current funds and the potential to increase those funds in the future. We plan to use these resources in meeting our commitments and in achieving our business objectives.
We believe that our current cash and cash equivalents and any cash generated from operations will be sufficient to meet our ongoing operating requirements for the foreseeable future.
As of December 31, 2021, we had cash and cash equivalents outside the U.S. in certain of our foreign operations of $30.3 million. We intend to permanently reinvest this cash held by our foreign subsidiaries except for Excel-Tech and Natus Ireland subsidiaries, which we intend to repatriate. If, however, a portion of these permanently reinvested funds were needed and distributed to our operations in the United States, we may be subject to additional U.S. income taxes and foreign withholding taxes depending on facts and circumstances at the time of distribution. The amount of taxes due would depend on the amount and manner of repatriation, as well as the location from where the funds were repatriated.
We have a Credit Agreement with JP Morgan Chase Bank (“JP Morgan”), Citibank, NA (“Citibank”) and Wells Fargo Bank, National Association (“Wells Fargo”). During the third quarter of 2020 we amended the terms of the Credit Agreement to extend the maturity of the original agreement and to reduce the aggregate value of revolving credit facility, and amend certain covenants. The amended Credit Agreement provides for an aggregate $150.0 million of secured revolving credit facility.
The Credit Agreement contains covenants, including covenants relating to maintenance of books and records, financial reporting and notification, compliance with laws, maintenance of properties and insurance, and limitations on guaranties, investments, issuance of debt, lease obligations and capital expenditures. The Credit Agreement provides for events of default, including failure to pay any principal or interest when due, failure to perform or observe covenants, bankruptcy or insolvency events and the occurrence of a material adverse effect. The Credit Agreement matures on September 25, 2023, at which time all principal amounts outstanding under the Credit Agreement will be due and payable. We have no other significant credit
36
facilities. As of December 31, 2021 we had no outstanding balance under the Credit Facility.
December 31, 2021December 31, 2020December 31, 2019
Cash, cash equivalents, and investments$75,595 $82,082 $63,297 
Debt— 55,840 54,665 
Working capital162,690 125,950 126,928 
 Year Ended
 December 31, 2021December 31, 2020December 31, 2019
Net cash provided by operating activities$63,995 $34,426 $60,060 
Net cash used in investing activities(1,946)(12,606)(5,339)
Net cash used in financing activities(60,662)(10,877)(48,532)
Comparison of 2021, 2020, and 2019
During 2021 cash generated from operating activities of $64.0 million was the result of $13.2 million of net income, non-cash adjustments to net income of $43.5 million, and net cash outflows of $7.3 million from changes in operating assets and liabilities. The non-cash adjustments were $28.1 million of depreciation and amortization expense, $14.2 million from share-based compensation, $4.0 million of warranty reserves, and $0.2 million of accounts receivable reserves, offset by deferred taxes of $4.4 million. Cash used in investing activities during the period was $1.9 million and consisted of cash used of $3.6 million to acquire other property and equipment, and $1.0 million of equity method investments offset by $2.7 million of proceeds from disposal of assets held for sale. Cash used in financing activities during the year ended December 31, 2021 was $60.7 million and consisted of repayments of $57.0 million of our outstanding debt under the Credit Facility, $4.1 million for taxes paid related to net share settlement of equity awards, $0.4 million of principal payments of financing lease liability, offset by proceeds from stock option exercises and Employee Stock Purchase Program (“ESPP”) purchases of $0.9 million.
During 2020 cash generated from operating activities of $34.4 million was the result of $16.6 million of net loss, non-cash adjustments to net loss of $49.6 million, and net cash outflows of $1.4 million from changes in operating assets and liabilities. The non-cash adjustments were $28.1 million of depreciation and amortization expense, $9.6 million from share-based compensation, $6.7 million of an impairment of intangible assets, $2.0 million of warranty reserves, $1.9 million of loss on commencement of sales-type leases, $1.4 million of non-cash lease expense, and $1.2 million of accounts receivable reserves, offset by deferred taxes of $1.6 million. Cash used in investing activities during the period was $12.6 million and consisted of cash used of $8.6 million to acquire other property and equipment, $2.0 million of an acquisition, and $2.0 million of equity method investments. Cash used in financing activities during the year ended December 31, 2020 was $10.9 million and consisted of repayments of $58.0 million of our outstanding debt under the Credit Facility, $10.5 million for repurchases of common stock under our share repurchase program, $2.0 million for taxes paid related to net share settlement of equity awards, $1.2 million of deferred debt issuance costs, $0.5 million of principal payments of financing lease liability, offset by proceeds from borrowing of $60.0 million and proceeds from stock option exercises and Employee Stock Purchase Program (“ESPP”) purchases of $1.3 million.
During 2019 cash generated from operating activities of $60.1 million was the result of $15.7 million of net loss, non-cash adjustments to net loss of $65.9 million, and net cash outflows of $9.9 million from changes in operating assets and liabilities. The non-cash adjustments were $30.7 million of depreciation and amortization expense, $24.6 million of impairment for the sale of Medix, $8.4 million from share-based compensation, $4.3 million of accounts receivable reserves, and $2.9 million of warranty reserves, offset by deferred taxes of $5.4 million. Cash used in investing activities during the period was $5.3 million and consisted of cash used to acquire other property and equipment. Cash used in financing activities during the year ended December 31, 2019 was $48.5 million and consisted of repayments of $50.0 million of our outstanding debt under the Credit Facility, $1.7 million for taxes paid related to net share settlement of equity awards, $0.5 million of principal payments of financing lease liability, offset by proceeds from stock option exercises and Employee Stock Purchase Program (“ESPP”) purchases of $3.6 million.
37
Future Liquidity
Our future liquidity and capital requirements will depend on numerous factors, including the:
•Extent to which we make acquisitions;
•Amount and timing of revenue;
•Extent to which our existing and new products gain market acceptance;
•Cost and timing of product development efforts and the success of these development efforts;
•Cost and timing of marketing and selling activities; and
•Availability to borrow under line of credit arrangements and the availability of other means of financing.
Contractual Obligations
In the normal course of business, we enter into obligations and commitments that require future contractual payments. The commitments result primarily from purchase orders placed with contract vendors that manufacture some of the components used in our medical devices and related disposable supply products, purchase orders placed for employee benefits and outside services, as well as commitments for leased office space, leased equipment, and bank debt.
As of December 31, 2021, we have unconditional purchase obligations of $136.5 million that payments are due within the next year and $41.9 million due within one to three years. Purchase obligations are defined as agreements to purchase goods or services that are enforceable and legally binding. Included in the purchase obligations are obligations related to purchase orders for inventory purchases under our standard terms and conditions and under negotiated agreements with vendors. We expect to receive consideration (products or services) for these purchase obligations. The purchase obligation amount does not represent all anticipated purchases in the future, but represent only those items for which we are contractually obligated. This does not include obligations under employment agreements for services rendered in the ordinary course of business.
As of December 31, 2021, we have estimated interest payments of $1.2 million due less than one year and $1.0 million due within one to three years. These interest payments are an estimate of expected interest payments but could vary materially based on the timing of future loan draws and payments. See Note 11 of our Consolidated Financial Statements for further discussion on debt and credit arrangements.
As of December 31, 2021, we have $5.60 million of tax obligation relating to repatriation tax. The repatriation tax is a one-time transition tax on the mandatory deemed repatriation of cumulative foreign earnings as of December 31, 2017 due to the enactment in December 2017 of the Tax Act.

We are not able to reasonably estimate the timing of any potential payments for uncertain tax positions under Accounting Standards Codification (“ASC”) 740, Accounting for Uncertainty in Income Taxes—an interpretation of FASB Statement 109, therefore contractual obligations exclude any potential tax payments related to our ASC 740 liability for uncertain positions. See Note 17 of our Consolidated Financial Statements for further discussion on income taxes.
Quantitative and Qualitative Disclosures about Market Risk
We are exposed to various market risks, including changes in foreign currency exchange rates and interest rates that could adversely affect our results of operations and financial condition.

Foreign Exchange Rate Risk
We develop products in the U.S, Canada, and Europe, and sell those products into more than 100 countries throughout the world. As a result, our financial results could be affected by factors such as changes in foreign currency exchange rates or weak economic conditions in foreign markets. Most of our sales in Europe and Asia are denominated in the U.S. Dollar and Euro, with a portion of our sales denominated in the Canadian dollar and British pound. As our sales in currencies other than the U.S. dollar increase, our exposure to foreign currency fluctuations may increase. We do not currently hold derivatives to hedge our exposure to foreign currency exchange rate fluctuations; however, we may choose to hedge our exposure in the future.
In addition, changes in exchange rates also may affect the end-user prices of our products compared to those of our foreign competitors, who may be selling their products based on local currency pricing. These factors may make our products less competitive in some countries.
All of the potential changes noted above are based on sensitivity analyses performed on our financial position as of December 31, 2021. Actual results may differ as our analysis of the effects of changes in interest rates does not account for, changes in the relationship between short-term and long-term interest rates.
38
Interest Rate Risk
    In 2018, we entered into an interest rate swap agreement with a notional amount of $40.0 million, designated as a cash flow hedge, to hedge the variability of cash flows in interest payments associated with our floating-rate debt. This interest rate swap agreement matured in September 2021 and converted a portion of our LIBOR floating-Rate debt to fixed-rate debt. We do not have plans to enter into another interest rate swap agreement at this time.

Cautionary Information Regarding Forward Looking Statements
This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 about Natus Medical Incorporated. Forward-looking statements can be identified by the words “expects”, “anticipates”, “believes”, “intends”, “estimates”, “plans”, “will”, “outlook” and similar expressions. Forward-looking statements are based on management's current plans, estimates, assumptions and projections, and speak only as of the date they are made. These forward-looking statements within Item 7 include, without limitation, statements regarding the impact of the COVID-19 pandemic on our business, the sufficiency of our current cash, cash equivalents and short-term investment balances, any cash generated from operations to meet our ongoing operating and capital requirements for the foreseeable future, outcomes of new product development, improved operations performance and profitability as the result of restructuring activities, and our intent to acquire additional technologies, products or businesses.
Forward-looking statements are not guarantees of future performance and are subject to substantial risks and uncertainties that could cause the actual results predicted in the forward-looking statements as well as our future financial condition and results of operations to differ materially from our historical results or currently anticipated results. Investors should carefully review the information contained under the caption “Risk Factors” contained in Item 1A of this report for a description of risks and uncertainties. All forward-looking statements are based on information available to us on the date hereof, and we assume no obligation to update forward-looking statements.

ITEM 7A.     Quantitative and Qualitative Disclosures About Market Risk
The information required by this Item is set forth in the section entitled Management’s Discussion and Analysis of Financial Condition and Results of Operations—Quantitative and Qualitative Disclosures About Market Risk, and is incorporated by reference in this section.
ITEM 8.     Financial Statements and Supplementary Data
The Consolidated Financial Statements and Supplementary Data required by this Item are set forth where indicated in Item 15 of this report.
ITEM 9.    Changes in and Disagreements With Accountants on Accounting and Financial Disclosure
None.
ITEM 9A.     Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Under the rules of the Securities and Exchange Commission, “disclosure controls and procedures” are controls and other procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in our reports that we file or submit under the Securities Exchange Act of 1934 is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.
Our management, including our chief executive officer and chief financial officer, does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud due to inherent limitations of internal controls. Because of such limitations, there is a risk that material misstatements will not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.
Our management, with the participation of our chief executive officer and our chief financial officer, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, our management, including our chief executive officer and chief financial officer, has concluded that our disclosure controls and procedures were effective as of December 31, 2021.
39
Management’s Report on Internal Control Over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) under the Exchange Act. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Internal control over financial reporting cannot provide absolute assurance of achieving financial reporting objectives because of the inherent limitations of any system of internal control. Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses of judgment and breakdowns resulting from human failures. Internal control over financial reporting also can be circumvented by collusion or improper overriding of controls. As a result of such limitations, there is risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.
Based on our evaluation under the criteria set forth in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, our management concluded that as of December 31, 2021 our internal control over financial reporting was effective to provide reasonable assurance regarding the reliability of financial reporting.
Our independent registered public accounting firm, KPMG LLP, has audited the consolidated financial statements included in this Annual Report on Form 10-K and also audited the effectiveness of our internal control over financial reporting as of December 31, 2021. KPMG LLP’s report over effectiveness of our internal control over financial reporting is included herein in Part II, Item 9A of this Annual Report on Form 10-K.
Changes in Internal Control over Financial Reporting
There has been no change in the Company's internal control over financial reporting during the Company's fourth quarter of 2021, that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

    
40
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Stockholders and Board of Directors
Natus Medical Incorporated:
Opinion on Internal Control Over Financial Reporting
We have audited Natus Medical Incorporated and subsidiaries’ (the Company) internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2021 and 2020, the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2021, and the related notes and financial statement schedule II: Valuation and Qualifying Accounts (collectively, the consolidated financial statements), and our report dated February 25, 2022 expressed an unqualified opinion on those consolidated financial statements.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ KPMG LLP
San Francisco, California
February 25, 2022

41
ITEM 9B.    Other Information
None.

ITEM 9C.    Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Not applicable.

PART III
We will provide information that is responsive to this Part III in our Definitive Proxy Statement for our 2022 Annual Meeting of Stockholders (our “2022 Proxy Statement”) or in an amendment to this Annual Report not later than 120 days after the end of the fiscal year covered by this Annual Report. That information is incorporated into this Part III by reference.
ITEM 10.    Directors, Executive Officers, and Corporate Governance
We will provide certain other information that is responsive to this Item 10 in our 2022 Proxy Statement or in an amendment to this Annual Report not later than 120 days after the end of the fiscal year covered by this Annual Report. That information is incorporated into this Item 10 by reference.
Audit Committee and Audit Committee Financial Expert
The members of the Audit Committee of our Board of Directors are Ilan Daskal, Eric J. Guerin, and Alice D. Schroeder. Our Board of Directors has determined that Ilan Daskal is an audit committee financial expert as defined in Item 407(d) of Regulation S-K. All of the members of our audit committee are considered “independent” as the term is used in Item 7(d)(3)(iv) of Schedule 14A under the Exchange Act.
Code of Conduct and Ethics
We have a code of conduct and ethics that applies to all of our employees, including our principal executive officer, principal financial officer, and principal accounting officer or controller. This code of conduct and ethics is posted on our internet website. The internet address for our website is www.natus.com, and the code of conduct and ethics may be found in the “Governance” section of our “Investor” webpage.
We intend to satisfy the disclosure requirement under Item 10 of Form 8-K regarding certain amendments to, or waivers from, provisions of this code of conduct and ethics by posting such information on our website, at the address and location specified above, or as otherwise required by The Nasdaq Stock Market.

ITEM 11.    Executive Compensation
We will provide information that is responsive to this Item 11 in our 2022 Proxy Statement or in an amendment to this Annual Report not later than 120 days after the end of the fiscal year covered by this Annual Report. That information is incorporated into this Item 11 by reference.

ITEM 12.     Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Equity Compensation Plan Information
The following table sets forth information about the number of shares of common stock that can be issued under our 2021 Stock Awards Plan as of December 31, 2021.
Plan CategoryNumber of Securities
to be Issued upon
Exercise of
Outstanding
Options, Warrants,
Awards and Rights		Weighted-Average
Exercise Price of
Outstanding
Options, Warrants,
Awards and Rights		Number of Securities
Remaining Available for
Future Issuance under
Equity Compensation Plans
(excluding securities
reflected in the first column)
Equity compensation plans approved by security holders860,966 $22.84 2,917,938 
Equity compensation plans not approved by security holders— — — 
Total860,966 22.84 2,917,938 
42
We will provide certain other information that is responsive to this Item 12 in our 2022 Proxy Statement or in an amendment to this Annual Report not later than 120 days after the end of the fiscal year covered by this Annual Report. That information is incorporated into this Item 12 by reference.
ITEM 13.     Certain Relationships and Related Transactions, and Director Independence
We will provide information that is responsive to this Item 13 in our 2022 Proxy Statement or in an amendment to this Annual Report not later than 120 days after the end of the fiscal year covered by this Annual Report. That information is incorporated into this Item 13 by reference.
ITEM 14.     Principal Accounting Fees and Services
We will provide information that is responsive to this Item 14 in our 2022 Proxy Statement or in an amendment to this Annual Report not later than 120 days after the end of the fiscal year covered by this Annual Report. That information is incorporated into this Item 14 by reference.
PART IV 
ITEM 15.    Exhibits, Financial Statement Schedules
(a)(2) Financial Statement Schedule
SCHEDULE II: VALUATION AND QUALIFYING ACCOUNTS
For the years ended December 31, 2021, 2020 and 2019
(In thousands)
Balance at
Beginning
of Period		Additions
Charged to
Expense		DeductionsBalance
at End
of Period
Year ended December 31, 2021
Allowance for doubtful accounts$6,213 $181 $(1,123)$5,271 
Valuation allowance969 — (35)934 
Warranty reserve5,195 3,989 (3,142)6,042 
Year ended December 31, 2020
Allowance for doubtful accounts$7,384 $1,190 $(2,361)$6,213 
Valuation allowance606 363 — 969 
Warranty reserve6,404 2,009 (3,218)5,195 
Year ended December 31, 2019
Allowance for doubtful accounts$6,960 $4,262 $(3,838)$7,384 
Valuation allowance637 — (31)606 
Warranty reserve9,391 3,949 (6,936)6,404 
(a)(3) Exhibits
The Exhibits listed in the Index to Exhibits, which appears immediately preceding the signature page and is incorporated herein by reference, are filed as part of this 10-K.
43
NATUS MEDICAL INCORPORATED
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

F-1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Stockholders and Board of Directors
Natus Medical Incorporated:
Opinion on the Consolidated Financial Statements
We have audited the accompanying consolidated balance sheets of Natus Medical Incorporated and subsidiaries (the Company) as of December 31, 2021 and 2020, the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2021, and the related notes and financial statement schedule II: Valuation and Qualifying Accounts (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2021, in conformity with U.S. generally accepted accounting principles.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated February 25, 2022 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.
Basis for Opinion
These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.
Evaluation of net realizable value adjustments for excess or obsolete inventory
As discussed in Note 4 to the consolidated financial statements, the Company had inventory with a carrying value of $81.4 million at December 31, 2021, of which $67.7 million is classified as current and $13.7 million is classified as non-current. As discussed in Note 1 to the consolidated financial statements, the Company reduces the carrying value of inventory for any differences between its cost and estimated net realizable value. Net realizable value is estimated by evaluating ending inventories for excess quantities, obsolescence, and other factors that potentially impact the Company’s ability to consume its inventory. In making its estimate of net realizable value, the Company’s evaluation includes an analysis of historical sales by product, projections of future demand by product, and obsolescence by product.
We identified the evaluation of net realizable value adjustments for excess or obsolete inventory as a critical audit matter. A high degree of auditor judgment was required in assessing the identification of the subset of inventory requiring net realizable value adjustments given the inherent uncertainty in projecting future demand and complexity involved in assessing the Company’s analysis of historical sales by product, projections of future demand, and assessment of obsolescence.
F-2
The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of an internal control related to the Company's identification of the subset of inventory requiring net realizable value adjustments. In evaluating potential excess inventory, we compared on-hand inventory to the Company's estimate of future inventory consumption. For certain products, we evaluated the estimate of future demand through an analysis of historical inventory sales by product and information obtained from the Company's manufacturing planning department. We obtained internal and external product inspection reports to identify inventory subject to remediation and evaluated the Company's assessment of obsolescence. We also compared the Company's estimate of net realizable value adjustments for identified excess or obsolete inventory to the prior period estimate and to actual inventory scrapping history.

/s/ KPMG LLP
We have served as the Company's auditor since 2014.

San Francisco, California
February 25, 2022

F-3
NATUS MEDICAL INCORPORATED
CONSOLIDATED BALANCE SHEETS
(In thousands, except share amounts) 
 December 31,
 20212020
ASSETS
Current assets:
Cash and cash equivalents$75,595 $82,082 
Accounts receivable, net of allowance for doubtful accounts of $5,271 and $6,213111,760 93,133 
Inventories67,745 75,650 
Prepaid expenses and other current assets22,191 20,837 
Total current assets277,291 271,702 
Property and equipment, net21,783 24,516 
Operating lease right-of-use assets9,288 11,669 
Intangible assets, net65,513 92,741 
Goodwill148,657 151,299 
Deferred income tax23,161 27,563 
Other assets18,595 20,904 
Total assets$564,288 $600,394 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$36,405 $23,429 
Current portion of long-term debt— 50,000 
Current portion of operating lease liabilities4,964 6,779 
Accrued liabilities48,135 44,236 
Deferred revenue25,097 21,308 
Total current liabilities114,601 145,752 
Long-term liabilities:
Other liabilities17,237 18,451 
Long-term debt— 5,840 
Operating lease liabilities 6,567 8,959 
Deferred income tax1,133 10,298 
Total liabilities139,538 189,300 
Commitments and contingencies (Note 20)
Stockholders’ equity:
Common stock, $0.001 par value; 120,000,000 shares authorized; shares issued and outstanding 34,225,682 in 2021 and 33,911,703 in 2020353,737 342,828 
Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding in 2021 and in 2020— — 
Retained earnings84,486 71,309 
Accumulated other comprehensive loss(13,473)(3,043)
Total stockholders’ equity424,750 411,094 
Total liabilities and stockholders’ equity$564,288 $600,394 
The accompanying notes are an integral part of these Consolidated Financial Statements.
F-4
NATUS MEDICAL INCORPORATED
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts) 
 Years Ended December 31,
 202120202019
Revenue$473,438 $415,684 $495,175 
Cost of revenue193,015 185,912 196,551 
Intangibles amortization6,743 13,241 6,916 
Gross profit273,680 216,531 291,708 
Operating expenses:
Marketing and selling116,014 107,282 129,109 
Research and development56,306 61,296 58,733 
General and administrative52,753 49,113 59,649 
Intangibles amortization17,129 15,224 15,144 
Restructuring7,699 3,809 44,739 
Total operating expenses249,901 236,724 307,374 
Income (loss) from operations23,779 (20,193)(15,666)
Other expense, net(4,424)(1,872)(5,591)
Income (loss) before provision (benefit) for income tax19,355 (22,065)(21,257)
Provision (benefit) for income tax6,178 (5,452)(5,586)
Net income (loss)$13,177 $(16,613)$(15,671)
Net income (loss) per share:
Basic$0.39 $(0.49)$(0.47)
Diluted$0.39 $(0.49)$(0.47)
Weighted average shares used in the calculation of net income (loss) per share:
Basic33,670 33,562 33,696 
Diluted33,974 33,562 33,696 
The accompanying notes are an integral part of these Consolidated Financial Statements.
F-5
NATUS MEDICAL INCORPORATED
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(In thousands, except per share amounts) 
 Years Ended December 31,
 202120202019
Net income (loss)13,177 (16,613)(15,671)
Other comprehensive income (loss):
Foreign currency translation adjustment(10,640)13,205 (1,576)
Interest rate swap designated as a cash flow hedge119 27 (180)
Reclassification of losses on interest rate swap designated as a cash flow hedge91 — — 
Reclassification of stranded tax effects upon adoption of ASU 2018-02— — (1,332)
Reclassification of deferred foreign currency related adjustments related to the sale of Medix (See FN 22)
— — 24,845 
Total other comprehensive income (loss) (10,430)13,232 21,757 
Comprehensive income (loss)$2,747 $(3,381)$6,086 
The accompanying notes are an integral part of these Consolidated Financial Statements.


F-6
NATUS MEDICAL INCORPORATED
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(In thousands, except share amounts) 
 Common StockRetained
Earnings		Accumulated
Other
Comprehensive
Loss		Stockholders’
Equity
 SharesAmount
Balances, December 31, 201833,804,379 $334,215 $102,261 $(38,032)$398,444 
Reclassification of stranded tax effects for ASU 2018-02— — 1,332 (1,332)— 
Vesting of restricted stock units42,130 — — — — 
Net issuance of restricted stock awards175,833 — — — — 
Employee stock purchase plan53,839 1,354 — — 1,354 
Stock-based compensation expense— 8,315 — — 8,315 
Taxes paid related to net share settlement of equity awards(51,784)(1,689)— — (1,689)
Exercise of stock options124,303 2,281 — — 2,281 
Other comprehensive income— — — 23,089 23,089 
Net loss— — (15,671)— (15,671)
Balances, December 31, 201934,148,700 $344,476 $87,922 $(16,275)$416,123 
Vesting of restricted stock units14,033 — — — — 
Net issuance of restricted stock awards204,057 — — — — 
Employee stock purchase plan73,347 1,314 — — 1,314 
Stock-based compensation expense— 9,527 — — 9,527 
Repurchase of company stock(465,117)(10,495)— — (10,495)
Taxes paid related to net share settlement of equity awards(63,317)(1,994)— — (1,994)
Other comprehensive income— — — 13,232 13,232 
Net loss— — (16,613)— (16,613)
Balances, December 31, 202033,911,703 $342,828 $71,309 $(3,043)$411,094 
Vesting of restricted stock units205,082 — — — — 
Net issuance of restricted stock awards252,064 — — — — 
Employee stock purchase plan28,158 611 — — 611 
Stock-based compensation expense— 14,161 — — 14,161 
Taxes paid related to net share settlement of equity awards
(183,112)(4,107)— — (4,107)
Exercise of stock options11,787 244 — — 244 
Other comprehensive income— — — (10,430)(10,430)
Net loss— — 13,177 13,177 
Balances, December 31, 202134,225,682 $353,737 $84,486 $(13,473)$424,750 
The accompanying notes are an integral part of these Consolidated Financial Statements.
F-7
NATUS MEDICAL INCORPORATED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
 Year Ended December 31,
202120202019
Operating activities:
Net income (loss)$13,177 $(16,613)$(15,671)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Provision for losses on accounts receivable181 1,190 4,262 
Depreciation and amortization28,091 28,115 30,722 
Loss on commencement of sales-type leases3 1,881 — 
Loss on equity method investment adjustment602 133 — 
(Gain) Loss on disposal of property and equipment(1,426)268 449 
Impairment of intangible assets2,004 6,678 — 
Impairment of property and equipment279 — — 
Impairment charge for sale of entity— — 24,571 
Warranty reserve3,989 2,009 2,886 
Stock-based compensation14,161 9,566 8,352 
Non cash lease expense— 1,353 — 
Deferred taxes(4,386)(1,577)(5,364)
Changes in operating assets and liabilities, net of assets and liabilities acquired in acquisitions:
Accounts receivable(13,111)17,651 7,139 
Inventories4,830 1,939 7,185 
Other assets(1,880)(1,055)(2,486)
Accounts payable13,530 (4,523)(1,367)
Accrued liabilities(507)(13,427)(4,010)
Deferred revenue4,458 838 3,392 
Net cash provided by operating activities63,995 34,426 60,060 
Investing activities:
Acquisition of businesses, net of cash acquired— (1,997)— 
Acquisition of property and equipment(3,620)(8,609)(5,326)
Acquisition of intangible assets— — (13)
Proceeds from sale of property and equipment2,674 — — 
Purchases of equity investments(1,000)(2,000)— 
Net cash used in investing activities(1,946)(12,606)(5,339)
Financing activities:
Proceeds from stock option exercises and ESPP855 1,314 3,635 
Principal payments of financing lease liability(410)(527)(478)
Repurchase of company stock— (10,495)— 
Taxes paid related to net share settlement of equity awards(4,107)(1,994)(1,689)
Proceeds from long-term borrowings— 60,000 — 
Deferred debt issuance costs— (1,175)— 
Payments on borrowings(57,000)(58,000)(50,000)
Net cash used in financing activities(60,662)(10,877)(48,532)
Exchange rate effect on cash and cash equivalents(7,874)7,842 735 
Net increase (decrease) in cash and cash equivalents(6,487)18,785 6,924 
Cash and cash equivalents, beginning of year82,082 63,297 56,373 
Cash and cash equivalents, end of year$75,595 $82,082 $63,297 
Supplemental disclosure of cash flow information:
Cash paid for interest$1,180 $3,110 $4,580 
Cash paid for income taxes$3,782 $6,825 $6,445 
Non-cash investing activities:
Property and equipment included in accounts payable$56 $(51)$69 
Inventory transferred to property and equipment$1,167 $1,303 $300 
Transfer of leased assets to sales-type leases$13 $4,107 $— 
 The accompanying notes are an integral part of these Consolidated Financial Statements.
F-8
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Years Ended December 31, 2021, 2020 and 2019
1—ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES
Organization
Natus Medical Incorporated (“we”, “our”, “us”) was incorporated in California in May 1987 and reincorporated in Delaware in August 2000. We are a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, software systems for managing and tracking disorders and diseases for public health laboratories, computer-based audiological, otoneurologic and vestibular instrumentation for hearing and balance care professionals.
Basis of Presentation and Principles of Consolidation
The accompanying Consolidated Financial Statements includes our accounts and accounts of our wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Certain reclassifications to the prior periods have been made to conform to the current period presentation.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the Consolidated Financial Statements and the reported amount of revenue and expenses during the reporting period. Such estimates include allowances for potentially uncollectible accounts receivable, valuation of inventory, intangible assets, goodwill, share-based compensation, valuation of deferred income taxes, reserves for warranty obligations, and the provision for income taxes including uncertain positions. Actual results could differ from those estimates.
Revenue recognition
Revenue is recognized when obligations under the terms of a contract with a customer are satisfied; generally this occurs with the transfer of control of devices, supplies, or services. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services.
For the majority of devices and supplies, we transfer control and recognize revenue when products ship from the warehouse to the customer. We generally do not provide rights of return on devices and supplies. Freight charges billed to customers are included in revenue and freight-related expenses are charged to cost of revenue.
Depending on the terms of the arrangement, we may also defer the recognition of a portion of the consideration received because we have to satisfy a future obligation (e.g. installation). Judgment is required to determine the standalone selling price for each distinct performance obligation. Our estimate of SSP is a point estimate.  The estimate is calculated annually for each performance obligation that is not sold separately. In instances where SSP is not directly observable, such as when we do not sell the product or service separately, the SSP is determined using information that may include market conditions and other observable inputs.
We sell separately-priced service contracts that extend maintenance coverages for both medical devices and data management systems beyond the base agreements to customers. The separately priced service contracts range from 12 months to 60 months. We receive payment at the inception of the contract and recognize revenue ratably over the service period.
For products containing embedded software, we have determined that the hardware and software components function together to deliver the products' essential functionality and are considered a combined performance obligation. Revenue recognition policies for sales of these products are substantially the same as for other tangible products.
Inventory Valuation
Inventories are carried at the lower of cost or net realizable value, with cost being determined using the first-in, first-out method. The carrying value of our inventory is reduced for any difference between cost and estimated net realizable value of the inventory. We determine net realizable value by evaluating ending inventories for excess quantities, obsolescence, and other factors that could impact our ability to consume inventory for its intended use. Our evaluation includes an analysis of historical sales by product, projections of future demand by product, and an analysis of obsolescence by product. Adjustments to the
F-9
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Years Ended December 31, 2021, 2020 and 2019
value of inventory establish a new cost basis and are considered permanent even if circumstances later suggest that increased carrying amounts are recoverable. If demand is higher than expected, we may sell inventory that had previously been written down.
Intangible assets
We amortize intangible assets with finite lives over the estimate of their useful lives. Any future changes that would limit their useful lives or any determination that these assets are carried at amounts greater than their estimated fair value could result in acceleration of amortization over a revised useful life.
We review intangible assets with indefinite lives for impairment on an annual basis and finite lives for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Recoverability of the finite-lived intangible assets is assessed based on the estimated undiscounted future cash flows expected to result from the use and eventual disposition of the asset. If the undiscounted future cash flows are less than the carrying amount, the finite-lived intangible assets are considered to be impaired. The amount of the impairment loss, if any, is measured as the difference between the carrying amount of the asset and its fair value. We estimate the fair value of finite-lived intangible assets by using an income approach or, when available and appropriate, using a market approach.
Goodwill
Goodwill is not amortized but is subject to an annual impairment analysis, which is performed as of October 1st; this assessment is also performed whenever there is a change in circumstances that indicates the carrying value of goodwill may be impaired.
Goodwill is tested for impairment at the reporting unit level. Our three strategic business units, Neuro, Newborn Care and Hearing & Balance are consolidated into one unit. We have concluded that we have one operating segment and one reporting unit for purposes of goodwill impairment testing in 2021, 2020, and 2019.
In accordance with accounting standards we perform a qualitative assessment to test goodwill for impairment prior to the performing the first step of the goodwill impairment process. Qualitative factors considered in this assessment include industry and market considerations, overall financial performance and other relevant events and factors affecting the reporting unit.
Based on the qualitative assessment in 2021, 2020, and 2019, we determined the fair value of goodwill was more likely than not greater than its carrying amount, and no further analysis was needed.
Lessee Leases
We determine if an arrangement is a lease at inception of the lease. Right-of-use (“ROU”) assets represent the right to use an underlying asset for the lease term, and lease liabilities represent an obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit borrowing rate, generally we use an incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at the lease commencement date. We use the implicit rate when readily determinable. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include options to exclude or terminate the lease when it is reasonably certain that they will exercise that option. Lease expense for lease payments are recognized on a straight-line basis over the lease term.
Operating leases are included in operating lease ROU assets, accrued liabilities, and operating lease liabilities in our consolidated balance sheet. Finance leases are included in property and equipment, accrued liabilities, and other liabilities in the consolidated balance sheet.
We have lease agreements with lease and non-lease components, which are generally accounted for based on the type of asset. For real estate and telecom leases, we account for these components separately. For equipment leases, such as office equipment and vehicles, we account for the lease and non-lease components as a single lease component.
Lessor Leases
We determine if an arrangement is a lease at inception of the lease. We entered into a five-year non-cancelable exclusive supply agreement with a customer to provide hearing screening products which commenced on January 1, 2020. The agreement includes automatic renewal options for successive three-year periods. Notice of non-renewal must be provided to Natus at least twelve months prior to the end of the current term. The agreement does not contain any purchase options or residual value guarantees.
F-10
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Years Ended December 31, 2021, 2020 and 2019
Pricing of the exclusive supply agreement is structured on a fee per baby screened basis. The per baby fee is inclusive of all products and services to be provided under the terms of the agreement which include hearing screening hardware, consumables required to complete each screen, and related maintenance. The pricing structure also includes a guaranteed minimum payment per unit per contract year for each unit of equipment supplied.
Sales-Type Leases
The guaranteed minimum payment for each unit of equipment supplied represents the fixed transaction price and is allocated to separate performance obligations, consisting of hardware products, consumables, and maintenance, proportionally based on the standalone selling price of each performance obligation. Standalone selling price is best evidenced by the price we charge for the good or service when selling it separately in similar circumstances to similar customers. Other than for the renewal of annual support services contracts, our products and services are not generally sold separately. We use an amount discounted from the list price as a best estimated selling price.
For sales-type leases, we recognize revenues for hearing screening hardware products at the net present value of their guaranteed minimum payment standalone selling price allocation upon delivery of the hardware. We recognize consumables and maintenance revenues associated with the sales-type leases over the term of the agreement on a weighted average as actual screens are performed.
Operating Leases
Under the terms of the exclusive supply agreement, hospitals where we were previously providing hearing screening services were provided the option to transition to the exclusive supply agreement. Hospitals which chose to transition continued to use their existing Natus hardware. Based on the remaining useful life of the existing hardware and the date new hardware is supplied after the commencement of the lease, some of these leases were classified as operating leases.
For operating leases, rental income is recognized on a straight-line basis over the term of the associated lease. Leased assets classified as operating leases are carried at amortized cost net of accumulated depreciation in property and equipment, net on the condensed consolidated balance sheet. The depreciation expense of the leased assets is recognized on a straight-line basis over the useful life of the asset, and recorded in cost of revenue in the condensed consolidated statements of operations.
Long lived assets
We continually monitor events and changes in circumstances that could indicate that carrying amounts of our long-lived assets, including property and equipment, intangible assets and leases, may not be recoverable. When such events or changes in circumstances occur, we will assess the recoverability by determining whether the carrying value of an asset group will be recovered through undiscounted expected future cash flows. If the future undiscounted cash flows are less than the carrying amount of the asset group, we will recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets.
Liability for product warranties
We provide a warranty for products that is generally one year in length. In some cases, regulations may require us to provide repair or remediation beyond the typical warranty period. If any products contain defects, we may be required to incur additional repair and remediation costs. Service, repair and calibration services are provided by a combination of our owned facilities and vendors on a contract basis.
We accrue estimated product warranty costs at the time of sale based on historical experience. A warranty reserve is included in accrued liabilities for the expected future costs of servicing products. Additions to the reserve are based on management’s best estimate of probable liability. We consider a combination of factors including material and labor costs, regulatory requirements, and other judgments in determining the amount of the reserve. The reserve is reduced as costs are incurred to honor existing warranty and regulatory obligations.
Share-based compensation
We recognize share-based compensation expense associated with employee stock options under the single-option straight line method over the requisite service period, which is generally a four-year vesting period and ten-year contractual term pursuant to ASC Topic 718, Compensation-Stock Compensation. See Note 15 of the Consolidated Financial Statements.
For employee stock options, the value of each option is estimated on the date of grant using the Black-Scholes option pricing model, which was developed for use in estimating the value of freely traded options. Similar to other option pricing models, the Black-Scholes method requires the input of highly subjective assumptions, including stock price volatility. Changes in the subjective input assumptions can materially affect the estimated fair value of the employee stock options.
F-11
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Years Ended December 31, 2021, 2020 and 2019
We recognize share-based compensation associated with Restricted Stock Awards (“RSA”) and Restricted Stock Units (“RSU”). RSAs and RSUs vest ratably over a three-year period for employees. RSAs and RSUs for executives vest over a four-year period; 25% on each of the annual anniversaries. RSAs and RSUs for non-employees (Board of Directors) vest over a one-year period; 100% on the first anniversary. The value is estimated based on the market value of Natus common stock on the date of issuance pursuant to ASC Topic 718, Compensation-Stock Compensation.
We grant market stock unit (“MSU”) awards to certain employees. We estimate the fair value of MSUs at the date of grant using a Monte Carlo simulation model and amortize those fair values over the requisite service period, which is generally three years. The Monte Carlo simulation model that we use to estimate the fair value of market-based MSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the market-based MSUs, which is determined at the date of grant, must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the achievement of the specified market criteria.
We also grant performance stock unit (“PSU”) awards to our CEO and CFO. These PSUs fully vest after a performance period and have separate performance goals than MSUs. We estimate fair value of performance stock unit awards based on the share price and other pertinent factors on the grant date. Compensation expense for performance stock unit awards are recognized on a straight-line basis over the requisite service period of the award when performance condition is probable to occur. We assess the achievement probability of the performance conditions each period and adjust compensation expense if necessary. Provided that the requisite service is rendered, the shares will become vested and payout will occur based on the outcome of the performance condition. Any unrecognized compensation cost shall be recognized when the award becomes vested.
We issue new shares of common stock upon the exercise of stock options and the vesting of RSAs, RSUs, MSUs, and PSUs.
Forfeitures of employee stock options and awards are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. Share-based compensation expense is recorded net of estimated forfeitures, such that expense is recorded only for those share-based awards that are expected to vest.
Cash Equivalents
All highly liquid investments purchased with an original maturity or remaining maturity upon purchase of three months or less are classified as cash equivalents.
Allowance for Doubtful Accounts
We estimate the allowance for potentially uncollectible accounts receivable based on historical collection experience within the markets in which we operate and other customer-specific information, such as bankruptcy filings or customer liquidity problems. When all internal efforts have been exhausted to collect the receivable, it is written off and relieved from the reserve.
Fair Value of Financial Instruments
Financial instruments include cash and cash equivalents, accounts receivable, and accounts payable. Cash is reported at its fair value on the balance sheet dates. The recorded carrying amounts of accounts receivable and accounts payable approximate their fair values due to the short-term maturities.
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation. Depreciation expense is computed using the straight-line method over estimated useful lives of the respective assets, which are three to five years for office furniture and equipment, computer software and hardware, demonstration and loaned equipment, and 30 to 40 years for buildings. Leasehold improvements are amortized over the shorter of the lease term or the estimated useful life of the improvement. Land is not depreciated. Costs associated with acquiring and installing software to be used for internal purposes are capitalized and amortized on a straight-line basis over three years.
Research & Development Costs
Costs incurred in research and development are charged to operations as incurred.
F-12
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Years Ended December 31, 2021, 2020 and 2019
Income Taxes
We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statements carrying value of assets and liabilities and the tax basis of those assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.
We record net deferred tax assets to the extent it is more likely than not that the assets will be realized. In making such determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations. To the extent that previously reserved deferred tax assets are estimated to be realizable, we adjust the valuation allowance which reduces the provision for income taxes.
We recognize the tax benefit of uncertain tax positions in the financial statements as defined in ASC Topic 740, Income Tax. When the tax position is deemed more likely than not of being sustained, we recognize the largest amount of tax benefit that is greater than 50 percent likely of being ultimately realized upon settlement, as defined in ASC 740-10-05.
Foreign Currency
The functional currency of our subsidiaries outside of North America is generally the local currency of the country where the subsidiary is located. Accordingly, foreign currency translation adjustments relating to the translation of foreign subsidiary financial statements are included as a component of accumulated other comprehensive loss. We have recorded $(10.6) million, $13.2 million, and $(1.6) million of foreign currency translation gains (losses) for the years ended December 31, 2021, 2020 and 2019, respectively.
Gains and losses from transactions denominated in currencies other than the functional currencies are included in other income and expense. In 2021, 2020, and 2019, net foreign currency transaction gains (losses) were $(2.0) million, $2.0 million, and $(0.8) million, respectively. Foreign currency gains and losses result primarily from fluctuations in the exchange rate between the U.S. dollar, Canadian dollar, Euro, British pound, and Danish kroner.
We divested our wholly owned subsidiary, Medix, on April 2, 2019 via a stock sale. Included in the year ended December 31, 2019 is the impact of the sale of Medix, which was completed as of June 30, 2019, and the deferred foreign currency related translation adjustments previously in accumulated other comprehensive income have been released from the balance sheet along with the held for sale accrual (See Note 22 - Sale of a Certain Subsidiary).
Comprehensive Income
We break out the major components and report as a single total the change in net assets during the period as defined in ASC Topic 220, Comprehensive Income. The consolidated statement of comprehensive income (loss) has been separately stated from the consolidated statements of operations. Accumulated other comprehensive loss consists of translation gains and losses on foreign subsidiary financial statements, interest rate swap designated as a cash flow hedge, reclassifications from the adoption of ASU 2018-02, and reclassification of previously recorded deferred foreign currency related translation adjustment losses upon the divestiture of Medix.
Basic and Diluted Net Income per Share
We compute net income per share as defined in ASC Topic 260, Earnings per Share. Basic net income per share is based upon the weighted average number of common shares outstanding during the period. Diluted net income per share is based upon the weighted average number of common shares outstanding and dilutive common stock equivalents outstanding during the period. Common stock equivalents are options granted, shares of restricted stock, and shares of market stock issued under the stock awards plans and are calculated under the treasury stock method. Common equivalent shares from unexercised stock options and restricted stock are excluded from the computation when there is a loss as the effect is anti-dilutive, or if the exercise price of such options is greater than the average market price of the stock for the period.
Recently Adopted Accounting Pronouncements
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740), Simplifying the Accounting for Income Tax. This update includes removal of certain exceptions to the general principles of ASC 740, Income taxes, and simplification in several other areas such as accounting for franchise tax (or similar tax) that is partially based on income. We early adopted the ASU in the second quarter of 2020. Upon adoption, we recorded an additional income tax benefit of $0.9 million due to the elimination of the year-to-date loss limitation rules that limited the interim tax period tax benefit.
F-13
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Years Ended December 31, 2021, 2020 and 2019
In October 2020, the FASB issued ASU 2020-10, Codification Improvements. This update improves consistency by amending the Codification to include all disclosure guidance in appropriate disclosure sections. Also, the update clarifies application of various provisions in the Codification by amending and adding new headings, cross-referencing to other guidance, and refining or correcting terminology. ASU 2020-10 was effective for annual period starting December 15, 2020. The adoption of this ASU did not have an impact on our consolidated financial statements.
In July 2021, the FASB issued ASU 2021-05, Leases (Topic 842): Lessors-Certain Leases with Variable Lease Payments. This update addresses stakeholders' concerns by amending the lease classification requirements for lessors to align them with practice under Topic 840. Lessors should classify and account for a lease with variable lease payments that do not depend on a reference index or a rate as an operating lease if the lease would have been classified as a sales-type lease or a direct financing lease in accordance with 842-10-25-2 through 25-3 and the lessors would have otherwise recognized a day-one loss. ASU 2021-05 is effective for fiscal years beginning after December 15, 2021. We have early adopted the ASU on a prospective basis in the third quarter of the current fiscal year. The adoption of ASU 2021-05 did not have an impact on our consolidated financial statements.

2—REVENUE
    Contract assets for the periods presented primarily represent the difference between revenue recognized based on the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Deferred revenue for the periods presented was primarily related to extended service contracts, installation, and training, for which the service fees are billed up-front. The associated deferred revenue is generally recognized ratably over the extended service period or when installation and training are complete.

The following table summarized the changes in the contract assets and contract liability balances for the year ended December 31, 2021 (in thousands):

Unbilled AR, December 31, 2020$1,925 
Additions58 
Transferred to Trade Receivable(1,731)
Unbilled AR, December 31, 2021$252 
Deferred Revenue, December 31, 2020$25,723 
Additions24,053 
Revenue Recognized(19,679)
Deferred Revenue, December 31, 2021$30,097 
    At December 31, 2021, the contract assets of $0.3 million were included in accounts receivable in the consolidated balance sheet. At December 31, 2021, the short-term portion of the contract liability of $25.1 million and the long-term portion of $5.0 million were included in deferred revenue and other long-term liabilities respectively, in the consolidated balance sheet. As of December 31, 2021, we expect to recognize revenue associated with deferred revenue of approximately $25.0 million in 2022, $2.7 million in 2023, $1.5 million in 2024, $0.5 million in 2025, and $0.4 million thereafter.

F-14
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Years Ended December 31, 2021, 2020 and 2019
3—ALLOWANCE FOR DOUBTFUL ACCOUNTS

We estimate the lifetime allowance for doubtful, potentially uncollectible, accounts receivable upon their inception based on historical collection experience within the markets in which we operate, customer-specific information such as bankruptcy filings or customer liquidity problems, current conditions, and reasonable and supportable forecasts about the future.
Our allowance for doubtful accounts is presented as a reduction to accounts receivable on our consolidated balance sheet. When all internal efforts have been exhausted to collect the receivable, it is written off and relieved from the reserve.
The details of activity in allowance for doubtful accounts are as follows (in thousands):
 December 31,
 20212020
Balance, beginning of period$6,213 $7,384 
Additions charged to expense181 1,190 
Write-offs charged against allowance(1,123)(2,361)
Balance, end of period$5,271 $6,213 

4—INVENTORIES
Inventories consist of (in thousands):
 December 31,
 20212020
Raw materials and subassemblies$20,750 $22,583 
Work in process2,825 2,294 
Finished goods57,836 65,695 
Total Inventories81,411 90,572 
Less: Non-current Inventories(13,666)(14,922)
Inventories$67,745 $75,650 
Non-current inventory consists of service components used to repair products held by customers pursuant to warranty obligations and extended service contracts, including service components for products that we no longer sell, inventory purchased for lifetime buys, inventory built as a last-time build, and inventory that is turning at a slow rate. We believe that these inventories will be utilized for their intended purpose.

5—PROPERTY AND EQUIPMENT
Property and equipment consist of (in thousands):
 December 31,
 20212020
Land$1,782 $1,792 
Buildings7,238 7,365 
Leasehold improvements7,722 8,050 
Finance lease right-of-use assets2,356 2,555 
Office furniture and equipment20,637 22,148 
Computer software and hardware11,308 10,246 
Demonstration and loaned equipment4,050 3,086 
55,093 55,242 
Accumulated depreciation(33,310)(30,726)
Total$21,783 $24,516 
Depreciation expense of property and equipment was $6.3 million, $6.2 million, and $6.6 million in the years ending December 31, 2021, 2020 and 2019, respectively.
F-15
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Years Ended December 31, 2021, 2020 and 2019

6—INTANGIBLE ASSETS
The following table summarizes the components of gross and net intangible asset balances (in thousands):
 December 31, 2021December 31, 2020
 Gross
Carrying
Amount		Accumulated
Impairment		Accumulated
Amortization		Net Book
Value		Gross
Carrying
Amount		Accumulated
Impairment		Accumulated
Amortization		Net Book
Value
Intangible assets with definite lives:
Technology$99,920 (6,039)$(66,679)$27,202 $112,138 (12,480)$(64,203)$35,455 
Customer related89,794 (50)(57,133)32,611 94,526 (50)(51,247)43,229 
Trade names45,593 (3,260)(36,960)5,373 47,058 (3,677)(31,890)11,491 
Internally developed software13,281 — (12,985)296 13,281 — (12,845)436 
Patents2,705 (133)(2,572)— 2,810 (133)(2,677)— 
Service Agreements800 — (769)31 1,190 — (1,119)71 
Total definite-lived intangible assets252,093 (9,482)(177,098)65,513 271,003 (16,340)(163,981)90,682 
Intangible assets with indefinite lives:
Intellectual Property2,004 (2,004)— — 2,059 — — 2,059 
Total intangible assets254,097 (11,486)(177,098)65,513 273,062 (16,340)(163,981)92,741 
Finite lived intangible assets are amortized over their weighted average lives, which are 14 years for technology, 13 years for patents, 10 years for customer-related intangibles, 7 years for trade names, 6 years for internally developed software, 2 years for service agreements, and 11 years weighted average in total.
Internally developed software consists of $11.1 million relating to costs incurred for development of internal use computer software and $2.2 million for development of software to be sold.
During the third quarter of 2020 we recorded an impairment charge related to intangible assets of $6.7 million of which $6.4 million was recorded within intangibles amortization within cost of revenue and $0.3 million was recorded within intangibles amortization within operating expense on our income statement. The impairment related to an end of life decision for an acquired tradename and technology at which time we made the decision to discontinue sales of the related product rather than continuing to invest in the product.
During the fourth quarter of 2021 we recorded an impairment charge related to intangible assets of $2.0 million which was recorded within intangibles amortization within operating expense on our income statement. The impairment was a management decision to abandon further development of the product using intellectual property.
Amortization expense related to intangible assets with finite and indefinite lives, including impairment charges described above, was as follows (in thousands):
 Years Ended December 31,
 202120202019
Technology$6,907 $13,417 $6,906 
Customer related9,040 8,825 8,662 
Trade names5,881 6,182 6,111 
Intellectual Property2,004 — — 
Internally developed software141 239 1,438 
Patents— — 60 
Service Agreements40 40 322 
Total amortization$24,013 $28,703 $23,499 
The amortization expense amounts shown above include internally developed software not held for sale of $0.1 million, $0.2 million, and $1.3 million for the years ended 2021, 2020, and 2019, respectively. The amortization expense for internally developed software not held for sale is recorded within our income statement as a general and administrative operating expense. The amount in the table shown above for intellectual property relates to the impairment charge recorded during the fourth quarter of 2021.
F-16
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Years Ended December 31, 2021, 2020 and 2019
Expected annual amortization expense related to amortizable intangible assets is as follows (in thousands):
2022$17,634 
202314,865 
202412,970 
202512,362 
20262,408 
Thereafter5,274 
Total expected amortization expense$65,513 
        
7—GOODWILL
The carrying amount of goodwill and the changes in those balances are as follows (in thousands):
As of December 31, 2019$146,367 
Purchase Accounting Adjustments1,207 
Foreign currency translation$3,725 
As of December 31, 2020151,299 
Foreign currency translation(2,642)
As of December 31, 2021$148,657 

8—LEASES
    
Lessee Leases

We have operating and finance leases for offices, warehouses, and certain equipment. The leases have remaining lease terms of one to eight years, some of which include options to extend the leases for up to ten years. Our leases do not have any residual value guarantees or any restrictions or covenants imposed by leases.

Components of lease cost were as follows (in thousands):
 Year Ended 
 December 31,
 20212020
Operating lease cost$6,046 $6,696 
Finance lease cost:
Amortization of right-of-use assets (principal payments)384 395 
Interest on lease liabilities34 49 
Short-term lease cost22 7 
Variable lease cost1,958 2,541 
Sublease income(81)(61)
Total lease cost$8,363 $9,627 
Supplemental cash flow information related to leases was as follows (in thousands):
F-17
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Years Ended December 31, 2021, 2020 and 2019
 Year Ended 
 December 31,
 20212020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$12,636 $13,979 
Operating cash flows from finance leases19 32 
Financing cash flows from finance leases410 527 
Right-of-use assets obtained in exchange for lease obligations:
Operating leases3,055 3,290 
Finance leases98 337 

Supplemental balance sheet information related to leases was as follows (in thousands):
 December 31, 2021December 31, 2020
Operating Leases
Operating lease right-of-use assets$9,288 $11,669 
Current portion of operating lease liabilities
$4,964 $6,779 
Operating lease liabilities6,567 8,959 
Total operating lease liabilities$11,531 $15,738 
Finance Leases
Property and equipment, gross$2,356 $2,555 
Accumulated amortization(1,906)(1,705)
Property and equipment, net$450 $850 
Accrued liabilities$231 $414 
Other liabilities230 446 
Total finance lease liabilities$461 $860 
Weighted Average Remaining Lease Term
Operating leases2.97 years3.33 years
Finance leases2.40 years2.68 years
Weighted Average Discount Rate
Operating leases5.4 %5.4 %
Finance leases5.1 %5.1 %

    As of December 31, 2021, future minimum lease payments included in the measurement of lease liabilities on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):
F-18
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Years Ended December 31, 2021, 2020 and 2019
Year ending December 31, Operating LeasesFinance Leases
2022$5,440 $240 
20233,404 159 
20241,959 63 
2025957 17 
2026630 — 
Thereafter105 — 
Total lease payments12,495 479 
Less imputed interest(964)(18)
Total$11,531 $461 

Lessor Leases

Pricing of our exclusive hearing screening supply agreement is structured on a fee per baby screened basis and includes a guaranteed minimum payment per unit per contract year for each unit of equipment supplied. We recognize revenues for the hardware products upon commencement of each lease at the net present value of their guaranteed minimum payment standalone selling price allocation. The remaining variable fees are recognized as revenue over the remaining lease term. The following table provides the profit recognized for sales-type leases at their commencement (net sales includes the initial allocation of fixed costs plus allocation of incremental variable fees and excludes the revenue associated with non-lease components associated with hearing screening supplies and maintenance that are recognized as revenue over the remaining lease term) (in thousands):
 Year Ended 
 December 31,
 20212020
Net Sales$10 $2,226 
Cost of Sales13 4,107 
Gross Loss$(3)$(1,881)


The following table provides lease income related to variable lease payments on our sales-type leases not included in the measurement of the lease receivable (in thousands):
 Year Ended 
 December 31,
 20212020
Variable lease income$877 $420 

The following table provides lease income on our operating leases (in thousands):
 Year Ended 
 December 31,
 20212020
Lease income on operating leases$197 $291 

The receivables as a result of our sales-type leases are collateralized by the underlying equipment leased and consist of the following components (in thousands):

F-19
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Years Ended December 31, 2021, 2020 and 2019
 Year Ended 
 December 31,
 20212020
Net minimum lease payments to be received$1,209 $1,777 
Less: Unearned interest income portion— — 
Net investment in sales-type leases$1,209 $1,777 
Less: Current portion(447)(444)
Long-term net investment in sales-type leases$762 $1,333 

As of December 31, 2021, future minimum lease payments and the reconciliation to net investment in sales-type leases reported on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):

Year Ended December 31,Sales-Type LeasesOperating Leases
2022447 — 
2023399 — 
2024363 — 
2025— — 
2026— — 
Thereafter— — 
Total future minimum lease payments1,209 — 
Less: imputed interest— — 
Total$1,209 $— 

9—ACCRUED LIABILITIES
Accrued liabilities consist of (in thousands):
 December 31,
 20212020
Compensation and related benefits$22,734 $20,409 
Accrued federal, state, and local taxes
9,855 9,118 
Warranty reserve6,042 5,195 
Accrued professional fees3,573 3,699 
Accrued amounts due to customers2,597 2,743 
Self-funded insurance expense835 911 
Accrued travel794 123 
Accrued selling expenses494 311 
Other1,211 1,727 
Total$48,135 $44,236 

10—LONG-TERM OTHER LIABILITIES
F-20
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Years Ended December 31, 2021, 2020 and 2019
Long-term other liabilities consist of (in thousands):
 December 31,
 20212020
Long-term taxes payable$10,678 $10,949 
Non-current deferred revenue5,001 4,416 
Long-term earnout payable1,184 1,286 
Finance lease liabilities230 446 
CARES Act payroll tax payable— 1,354 
Other144 — 
Total$17,237 $18,451 

11—DEBT AND CREDIT ARRANGEMENTS
We have a Credit Agreement with JP Morgan Chase Bank ("JP Morgan"), Citibank, NA (“Citibank”), and Wells Fargo Bank, National Association (“Wells Fargo”). During the third quarter of 2020 we amended the terms of the Credit Agreement to extend the maturity date of the original agreement, reduce the aggregate value of the revolving facility, and amend certain covenants. The amended Credit Agreement provides for an aggregate $150 million of secured revolving credit facility. The Credit Agreement contains covenants, including covenants relating to maintenance of books and records, financial reporting and notification, compliance with laws, maintenance of properties and insurance, and limitations on guaranties, investments, issuance of debt, lease obligations and capital expenditures, and is secured by virtually all of our assets. The Credit Agreement provides for events of default, including failure to pay any principal or interest when due, failure to perform or observe covenants, bankruptcy or insolvency events and the occurrence of the event has a material adverse effect. We have no other significant credit facilities. As of December 31, 2021, no amounts were outstanding under the Credit Agreement.
In addition to the customary restrictive covenants listed above, the Credit Agreement also contains financial covenants that require us to maintain a certain leverage ratio and fixed charge coverage ratio, each as defined in the Credit Agreement:
•Leverage Ratio, as defined, to be no higher than 3.25 to 1.00.
•Interest Coverage Ratio, as defined, to be at least 1.75 to 1.00 at all times.
Pursuant to the terms of the Credit Agreement, the outstanding principal balance will bear interest at either (a) a fluctuating rate per annum equal to the Applicable Rate, as defined in the Credit Agreement, depending on our leverage ratio plus the higher of (i) the federal funds rate plus one-half of one percent per annum; (ii) the prime rate in effect on such a day; and (iii) the LIBOR rate plus one percent, or (b) a fluctuating rate per annum of LIBOR Rate plus the Applicable Rate, which ranges between 2.25% to 3.50%. The Credit Agreement matures on September 25, 2023, at which time all principal amounts outstanding under the Credit Agreement will be due and payable.
As of June 30, 2021, we have discontinued our interest rate swap derivative. There are no amounts outstanding under our Credit Agreement and the termination date of the hedge was September 23, 2021. Upon the discontinuation of the hedge relationship, we have reclassified the unrealized gains or losses recorded in accumulated other comprehensive income (“AOCI”) to earnings.
12—RESERVE FOR PRODUCT WARRANTIES
We provide a warranty for products that is generally one year in length and in some cases, regulations may require us to provide repair or remediation beyond the typical warranty period. If any of the products contain defects, we may be required to incur additional repair and remediation costs. Service, repair and calibration services are provided by a combination of our owned facilities and vendors on a contract basis.
A warranty reserve is included in accrued liabilities for the expected future costs of servicing products. Additions to the reserve are based on management's best estimate of probable liability. We consider a combination of factors including material and labor costs, regulatory requirements, and other judgments in determining the amount of reserve. The reserve is reduced as costs are incurred to honor existing warranty and regulatory obligations.
As of December 31, 2021, we have accrued $6.0 million for product related warranties. The estimates we use in projecting future product warranty costs may prove to be incorrect. Any future determination that product warranty reserves are understated could result in increases to cost of sales and reductions in operating profits and results of operations.
F-21
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Years Ended December 31, 2021, 2020 and 2019

13—STOCKHOLDERS’ EQUITY
Common Stock—We have 120,000,000 shares of common stock authorized at a par value or $0.001 per share. 
Preferred Stock—We have 10,000,000 shares of preferred stock authorized at a par value of $0.001 per share. In accordance with the terms of the amended and restated certificate of incorporation, the Board of Directors is authorized to provide for the issuance of one or more series of preferred stock, including increases or decreases to the series. The Board of Directors has the authority to set the rights, preferences, and terms of such shares. As of December 31, 2021, no shares of preferred stock were issued and outstanding.

14—EARNINGS PER SHARE
The components of basic and diluted EPS are as follows (in thousands, except per share amounts): 
 December 31,
202120202019
Net income (loss)$13,177 $(16,613)$(15,671)
Weighted average common shares33,670 33,562 33,696 
Dilutive effect of stock based awards304 — — 
Diluted Shares33,974 33,562 33,696 
Basic income (loss) per share$0.39 $(0.49)$(0.47)
Diluted income (loss) per share$0.39 $(0.49)$(0.47)
Shares excluded from calculation of diluted EPS— 66 104 

15—SHARE-BASED COMPENSATION
Share-Based Compensation Expense—We account for share-based compensation in accordance with ASC Topic 718, Compensation—Stock Compensation. Share-based compensation was recognized as follows in the consolidated statement of income (in thousands):
 December 31,
 202120202019
Cost of revenue$394 $319 $264 
Marketing and selling2,201 1,938 1,024 
Research and development1,406 1,099 800 
General and administrative10,160 6,171 6,227 
Total expense$14,161 $9,527 $8,315 
A significant modification impacted stock compensation expense related to the CEO transition in late December 2021. As part of the separation agreement, the former CEO received the benefit of immediate accelerated vesting for all forms of unvested stock (stock options, restricted stock awards, restricted stock units, performance-based stock and market-based stock). The accelerated vesting was not subject to any future service conditions. Under ASC 718, the stock options, restricted stock awards and restricted stock units service periods were modified to end on the separation date. The acceleration was contemplated in the CEO's original employment agreement, which resulted in compensation cost recognized at the grant date fair value of the original grants. The performance-based and market-based units were treated as a Type III modification (from improbable to probable) as the stock would be forfeited if the full vesting period was not achieved due to separation. As such, the terms and conditions of the performance-based and market-based units were modified to change the vesting conditions where two measurements were computed, and the net impact of truing up the cumulative compensation expense to the fair value of the modified award was recorded in the income statement, resulting in a $1.1 million net benefit in compensation cost, classified as restructuring expense in the consolidated statements of operations, for the year ended December 31, 2021.
Stock Awards Plans—Natus' 2021 Stock Awards Plan (the “Plan”) provides for the granting of the following:
•Incentive stock options to employees;
F-22
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Years Ended December 31, 2021, 2020 and 2019
•Non-statutory stock options to employees, directors and consultants;
•Restricted stock awards and restricted stock units;
•Market stock units;
•Performance stock units;
•Stock bonuses; and
•Stock appreciation rights.
As of December 31, 2021, there were 2,917,938 shares available for future awards under the plan.
Under the Plan, stock options may be issued at not less than the fair market value of the common stock on the date of grant, as determined by the Board of Directors. Options issued under the Plan become exercisable as determined by the Board of Directors and expire no more than six years after the date of grant. Most options vest ratably over four years.
Stock Option Activity—Stock option activity under the stock awards plans for the year ended December 31, 2021 is summarized as follows:  
Number of
Shares		Weighted
Average
Exercise Price
Outstanding, December 31, 2020 (37,062 shares exercisable at a weighted average exercise price of $35.25 per share)331,585 $23.94 
Granted200,146 $20.61 
Exercised(11,787)$20.68 
Forfeited(25,387)$20.68 
Outstanding, December 31, 2021 (320,512 shares exercisable at a weighted average exercise price of $24.01 per share)494,557 $— 
As of December 31, 2021, unrecognized compensation related to the unvested portion of stock options was approximately $1.0 million, which is expected to be recognized over a weighted average period of 3.1 years. The intrinsic value of options exercised, representing the difference between the closing stock price of common stock on the date of the exercise and the exercise price, in the years ended December 31, 2021, 2020 and 2019 was $0.0 million, $0.0 million, and $1.4 million, respectively.
As of December 31, 2021, there were: (i) 484,507 options vested and expected to vest with a weighted average exercise price of $22.88, an intrinsic value of $1.3 million, and a weighted average remaining contractual term of 4.0 years; and (ii) 320,512 options exercisable with a weighted average exercise price of $24.01, an intrinsic value of $0.8 million, and a weighted average remaining contractual term of 1.5 years.
Black-Scholes Inputs—The fair value of option grants was estimated using the Black-Scholes option pricing model with the following weighted average assumptions:
 December 31,December 31,
 20212020
Weighted-average fair value of options granted$7.50$6.54
Expected life in years5.94.5
Risk-free interest rate0.3%0.2%
Expected volatility38%38%
Dividend yieldNoneNone
We did not grant any stock options during December 31, 2019.
The expected life of options is based primarily on historical share option exercise experience of the employees for options granted. All options are treated as a single group in the determination of expected life, as we do not currently expect substantially different exercise or post-vesting termination behavior among the employee population. The risk-free interest rate is based on the U.S. Treasury yield for a term consistent with the expected life of the awards in effect at the time of grant.
F-23
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Years Ended December 31, 2021, 2020 and 2019
Expected volatility is based primarily on historical volatility data of our common stock. We have no history or expectation of paying dividends on common stock.
Share-based compensation expense associated with options is based on awards ultimately expected to vest. At the time of an option grant, we estimate the expected future rate of forfeitures based on historical experience. These estimates are revised, if necessary, in subsequent periods if actual forfeiture rates differ from those estimates. If the actual forfeiture rate is lower than estimated we will record additional expense and if the actual forfeiture is higher than estimated we will record a recovery of prior expense.
Restricted Stock Awards Activity—The following table summarizes the activity for restricted stock awards during the year ended December 31, 2021:
 
SharesWeighted
Average
Grant
Date Fair
Value
Unvested at December 31, 2020380,089 $31.84 
Granted320,814 $22.04 
Vested(320,541)$29.54 
Forfeited(40,592)$25.54 
Unvested at December 31, 2021339,770 $26.15 
As of December 31, 2021, unrecognized compensation related to the unvested portion of stock awards was $5.1 million, which is expected to be recognized over a weighted average period of 2.1 years. The fair market value of outstanding restricted stock awards at December 31, 2021 was $8.1 million. For the restricted stock awards granted during the years ended December 31, 2021, 2020, 2019, the weighted average grant date fair values were $22.04, $29.74, and $31.53, respectively. The total grant date fair value of restricted stock awards vested during fiscal year 2021, 2020, and 2019 was $8.6 million, $5.5 million, and $4.7 million, respectively. For the restricted stock awards that vested during the years ended December 31, 2021, 2020, and 2019, the total intrinsic value was $6.7 million, $4.8 million, and $4.0 million, respectively.
Restricted Stock Units Activity—The following table summarizes restricted stock units activity, including performance and market stock units granted at the valuation date (which may be subject to additional awards or forfeitures depending on the outcome of the performance measures at the end of the performance period) for the year ended December 31, 2021:
 
SharesWeighted
Average
Grant
Date Fair
Value
Outstanding at December 31, 2020212,601 $37.27 
Awarded400,005 $26.43 
Released(205,082)$31.34 
Forfeited(40,959)$36.20 
Outstanding at December 31, 2021366,565 $28.87 
As of December 31, 2021, unrecognized compensation related to the unvested portion of stock units was $8.0 million, which is expected to be recognized over a weighted average period of 2.9 years. The aggregate intrinsic value of outstanding restricted stock units at December 31, 2021 was $8.7 million. For the restricted stock units granted during the years December 31, 2021, 2020, 2019, the weighted average grant date fair values were $26.43, $35.42, and $38.62, respectively. The total grant date fair value of restricted stock units vested during fiscal year 2021, 2020, and 2019 was $5.7 million, $0.5 million, and $1.4 million, respectively. For the restricted stock units that vested during the years ended December 31, 2021, 2020, and 2019, the total intrinsic value was $4.7 million, $0.5 million, and $1.3 million, respectively.
Employee Stock Purchase Plan—Under Natus' 2011 Employee Stock Purchase Plan (the “ESPP”), U.S. employees can elect to have salary withholdings of up to 15% of eligible compensation to a maximum of $10,625 per offering period, to purchase shares of common stock on April 30 and October 31 of each year. The purchase price for shares acquired under the
F-24
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Years Ended December 31, 2021, 2020 and 2019
ESPP is 85% of the fair market value on the last day of the offering period. As of December 31, 2021, there are no shares reserved for future issuance under the ESPP.
Because the ESPP does not have a “look back” feature, the compensation expense associated with the Plan is not measured by the use of the Black-Scholes pricing model, but rather by measuring the difference between the fair market value of common stock on the last day of the offering period and the purchase price for the offering period, which is 85% of the fair market value. Compensation expense associated with the ESPP for the years ended December 31, 2021, 2020 and 2019, respectively, was $0.1 million, $0.2 million, and $0.2 million. 

16—OTHER INCOME (EXPENSE), NET
Other income (expense), net consists of (in thousands): 
 Years Ended December 31,
 202120202019
Interest income$87 $11 $250 
Interest expense(1,872)(3,656)(4,941)
Foreign currency gain (loss)(1,957)1,988 (765)
Other(682)(215)(135)
Total other expense, net$(4,424)$(1,872)$(5,591)

17—INCOME TAXES
Income (loss) before provision for income tax is as follows (in thousands): 
 Years Ended December 31,
 202120202019
U.S.$18,629 $1,908 $(22,851)
Foreign726 (23,973)1,594 
Income (loss) before provision for income tax$19,355 $(22,065)$(21,257)

The components of income tax expense (benefit) for the years ended December 31, 2021, 2020 and 2019 (in thousands): 
 Years Ended December 31,
 202120202019
Current
U.S. Federal$946 $(3,976)$(948)
U.S. State and local368 145 561 
Non-U.S.7,523 1,241 8,386 
Total current tax expense (benefit)8,837 (2,590)7,999 
Deferred
U.S. Federal4,583 2,049 (7,491)
U.S. State and local184 533 (816)
Non-U.S.(7,426)(5,444)(5,278)
Total deferred tax benefit(2,659)(2,862)(13,585)
Total income expense (benefit)$6,178 $(5,452)$(5,586)
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of deferred tax assets and liabilities as of December 31, 2021 and 2020 are as follows (in thousands): 
F-25
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Years Ended December 31, 2021, 2020 and 2019
 December 31,
 20212020
Deferred tax assets:
Net operating loss carryforwards$12,439 $9,099 
Credit carryforwards1,213 5,768 
Accruals deductible in different periods15,650 15,368 
Employee benefits925 1,016 
Operating leases2,766 3,967 
Total deferred tax assets32,993 35,218 
Valuation allowance(934)(969)
Total net deferred tax assets$32,059 $34,249 
Deferred tax liabilities:
Basis difference in fixed and intangible assets(7,007)(13,214)
Operating leases(2,224)(2,970)
Foreign earnings to be repatriated(800)(800)
Total deferred tax liabilities(10,031)(16,984)
Total net deferred tax assets$22,028 $17,265 
The income tax expense (benefit) in the accompanying statements of income differs from the provision calculated by applying the U.S. federal statutory income tax rate of 21% in 2021, 2020, and 2019 to income before taxes due to the following: 
 Years Ended December 31,
 202120202019
Federal statutory tax expense$4,065 $(4,634)$(4,464)
State tax expense605 661 (300)
Foreign taxes at rates less than U.S. rates(609)1,050 (2,205)
Equity compensation2,581 1,161 824 
Tax credits(1,393)(1,641)(1,428)
Uncertain tax position1,553 3,002 2,910 
Lapse of statute(365)(2,718)(3,961)
Repatriation tax net of foreign tax credits— — 172 
Federal NOL Carryback(454)(1,621)— 
Tax audits97 (224)— 
Withholding taxes254 — 1,107 
Global intangible low-taxed income net of foreign tax credits— — 1,601 
Return to provision(704)(946)560 
Other548 458 (402)
Total expense (benefit)$6,178 $(5,452)$(5,586)
At December 31, 2021, we had U.S. state net operating loss carryforwards of $16.9 million, of which immaterial portions will begin to expire in 2022 and the majority have long carryforward periods ranging primarily from 10 years to indefinite. At December 31, 2021, we had U.S. state R&D credit carryforwards of $1.3 million, which will begin to expire in 2022. At December 31, 2021, we had $0.1 million of U.S. foreign tax credit carryforwards that can be used to offset future U.S. tax liabilities related to foreign source taxable income. The foreign tax credits will start to expire in 2022.
At December 31, 2021, certain foreign subsidiaries had deferred tax assets attributable to net operating loss carryforwards as follows: $0.8 million in France, $8.7 million in Denmark, $0.3 million in Canada, $0.2 million in China, and $0.3 million in Germany. These foreign net operating loss carryforwards, ranging from 6 years utilization period to indefinite utilization period, if not utilized to offset taxable income in future periods, will begin to expire in various amounts beginning in 2026.
F-26
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Years Ended December 31, 2021, 2020 and 2019
A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. Accordingly, valuation allowances of $0.9 million and $1.0 million were recorded at December 31, 2021 and 2020, respectively. The decrease of $0.1 million in valuation allowance was primarily due to a valuation allowance recorded against certain U.S. state credits, which are expected to expire before fully utilized, and release of prior Canadian valuation allowances.
The realizability of the deferred tax assets is primarily dependent on our ability to generate sufficient taxable income in future periods. We record net deferred tax assets to the extent it is more likely than not that the assets will be realized. In making such determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations. To the extent that previously reserved deferred tax assets are estimated to be realizable, we adjust the valuation allowance which reduces the provision for income taxes. Weighing all of the positive and negative evidence, we have recorded a valuation allowance related primarily to net operating losses in certain foreign jurisdictions where it is more likely than not that the tax benefit of the net operating losses will not be realized.
There are no changes to the position on our permanent reinvestment of earnings from foreign operations. As of December 31, 2021, we intend to distribute all of the earnings from Excel-Tech and Natus Ireland in excess of their operational needs. We intend to permanently reinvest the earnings of remaining foreign subsidiaries. The other remaining foreign subsidiaries have both the intent and ability to indefinitely reinvest its undistributed earnings.
Uncertain Tax Positions
A reconciliation of the beginning and ending amount of unrecognized tax benefits (excluding interest and penalties) is as follows (in thousands): 
Balance at December 31, 2018$7,227 
Decreases for tax positions related to prior years(48)
Increases for tax positions related to the current year495 
Decrease due to lapse of statutes of limitations(3,763)
Foreign exchange difference6 
Balance at December 31, 2019$3,917 
Increases for tax positions related to prior years2,454 
Increases for tax positions related to the current year104 
Decrease due to lapse of statutes of limitations(2,416)
Foreign exchange difference83 
Balance at December 31, 2020$4,142 
Increases for tax positions related to the current year1,067 
Decrease due to lapse of statutes of limitations(279)
Foreign exchange difference(82)
Balance at December 31, 2021$4,848 
For the year ended December 31, 2021, our net unrecognized tax benefits increased by $0.7 million resulting in a corresponding $0.7 million increase in income tax expense. The increase was primarily attributable to the increase in uncertain tax positions related to the current year in certain jurisdictions.
The unrecognized tax benefits for the tax years ended December 31, 2021, 2020 and 2019 were $4.8 million, $4.1 million and $3.9 million, respectively which include $4.6 million, $3.8 million and $3.6 million, respectively, that would impact the effective tax rate if recognized.
We expect a range from zero to $0.8 million of unrecognized tax benefit that will impact the effective tax rate in the next 12 months due to the lapse of statute of limitations provided that no taxing authority conducts a new examination.
At December 31, 2021, 2020 and 2019, we had cumulatively accrued $0.9 million, $0.5 million, and $0.4 million for estimated interest and penalties related to uncertain tax positions. We record interest and penalties related to unrecognized tax positions as a component of income tax expense (benefit), which totaled approximately $0.3 million, $0.1 million, and $(0.1) million for the years ended December 31, 2021, 2020, and 2019, respectively.
F-27
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Years Ended December 31, 2021, 2020 and 2019
We are currently unaware of any uncertain tax positions that could result in significant additional payments, accruals, or other material deviation in this estimate over the next 12 months.
As of December 31, 2021, we are currently under U.S. federal IRS examination for tax years 2018 and 2019.
Our tax returns remain open to examination as follows: U.S. federal, 2017 through 2020; U.S. states, generally 2016 through 2020; and significant foreign jurisdictions, generally 2016 through 2020.

18—EMPLOYEE BENEFIT PLAN
We offer pre-tax and after-tax 401(k) savings plan options under which eligible U.S. employees may elect to have a portion of their salary deferred and contributed to the plan. Employer matching contributions are determined by management and are discretionary. Employer matching contributions were $3.7 million, $3.2 million, and $3.6 million respectively, in the years ended December 31, 2021, 2020, and 2019. For new hires, employer contributions vest ratably over the first two years of employment.

19—SEGMENT, CUSTOMER, AND GEOGRAPHIC INFORMATION
We determine our reportable segments by first identifying our operating segments, and then by assessing whether any components of these segments constitute a business for which discrete financial information is available and where segment management regularly reviews the operating results of that component. Historically, our operating segments were based on its three strategic business units. In January 2019, we announced the transition of our operating structure from three strategic business units to a single, unified company with globally led operational teams in Sales and Marketing, Manufacturing, Research and Development, Quality, and General and Administrative functions.
Following the reorganization, we operate as one operating segment and one reportable segment, which provides medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. Financial information is reviewed on a consolidated basis for purposes of making operating decisions and assessing financial performance. Consolidated financial information is accompanied by disaggregated information about revenues by end market and geographic region. We do not assess the performance of our end markets or geographic regions on measures of profit or loss, or asset-based metrics. We have disclosed the revenues for each end market and geographic region to provide the reader of the financial statements transparency into our operations.
The following tables present revenue and long-lived asset information by end market and geographic region. Revenue is based on the destination of the shipments and long-lived assets are based on the physical location of the assets (in thousands):
F-28
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Years Ended December 31, 2021, 2020 and 2019
 
 Years Ended December 31,
 202120202019
Consolidated Revenue:
United States$285,979 $252,496 $292,400 
Foreign countries187,459 163,188 202,775 
$473,438 $415,684 $495,175 
Revenue by End Market:
Neuro
Devices and Systems$220,929 $179,464 $220,306 
Supplies63,838 56,275 66,059 
Services— — 871 
Total Neuro Revenue$284,767 $235,739 $287,236 
Newborn Care
Devices and Systems$55,174 $52,284 $53,465 
Supplies33,710 36,174 38,264 
Services16,139 16,566 19,183 
Total Newborn Care Revenue$105,023 $105,024 $110,912 
Hearing & Balance
Devices and Systems$78,652 $70,738 $92,050 
Supplies4,996 4,183 4,977 
Total Hearing & Balance Revenue$83,648 $74,921 $97,027 
Total Revenue$473,438 $415,684 $495,175 
Long-lived asset information by geographic region is as follows (in thousands):
Years Ended December 31,
20212020
Property and equipment, net:
United States$9,642 $10,998 
Ireland6,223 6,716 
Canada3,594 3,775 
Denmark1,262 1,787 
Other foreign countries1,062 1,240 
$21,783 $24,516 
During the years ended December 31, 2021, 2020 and 2019, no single customer or foreign country contributed to more than 10% of revenue.

20—COMMITMENTS AND CONTINGENCIES
Purchase commitments—We have various purchase obligations for goods or services totaling $178.4 million at December 31, 2021, which are expected to be paid $136.5 million in 2022 and $41.9 million thereafter.
Legal matters—We currently are, and may from time to time become, a party to various legal proceedings or claims that arise in the ordinary course of business. Our managements reviews these matters if and when they arise and believes that the resolution of any such matters currently known will not have a material effect on our results of operations or financial position.

F-29
NATUS MEDICAL INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Years Ended December 31, 2019, 2018 and 2017
21—FAIR VALUE MEASUREMENTS
ASC 820 defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. Fair value is defined under ASC 820 as the exit price associated with the sale of an asset or transfer of a liability in an orderly transaction between market participants at the measurement date. ASC 820 establishes the following three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value:
Level 1—Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.
Level 2—Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets and liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3—Unobservable inputs that are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.
During the third quarter of 2021, we sold vacant land located in Canada for $1.6 million resulting in a gain of $0.7 million. Also during this period, we sold a building located in the United Kingdom for $1.1 million resulting in a gain of $0.8 million. The gain on disposal of these assets is reported in general and administrative expense in the condensed consolidated statements of operations. The book value of these assets was in other current assets on the accompanying condensed consolidated balance sheet.
The following financial instruments are not measured at fair value on the consolidated balance sheet as of December 31, 2021 and 2020, but require disclosure of fair values: cash and cash equivalents, accounts receivable, and accounts payable. The carrying value of these financial instruments approximates fair values because of the relatively short maturity.
The carrying amount of our short-term and long-term debt approximates fair value based on Level 2 inputs since the debt carries a variable interest rate that is tied to the current LIBOR rate plus a spread.

22—SALE OF CERTAIN SUBSIDIARY
    We divested our wholly owned subsidiary, Medix, on April 2, 2019, via a stock sale to the local managing director, a related party. In exchange for the stock, we received $2.5 thousand in cash and provided Medix with a $2.2 million limited-recourse loan secured by real estate assets of Medix. The fair market value of the loan was adjusted as necessary to reflect any changes in market environment or the value of the building. During the second quarter of 2021, we received a $0.9 million payment of which the loan receivable of $0.7 million was fully repaid and a $0.2 million gain was recognized.

    The held for sale criteria under GAAP was met in the first quarter of 2019. As such, we completed an asset impairment analysis which resulted in the full impairment of all assets held for sale. We recognized an impairment loss of $24.6 million which included an accrual for the anticipated realization of deferred foreign currency related translation adjustments in accumulated other comprehensive income of $24.8 million, net of tax, and an adjustment of $4.6 million for assets with a book value in excess of their fair market value. Included in the year ended December 31, 2019, is the impact of the sale of Medix, which was completed as of June 30, 2019, and the deferred foreign currency related translation adjustments previously in accumulated other comprehensive income have been released from the balance sheet along with the held for sale accrual.

ITEM 16.    Form 10-K Summary
Not Applicable.

F-30
EXHIBIT INDEX
  Incorporated By Reference
Exhibit No.ExhibitFilingExhibit No.File No.File Date
S-13.1.1333-441388/18/2000
8-K3.1 000-330019/13/2012
8-K3.1 000-330016/7/2019
8-K3.1 000-3300112/16/2019
S-1/A4.1 333-441382/9/2001
8-A3.1.2000-330019/6/2002
10-K4.3 000-3300112/31/2019
S-110.1 333-441388/18/2000
8-K10.1 000-3300112/18/2018
8-K10.1.1000-3300112/18/2018
8-K10.1.2000-3300112/18/2018
8-K10.1.3000-3300112/18/2018
8-K10.1.4000-3300112/18/2018
8-K10.1 000-330011/4/2006
S-110.3.1333-441388/18/2000
10-Q10.2 000-330018/9/2006
10-K10.2.3000-330013/14/2008
10-Q10.02 000-330015/9/2008
S-110.4.1333-441388/18/2000
S-110.15 333-441382/9/2001
S-110.15.1333-441382/9/2001

  Incorporated By Reference
Exhibit No.ExhibitFilingExhibit No.File No.File Date
8-K10.2 000-330011/4/2006
14-A— 000-330014/20/2011
10-Q10.1 000-3300111/7/2011
10-Q10.2 000-3300111/7/2011
10-Q10.3 000-3300111/7/2011
14-A— 000-330014/20/2011
14-A— 000-330014/20/2011
10-K10.10 000-330013/10/2009
10-K000-330013/16/2015
8-K99.1 000-330014/22/2013
10-Q10.16 000-330018/8/2018
8-K10.1 000-3300110/9/2015
10-Q000-330012/29/2016
10-Q10.2 000-3300111/3/2016
10-Q10.1 000-3300111/3/2016
10-Q10.3 000-3300111/3/2016
8-K99.1 000-330018/29/2018
10-Q10.18 000-3300111/8/2018
10-Q10.1 000-330019/30/2020

  Incorporated By Reference
Exhibit No.ExhibitFilingExhibit No.File No.File Date
14-A— 000-330014/28/2021
8-K10.1 000-3300112/13/2021
8-K10.2 000-3300112/13/2021
101The following financial information from Natus Medical Incorporated Annual Report on Form 10-K for the fiscal year ended December 31, 2021, formatted in XBRL (eXtensible Business Reporting Language): (i) Consolidated Balance Sheets as of December 31, 2021 and December 31, 2020, (ii) Consolidated Statements of Operations for the years ended December 31, 2021, 2020 and 2019, (iii) Consolidated Statements of Comprehensive Income for the years ended December 31, 2021, 2020 and 2019 (iv) Consolidated Statements of Cash Flows for the years ended December 31, 2021, 2020and 2019, (v) Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2021, 2020 and 2019, and (vi) the Notes to Consolidated Financial Statements.
104The cover page of the Annual Report on Form 10-K formatted in Inline XBRL (included in Exhibit 101).

 *    Indicates a management contract or compensatory plan or arrangement

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned thereunto duly authorized. 
NATUS MEDICAL INCORPORATED
By /s/    THOMAS J. SULLIVAN  
 Thomas J. Sullivan
President, Chief Executive Officer and Director
By /s/    B. DREW DAVIES        
 B. Drew Davies
Executive Vice President and Chief Financial Officer
Dated: February 25, 2022
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Thomas J. Sullivan and B. Drew Davies and each of them acting individually, as his or her attorney-in-fact, each with full power of substitution, for him or her in any and all capacities, to sign any and all amendments to this Report on Form 10-K, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission.
Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed by the following persons on behalf of the registrant and in the capacity and dates indicated: 
Signature  Title Date
/S/    THOMAS J. SULLIVAN
  President, Chief Executive Officer and Director (Principal Executive Officer) February 25, 2022
(Thomas J. Sullivan)
/S/    B. DREW DAVIES
  Executive Vice President & Chief Financial Officer (Principal Financial and Accounting Officer) February 25, 2022
(B. Drew Davies)
/S/    JOSHUA H. LEVINE
  Chairperson of the Board of Directors February 25, 2022
(Joshua H. Levine)
/S/    ILAN DASKAL
  Director February 25, 2022
(Ilan Daskal)
/S/    ERIC J. GUERIN
  Director February 25, 2022
(Eric J. Guerin)
/S/    LISA W. HEINE
  Director February 25, 2022
(Lisa W. Heine)
/S/   BRYANT M. MOORE
DirectorFebruary 25, 2022
(Bryant M. Moore)
/S/   ALICE D. SCHROEDER
  Director February 25, 2022
(Alice D. Schroeder)


 EX-21.1 2 exhibit211123121.htm EX-21.1 Document

EXHIBIT 21.1
SIGNIFICANT SUBSIDIARIES OF THE REGISTRANT
 
STATE or JURISDICTION
of INCORPORATION
PERCENT of
OWNERSHIP
Natus Manufacturing LimitedIreland100%
Natus Medical Denmark ApSDenmark100%
Excel-Tech Corp.Canada100%


 EX-23.1 3 exhibit231123121.htm EX-23.1 Document
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (Nos. 333‑65584, 333-133657, 333-174702, 333-229314, and 333-257966) on Form S-8 and registration statements (Nos. 333-133480, 333-150503, and 333-171489) on Form S-3 of our reports dated February 25, 2022, with respect to the consolidated financial statements of Natus Medical Incorporated and the effectiveness of internal control over financial reporting.
/s/ KPMG LLP
San Francisco, California
February 25, 2022

 EX-31.1 4 exhibit311123121.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Thomas J. Sullivan, certify that:
1. I have reviewed this report on Form 10-K of Natus Medical Incorporated, (the "Registrant");
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.
 
Date:February 25, 2022  
   /s/ Thomas J. Sullivan
   Thomas J. Sullivan
   President and Chief Executive Officer


 EX-31.2 5 exhibit312123121.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, B. Drew Davies, certify that:
1. I have reviewed this report on Form 10-K of Natus Medical Incorporated, (the "Registrant");
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
5. The Registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.
 
Date:February 25, 2022  
   /s/ B. Drew Davies
   B. Drew Davies
   Executive Vice President
   and Chief Financial Officer


 EX-32.1 6 exhibit321123121.htm EX-32.1 Document

EXHIBIT 32.1
CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER
PURSUANT TO TITLE 18, UNITED STATES CODE, SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Natus Medical Incorporated (the “Company”) on Form 10-K for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Thomas J. Sullivan, President and Chief Executive Officer of the Company, certify, pursuant to Title 18, United States Code, Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
/s/ Thomas J. Sullivan
Print Name: Thomas J. Sullivan
Title: President and Chief Executive Officer
Date: February 25, 2022

In connection with the Annual Report of Natus Medical Incorporated (the “Company”) on Form 10-K for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, B. Drew Davies, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to Title 18, United States Code, Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
/s/ B. Drew Davies
Print Name: B. Drew Davies
Title: Executive Vice President and Chief Financial Officer
Date:February 25, 2022


 EX-101.SCH 7 ntus-20211231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 1001002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1002003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 1004005 - Statement - Consolidated Statements of Comprehensive Income (Loss) Consolidated Statement of Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 1005006 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 1006007 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 2101101 - Disclosure - Organization and Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2202201 - Disclosure - Organization and Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2403401 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2104102 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Revenue - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Revenue - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Revenue - Unbilled AR and Deferred Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 2108103 - Disclosure - Allowance for Doubtful Accounts link:presentationLink link:calculationLink link:definitionLink 2309302 - Disclosure - Allowance for Doubtful Accounts (Tables) link:presentationLink link:calculationLink link:definitionLink 2410404 - Disclosure - Allowance for Doubtful Accounts (Details) link:presentationLink link:calculationLink link:definitionLink 2111104 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 2312303 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 2413405 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 2414406 - Disclosure - Inventories - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2115105 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 2316304 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 2417407 - Disclosure - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2418408 - Disclosure - Property and Equipment - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2119106 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 2320305 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 2421409 - Disclosure - Intangible Assets - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2422410 - Disclosure - Intangible Assets - Components of Gross and Net Intangible Asset Balances (Details) link:presentationLink link:calculationLink link:definitionLink 2423411 - Disclosure - Intangible Assets - Schedule of Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2424412 - Disclosure - Intangible Assets - Expected Annual Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2125107 - Disclosure - Goodwill link:presentationLink link:calculationLink link:definitionLink 2326306 - Disclosure - Goodwill (Tables) link:presentationLink link:calculationLink link:definitionLink 2427413 - Disclosure - Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 2128108 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 2329307 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 2430414 - Disclosure - Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2431415 - Disclosure - Leases - Lease Cost (Details) link:presentationLink link:calculationLink link:definitionLink 2432416 - Disclosure - Leases - Supplemental Cash Flow (Details) link:presentationLink link:calculationLink link:definitionLink 2433417 - Disclosure - Leases - Supplemental Balance Sheet (Details) link:presentationLink link:calculationLink link:definitionLink 2434418 - Disclosure - Leases - Lease Maturities (Details) link:presentationLink link:calculationLink link:definitionLink 2435419 - Disclosure - Leases - Lease Income (Details) link:presentationLink link:calculationLink link:definitionLink 2436420 - Disclosure - Leases - Sales Type Lease Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 2436420 - Disclosure - Leases - Sales Type Lease Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 2437421 - Disclosure - Leases - Lease Payments Receivable Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 2437421 - Disclosure - Leases - Lease Payments Receivable Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 2138109 - Disclosure - Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 2339308 - Disclosure - Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 2440422 - Disclosure - Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2141110 - Disclosure - Long-Term Other Liabilities link:presentationLink link:calculationLink link:definitionLink 2342309 - Disclosure - Long-Term Other Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 2443423 - Disclosure - Long-Term Other Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2144111 - Disclosure - Debt and Credit Arrangements link:presentationLink link:calculationLink link:definitionLink 2445424 - Disclosure - Debt and Credit Arrangements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2146112 - Disclosure - Reserve for Product Warranties link:presentationLink link:calculationLink link:definitionLink 2447425 - Disclosure - Reserve for Product Warranties (Details) link:presentationLink link:calculationLink link:definitionLink 2148113 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2449426 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 2150114 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2351310 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2452427 - Disclosure - Earnings Per Share - Components of Basic and Diluted EPS (Detail) link:presentationLink link:calculationLink link:definitionLink 2153115 - Disclosure - Share-Based Compensation link:presentationLink link:calculationLink link:definitionLink 2354311 - Disclosure - Share-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 2455428 - Disclosure - Share-Based Compensation - Share-based Compensation Expense Allocation (Details) link:presentationLink link:calculationLink link:definitionLink 2456429 - Disclosure - Share-Based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2457430 - Disclosure - Share-Based Compensation - Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2458431 - Disclosure - Share-Based Compensation - Valuation Inputs (Details) link:presentationLink link:calculationLink link:definitionLink 2459432 - Disclosure - Share-Based Compensation - Restricted Stock Award Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2460433 - Disclosure - Share-Based Compensation - Restricted Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2161116 - Disclosure - Other Income (Expense), Net link:presentationLink link:calculationLink link:definitionLink 2362312 - Disclosure - Other Income (Expense), Net (Tables) link:presentationLink link:calculationLink link:definitionLink 2463434 - Disclosure - Other Income (Expense), Net (Details) link:presentationLink link:calculationLink link:definitionLink 2164117 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2365313 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 2466435 - Disclosure - Income Taxes - Income Loss before Provision (Benefit) for Income Tax (Details) link:presentationLink link:calculationLink link:definitionLink 2467436 - Disclosure - Income Taxes - Component of Income Tax Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2468437 - Disclosure - Income Taxes - Components of Deferred Tax Asset and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2469438 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2470439 - Disclosure - Income Taxes - Reconciliation of Income tax Expense from Continuous Operation (Details) link:presentationLink link:calculationLink link:definitionLink 2471440 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 2172118 - Disclosure - Employee Benefit Plan link:presentationLink link:calculationLink link:definitionLink 2473441 - Disclosure - Employee Benefit Plan (Details) link:presentationLink link:calculationLink link:definitionLink 2174119 - Disclosure - Segment, Customer and Geographic Information link:presentationLink link:calculationLink link:definitionLink 2375314 - Disclosure - Segment, Customer and Geographic Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2476442 - Disclosure - Segment, Customer and Geographic Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2477443 - Disclosure - Segment, Customer and Geographic Information (Details) link:presentationLink link:calculationLink link:definitionLink 2178120 - Disclosure - Commitments And Contingencies link:presentationLink link:calculationLink link:definitionLink 2479444 - Disclosure - Commitments And Contingencies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2180121 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2481445 - Disclosure - Fair Value Measurements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2182122 - Disclosure - Sale of Certain Subsidiary Assets Sale of Certain Subsidiary Assets link:presentationLink link:calculationLink link:definitionLink 2483446 - Disclosure - Sale of Certain Subsidiary (Details) link:presentationLink link:calculationLink link:definitionLink 2184123 - Disclosure - Schedule II: Valuation And Qualifying Accounts link:presentationLink link:calculationLink link:definitionLink 2485447 - Disclosure - Schedule II: Valuation And Qualifying Accounts (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 ntus-20211231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 ntus-20211231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 ntus-20211231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cost of Sales Cost of Goods Sold, Sales-type Lease Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Statutory tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Basic and Diluted Net Income per Share Earnings Per Share, Policy [Policy Text Block] U.S. State and local Current State and Local Tax Expense (Benefit) Vested, Shares Release, units Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Net income (loss) Net loss Net Income (Loss) Attributable to Parent Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Preferred stock, outstanding Preferred stock outstanding Preferred Stock, Shares Outstanding Compensation and related benefits Employee-related Liabilities, Current Income Statement Location [Axis] Income Statement Location [Axis] Goodwill Goodwill Disclosure [Text Block] Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Statistical Measurement [Domain] Statistical Measurement [Domain] Security Exchange Name Security Exchange Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Proceeds from Sale of Property, Plant, and Equipment Proceeds from Sale of Property, Plant, and Equipment Forfeited, Weighted - average grant date fair value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Offering price, percentage of fair market value Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Contract with Customer, Asset and Liability [Table Text Block] Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Employees [Member] Employees [Member] Employees [Member] Cancelled (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Weighted average remaining lease term, operating leases Operating Lease, Weighted Average Remaining Lease Term Foreign Currency Foreign Currency Transactions and Translations Policy [Policy Text Block] Assets, Fair Value Adjustment Assets, Fair Value Adjustment Other assets Other Assets, Noncurrent Segments [Axis] Segments [Axis] Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Retirement Benefits [Abstract] Accumulated Impairment Impairment of Intangible Assets Defined Lived (excluding Goodwill) Impairment of Intangible Assets Defined Lived (excluding Goodwill) Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Raw materials and subassemblies Inventory, Raw Materials and Supplies, Net of Reserves Entity File Number Entity File Number Sales Type Lease, Net Investment In Lease Sales Type Lease, Net Investment In Lease [Table Text Block] Sales Type Lease, Net Investment In Lease Other income (expense), net Schedule of Other Nonoperating Income (Expense) [Table Text Block] Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Lease income on operating leases Operating Lease, Lease Income Operating Lease, Lease Income Operating Lease, Lease Income [Table Text Block] Global intangible low-taxed income net of foreign tax credits Effective Income Tax Rate Reconciliation, Global Intangible Low-Taxed Income Net of Foreign Tax Credits, Amount Effective Income Tax Rate Reconciliation, Global Intangible Low-Taxed Income Net of Foreign Tax Credits, Amount Intrinsic value of options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Finance Leases, property and equipment Finance Lease, Right-Of-Use Asset, Gross Finance Lease, Right-Of-Use Asset, Gross SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] Additions Charged to Expense SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense Intangibles amortization Amortization of Intangible Assets Increases for tax positions related to prior years Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Variable lease cost Variable Lease, Cost Deferred Tax Assets, Net Deferred Tax Assets, Net Deferred Tax Assets, Net Employee benefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits Shares excluded from calculations of diluted EPS Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Weighted average discount rate, operating leases Operating Lease, Weighted Average Discount Rate, Percent Inventories Schedule of Inventory, Current [Table Text Block] Revenue Recognized Contract with Customer, Liability, Revenue Recognized Research and development [Member] Research and Development Expense [Member] Buildings [Member] Building [Member] Tax Cuts and Jobs Act, Reclassification from AOCI to Retained Earnings, Tax Effect Tax Cuts and Jobs Act, Reclassification from AOCI to Retained Earnings, Tax Effect Total net deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Granted, Weighted - average grant date fair value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Fair value, vested in period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Sales-type Lease, Selling Profit (Loss) Gross Loss Sales-type Lease, Selling Profit (Loss) Title of Individual [Domain] Title of Individual [Domain] Schedule of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Aggregate intrinsic value of outstanding restricted stock units Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Award Type [Domain] Award Type [Domain] Gain on note receivable from related party Gain On Notes Receivable From Related Parties Gain On Notes Receivable From Related Parties Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Local Phone Number Local Phone Number Credit Facility [Domain] Credit Facility [Domain] ASSETS Assets [Abstract] Related Party Transactions [Abstract] Related Party Transactions [Abstract] Accrued selling expenses Accrued Selling Expense, Current Accrued Selling Expense, Current Weighted average shares exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Land [Member] Land [Member] Weighted average exercise price of vested stock Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Right-of-use assets obtained in exchange for lease obligations: finance leases Right-of-Use Asset Obtained in Exchange for Finance Lease Liability Goodwill Goodwill and Intangible Assets, Policy [Policy Text Block] Warranty reserve Product Warranty Expense Granted, Shares Awarded, units Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding in 2021 and in 2020 Preferred Stock, Value, Issued Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Proceeds from stock option exercises and ESPP Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised Outstanding, beginning of period (shares) Outstanding, end of period (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Trade names [Member] Trade names Trade Names [Member] Retained Earnings Retained Earnings [Member] Debt Instrument [Axis] Debt Instrument [Axis] CHINA CHINA Long-term liabilities: Liabilities, Noncurrent [Abstract] Other Liabilities Disclosure [Abstract] Other Liabilities Disclosure [Abstract] Commitments And Contingencies Commitments and Contingencies Disclosure [Text Block] Vesting of restricted stock units (shares) Vesting Of Restricted Stock Units Shares Vesting of restricted stock units shares. Related Party [Axis] Related Party [Axis] Less: Unearned interest income portion Sales-type and Direct Financing Leases, Lease Receivable, Undiscounted Excess Amount Accounts receivable Increase (Decrease) in Accounts Receivable 2025 Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Four Right-of-use assets obtained in exchange for lease obligations: operating leases Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Germany GERMANY Deferred tax assets and liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Non-cash investing activities: Other Noncash Investing and Financing Items [Abstract] Employee maximum withholding rate (percent) Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Vesting percentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Taxes paid related to net share settlement of equity awards (shares) Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Denmark Denmark DENMARK Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Long-Term Other Liabilities Other Noncurrent Liabilities [Table Text Block] Finance Lease, Principal Payments Financing cash flows from finance leases Finance Lease, Principal Payments Deferred revenue Increase (Decrease) in Deferred Revenue Operating Expense Operating Expense [Member] Number of operating segments Number of Operating Segments Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Basic Basic earnings per share (in dollars per share) Earnings Per Share, Basic Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Total Inventories Inventory Current and Noncurrent Inventory current and noncurrent. 2022 Lessee, Operating Lease, Liability, to be Paid, Year Three Revenue Revenue from Contract with Customer [Text Block] Sublease income Sublease Income Transfer of leased assets to sales-type leases Transfer Of Leased Assets To Sales-Type Leases Transfer Of Leased Assets To Sales-Type Leases Thereafter Finite-Lived Intangible Asset, Expected Amortization, after Year Five Unvested, beginning of period, Shares Unvested, end of period, Shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Service Agreements Service Agreements [Member] SEC Schedule, 12-09, Allowance, Credit Loss [Member] SEC Schedule, 12-09, Allowance, Credit Loss [Member] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] Canada CANADA Shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Schedule II: of Valuation and Qualifying Accounts SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Credit carryforwards Deferred Tax Assets, Tax Credit Carryforwards Cumulative Effect, Period of Adoption, Adjustment Cumulative Effect, Period of Adoption, Adjustment [Member] Taxes paid related to net share settlement of equity awards Share-based Payment Arrangement, Decrease for Tax Withholding Obligation Shares available for future awards Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Operating cash flows from operating leases Operating Lease, Payments Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax 2026 Lessor, Operating Lease, Payment to be Received, Year Five Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Reclassification of deferred foreign currency related adjustments related to the sale of Medix (See FN 22) Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax Provision for losses on accounts receivable Additions charged to expense Accounts Receivable, Credit Loss Expense (Reversal) Revenue and long-lived asset information by geographic region Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Goodwill [Roll Forward] Goodwill [Roll Forward] Long-term earnout payable Earnout Liability, Noncurrent Earnout Liability, Noncurrent Entity Voluntary Filers Entity Voluntary Filers Finance Lease, Right-of-Use Asset Finance Lease, Right-of-Use Asset, after Accumulated Amortization Investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] State tax expense Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Internally developed software Software Development [Member] Entity Small Business Entity Small Business Repatriation tax net of foreign tax credits Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount Operating Leases Lessee, Operating Lease, Liability, Payment, Due [Abstract] Increases for tax positions related to the current year Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Non cash lease expense Noncash Lease Expense Noncash Lease Expense Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Total liabilities and stockholders’ equity Liabilities and Equity Other Other Accrued Liabilities, Current Long-term net investment in sales-type leases Net Investment in Lease, before Allowance for Credit Loss, Noncurrent Other Income and Expenses [Abstract] Other Income and Expenses [Abstract] Total Lessor, Operating Lease, Payments to be Received Contract with Customer, Liability, Current Contract with Customer, Liability, Current 2024 Lessee, Operating Lease, Liability, to be Paid, Year Five Variable lease income Sales-type Lease, Variable Lease Income Exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Sales-type Lease, Lease Income Sales-type Lease, Lease Income [Table Text Block] Supplies [Member] Supplies [Member] Supplies [Member] Additions Contract With Customer, Asset, Increase From Performance Obligation Satisfied Contract With Customer, Asset, Increase From Performance Obligation Satisfied Impairment of intangible assets Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Unrecognized tax would impact effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate 2024 Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Three Accounts payable Increase (Decrease) in Accounts Payable Property, Plant and Equipment, Net [Abstract] Property, Plant and Equipment, Net [Abstract] Exercisable, weighted average price (in dollars per share) Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] Earnings Per Share Earnings Per Share [Text Block] Lessor, lease term Lessor, Operating Lease, Term of Contract Operating expenses: Operating Expenses [Abstract] Entity Interactive Data Current Entity Interactive Data Current 2022 Finite-Lived Intangible Asset, Expected Amortization, Year Four Exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Minimum Minimum [Member] Long-term taxes payable Liability for Uncertainty in Income Taxes, Noncurrent Gross profit Gross Profit 2021 Lessee, Operating Lease, Liability, to be Paid, Year Two Operating Lease Receivable, Maturity Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block] Income (loss) before provision (benefit) for income tax Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Preferred stock, shares authorized Preferred stock authorized Preferred Stock, Shares Authorized Unrecognized tax benefits Beginning-Unrecognized Tax Benefits Ending-Unrecognized Tax Benefits Unrecognized Tax Benefits Income Tax Authority [Domain] Income Tax Authority [Domain] Total deferred tax assets Deferred Tax Assets, Gross France FRANCE Thereafter Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, after Year Five Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Neurology Products [Member] Neurology Products [Member] Neurology Products [Member] Entity Address, State or Province Entity Address, State or Province Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Leases Lessee, Finance Leases [Text Block] 2022 Lessor, Operating Lease, Payment to be Received, Year One Additions Contract With Customer, Liability, Increase From Cash Receipts Contract With Customer, Liability, Increase From Cash Receipts Reclassification of stranded tax effects upon adoption of ASU 2018-02 Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent Deferred income tax Deferred Income Tax Assets, Net UNITED KINGDOM UNITED KINGDOM Current liabilities: Liabilities, Current [Abstract] Revenue recognition Revenue [Policy Text Block] General and administrative General and Administrative Expense Acquisition of businesses, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Restatement [Axis] Revision of Prior Period [Axis] Debt and Credit Arrangements Debt Disclosure [Text Block] Summary of components of income tax expense Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Weighted average exercise price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Shares exercisable (in shares) Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable Line of Credit [Member] Line of Credit [Member] Share-Based Compensation Share-based Payment Arrangement [Text Block] Inventories Inventory Disclosure [Text Block] Leases Lessee, Leases [Policy Text Block] OtometricsProducts [Member] OtometricsProducts [Member] OtometricsProducts [Member] Interest and penalties related to uncertain tax positions Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Accounting Policies [Abstract] Accounting Policies [Abstract] Total amortization Amortization of Intangible Assets, Production and Nonproduction Amortization of Intangible Assets, Production and Nonproduction Number of reporting segments Number of Reportable Segments Accrued professional fees Accrued Professional Fees, Current 2025 Lessor, Operating Lease, Payment to be Received, Year Four U.S. Federal Current Federal Tax Expense (Benefit) Total Total operating lease liabilities Operating Lease, Liability Impairment charge for sale of entity Impairment Charge on Reclassified Assets Document Transition Report Document Transition Report Net foreign currency transaction gains (losses) Foreign currency gain (loss) Foreign Currency Transaction Gain (Loss), before Tax Common stock, $0.001 par value; 120,000,000 shares authorized; shares issued and outstanding 34,225,682 in 2021 and 33,911,703 in 2020 Common Stock, Value, Issued Weighted average discount rate, finance leases Finance Lease, Weighted Average Discount Rate, Percent Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Other expense, net Total other expense, net Nonoperating Income (Expense) Weighted average period of recognition of unrecognized compensation expense Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Unvested, beginning of period, Weighted - average grant date fair value Unvested, end of period, Weighted - average grant date fair value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Commitments and contingencies (Note 20) Commitments and Contingencies Leases Lessee, Operating Leases [Text Block] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Emerging Growth Company Entity Emerging Growth Company Amortization of right-of-use assets (principal payments) Finance Lease, Right-of-Use Asset, Amortization Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss, Current Restricted Stock Awards [Member] Restricted Stock [Member] Employee Benefit Plan Compensation and Employee Benefit Plans [Text Block] Deferred debt issuance costs Payments of Debt Issuance Costs ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Receivables [Abstract] Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Non-U.S. Deferred Foreign Income Tax Expense (Benefit) Auditor Name Auditor Name Cover page. Cover [Abstract] Other Foreign countries [Member] Foreign Countries [Member] Foreign countries. Cost of revenue Costs and Expenses Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Market Stock Unit Market Stock Unit [Member] Market Stock Unit Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Less imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items] Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items] Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items] Notes receivable, related parties Notes Receivable, Related Parties Income Tax Authority [Axis] Income Tax Authority [Axis] Work in process Inventory, Work in Process, Net of Reserves Thereafter Finance Lease, Liability, to be Paid, after Year Five Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Less: Current portion Net Investment in Lease, before Allowance for Credit Loss, Current Accrued liabilities Total Accrued Liabilities, Current Property and equipment included in accounts payable Capital Expenditures Incurred But Not Yet Paid (Prepayments For Capital Expenditures) Capital Expenditures Incurred But Not Yet Paid (Prepayments For Capital Expenditures) Less imputed interest Finance Lease, Liability, Undiscounted Excess Amount Finished goods Inventory, Finished Goods, Net of Reserves Current Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract] Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract] Share-based Payment Arrangement, Option [Member] Share-based Payment Arrangement, Option [Member] Equity [Abstract] Equity [Abstract] Comprehensive Income Comprehensive Income, Policy [Policy Text Block] Accumulated Impairment Accumulated Impairment of Intangible Assets (excluding Goodwill) Accumulated Impairment of Intangible Assets (excluding Goodwill) Liability for product warranties Standard Product Warranty, Policy [Policy Text Block] Exchange rate effect on cash and cash equivalents Effect of Exchange Rate on Cash and Cash Equivalents 2024 Finance Lease, Liability, to be Paid, Year Five Interest income Investment Income, Interest Common Stock Common Stock [Member] Variable Rate [Axis] Variable Rate [Axis] Product warranty period Standard Product Warranty Period Standard product warranty period. Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Segment, Customer and Geographic Information Segment Reporting Disclosure [Text Block] Weighted average remaining lease term, finance leases Finance Lease, Weighted Average Remaining Lease Term Income (loss) from operations Operating Income (Loss) Employer matching contributions Defined Contribution Plan, Employer Discretionary Contribution Amount Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Current portion of operating lease liabilities Operating Lease, Liability, Current Organization and Significant Accounting Policies Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] 2020 Finite-Lived Intangible Asset, Expected Amortization, Year Two Product Warranties Disclosures [Abstract] Product Warranties Disclosures [Abstract] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Document Fiscal Year Focus Document Fiscal Year Focus Total future minimum lease payments Lessor, Operating Lease, Payments To Be Received Before Imputed Interest Lessor, Operating Lease, Payments To Be Received Before Imputed Interest Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Stock-based compensation Share-based Payment Arrangement, Noncash Expense Variable Rate [Domain] Variable Rate [Domain] Cash and cash equivalents Cash and cash equivalents, beginning of year Cash and cash equivalents, end of year Cash and Cash Equivalents, at Carrying Value Depreciation expense Depreciation Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Payments on borrowings Repayments of Debt Allowance for Doubtful Accounts Allowance for Credit Losses [Text Block] Related Party Transaction, Amounts of Transaction Related Party Transaction, Amounts of Transaction Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Deferred taxes Increase (Decrease) in Deferred Income Taxes Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Accrued liabilities Increase (Decrease) in Accrued Liabilities Restricted Stock Units Activity Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Cash paid for income taxes Income Taxes Paid Equity compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount Other Other Nonoperating Income (Expense) Acquisition of property and equipment Payments to Acquire Property, Plant, and Equipment Long-Term Other Liabilities Other Liabilities Disclosure [Text Block] Maximum Maximum [Member] Share-based Payment Arrangement [Abstract] Share-based Payment Arrangement [Abstract] Total liabilities Liabilities Unbilled Revenues [Member] Unbilled Revenues [Member] Deferred tax assets: Deferred Tax Assets, Net [Abstract] Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] 2019 Finite-Lived Intangible Asset, Expected Amortization, Year One Award Type [Axis] Award Type [Axis] Granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Lessee, Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, Maturity [Table Text Block] Total stockholders’ equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent Stockholders' Equity Attributable to Parent Billing Status, Type [Axis] Billing Status, Type [Axis] Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Table] Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Table] Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Table] Costs incurred for development of software to be sold Capitalized Software Development Costs for Software Sold to Customers Tax net operating loss carryforwards Operating Loss Carryforwards Common Stock, shares issued Common Stock, Shares, Issued Preferred stock, issued Preferred stock issued Preferred Stock, Shares Issued City Area Code City Area Code Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Ireland IRELAND Entity Address, City or Town Entity Address, City or Town Number of strategic business units Number Of Strategic Business Units Number Of Strategic Business Units Intangible Assets Intangible Assets Disclosure [Text Block] Repurchase of company stock Payments for Repurchase of Common Stock Estimated useful lives of property and equipment Property, Plant and Equipment, Useful Life Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Basis difference in fixed and intangible assets Deferred Tax Liabilities Basis Difference In Fixed And Intangible Assets Deferred tax liabilities basis difference in fixed and intangible assets. Uncertain Tax Positions Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Net Book Value Indefinite Lived Intangible Assets (Excluding Goodwill), Net of Impairments Indefinite Lived Intangible Assets (Excluding Goodwill), Net of Impairments Operating lease liabilities Operating Lease, Liability, Noncurrent 2022 Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year One Total lease payments Finance Lease, Liability, Payment, Due Total current tax expense Current Income Tax Expense (Benefit) Interest expense Interest Expense 2020 Finance Lease, Liability, to be Paid, Year One Deferred Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Finance leases, accumulated amortization Finance Lease, Right-Of-Use Asset, Accumulated Depreciation Finance Lease, Right-Of-Use Asset, Accumulated Depreciation Retained earnings Retained Earnings (Accumulated Deficit) Research & Development Costs Research, Development, and Computer Software, Policy [Policy Text Block] Share based compensation, expiration period Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Restricted Stock Units [Member] Restricted Stock Units (RSUs) [Member] Self-funded insurance expense Self Insurance Reserve, Current Components of Gross and Net Intangible Asset Balances Schedule of Finite and Indefinite Lived Intangible Assets [Table Text Block] Schedule of finite and indefinite lived intangible assets. Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Employee stock purchase plan (shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Restatement [Domain] Revision of Prior Period [Domain] Entity Filer Category Entity Filer Category Total finance lease liabilities Total Finance Lease, Liability Total deferred tax liabilities Deferred Tax Liabilities, Gross Remaining lease term Lessee, Operating Lease, Remaining Lease Term Schedule Of Income Taxes [Line Items] Schedule Of Income Taxes [Line Items] Schedule Of Income Taxes [Line Items] Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate On each of the third and fourth anniversaries of the vesting date[Member] Share-based Payment Arrangement, Tranche Two [Member] Income Statement [Abstract] Income Statement [Abstract] Entity Registrant Name Entity Registrant Name Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] 2022 Finance Lease, Liability, to be Paid, Year Three 2023 Finance Lease, Liability, to be Paid, Year Four Deductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction Devices and Systems [Member] Devices and Systems [Member] Devices and systems. Gross Carrying Amount Indefinite-lived Intangible Assets (Excluding Goodwill) 2021 Finance Lease, Liability, to be Paid, Year Two Withholding taxes Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Cancelled (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Provision (benefit) for income tax Provision (benefit) for income tax Total expense (benefit) Income Tax Expense (Benefit) Accounts receivable, net of allowance for doubtful accounts of $5,271 and $6,213 Accounts Receivable, after Allowance for Credit Loss, Current Amendment Flag Amendment Flag Proceeds from long-term borrowings Proceeds from Issuance of Long-term Debt Equity Components [Axis] Equity Components [Axis] Assets and Liabilities, Lessee Assets and Liabilities, Lessee [Table Text Block] Assets and Liabilities, Lessee [Table Text Block] Entity Tax Identification Number Entity Tax Identification Number SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] Demonstration and loaned equipment [Member] Demonstration and Loaned Equipment [Member] Demonstration and loaned equipment. Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Total current assets Assets, Current Marketing and sales [Member] Selling and Marketing Expense [Member] Intellectual Property Intellectual Property [Member] Total lease payments Lessee, Operating Lease, Liability, to be Paid Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Forfeited, Shares Forfeited, units Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Inventories Inventory, Net Receivables Billing Status [Domain] Receivables Billing Status [Domain] Interest rate swap designated as a cash flow hedge Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax Share-based compensation Share-based Payment Arrangement [Policy Text Block] Repurchase of company stock Stock Repurchased During Period, Value Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] U.S. Federal Deferred Federal Income Tax Expense (Benefit) Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] Compensation expense associated with the ESPP Employee Stock Ownership Plan (ESOP), Compensation Expense Increase in valuation allowance Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Unrecognized compensation expense related to unvested portion of stock options Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Current portion of long-term debt Long-term Debt, Current Maturities Product and Service [Axis] Product and Service [Axis] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Accounts Receivable, Allowance for Credit Loss [Roll Forward] Accounts Receivable, Allowance for Credit Loss [Roll Forward] Other Income (Expense), Net Other Income and Other Expense Disclosure [Text Block] Reserve for Product Warranties Product Warranty Disclosure [Text Block] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Entity Public Float Entity Public Float Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Unrecognized compensation of unvested awards Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Weighted-average fair value of options granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Component [Domain] Equity Component [Domain] Unvested, beginning of period, Shares Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number Short-term lease cost Short-term Lease, Cost Stock-based compensation expense (shares) Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Marketing and selling Selling and Marketing Expense 2020 Lessee, Operating Lease, Liability, to be Paid, Year One Repurchase of company stock (shares) Stock Repurchased During Period, Shares Federal NOL Carryback Effective Income Tax Rate Reconciliation, Federal Net Operating Loss Carryback, Amount Effective Income Tax Rate Reconciliation, Federal Net Operating Loss Carryback, Amount Accumulated Impairment Accumulated Impairment Impairment of Intangible Assets Indefined Lived (excluding Goodwill) Impairment of Intangible Assets Indefined Lived (excluding Goodwill) Plan modification, incremental cost Share-based Payment Arrangement, Plan Modification, Incremental Cost Lessor, renewal term Lessor, Operating Lease, Renewal Term Statement [Line Items] Statement [Line Items] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] Accruals deductible in different periods Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] 2023 Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Two Revenue, Remaining Performance Obligation, Amount Revenue, Remaining Performance Obligation, Amount Purchases of equity investments Payments to Acquire Investments Stock-based compensation expense Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Domestic Tax Authority Domestic Tax Authority [Member] CARES Act payroll tax payable Accrued Payroll Taxes, Noncurrent, CARES Act Accrued Payroll Taxes, Noncurrent, CARES Act Net issuance of restricted stock awards Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Eligible compensation of employees Maximum Eligible Compensation Maximum eligible compensation. 2023 Lessee, Operating Lease, Liability, to be Paid, Year Four Gross Carrying Amount Intangible Assets, Gross (Excluding Goodwill) Debt Disclosure [Abstract] Debt Disclosure [Abstract] Finance leases, accrued liabilities Finance Lease, Liability, Current Purchase price for shares acquired Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent Allowance for Doubtful Accounts Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Valuation allowance Valuation allowances Deferred Tax Assets, Valuation Allowance Contract with Customer, Liability, Noncurrent Contract with Customer, Liability, Noncurrent Auditor Location Auditor Location Segment Reporting [Abstract] Segment Reporting [Abstract] Schedule Of Income Taxes [Table] Schedule Of Income Taxes [Table] Schedule Of Income Taxes [Table] Weighted average life of intangible assets Finite-Lived Intangible Asset, Useful Life Net minimum lease payments to be received Net minimum lease payments to be received Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received Interest on lease liabilities Finance Lease, Interest Expense Use of Estimates Use of Estimates, Policy [Policy Text Block] Granted (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Components of Basic and Diluted EPS Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Document Annual Report Document Annual Report Share-Based Compensation Expense Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Finance Leases Finance Lease, Liability, Payment, Due [Abstract] Non-current deferred revenue Deferred Revenue, Noncurrent Contract with customer, service period Contract With Customer, Service Period Contract With Customer, Service Period Vesting [Axis] Vesting [Axis] Purchase Accounting Adjustments Goodwill, Translation and Purchase Accounting Adjustments Title of 12(b) Security Title of 12(b) Security Total assets Assets Citibank, National Association [Member] Citibank, National Association [Member] Citibank, National Association [Member] Director [Member] Director [Member] Common Stock, shares authorized Common Stock, Shares Authorized Weighted average remaining contractual term, exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Geographical [Domain] Geographical [Domain] Geographical [Domain] Ratio of Indebtedness to Net Capital Ratio of Indebtedness to Net Capital Title of Individual [Axis] Title of Individual [Axis] Document Type Document Type Product and Service [Domain] Product and Service [Domain] Research and development Research and Development Expense 2023 Lessor, Operating Lease, Payment to be Received, Year Two Fair market value of outstanding awards Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Fair Value Ratio of Interest Coverage Ratio of Interest Coverage Ratio of Interest Coverage Thereafter Lessor, Operating Lease, Payment to be Received, after Year Five Lease renewal term Lessee, Operating Lease, Renewal Term Increase in unrecognized tax benefits Unrecognized Tax Benefits, Period Increase (Decrease) Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Revolving credit facility [Member] Revolving Credit Facility [Member] Foreign exchange difference Unrecognized Tax Benefits, Increase Resulting from Foreign Currency Translation Foreign earnings to be repatriated Deferred tax liabilities related to foreign earnings Deferred Tax Liabilities, Undistributed Foreign Earnings Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Services [Member] Services [Member] Services [Member] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Tax credits carryforwards Tax Credit Carryforward, Amount SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member] SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Office furniture and equipment [Member] Furniture and Fixtures [Member] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Lease, Cost Lease, Cost [Table Text Block] Geographical [Axis] Geographical [Axis] Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] Basic (shares) Weighted average common shares Weighted Average Number of Shares Outstanding, Basic Diluted (in dollars per share) Diluted earnings per share (in dollars per share) Earnings Per Share, Diluted Segments [Domain] Segments [Domain] State and Local Jurisdiction State and Local Jurisdiction [Member] Repayment of notes receivable from related party Repayment of Notes Receivable from Related Parties Operating Loss Carryforward, Period Operating Loss Carryforward, Period Operating Loss Carryforward, Period Dilutive effect of stock based awards Weighted Average Number Diluted Shares Outstanding Adjustment Vesting [Domain] Vesting [Domain] Leasehold improvements [Member] Leaseholds and Leasehold Improvements [Member] Finance leases, property and equipment, net Finance Lease, Right-of-Use Asset, Net Finance Lease, Right-of-Use Asset, Net Foreign countries [Member] Non-US [Member] Foreign taxes at rates less than U.S. rates Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Intangible assets, net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Deferred Revenue, December 31, 2020 Deferred Revenue, December 31, 2021 Contract with Customer, Liability Short-term Investments Investment, Policy [Policy Text Block] Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract] Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract] Weighted average shares used in the calculation of net income (loss) per share: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Deferred income tax Deferred Income Tax Liabilities, Net Related Party Transaction [Line Items] Related Party Transaction [Line Items] Credit Agreement [Member] Credit Agreement [Member] Credit Agreement [Member] Vesting period Share based compensation, vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Total Interest and penalties related to uncertain tax positions Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Loss on equity method investment adjustment Income (Loss) from Equity Method Investments Return to provision Effective Income Tax Rate Reconciliation, Return To Provision Effective Income Tax Rate Reconciliation, Return To Provision Restricted Stock Awards Activity Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Fair Value Measurements Fair Value Disclosures [Text Block] Reconciliation of effective income tax rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Finance Lease, Liability, Maturity Finance Lease, Liability, Fiscal Year Maturity [Table Text Block] Newborn Care Products [Member] Newborn Care Products [Member] Newborn Care Products [Member] Costs incurred for development of internal use computer software Costs Incurred for Development of Internal Use Computer Software Costs incurred for development of internal use computer software. Restructuring Restructuring Charges Accounts payable Accounts Payable, Current Impairment, Long-Lived Asset, Held-for-Use Impairment, Long-Lived Asset, Held-for-Use Depreciation and amortization Depreciation, Depletion and Amortization 2021 Finite-Lived Intangible Asset, Expected Amortization, Year Three Significant foreign jurisdictions Foreign Tax Authority [Member] Deferred tax liabilities: Deferred Tax Liabilities, Gross [Abstract] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Inventories Increase (Decrease) in Inventories Unbilled AR, December 31, 2020 Unbilled AR, December 31, 2021 Contract with Customer, Asset, after Allowance for Credit Loss Foreign exchange difference Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation Common Stock, shares outstanding Common Stock, Shares, Outstanding Gain (Loss) on Sale of Assets and Asset Impairment Charges Gain (Loss) on Sale of Assets and Asset Impairment Charges Product reserve warranty Standard and Extended Product Warranty Accrual Operating leases Deferred Tax Liabilities, Right-Of-Use Assets Deferred Tax Liabilities, Right-Of-Use Assets Vesting of restricted stock units Vesting Of Restricted Stock Units Vesting of restricted stock units. Medix Medical Devices, SRL [Member] Medix Medical Devices, SRL [Member] Medix Medical Devices, SRL [Member] Lapse of statute Income Tax Reconciliation Lapse Of Statute And Audit Settlement On Uncertain Tax Position Income tax reconciliation lapse of statute and audit settlement on uncertain tax position. Other Other Sundry Liabilities, Noncurrent Internally developed software [Member] Computer Software, Intangible Asset [Member] Document Period End Date Document Period End Date Net issuance of restricted stock awards (shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Accrued federal, state, and local taxes Product Warranty Accrual, Current Number of reporting units Number of Reporting Units Acquisition of intangible assets Payments to Acquire Intangible Assets Entity Central Index Key Entity Central Index Key Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Movement in Deferred Revenue [Roll Forward] Movement in Deferred Revenue [Roll Forward] Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] U.S. State and local Deferred State and Local Income Tax Expense (Benefit) Total lease cost Lease, Cost Property and Equipment Property, Plant and Equipment [Table Text Block] Income Statement Location [Domain] Income Statement Location [Domain] Decreases for tax positions related to prior years Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Customer related Customer Relationships [Member] Lessor, notice of termination Lessor, Operating Lease, Notice of Termination Lessor, Operating Lease, Notice of Termination Property and equipment, net Total Property, Plant and Equipment, Net Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Total operating expenses Operating Expenses Other liabilities Total Other Liabilities, Noncurrent Other Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount Lender Name [Axis] Lender Name [Axis] Expected annual amortization expense related to amortizable intangible assets Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Debt Instrument [Line Items] Debt Instrument [Line Items] Trading Symbol Trading Symbol Net income (loss) per share: Earnings Per Share [Abstract] Property and Equipment, Gross Property, Plant and Equipment, Gross Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Activity [Table] Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Activity [Table] Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Activity [Table] Accrued Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Balance, beginning of period Balance, end of period Accounts Receivable, Allowance for Credit Loss Other assets Increase (Decrease) in Other Operating Assets Revenue Revenues Weighted average vested options Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number SEC Schedule, 12-09, Reserve, Warranty [Member] SEC Schedule, 12-09, Reserve, Warranty [Member] Sales-type and Direct Financing Leases, Lease Receivable, Fiscal Year Maturity [Abstract] Sales-type and Direct Financing Leases, Lease Receivable, Fiscal Year Maturity [Abstract] Outstanding, beginning of period (in dollars per share) Outstanding, end of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Leases Lessor, Leases [Policy Text Block] Long-term debt Long-term Debt, Excluding Current Maturities Patents Patents [Member] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Total expense Share-based Payment Arrangement, Expense Research Tax Credit Carryforward Research Tax Credit Carryforward [Member] Entity Current Reporting Status Entity Current Reporting Status Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Net Sales Sales-type Lease, Lease Income Intangibles amortization Cost, Amortization Other comprehensive income, net of ASU adoption impact Other Comprehensive Income (Loss), Net Of Tax And ASU Adoption Impact Other Comprehensive Income (Loss), Net Of Tax And ASU Adoption Impact Intrinsic value of options exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Payables and Accruals [Abstract] Payables and Accruals [Abstract] Income (loss) before provision (benefit) for income tax Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] (Gain) Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Gain (Loss) on Disposition of Property Plant Equipment Beginning balance (shares) Ending balance (shares) Shares, Issued Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] United States UNITED STATES Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share 2026 Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Five Income Tax Provision Income Tax Provision [Member] Income Tax Provision [Member] Warranty reserve Taxes Payable, Current Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Current assets: Assets, Current [Abstract] Gross Carrying Amount Finite-Lived Intangible Assets, Gross Valuation Allowance by Deferred Tax Asset [Axis] Valuation Allowance by Deferred Tax Asset [Axis] Net investment in sales-type leases Total Net Investment in Lease, before Allowance for Credit Loss Leases [Abstract] Leases [Abstract] Finite-Lived Intangible Assets, Net [Abstract] Finite-Lived Intangible Assets, Net [Abstract] Amortization expense related to intangible assets with definite lives Schedule of Finite-Lived Intangible Assets [Table Text Block] Income Taxes Income Tax, Policy [Policy Text Block] London Interbank Offered Rate (LIBOR) [Member] London Interbank Offered Rate (LIBOR) [Member] Long lived assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Deferred revenue Deferred Revenue, Current Intangible Assets Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Accrued amounts due to customers Customer Refund Liability, Current Less: Non-current Inventories Non-current Inventories Inventory, Noncurrent Exercise of stock options (shares) Exercised (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Purchase obligation, to be paid, year one Purchase Obligation, to be Paid, Year One Diluted (shares) Diluted Shares (in dollars per share) Weighted Average Number of Shares Outstanding, Diluted U.S. Income (Loss) from Continuing Operations before Income Taxes, Domestic Total other comprehensive income (loss) Other comprehensive income Other Comprehensive Income (Loss), Net of Tax Warranty, term Standard Product Warranty, Term Standard Product Warranty, Term Income Taxes Income Tax Disclosure [Text Block] Leases Lessor, Sales-type Leases [Text Block] Related Party [Domain] Related Party [Domain] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Stock Options Activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Debt Instrument, Basis Spread on Variable Rate Debt Instrument, Basis Spread on Variable Rate Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Write-offs charged against allowance Accounts Receivable, Allowance for Credit Loss, Writeoff Lapse of statutes of limitations Decrease due to lapse of statutes of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 2023 Finite-Lived Intangible Asset, Expected Amortization, Year Five Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Other expense, net Nonoperating Income (Expense) [Abstract] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Auditor Firm ID Auditor Firm ID Purchase obligation Purchase Obligation Credit Facility [Axis] Credit Facility [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Entity Address, Address Line One Entity Address, Address Line One Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Changes in operating assets and liabilities, net of assets and liabilities acquired in acquisitions: Increase (Decrease) in Operating Capital [Abstract] Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Employer matching contribution, ratable vesting period Defined Contribution Plan, Employer Matching Contribution, Ratable Vesting Period Defined Contribution Plan, Employer Matching Contribution, Ratable Vesting Period Vested, Weighted - average grant date fair value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value General and administrative General and Administrative Expense [Member] Principles of Consolidation Consolidation, Policy [Policy Text Block] Entity Shell Company Entity Shell Company Accrued travel Accrued Travel, Current Accrued Travel, Current Movement in Unbilled AR [Roll Forward] Movement in Unbilled Receivables [Roll Forward] Movement in Unbilled Receivables [Roll Forward] Expected life in years Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Total current liabilities Liabilities, Current Employee Stock Purchase Plan [Member] Employee Stock [Member] Taxes paid related to net share settlement of equity awards Payment, Tax Withholding, Share-based Payment Arrangement Sales-type Lease Receivable, Maturity Sales-type and Direct Financing Leases, Lease Receivable, Maturity [Table Text Block] Revolving credit facility with Wells Fargo Bank Line of Credit Facility, Maximum Borrowing Capacity Operating cash flows from finance leases Finance Lease, Interest Payment on Liability Foreign currency translation Goodwill, Foreign Currency Translation Gain (Loss) Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Intrinsic value of options vested and expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Current Fiscal Year End Date Current Fiscal Year End Date Transferred to Trade Receivable Contract with Customer, Asset, Reclassified to Receivable Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Long-lived assets Long-Lived Assets Tax audits Effective Income Tax Rate Reconciliation, Tax Audit Effective Income Tax Rate Reconciliation, Tax Audit Operating Leased Assets [Line Items] Operating Leased Assets [Line Items] Statement [Table] Statement [Table] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Statistical Measurement [Axis] Statistical Measurement [Axis] Federal statutory tax expense Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Finance leases, other liabilities Finance lease liabilities Finance Lease, Liability, Noncurrent Total expected amortization expense Finite-Lived Intangible Assets, Net Goodwill Beginning Balance Ending Balance Goodwill Operating leases Deferred Tax Assets, Lease Liabilities Deferred Tax Assets, Lease Liabilities Balance at Beginning of Period Balance at End of Period SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount Cost of revenue Cost of Sales [Member] 2024 Lessor, Operating Lease, Payment to be Received, Year Three Inventory Inventory, Policy [Policy Text Block] Tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Amount Non-U.S. Current Foreign Tax Expense (Benefit) Goodwill Schedule of Goodwill [Table Text Block] Technology Developed Technology Rights [Member] Operating lease cost Operating Lease, Cost Purchase Obligation, To Be Paid, After Year One Purchase Obligation, To Be Paid, After Year One Purchase Obligation, To Be Paid, After Year One Computer software and hardware [Member] Computer Equipment [Member] Sale of Certain Subsidiary Assets Related Party Transactions Disclosure [Text Block] Uncertain tax position Effective Income Tax Rate Reconciliation, Tax Contingency, Amount Less: imputed interest Lessor, Operating Lease, Imputed Interest Lessor, Operating Lease, Imputed Interest Schedule of Activity in Allowance for Doubtful Accounts Accounts Receivable, Allowance for Credit Loss [Table Text Block] Executives RSAs and RSUs [Member] Executive Officer [Member] Inventory transferred to property and equipment Property, Plant and Equipment, Gross, Period Increase (Decrease) Deferred Tax Asset [Domain] Deferred Tax Asset [Domain] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Total deferred tax expense (benefit) Deferred Income Tax Expense (Benefit) Adjustments to reconcile net income (loss) to net cash provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Weighted average remaining contractual term Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term EX-101.PRE 11 ntus-20211231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 12 ntus-20211231_g1.jpg begin 644 ntus-20211231_g1.jpg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end XML 13 R1.htm IDEA: XBRL DOCUMENT v3.22.0.1
Document and Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2021
Feb. 18, 2022
Jun. 30, 2021
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2021    
Document Transition Report false    
Entity File Number 000-33001    
Entity Registrant Name NATUS MEDICAL INC    
Entity Central Index Key 0000878526    
Current Fiscal Year End Date --12-31    
Document Fiscal Year Focus 2021    
Document Fiscal Period Focus FY    
Amendment Flag false    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 77-0154833    
Entity Address, Address Line One 3150 Pleasant View Road    
Entity Address, City or Town Middleton    
Entity Address, State or Province WI    
Entity Address, Postal Zip Code 53562    
City Area Code 608    
Local Phone Number 829-8500    
Title of 12(b) Security Common Stock, $0.001 par value per share    
Trading Symbol NTUS    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Public Float     $ 886,752,114
Entity Common Stock, Shares Outstanding   34,408,154  
Documents Incorporated by Reference Certain portions of the Registrant's Definitive Proxy Statement for the 2022 Annual Meeting of Stockholders or an amendment to this Annual Report on Form 10-K, to be filed with the Securities and Exchange Commission, are incorporated by reference into Part III of this Annual Report on Form 10-K.    
Auditor Location San Francisco, CA    
Auditor Name KPMG LLP    
Auditor Firm ID 185    
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 75,595 $ 82,082
Accounts receivable, net of allowance for doubtful accounts of $5,271 and $6,213 111,760 93,133
Inventories 67,745 75,650
Prepaid expenses and other current assets 22,191 20,837
Total current assets 277,291 271,702
Property and equipment, net 21,783 24,516
Operating lease right-of-use assets 9,288 11,669
Intangible assets, net 65,513 92,741
Goodwill 148,657 151,299
Deferred income tax 23,161 27,563
Other assets 18,595 20,904
Total assets 564,288 600,394
Current liabilities:    
Accounts payable 36,405 23,429
Current portion of long-term debt 0 50,000
Current portion of operating lease liabilities 4,964 6,779
Accrued liabilities 48,135 44,236
Deferred revenue 25,097 21,308
Total current liabilities 114,601 145,752
Long-term liabilities:    
Other liabilities 17,237 18,451
Long-term debt 0 5,840
Operating lease liabilities 6,567 8,959
Deferred income tax 1,133 10,298
Total liabilities 139,538 189,300
Commitments and contingencies (Note 20)
Stockholders’ equity:    
Common stock, $0.001 par value; 120,000,000 shares authorized; shares issued and outstanding 34,225,682 in 2021 and 33,911,703 in 2020 353,737 342,828
Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding in 2021 and in 2020 0 0
Retained earnings 84,486 71,309
Accumulated other comprehensive loss (13,473) (3,043)
Total stockholders’ equity 424,750 411,094
Total liabilities and stockholders’ equity $ 564,288 $ 600,394
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 5,271 $ 6,213
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common Stock, shares authorized 120,000,000 120,000,000
Common Stock, shares issued 34,225,682 33,911,703
Common Stock, shares outstanding 34,225,682 33,911,703
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, issued 0 0
Preferred stock, outstanding 0 0
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Revenue $ 473,438 $ 415,684 $ 495,175
Cost of revenue 193,015 185,912 196,551
Intangibles amortization 6,743 13,241 6,916
Gross profit 273,680 216,531 291,708
Operating expenses:      
Marketing and selling 116,014 107,282 129,109
Research and development 56,306 61,296 58,733
General and administrative 52,753 49,113 59,649
Intangibles amortization 17,129 15,224 15,144
Restructuring 7,699 3,809 44,739
Total operating expenses 249,901 236,724 307,374
Income (loss) from operations 23,779 (20,193) (15,666)
Other expense, net (4,424) (1,872) (5,591)
Income (loss) before provision (benefit) for income tax 19,355 (22,065) (21,257)
Provision (benefit) for income tax 6,178 (5,452) (5,586)
Net income (loss) $ 13,177 $ (16,613) $ (15,671)
Net income (loss) per share:      
Basic $ 0.39 $ (0.49) $ (0.47)
Diluted (in dollars per share) $ 0.39 $ (0.49) $ (0.47)
Weighted average shares used in the calculation of net income (loss) per share:      
Basic (shares) 33,670 33,562 33,696
Diluted (shares) 33,974 33,562 33,696
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Comprehensive Income (Loss) Consolidated Statement of Comprehensive Income (Loss) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Statement of Comprehensive Income [Abstract]      
Net loss $ 13,177 $ (16,613) $ (15,671)
Foreign currency translation adjustment (10,640) 13,205 (1,576)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax 119 27 (180)
Interest rate swap designated as a cash flow hedge (91) 0 0
Reclassification of stranded tax effects upon adoption of ASU 2018-02 0 0 1,332
Reclassification of deferred foreign currency related adjustments related to the sale of Medix (See FN 22) 0 0 (24,845)
Total other comprehensive income (loss) (10,430) 13,232 21,757
Comprehensive income (loss) $ 2,747 $ (3,381) $ 6,086
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Cumulative Effect, Period of Adoption, Adjustment
Tax Cuts and Jobs Act, Reclassification from AOCI to Retained Earnings, Tax Effect   $ 0     $ 1,332   $ (1,332)
Beginning balance at Dec. 31, 2018 $ 398,444   $ 334,215 $ 102,261   $ (38,032)  
Beginning balance (shares) at Dec. 31, 2018     33,804,379        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Vesting of restricted stock units 0            
Vesting of restricted stock units (shares)     42,130        
Net issuance of restricted stock awards 0            
Net issuance of restricted stock awards (shares)     175,833        
Employee stock purchase plan 1,354   $ 1,354        
Employee stock purchase plan (shares)     53,839        
Stock-based compensation expense 8,315   $ 8,315        
Taxes paid related to net share settlement of equity awards (1,689)   $ (1,689)        
Taxes paid related to net share settlement of equity awards (shares)     (51,784)        
Exercise of stock options 2,281   $ 2,281        
Exercise of stock options (shares)     124,303        
Other comprehensive income 21,757            
Other comprehensive income, net of ASU adoption impact 23,089         23,089  
Net loss (15,671)     (15,671)      
Ending balance at Dec. 31, 2019 416,123   $ 344,476 87,922   (16,275)  
Ending balance (shares) at Dec. 31, 2019     34,148,700        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Vesting of restricted stock units 0            
Vesting of restricted stock units (shares)     14,033        
Net issuance of restricted stock awards 0            
Net issuance of restricted stock awards (shares)     204,057        
Employee stock purchase plan 1,314   $ 1,314        
Employee stock purchase plan (shares)     73,347        
Stock-based compensation expense 9,527   $ 9,527        
Repurchase of company stock (10,495)   $ (10,495)        
Repurchase of company stock (shares)     (465,117)        
Taxes paid related to net share settlement of equity awards (1,994)   $ (1,994)        
Taxes paid related to net share settlement of equity awards (shares)     (63,317)        
Other comprehensive income 13,232         13,232  
Net loss (16,613)     (16,613)      
Ending balance at Dec. 31, 2020 411,094   $ 342,828 71,309   (3,043)  
Ending balance (shares) at Dec. 31, 2020     33,911,703        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Vesting of restricted stock units 0            
Vesting of restricted stock units (shares)     205,082        
Net issuance of restricted stock awards 0            
Net issuance of restricted stock awards (shares)     252,064        
Employee stock purchase plan 611   $ 611        
Employee stock purchase plan (shares)     28,158        
Stock-based compensation expense 14,161   $ 14,161        
Stock-based compensation expense (shares)     0        
Taxes paid related to net share settlement of equity awards (4,107)   $ (4,107)        
Taxes paid related to net share settlement of equity awards (shares)     (183,112)        
Exercise of stock options $ 244   $ 244        
Exercise of stock options (shares) 11,787   11,787        
Other comprehensive income $ (10,430)         (10,430)  
Net loss 13,177     13,177      
Ending balance at Dec. 31, 2021 $ 424,750   $ 353,737 $ 84,486   $ (13,473)  
Ending balance (shares) at Dec. 31, 2021     34,225,682        
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Operating activities:      
Net loss $ 13,177 $ (16,613) $ (15,671)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Provision for losses on accounts receivable 181 1,190 4,262
Depreciation and amortization 28,091 28,115 30,722
Sales-type Lease, Selling Profit (Loss) 3 1,881 0
Loss on equity method investment adjustment 602 133 0
(Gain) Loss on disposal of property and equipment (1,426) 268 449
Impairment of intangible assets 2,004 6,678 0
Impairment, Long-Lived Asset, Held-for-Use 279 0 0
Impairment charge for sale of entity 0 0 24,571
Warranty reserve 3,989 2,009 2,886
Stock-based compensation 14,161 9,566 8,352
Non cash lease expense 0 1,353 0
Deferred taxes (4,386) (1,577) (5,364)
Changes in operating assets and liabilities, net of assets and liabilities acquired in acquisitions:      
Accounts receivable (13,111) 17,651 7,139
Inventories 4,830 1,939 7,185
Other assets (1,880) (1,055) (2,486)
Accounts payable 13,530 (4,523) (1,367)
Accrued liabilities (507) (13,427) (4,010)
Deferred revenue 4,458 838 3,392
Net cash provided by operating activities 63,995 34,426 60,060
Investing activities:      
Acquisition of businesses, net of cash acquired 0 (1,997) 0
Acquisition of property and equipment (3,620) (8,609) (5,326)
Acquisition of intangible assets 0 0 (13)
Proceeds from Sale of Property, Plant, and Equipment 2,674 0 0
Purchases of equity investments (1,000) (2,000) 0
Net cash used in investing activities (1,946) (12,606) (5,339)
Financing activities:      
Proceeds from stock option exercises and ESPP 855 1,314 3,635
Finance Lease, Principal Payments (410) (527) (478)
Repurchase of company stock 0 (10,495) 0
Taxes paid related to net share settlement of equity awards (4,107) (1,994) (1,689)
Proceeds from long-term borrowings 0 60,000 0
Deferred debt issuance costs 0 (1,175) 0
Payments on borrowings (57,000) (58,000) (50,000)
Net cash used in financing activities (60,662) (10,877) (48,532)
Exchange rate effect on cash and cash equivalents (7,874) 7,842 735
Net increase (decrease) in cash and cash equivalents (6,487) 18,785 6,924
Cash and cash equivalents, beginning of year 82,082 63,297 56,373
Cash and cash equivalents, end of year 75,595 82,082 63,297
Supplemental disclosure of cash flow information:      
Cash paid for interest 1,180 3,110 4,580
Cash paid for income taxes 3,782 6,825 6,445
Non-cash investing activities:      
Property and equipment included in accounts payable 56 (51) 69
Inventory transferred to property and equipment 1,167 1,303 300
Transfer of leased assets to sales-type leases $ 13 $ 4,107 $ 0
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.22.0.1
Organization and Significant Accounting Policies
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Organization and Significant Accounting Policies ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES
Organization
Natus Medical Incorporated (“we”, “our”, “us”) was incorporated in California in May 1987 and reincorporated in Delaware in August 2000. We are a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, software systems for managing and tracking disorders and diseases for public health laboratories, computer-based audiological, otoneurologic and vestibular instrumentation for hearing and balance care professionals.
Basis of Presentation and Principles of Consolidation
The accompanying Consolidated Financial Statements includes our accounts and accounts of our wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Certain reclassifications to the prior periods have been made to conform to the current period presentation.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the Consolidated Financial Statements and the reported amount of revenue and expenses during the reporting period. Such estimates include allowances for potentially uncollectible accounts receivable, valuation of inventory, intangible assets, goodwill, share-based compensation, valuation of deferred income taxes, reserves for warranty obligations, and the provision for income taxes including uncertain positions. Actual results could differ from those estimates.
Revenue recognition
Revenue is recognized when obligations under the terms of a contract with a customer are satisfied; generally this occurs with the transfer of control of devices, supplies, or services. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services.
For the majority of devices and supplies, we transfer control and recognize revenue when products ship from the warehouse to the customer. We generally do not provide rights of return on devices and supplies. Freight charges billed to customers are included in revenue and freight-related expenses are charged to cost of revenue.
Depending on the terms of the arrangement, we may also defer the recognition of a portion of the consideration received because we have to satisfy a future obligation (e.g. installation). Judgment is required to determine the standalone selling price for each distinct performance obligation. Our estimate of SSP is a point estimate.  The estimate is calculated annually for each performance obligation that is not sold separately. In instances where SSP is not directly observable, such as when we do not sell the product or service separately, the SSP is determined using information that may include market conditions and other observable inputs.
We sell separately-priced service contracts that extend maintenance coverages for both medical devices and data management systems beyond the base agreements to customers. The separately priced service contracts range from 12 months to 60 months. We receive payment at the inception of the contract and recognize revenue ratably over the service period.
For products containing embedded software, we have determined that the hardware and software components function together to deliver the products' essential functionality and are considered a combined performance obligation. Revenue recognition policies for sales of these products are substantially the same as for other tangible products.
Inventory Valuation
Inventories are carried at the lower of cost or net realizable value, with cost being determined using the first-in, first-out method. The carrying value of our inventory is reduced for any difference between cost and estimated net realizable value of the inventory. We determine net realizable value by evaluating ending inventories for excess quantities, obsolescence, and other factors that could impact our ability to consume inventory for its intended use. Our evaluation includes an analysis of historical sales by product, projections of future demand by product, and an analysis of obsolescence by product. Adjustments to the
value of inventory establish a new cost basis and are considered permanent even if circumstances later suggest that increased carrying amounts are recoverable. If demand is higher than expected, we may sell inventory that had previously been written down.
Intangible assets
We amortize intangible assets with finite lives over the estimate of their useful lives. Any future changes that would limit their useful lives or any determination that these assets are carried at amounts greater than their estimated fair value could result in acceleration of amortization over a revised useful life.
We review intangible assets with indefinite lives for impairment on an annual basis and finite lives for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Recoverability of the finite-lived intangible assets is assessed based on the estimated undiscounted future cash flows expected to result from the use and eventual disposition of the asset. If the undiscounted future cash flows are less than the carrying amount, the finite-lived intangible assets are considered to be impaired. The amount of the impairment loss, if any, is measured as the difference between the carrying amount of the asset and its fair value. We estimate the fair value of finite-lived intangible assets by using an income approach or, when available and appropriate, using a market approach.
Goodwill
Goodwill is not amortized but is subject to an annual impairment analysis, which is performed as of October 1st; this assessment is also performed whenever there is a change in circumstances that indicates the carrying value of goodwill may be impaired.
Goodwill is tested for impairment at the reporting unit level. Our three strategic business units, Neuro, Newborn Care and Hearing & Balance are consolidated into one unit. We have concluded that we have one operating segment and one reporting unit for purposes of goodwill impairment testing in 2021, 2020, and 2019.
In accordance with accounting standards we perform a qualitative assessment to test goodwill for impairment prior to the performing the first step of the goodwill impairment process. Qualitative factors considered in this assessment include industry and market considerations, overall financial performance and other relevant events and factors affecting the reporting unit.
Based on the qualitative assessment in 2021, 2020, and 2019, we determined the fair value of goodwill was more likely than not greater than its carrying amount, and no further analysis was needed.
Lessee Leases
We determine if an arrangement is a lease at inception of the lease. Right-of-use (“ROU”) assets represent the right to use an underlying asset for the lease term, and lease liabilities represent an obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit borrowing rate, generally we use an incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at the lease commencement date. We use the implicit rate when readily determinable. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include options to exclude or terminate the lease when it is reasonably certain that they will exercise that option. Lease expense for lease payments are recognized on a straight-line basis over the lease term.
Operating leases are included in operating lease ROU assets, accrued liabilities, and operating lease liabilities in our consolidated balance sheet. Finance leases are included in property and equipment, accrued liabilities, and other liabilities in the consolidated balance sheet.
We have lease agreements with lease and non-lease components, which are generally accounted for based on the type of asset. For real estate and telecom leases, we account for these components separately. For equipment leases, such as office equipment and vehicles, we account for the lease and non-lease components as a single lease component.
Lessor Leases
We determine if an arrangement is a lease at inception of the lease. We entered into a five-year non-cancelable exclusive supply agreement with a customer to provide hearing screening products which commenced on January 1, 2020. The agreement includes automatic renewal options for successive three-year periods. Notice of non-renewal must be provided to Natus at least twelve months prior to the end of the current term. The agreement does not contain any purchase options or residual value guarantees.
Pricing of the exclusive supply agreement is structured on a fee per baby screened basis. The per baby fee is inclusive of all products and services to be provided under the terms of the agreement which include hearing screening hardware, consumables required to complete each screen, and related maintenance. The pricing structure also includes a guaranteed minimum payment per unit per contract year for each unit of equipment supplied.
Sales-Type Leases
The guaranteed minimum payment for each unit of equipment supplied represents the fixed transaction price and is allocated to separate performance obligations, consisting of hardware products, consumables, and maintenance, proportionally based on the standalone selling price of each performance obligation. Standalone selling price is best evidenced by the price we charge for the good or service when selling it separately in similar circumstances to similar customers. Other than for the renewal of annual support services contracts, our products and services are not generally sold separately. We use an amount discounted from the list price as a best estimated selling price.
For sales-type leases, we recognize revenues for hearing screening hardware products at the net present value of their guaranteed minimum payment standalone selling price allocation upon delivery of the hardware. We recognize consumables and maintenance revenues associated with the sales-type leases over the term of the agreement on a weighted average as actual screens are performed.
Operating Leases
Under the terms of the exclusive supply agreement, hospitals where we were previously providing hearing screening services were provided the option to transition to the exclusive supply agreement. Hospitals which chose to transition continued to use their existing Natus hardware. Based on the remaining useful life of the existing hardware and the date new hardware is supplied after the commencement of the lease, some of these leases were classified as operating leases.
For operating leases, rental income is recognized on a straight-line basis over the term of the associated lease. Leased assets classified as operating leases are carried at amortized cost net of accumulated depreciation in property and equipment, net on the condensed consolidated balance sheet. The depreciation expense of the leased assets is recognized on a straight-line basis over the useful life of the asset, and recorded in cost of revenue in the condensed consolidated statements of operations.
Long lived assets
We continually monitor events and changes in circumstances that could indicate that carrying amounts of our long-lived assets, including property and equipment, intangible assets and leases, may not be recoverable. When such events or changes in circumstances occur, we will assess the recoverability by determining whether the carrying value of an asset group will be recovered through undiscounted expected future cash flows. If the future undiscounted cash flows are less than the carrying amount of the asset group, we will recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets.
Liability for product warranties
We provide a warranty for products that is generally one year in length. In some cases, regulations may require us to provide repair or remediation beyond the typical warranty period. If any products contain defects, we may be required to incur additional repair and remediation costs. Service, repair and calibration services are provided by a combination of our owned facilities and vendors on a contract basis.
We accrue estimated product warranty costs at the time of sale based on historical experience. A warranty reserve is included in accrued liabilities for the expected future costs of servicing products. Additions to the reserve are based on management’s best estimate of probable liability. We consider a combination of factors including material and labor costs, regulatory requirements, and other judgments in determining the amount of the reserve. The reserve is reduced as costs are incurred to honor existing warranty and regulatory obligations.
Share-based compensation
We recognize share-based compensation expense associated with employee stock options under the single-option straight line method over the requisite service period, which is generally a four-year vesting period and ten-year contractual term pursuant to ASC Topic 718, Compensation-Stock Compensation. See Note 15 of the Consolidated Financial Statements.
For employee stock options, the value of each option is estimated on the date of grant using the Black-Scholes option pricing model, which was developed for use in estimating the value of freely traded options. Similar to other option pricing models, the Black-Scholes method requires the input of highly subjective assumptions, including stock price volatility. Changes in the subjective input assumptions can materially affect the estimated fair value of the employee stock options.
We recognize share-based compensation associated with Restricted Stock Awards (“RSA”) and Restricted Stock Units (“RSU”). RSAs and RSUs vest ratably over a three-year period for employees. RSAs and RSUs for executives vest over a four-year period; 25% on each of the annual anniversaries. RSAs and RSUs for non-employees (Board of Directors) vest over a one-year period; 100% on the first anniversary. The value is estimated based on the market value of Natus common stock on the date of issuance pursuant to ASC Topic 718, Compensation-Stock Compensation.
We grant market stock unit (“MSU”) awards to certain employees. We estimate the fair value of MSUs at the date of grant using a Monte Carlo simulation model and amortize those fair values over the requisite service period, which is generally three years. The Monte Carlo simulation model that we use to estimate the fair value of market-based MSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the market-based MSUs, which is determined at the date of grant, must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the achievement of the specified market criteria.
We also grant performance stock unit (“PSU”) awards to our CEO and CFO. These PSUs fully vest after a performance period and have separate performance goals than MSUs. We estimate fair value of performance stock unit awards based on the share price and other pertinent factors on the grant date. Compensation expense for performance stock unit awards are recognized on a straight-line basis over the requisite service period of the award when performance condition is probable to occur. We assess the achievement probability of the performance conditions each period and adjust compensation expense if necessary. Provided that the requisite service is rendered, the shares will become vested and payout will occur based on the outcome of the performance condition. Any unrecognized compensation cost shall be recognized when the award becomes vested.
We issue new shares of common stock upon the exercise of stock options and the vesting of RSAs, RSUs, MSUs, and PSUs.
Forfeitures of employee stock options and awards are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. Share-based compensation expense is recorded net of estimated forfeitures, such that expense is recorded only for those share-based awards that are expected to vest.
Cash Equivalents
All highly liquid investments purchased with an original maturity or remaining maturity upon purchase of three months or less are classified as cash equivalents.
Allowance for Doubtful Accounts
We estimate the allowance for potentially uncollectible accounts receivable based on historical collection experience within the markets in which we operate and other customer-specific information, such as bankruptcy filings or customer liquidity problems. When all internal efforts have been exhausted to collect the receivable, it is written off and relieved from the reserve.
Fair Value of Financial Instruments
Financial instruments include cash and cash equivalents, accounts receivable, and accounts payable. Cash is reported at its fair value on the balance sheet dates. The recorded carrying amounts of accounts receivable and accounts payable approximate their fair values due to the short-term maturities.
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation. Depreciation expense is computed using the straight-line method over estimated useful lives of the respective assets, which are three to five years for office furniture and equipment, computer software and hardware, demonstration and loaned equipment, and 30 to 40 years for buildings. Leasehold improvements are amortized over the shorter of the lease term or the estimated useful life of the improvement. Land is not depreciated. Costs associated with acquiring and installing software to be used for internal purposes are capitalized and amortized on a straight-line basis over three years.
Research & Development Costs
Costs incurred in research and development are charged to operations as incurred.
Income Taxes
We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statements carrying value of assets and liabilities and the tax basis of those assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.
We record net deferred tax assets to the extent it is more likely than not that the assets will be realized. In making such determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations. To the extent that previously reserved deferred tax assets are estimated to be realizable, we adjust the valuation allowance which reduces the provision for income taxes.
We recognize the tax benefit of uncertain tax positions in the financial statements as defined in ASC Topic 740, Income Tax. When the tax position is deemed more likely than not of being sustained, we recognize the largest amount of tax benefit that is greater than 50 percent likely of being ultimately realized upon settlement, as defined in ASC 740-10-05.
Foreign Currency
The functional currency of our subsidiaries outside of North America is generally the local currency of the country where the subsidiary is located. Accordingly, foreign currency translation adjustments relating to the translation of foreign subsidiary financial statements are included as a component of accumulated other comprehensive loss. We have recorded $(10.6) million, $13.2 million, and $(1.6) million of foreign currency translation gains (losses) for the years ended December 31, 2021, 2020 and 2019, respectively.
Gains and losses from transactions denominated in currencies other than the functional currencies are included in other income and expense. In 2021, 2020, and 2019, net foreign currency transaction gains (losses) were $(2.0) million, $2.0 million, and $(0.8) million, respectively. Foreign currency gains and losses result primarily from fluctuations in the exchange rate between the U.S. dollar, Canadian dollar, Euro, British pound, and Danish kroner.
We divested our wholly owned subsidiary, Medix, on April 2, 2019 via a stock sale. Included in the year ended December 31, 2019 is the impact of the sale of Medix, which was completed as of June 30, 2019, and the deferred foreign currency related translation adjustments previously in accumulated other comprehensive income have been released from the balance sheet along with the held for sale accrual (See Note 22 - Sale of a Certain Subsidiary).
Comprehensive Income
We break out the major components and report as a single total the change in net assets during the period as defined in ASC Topic 220, Comprehensive Income. The consolidated statement of comprehensive income (loss) has been separately stated from the consolidated statements of operations. Accumulated other comprehensive loss consists of translation gains and losses on foreign subsidiary financial statements, interest rate swap designated as a cash flow hedge, reclassifications from the adoption of ASU 2018-02, and reclassification of previously recorded deferred foreign currency related translation adjustment losses upon the divestiture of Medix.
Basic and Diluted Net Income per Share
We compute net income per share as defined in ASC Topic 260, Earnings per Share. Basic net income per share is based upon the weighted average number of common shares outstanding during the period. Diluted net income per share is based upon the weighted average number of common shares outstanding and dilutive common stock equivalents outstanding during the period. Common stock equivalents are options granted, shares of restricted stock, and shares of market stock issued under the stock awards plans and are calculated under the treasury stock method. Common equivalent shares from unexercised stock options and restricted stock are excluded from the computation when there is a loss as the effect is anti-dilutive, or if the exercise price of such options is greater than the average market price of the stock for the period.
Recently Adopted Accounting Pronouncements
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740), Simplifying the Accounting for Income Tax. This update includes removal of certain exceptions to the general principles of ASC 740, Income taxes, and simplification in several other areas such as accounting for franchise tax (or similar tax) that is partially based on income. We early adopted the ASU in the second quarter of 2020. Upon adoption, we recorded an additional income tax benefit of $0.9 million due to the elimination of the year-to-date loss limitation rules that limited the interim tax period tax benefit.
In October 2020, the FASB issued ASU 2020-10, Codification Improvements. This update improves consistency by amending the Codification to include all disclosure guidance in appropriate disclosure sections. Also, the update clarifies application of various provisions in the Codification by amending and adding new headings, cross-referencing to other guidance, and refining or correcting terminology. ASU 2020-10 was effective for annual period starting December 15, 2020. The adoption of this ASU did not have an impact on our consolidated financial statements.
In July 2021, the FASB issued ASU 2021-05, Leases (Topic 842): Lessors-Certain Leases with Variable Lease Payments. This update addresses stakeholders' concerns by amending the lease classification requirements for lessors to align them with practice under Topic 840. Lessors should classify and account for a lease with variable lease payments that do not depend on a reference index or a rate as an operating lease if the lease would have been classified as a sales-type lease or a direct financing lease in accordance with 842-10-25-2 through 25-3 and the lessors would have otherwise recognized a day-one loss. ASU 2021-05 is effective for fiscal years beginning after December 15, 2021. We have early adopted the ASU on a prospective basis in the third quarter of the current fiscal year. The adoption of ASU 2021-05 did not have an impact on our consolidated financial statements.
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.22.0.1
Revenue
 12 Months Ended
Dec. 31, 2021
Revenue from Contract with Customer [Abstract]  
Revenue REVENUE
    Contract assets for the periods presented primarily represent the difference between revenue recognized based on the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Deferred revenue for the periods presented was primarily related to extended service contracts, installation, and training, for which the service fees are billed up-front. The associated deferred revenue is generally recognized ratably over the extended service period or when installation and training are complete.

The following table summarized the changes in the contract assets and contract liability balances for the year ended December 31, 2021 (in thousands):

Unbilled AR, December 31, 2020$1,925 
Additions58 
Transferred to Trade Receivable(1,731)
Unbilled AR, December 31, 2021$252 
Deferred Revenue, December 31, 2020$25,723 
Additions24,053 
Revenue Recognized(19,679)
Deferred Revenue, December 31, 2021$30,097 
    At December 31, 2021, the contract assets of $0.3 million were included in accounts receivable in the consolidated balance sheet. At December 31, 2021, the short-term portion of the contract liability of $25.1 million and the long-term portion of $5.0 million were included in deferred revenue and other long-term liabilities respectively, in the consolidated balance sheet. As of December 31, 2021, we expect to recognize revenue associated with deferred revenue of approximately $25.0 million in 2022, $2.7 million in 2023, $1.5 million in 2024, $0.5 million in 2025, and $0.4 million thereafter.
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.22.0.1
Allowance for Doubtful Accounts
 12 Months Ended
Dec. 31, 2021
Receivables [Abstract]  
Allowance for Doubtful Accounts ALLOWANCE FOR DOUBTFUL ACCOUNTS
We estimate the lifetime allowance for doubtful, potentially uncollectible, accounts receivable upon their inception based on historical collection experience within the markets in which we operate, customer-specific information such as bankruptcy filings or customer liquidity problems, current conditions, and reasonable and supportable forecasts about the future.
Our allowance for doubtful accounts is presented as a reduction to accounts receivable on our consolidated balance sheet. When all internal efforts have been exhausted to collect the receivable, it is written off and relieved from the reserve.
The details of activity in allowance for doubtful accounts are as follows (in thousands):
 December 31,
 20212020
Balance, beginning of period$6,213 $7,384 
Additions charged to expense181 1,190 
Write-offs charged against allowance(1,123)(2,361)
Balance, end of period$5,271 $6,213 
XML 23 R11.htm IDEA: XBRL DOCUMENT v3.22.0.1
Inventories
 12 Months Ended
Dec. 31, 2021
Inventory Disclosure [Abstract]  
Inventories INVENTORIESInventories consist of (in thousands):
 December 31,
 20212020
Raw materials and subassemblies$20,750 $22,583 
Work in process2,825 2,294 
Finished goods57,836 65,695 
Total Inventories81,411 90,572 
Less: Non-current Inventories(13,666)(14,922)
Inventories$67,745 $75,650 
Non-current inventory consists of service components used to repair products held by customers pursuant to warranty obligations and extended service contracts, including service components for products that we no longer sell, inventory purchased for lifetime buys, inventory built as a last-time build, and inventory that is turning at a slow rate. We believe that these inventories will be utilized for their intended purpose.
XML 24 R12.htm IDEA: XBRL DOCUMENT v3.22.0.1
Property and Equipment
 12 Months Ended
Dec. 31, 2021
Property, Plant and Equipment [Abstract]  
Property and Equipment PROPERTY AND EQUIPMENT
Property and equipment consist of (in thousands):
 December 31,
 20212020
Land$1,782 $1,792 
Buildings7,238 7,365 
Leasehold improvements7,722 8,050 
Finance lease right-of-use assets2,356 2,555 
Office furniture and equipment20,637 22,148 
Computer software and hardware11,308 10,246 
Demonstration and loaned equipment4,050 3,086 
55,093 55,242 
Accumulated depreciation(33,310)(30,726)
Total$21,783 $24,516 
Depreciation expense of property and equipment was $6.3 million, $6.2 million, and $6.6 million in the years ending December 31, 2021, 2020 and 2019, respectively.
XML 25 R13.htm IDEA: XBRL DOCUMENT v3.22.0.1
Intangible Assets
 12 Months Ended
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets INTANGIBLE ASSETS
The following table summarizes the components of gross and net intangible asset balances (in thousands):
 December 31, 2021December 31, 2020
 Gross
Carrying
Amount		Accumulated
Impairment		Accumulated
Amortization		Net Book
Value		Gross
Carrying
Amount		Accumulated
Impairment		Accumulated
Amortization		Net Book
Value
Intangible assets with definite lives:
Technology$99,920 (6,039)$(66,679)$27,202 $112,138 (12,480)$(64,203)$35,455 
Customer related89,794 (50)(57,133)32,611 94,526 (50)(51,247)43,229 
Trade names45,593 (3,260)(36,960)5,373 47,058 (3,677)(31,890)11,491 
Internally developed software13,281 — (12,985)296 13,281 — (12,845)436 
Patents2,705 (133)(2,572)— 2,810 (133)(2,677)— 
Service Agreements800 — (769)31 1,190 — (1,119)71 
Total definite-lived intangible assets252,093 (9,482)(177,098)65,513 271,003 (16,340)(163,981)90,682 
Intangible assets with indefinite lives:
Intellectual Property2,004 (2,004)— — 2,059 — — 2,059 
Total intangible assets254,097 (11,486)(177,098)65,513 273,062 (16,340)(163,981)92,741 
Finite lived intangible assets are amortized over their weighted average lives, which are 14 years for technology, 13 years for patents, 10 years for customer-related intangibles, 7 years for trade names, 6 years for internally developed software, 2 years for service agreements, and 11 years weighted average in total.
Internally developed software consists of $11.1 million relating to costs incurred for development of internal use computer software and $2.2 million for development of software to be sold.
During the third quarter of 2020 we recorded an impairment charge related to intangible assets of $6.7 million of which $6.4 million was recorded within intangibles amortization within cost of revenue and $0.3 million was recorded within intangibles amortization within operating expense on our income statement. The impairment related to an end of life decision for an acquired tradename and technology at which time we made the decision to discontinue sales of the related product rather than continuing to invest in the product.
During the fourth quarter of 2021 we recorded an impairment charge related to intangible assets of $2.0 million which was recorded within intangibles amortization within operating expense on our income statement. The impairment was a management decision to abandon further development of the product using intellectual property.
Amortization expense related to intangible assets with finite and indefinite lives, including impairment charges described above, was as follows (in thousands):
 Years Ended December 31,
 202120202019
Technology$6,907 $13,417 $6,906 
Customer related9,040 8,825 8,662 
Trade names5,881 6,182 6,111 
Intellectual Property2,004 — — 
Internally developed software141 239 1,438 
Patents— — 60 
Service Agreements40 40 322 
Total amortization$24,013 $28,703 $23,499 
The amortization expense amounts shown above include internally developed software not held for sale of $0.1 million, $0.2 million, and $1.3 million for the years ended 2021, 2020, and 2019, respectively. The amortization expense for internally developed software not held for sale is recorded within our income statement as a general and administrative operating expense. The amount in the table shown above for intellectual property relates to the impairment charge recorded during the fourth quarter of 2021.
Expected annual amortization expense related to amortizable intangible assets is as follows (in thousands):
2022$17,634 
202314,865 
202412,970 
202512,362 
20262,408 
Thereafter5,274 
Total expected amortization expense$65,513 
XML 26 R14.htm IDEA: XBRL DOCUMENT v3.22.0.1
Goodwill
 12 Months Ended
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill GOODWILL
The carrying amount of goodwill and the changes in those balances are as follows (in thousands):
As of December 31, 2019$146,367 
Purchase Accounting Adjustments1,207 
Foreign currency translation$3,725 
As of December 31, 2020151,299 
Foreign currency translation(2,642)
As of December 31, 2021$148,657 
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases
 12 Months Ended
Dec. 31, 2021
Leases [Abstract]  
Leases LEASES
    
Lessee Leases

We have operating and finance leases for offices, warehouses, and certain equipment. The leases have remaining lease terms of one to eight years, some of which include options to extend the leases for up to ten years. Our leases do not have any residual value guarantees or any restrictions or covenants imposed by leases.

Components of lease cost were as follows (in thousands):
 Year Ended 
 December 31,
 20212020
Operating lease cost$6,046 $6,696 
Finance lease cost:
Amortization of right-of-use assets (principal payments)384 395 
Interest on lease liabilities34 49 
Short-term lease cost22 7 
Variable lease cost1,958 2,541 
Sublease income(81)(61)
Total lease cost$8,363 $9,627 
Supplemental cash flow information related to leases was as follows (in thousands):
 Year Ended 
 December 31,
 20212020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$12,636 $13,979 
Operating cash flows from finance leases19 32 
Financing cash flows from finance leases410 527 
Right-of-use assets obtained in exchange for lease obligations:
Operating leases3,055 3,290 
Finance leases98 337 

Supplemental balance sheet information related to leases was as follows (in thousands):
 December 31, 2021December 31, 2020
Operating Leases
Operating lease right-of-use assets$9,288 $11,669 
Current portion of operating lease liabilities
$4,964 $6,779 
Operating lease liabilities6,567 8,959 
Total operating lease liabilities$11,531 $15,738 
Finance Leases
Property and equipment, gross$2,356 $2,555 
Accumulated amortization(1,906)(1,705)
Property and equipment, net$450 $850 
Accrued liabilities$231 $414 
Other liabilities230 446 
Total finance lease liabilities$461 $860 
Weighted Average Remaining Lease Term
Operating leases2.97 years3.33 years
Finance leases2.40 years2.68 years
Weighted Average Discount Rate
Operating leases5.4 %5.4 %
Finance leases5.1 %5.1 %

    As of December 31, 2021, future minimum lease payments included in the measurement of lease liabilities on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):
Year ending December 31, Operating LeasesFinance Leases
2022$5,440 $240 
20233,404 159 
20241,959 63 
2025957 17 
2026630 — 
Thereafter105 — 
Total lease payments12,495 479 
Less imputed interest(964)(18)
Total$11,531 $461 

Lessor Leases

Pricing of our exclusive hearing screening supply agreement is structured on a fee per baby screened basis and includes a guaranteed minimum payment per unit per contract year for each unit of equipment supplied. We recognize revenues for the hardware products upon commencement of each lease at the net present value of their guaranteed minimum payment standalone selling price allocation. The remaining variable fees are recognized as revenue over the remaining lease term. The following table provides the profit recognized for sales-type leases at their commencement (net sales includes the initial allocation of fixed costs plus allocation of incremental variable fees and excludes the revenue associated with non-lease components associated with hearing screening supplies and maintenance that are recognized as revenue over the remaining lease term) (in thousands):
 Year Ended 
 December 31,
 20212020
Net Sales$10 $2,226 
Cost of Sales13 4,107 
Gross Loss$(3)$(1,881)


The following table provides lease income related to variable lease payments on our sales-type leases not included in the measurement of the lease receivable (in thousands):
 Year Ended 
 December 31,
 20212020
Variable lease income$877 $420 

The following table provides lease income on our operating leases (in thousands):
 Year Ended 
 December 31,
 20212020
Lease income on operating leases$197 $291 

The receivables as a result of our sales-type leases are collateralized by the underlying equipment leased and consist of the following components (in thousands):
 Year Ended 
 December 31,
 20212020
Net minimum lease payments to be received$1,209 $1,777 
Less: Unearned interest income portion— — 
Net investment in sales-type leases$1,209 $1,777 
Less: Current portion(447)(444)
Long-term net investment in sales-type leases$762 $1,333 

As of December 31, 2021, future minimum lease payments and the reconciliation to net investment in sales-type leases reported on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):

Year Ended December 31,Sales-Type LeasesOperating Leases
2022447 — 
2023399 — 
2024363 — 
2025— — 
2026— — 
Thereafter— — 
Total future minimum lease payments1,209 — 
Less: imputed interest— — 
Total$1,209 $— 
Leases LEASES
    
Lessee Leases

We have operating and finance leases for offices, warehouses, and certain equipment. The leases have remaining lease terms of one to eight years, some of which include options to extend the leases for up to ten years. Our leases do not have any residual value guarantees or any restrictions or covenants imposed by leases.

Components of lease cost were as follows (in thousands):
 Year Ended 
 December 31,
 20212020
Operating lease cost$6,046 $6,696 
Finance lease cost:
Amortization of right-of-use assets (principal payments)384 395 
Interest on lease liabilities34 49 
Short-term lease cost22 7 
Variable lease cost1,958 2,541 
Sublease income(81)(61)
Total lease cost$8,363 $9,627 
Supplemental cash flow information related to leases was as follows (in thousands):
 Year Ended 
 December 31,
 20212020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$12,636 $13,979 
Operating cash flows from finance leases19 32 
Financing cash flows from finance leases410 527 
Right-of-use assets obtained in exchange for lease obligations:
Operating leases3,055 3,290 
Finance leases98 337 

Supplemental balance sheet information related to leases was as follows (in thousands):
 December 31, 2021December 31, 2020
Operating Leases
Operating lease right-of-use assets$9,288 $11,669 
Current portion of operating lease liabilities
$4,964 $6,779 
Operating lease liabilities6,567 8,959 
Total operating lease liabilities$11,531 $15,738 
Finance Leases
Property and equipment, gross$2,356 $2,555 
Accumulated amortization(1,906)(1,705)
Property and equipment, net$450 $850 
Accrued liabilities$231 $414 
Other liabilities230 446 
Total finance lease liabilities$461 $860 
Weighted Average Remaining Lease Term
Operating leases2.97 years3.33 years
Finance leases2.40 years2.68 years
Weighted Average Discount Rate
Operating leases5.4 %5.4 %
Finance leases5.1 %5.1 %

    As of December 31, 2021, future minimum lease payments included in the measurement of lease liabilities on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):
Year ending December 31, Operating LeasesFinance Leases
2022$5,440 $240 
20233,404 159 
20241,959 63 
2025957 17 
2026630 — 
Thereafter105 — 
Total lease payments12,495 479 
Less imputed interest(964)(18)
Total$11,531 $461 

Lessor Leases

Pricing of our exclusive hearing screening supply agreement is structured on a fee per baby screened basis and includes a guaranteed minimum payment per unit per contract year for each unit of equipment supplied. We recognize revenues for the hardware products upon commencement of each lease at the net present value of their guaranteed minimum payment standalone selling price allocation. The remaining variable fees are recognized as revenue over the remaining lease term. The following table provides the profit recognized for sales-type leases at their commencement (net sales includes the initial allocation of fixed costs plus allocation of incremental variable fees and excludes the revenue associated with non-lease components associated with hearing screening supplies and maintenance that are recognized as revenue over the remaining lease term) (in thousands):
 Year Ended 
 December 31,
 20212020
Net Sales$10 $2,226 
Cost of Sales13 4,107 
Gross Loss$(3)$(1,881)


The following table provides lease income related to variable lease payments on our sales-type leases not included in the measurement of the lease receivable (in thousands):
 Year Ended 
 December 31,
 20212020
Variable lease income$877 $420 

The following table provides lease income on our operating leases (in thousands):
 Year Ended 
 December 31,
 20212020
Lease income on operating leases$197 $291 

The receivables as a result of our sales-type leases are collateralized by the underlying equipment leased and consist of the following components (in thousands):
 Year Ended 
 December 31,
 20212020
Net minimum lease payments to be received$1,209 $1,777 
Less: Unearned interest income portion— — 
Net investment in sales-type leases$1,209 $1,777 
Less: Current portion(447)(444)
Long-term net investment in sales-type leases$762 $1,333 

As of December 31, 2021, future minimum lease payments and the reconciliation to net investment in sales-type leases reported on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):

Year Ended December 31,Sales-Type LeasesOperating Leases
2022447 — 
2023399 — 
2024363 — 
2025— — 
2026— — 
Thereafter— — 
Total future minimum lease payments1,209 — 
Less: imputed interest— — 
Total$1,209 $— 
Leases LEASES
    
Lessee Leases

We have operating and finance leases for offices, warehouses, and certain equipment. The leases have remaining lease terms of one to eight years, some of which include options to extend the leases for up to ten years. Our leases do not have any residual value guarantees or any restrictions or covenants imposed by leases.

Components of lease cost were as follows (in thousands):
 Year Ended 
 December 31,
 20212020
Operating lease cost$6,046 $6,696 
Finance lease cost:
Amortization of right-of-use assets (principal payments)384 395 
Interest on lease liabilities34 49 
Short-term lease cost22 7 
Variable lease cost1,958 2,541 
Sublease income(81)(61)
Total lease cost$8,363 $9,627 
Supplemental cash flow information related to leases was as follows (in thousands):
 Year Ended 
 December 31,
 20212020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$12,636 $13,979 
Operating cash flows from finance leases19 32 
Financing cash flows from finance leases410 527 
Right-of-use assets obtained in exchange for lease obligations:
Operating leases3,055 3,290 
Finance leases98 337 

Supplemental balance sheet information related to leases was as follows (in thousands):
 December 31, 2021December 31, 2020
Operating Leases
Operating lease right-of-use assets$9,288 $11,669 
Current portion of operating lease liabilities
$4,964 $6,779 
Operating lease liabilities6,567 8,959 
Total operating lease liabilities$11,531 $15,738 
Finance Leases
Property and equipment, gross$2,356 $2,555 
Accumulated amortization(1,906)(1,705)
Property and equipment, net$450 $850 
Accrued liabilities$231 $414 
Other liabilities230 446 
Total finance lease liabilities$461 $860 
Weighted Average Remaining Lease Term
Operating leases2.97 years3.33 years
Finance leases2.40 years2.68 years
Weighted Average Discount Rate
Operating leases5.4 %5.4 %
Finance leases5.1 %5.1 %

    As of December 31, 2021, future minimum lease payments included in the measurement of lease liabilities on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):
Year ending December 31, Operating LeasesFinance Leases
2022$5,440 $240 
20233,404 159 
20241,959 63 
2025957 17 
2026630 — 
Thereafter105 — 
Total lease payments12,495 479 
Less imputed interest(964)(18)
Total$11,531 $461 

Lessor Leases

Pricing of our exclusive hearing screening supply agreement is structured on a fee per baby screened basis and includes a guaranteed minimum payment per unit per contract year for each unit of equipment supplied. We recognize revenues for the hardware products upon commencement of each lease at the net present value of their guaranteed minimum payment standalone selling price allocation. The remaining variable fees are recognized as revenue over the remaining lease term. The following table provides the profit recognized for sales-type leases at their commencement (net sales includes the initial allocation of fixed costs plus allocation of incremental variable fees and excludes the revenue associated with non-lease components associated with hearing screening supplies and maintenance that are recognized as revenue over the remaining lease term) (in thousands):
 Year Ended 
 December 31,
 20212020
Net Sales$10 $2,226 
Cost of Sales13 4,107 
Gross Loss$(3)$(1,881)


The following table provides lease income related to variable lease payments on our sales-type leases not included in the measurement of the lease receivable (in thousands):
 Year Ended 
 December 31,
 20212020
Variable lease income$877 $420 

The following table provides lease income on our operating leases (in thousands):
 Year Ended 
 December 31,
 20212020
Lease income on operating leases$197 $291 

The receivables as a result of our sales-type leases are collateralized by the underlying equipment leased and consist of the following components (in thousands):
 Year Ended 
 December 31,
 20212020
Net minimum lease payments to be received$1,209 $1,777 
Less: Unearned interest income portion— — 
Net investment in sales-type leases$1,209 $1,777 
Less: Current portion(447)(444)
Long-term net investment in sales-type leases$762 $1,333 

As of December 31, 2021, future minimum lease payments and the reconciliation to net investment in sales-type leases reported on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):

Year Ended December 31,Sales-Type LeasesOperating Leases
2022447 — 
2023399 — 
2024363 — 
2025— — 
2026— — 
Thereafter— — 
Total future minimum lease payments1,209 — 
Less: imputed interest— — 
Total$1,209 $— 
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.22.0.1
Accrued Liabilities
 12 Months Ended
Dec. 31, 2021
Payables and Accruals [Abstract]  
Accrued Liabilities ACCRUED LIABILITIESAccrued liabilities consist of (in thousands):
 December 31,
 20212020
Compensation and related benefits$22,734 $20,409 
Accrued federal, state, and local taxes
9,855 9,118 
Warranty reserve6,042 5,195 
Accrued professional fees3,573 3,699 
Accrued amounts due to customers2,597 2,743 
Self-funded insurance expense835 911 
Accrued travel794 123 
Accrued selling expenses494 311 
Other1,211 1,727 
Total$48,135 $44,236 
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.22.0.1
Long-Term Other Liabilities
 12 Months Ended
Dec. 31, 2021
Other Liabilities Disclosure [Abstract]  
Long-Term Other Liabilities LONG-TERM OTHER LIABILITIESLong-term other liabilities consist of (in thousands):
 December 31,
 20212020
Long-term taxes payable$10,678 $10,949 
Non-current deferred revenue5,001 4,416 
Long-term earnout payable1,184 1,286 
Finance lease liabilities230 446 
CARES Act payroll tax payable— 1,354 
Other144 — 
Total$17,237 $18,451 
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.22.0.1
Debt and Credit Arrangements
 12 Months Ended
Dec. 31, 2021
Debt Disclosure [Abstract]  
Debt and Credit Arrangements DEBT AND CREDIT ARRANGEMENTS
We have a Credit Agreement with JP Morgan Chase Bank ("JP Morgan"), Citibank, NA (“Citibank”), and Wells Fargo Bank, National Association (“Wells Fargo”). During the third quarter of 2020 we amended the terms of the Credit Agreement to extend the maturity date of the original agreement, reduce the aggregate value of the revolving facility, and amend certain covenants. The amended Credit Agreement provides for an aggregate $150 million of secured revolving credit facility. The Credit Agreement contains covenants, including covenants relating to maintenance of books and records, financial reporting and notification, compliance with laws, maintenance of properties and insurance, and limitations on guaranties, investments, issuance of debt, lease obligations and capital expenditures, and is secured by virtually all of our assets. The Credit Agreement provides for events of default, including failure to pay any principal or interest when due, failure to perform or observe covenants, bankruptcy or insolvency events and the occurrence of the event has a material adverse effect. We have no other significant credit facilities. As of December 31, 2021, no amounts were outstanding under the Credit Agreement.
In addition to the customary restrictive covenants listed above, the Credit Agreement also contains financial covenants that require us to maintain a certain leverage ratio and fixed charge coverage ratio, each as defined in the Credit Agreement:
•Leverage Ratio, as defined, to be no higher than 3.25 to 1.00.
•Interest Coverage Ratio, as defined, to be at least 1.75 to 1.00 at all times.
Pursuant to the terms of the Credit Agreement, the outstanding principal balance will bear interest at either (a) a fluctuating rate per annum equal to the Applicable Rate, as defined in the Credit Agreement, depending on our leverage ratio plus the higher of (i) the federal funds rate plus one-half of one percent per annum; (ii) the prime rate in effect on such a day; and (iii) the LIBOR rate plus one percent, or (b) a fluctuating rate per annum of LIBOR Rate plus the Applicable Rate, which ranges between 2.25% to 3.50%. The Credit Agreement matures on September 25, 2023, at which time all principal amounts outstanding under the Credit Agreement will be due and payable.
As of June 30, 2021, we have discontinued our interest rate swap derivative. There are no amounts outstanding under our Credit Agreement and the termination date of the hedge was September 23, 2021. Upon the discontinuation of the hedge relationship, we have reclassified the unrealized gains or losses recorded in accumulated other comprehensive income (“AOCI”) to earnings.
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.22.0.1
Reserve for Product Warranties
 12 Months Ended
Dec. 31, 2021
Product Warranties Disclosures [Abstract]  
Reserve for Product Warranties RESERVE FOR PRODUCT WARRANTIES
We provide a warranty for products that is generally one year in length and in some cases, regulations may require us to provide repair or remediation beyond the typical warranty period. If any of the products contain defects, we may be required to incur additional repair and remediation costs. Service, repair and calibration services are provided by a combination of our owned facilities and vendors on a contract basis.
A warranty reserve is included in accrued liabilities for the expected future costs of servicing products. Additions to the reserve are based on management's best estimate of probable liability. We consider a combination of factors including material and labor costs, regulatory requirements, and other judgments in determining the amount of reserve. The reserve is reduced as costs are incurred to honor existing warranty and regulatory obligations.
As of December 31, 2021, we have accrued $6.0 million for product related warranties. The estimates we use in projecting future product warranty costs may prove to be incorrect. Any future determination that product warranty reserves are understated could result in increases to cost of sales and reductions in operating profits and results of operations.
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity
 12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Stockholders' Equity STOCKHOLDERS’ EQUITYCommon Stock—We have 120,000,000 shares of common stock authorized at a par value or $0.001 per share. Preferred Stock—We have 10,000,000 shares of preferred stock authorized at a par value of $0.001 per share. In accordance with the terms of the amended and restated certificate of incorporation, the Board of Directors is authorized to provide for the issuance of one or more series of preferred stock, including increases or decreases to the series. The Board of Directors has the authority to set the rights, preferences, and terms of such shares. As of December 31, 2021, no shares of preferred stock were issued and outstanding.
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.22.0.1
Earnings Per Share
 12 Months Ended
Dec. 31, 2021
Earnings Per Share [Abstract]  
Earnings Per Share EARNINGS PER SHAREThe components of basic and diluted EPS are as follows (in thousands, except per share amounts): 
 December 31,
202120202019
Net income (loss)$13,177 $(16,613)$(15,671)
Weighted average common shares33,670 33,562 33,696 
Dilutive effect of stock based awards304 — — 
Diluted Shares33,974 33,562 33,696 
Basic income (loss) per share$0.39 $(0.49)$(0.47)
Diluted income (loss) per share$0.39 $(0.49)$(0.47)
Shares excluded from calculation of diluted EPS— 66 104 
XML 34 R22.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation
 12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Share-Based Compensation SHARE-BASED COMPENSATION
Share-Based Compensation Expense—We account for share-based compensation in accordance with ASC Topic 718, Compensation—Stock Compensation. Share-based compensation was recognized as follows in the consolidated statement of income (in thousands):
 December 31,
 202120202019
Cost of revenue$394 $319 $264 
Marketing and selling2,201 1,938 1,024 
Research and development1,406 1,099 800 
General and administrative10,160 6,171 6,227 
Total expense$14,161 $9,527 $8,315 
A significant modification impacted stock compensation expense related to the CEO transition in late December 2021. As part of the separation agreement, the former CEO received the benefit of immediate accelerated vesting for all forms of unvested stock (stock options, restricted stock awards, restricted stock units, performance-based stock and market-based stock). The accelerated vesting was not subject to any future service conditions. Under ASC 718, the stock options, restricted stock awards and restricted stock units service periods were modified to end on the separation date. The acceleration was contemplated in the CEO's original employment agreement, which resulted in compensation cost recognized at the grant date fair value of the original grants. The performance-based and market-based units were treated as a Type III modification (from improbable to probable) as the stock would be forfeited if the full vesting period was not achieved due to separation. As such, the terms and conditions of the performance-based and market-based units were modified to change the vesting conditions where two measurements were computed, and the net impact of truing up the cumulative compensation expense to the fair value of the modified award was recorded in the income statement, resulting in a $1.1 million net benefit in compensation cost, classified as restructuring expense in the consolidated statements of operations, for the year ended December 31, 2021.
Stock Awards Plans—Natus' 2021 Stock Awards Plan (the “Plan”) provides for the granting of the following:
•Incentive stock options to employees;
•Non-statutory stock options to employees, directors and consultants;
•Restricted stock awards and restricted stock units;
•Market stock units;
•Performance stock units;
•Stock bonuses; and
•Stock appreciation rights.
As of December 31, 2021, there were 2,917,938 shares available for future awards under the plan.
Under the Plan, stock options may be issued at not less than the fair market value of the common stock on the date of grant, as determined by the Board of Directors. Options issued under the Plan become exercisable as determined by the Board of Directors and expire no more than six years after the date of grant. Most options vest ratably over four years.
Stock Option Activity—Stock option activity under the stock awards plans for the year ended December 31, 2021 is summarized as follows:  
Number of
Shares		Weighted
Average
Exercise Price
Outstanding, December 31, 2020 (37,062 shares exercisable at a weighted average exercise price of $35.25 per share)331,585 $23.94 
Granted200,146 $20.61 
Exercised(11,787)$20.68 
Forfeited(25,387)$20.68 
Outstanding, December 31, 2021 (320,512 shares exercisable at a weighted average exercise price of $24.01 per share)494,557 $— 
As of December 31, 2021, unrecognized compensation related to the unvested portion of stock options was approximately $1.0 million, which is expected to be recognized over a weighted average period of 3.1 years. The intrinsic value of options exercised, representing the difference between the closing stock price of common stock on the date of the exercise and the exercise price, in the years ended December 31, 2021, 2020 and 2019 was $0.0 million, $0.0 million, and $1.4 million, respectively.
As of December 31, 2021, there were: (i) 484,507 options vested and expected to vest with a weighted average exercise price of $22.88, an intrinsic value of $1.3 million, and a weighted average remaining contractual term of 4.0 years; and (ii) 320,512 options exercisable with a weighted average exercise price of $24.01, an intrinsic value of $0.8 million, and a weighted average remaining contractual term of 1.5 years.
Black-Scholes Inputs—The fair value of option grants was estimated using the Black-Scholes option pricing model with the following weighted average assumptions:
 December 31,December 31,
 20212020
Weighted-average fair value of options granted$7.50$6.54
Expected life in years5.94.5
Risk-free interest rate0.3%0.2%
Expected volatility38%38%
Dividend yieldNoneNone
We did not grant any stock options during December 31, 2019.
The expected life of options is based primarily on historical share option exercise experience of the employees for options granted. All options are treated as a single group in the determination of expected life, as we do not currently expect substantially different exercise or post-vesting termination behavior among the employee population. The risk-free interest rate is based on the U.S. Treasury yield for a term consistent with the expected life of the awards in effect at the time of grant.
Expected volatility is based primarily on historical volatility data of our common stock. We have no history or expectation of paying dividends on common stock.
Share-based compensation expense associated with options is based on awards ultimately expected to vest. At the time of an option grant, we estimate the expected future rate of forfeitures based on historical experience. These estimates are revised, if necessary, in subsequent periods if actual forfeiture rates differ from those estimates. If the actual forfeiture rate is lower than estimated we will record additional expense and if the actual forfeiture is higher than estimated we will record a recovery of prior expense.
Restricted Stock Awards Activity—The following table summarizes the activity for restricted stock awards during the year ended December 31, 2021:
 
SharesWeighted
Average
Grant
Date Fair
Value
Unvested at December 31, 2020380,089 $31.84 
Granted320,814 $22.04 
Vested(320,541)$29.54 
Forfeited(40,592)$25.54 
Unvested at December 31, 2021339,770 $26.15 
As of December 31, 2021, unrecognized compensation related to the unvested portion of stock awards was $5.1 million, which is expected to be recognized over a weighted average period of 2.1 years. The fair market value of outstanding restricted stock awards at December 31, 2021 was $8.1 million. For the restricted stock awards granted during the years ended December 31, 2021, 2020, 2019, the weighted average grant date fair values were $22.04, $29.74, and $31.53, respectively. The total grant date fair value of restricted stock awards vested during fiscal year 2021, 2020, and 2019 was $8.6 million, $5.5 million, and $4.7 million, respectively. For the restricted stock awards that vested during the years ended December 31, 2021, 2020, and 2019, the total intrinsic value was $6.7 million, $4.8 million, and $4.0 million, respectively.
Restricted Stock Units Activity—The following table summarizes restricted stock units activity, including performance and market stock units granted at the valuation date (which may be subject to additional awards or forfeitures depending on the outcome of the performance measures at the end of the performance period) for the year ended December 31, 2021:
 
SharesWeighted
Average
Grant
Date Fair
Value
Outstanding at December 31, 2020212,601 $37.27 
Awarded400,005 $26.43 
Released(205,082)$31.34 
Forfeited(40,959)$36.20 
Outstanding at December 31, 2021366,565 $28.87 
As of December 31, 2021, unrecognized compensation related to the unvested portion of stock units was $8.0 million, which is expected to be recognized over a weighted average period of 2.9 years. The aggregate intrinsic value of outstanding restricted stock units at December 31, 2021 was $8.7 million. For the restricted stock units granted during the years December 31, 2021, 2020, 2019, the weighted average grant date fair values were $26.43, $35.42, and $38.62, respectively. The total grant date fair value of restricted stock units vested during fiscal year 2021, 2020, and 2019 was $5.7 million, $0.5 million, and $1.4 million, respectively. For the restricted stock units that vested during the years ended December 31, 2021, 2020, and 2019, the total intrinsic value was $4.7 million, $0.5 million, and $1.3 million, respectively.
Employee Stock Purchase Plan—Under Natus' 2011 Employee Stock Purchase Plan (the “ESPP”), U.S. employees can elect to have salary withholdings of up to 15% of eligible compensation to a maximum of $10,625 per offering period, to purchase shares of common stock on April 30 and October 31 of each year. The purchase price for shares acquired under the
ESPP is 85% of the fair market value on the last day of the offering period. As of December 31, 2021, there are no shares reserved for future issuance under the ESPP. Because the ESPP does not have a “look back” feature, the compensation expense associated with the Plan is not measured by the use of the Black-Scholes pricing model, but rather by measuring the difference between the fair market value of common stock on the last day of the offering period and the purchase price for the offering period, which is 85% of the fair market value. Compensation expense associated with the ESPP for the years ended December 31, 2021, 2020 and 2019, respectively, was $0.1 million, $0.2 million, and $0.2 million.
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.22.0.1
Other Income (Expense), Net
 12 Months Ended
Dec. 31, 2021
Other Income and Expenses [Abstract]  
Other Income (Expense), Net OTHER INCOME (EXPENSE), NET
Other income (expense), net consists of (in thousands): 
 Years Ended December 31,
 202120202019
Interest income$87 $11 $250 
Interest expense(1,872)(3,656)(4,941)
Foreign currency gain (loss)(1,957)1,988 (765)
Other(682)(215)(135)
Total other expense, net$(4,424)$(1,872)$(5,591)
XML 36 R24.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes
 12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Income Taxes INCOME TAXES
Income (loss) before provision for income tax is as follows (in thousands): 
 Years Ended December 31,
 202120202019
U.S.$18,629 $1,908 $(22,851)
Foreign726 (23,973)1,594 
Income (loss) before provision for income tax$19,355 $(22,065)$(21,257)

The components of income tax expense (benefit) for the years ended December 31, 2021, 2020 and 2019 (in thousands): 
 Years Ended December 31,
 202120202019
Current
U.S. Federal$946 $(3,976)$(948)
U.S. State and local368 145 561 
Non-U.S.7,523 1,241 8,386 
Total current tax expense (benefit)8,837 (2,590)7,999 
Deferred
U.S. Federal4,583 2,049 (7,491)
U.S. State and local184 533 (816)
Non-U.S.(7,426)(5,444)(5,278)
Total deferred tax benefit(2,659)(2,862)(13,585)
Total income expense (benefit)$6,178 $(5,452)$(5,586)
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of deferred tax assets and liabilities as of December 31, 2021 and 2020 are as follows (in thousands): 
 December 31,
 20212020
Deferred tax assets:
Net operating loss carryforwards$12,439 $9,099 
Credit carryforwards1,213 5,768 
Accruals deductible in different periods15,650 15,368 
Employee benefits925 1,016 
Operating leases2,766 3,967 
Total deferred tax assets32,993 35,218 
Valuation allowance(934)(969)
Total net deferred tax assets$32,059 $34,249 
Deferred tax liabilities:
Basis difference in fixed and intangible assets(7,007)(13,214)
Operating leases(2,224)(2,970)
Foreign earnings to be repatriated(800)(800)
Total deferred tax liabilities(10,031)(16,984)
Total net deferred tax assets$22,028 $17,265 
The income tax expense (benefit) in the accompanying statements of income differs from the provision calculated by applying the U.S. federal statutory income tax rate of 21% in 2021, 2020, and 2019 to income before taxes due to the following: 
 Years Ended December 31,
 202120202019
Federal statutory tax expense$4,065 $(4,634)$(4,464)
State tax expense605 661 (300)
Foreign taxes at rates less than U.S. rates(609)1,050 (2,205)
Equity compensation2,581 1,161 824 
Tax credits(1,393)(1,641)(1,428)
Uncertain tax position1,553 3,002 2,910 
Lapse of statute(365)(2,718)(3,961)
Repatriation tax net of foreign tax credits— — 172 
Federal NOL Carryback(454)(1,621)— 
Tax audits97 (224)— 
Withholding taxes254 — 1,107 
Global intangible low-taxed income net of foreign tax credits— — 1,601 
Return to provision(704)(946)560 
Other548 458 (402)
Total expense (benefit)$6,178 $(5,452)$(5,586)
At December 31, 2021, we had U.S. state net operating loss carryforwards of $16.9 million, of which immaterial portions will begin to expire in 2022 and the majority have long carryforward periods ranging primarily from 10 years to indefinite. At December 31, 2021, we had U.S. state R&D credit carryforwards of $1.3 million, which will begin to expire in 2022. At December 31, 2021, we had $0.1 million of U.S. foreign tax credit carryforwards that can be used to offset future U.S. tax liabilities related to foreign source taxable income. The foreign tax credits will start to expire in 2022.
At December 31, 2021, certain foreign subsidiaries had deferred tax assets attributable to net operating loss carryforwards as follows: $0.8 million in France, $8.7 million in Denmark, $0.3 million in Canada, $0.2 million in China, and $0.3 million in Germany. These foreign net operating loss carryforwards, ranging from 6 years utilization period to indefinite utilization period, if not utilized to offset taxable income in future periods, will begin to expire in various amounts beginning in 2026.
A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. Accordingly, valuation allowances of $0.9 million and $1.0 million were recorded at December 31, 2021 and 2020, respectively. The decrease of $0.1 million in valuation allowance was primarily due to a valuation allowance recorded against certain U.S. state credits, which are expected to expire before fully utilized, and release of prior Canadian valuation allowances.
The realizability of the deferred tax assets is primarily dependent on our ability to generate sufficient taxable income in future periods. We record net deferred tax assets to the extent it is more likely than not that the assets will be realized. In making such determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations. To the extent that previously reserved deferred tax assets are estimated to be realizable, we adjust the valuation allowance which reduces the provision for income taxes. Weighing all of the positive and negative evidence, we have recorded a valuation allowance related primarily to net operating losses in certain foreign jurisdictions where it is more likely than not that the tax benefit of the net operating losses will not be realized.
There are no changes to the position on our permanent reinvestment of earnings from foreign operations. As of December 31, 2021, we intend to distribute all of the earnings from Excel-Tech and Natus Ireland in excess of their operational needs. We intend to permanently reinvest the earnings of remaining foreign subsidiaries. The other remaining foreign subsidiaries have both the intent and ability to indefinitely reinvest its undistributed earnings.
Uncertain Tax Positions
A reconciliation of the beginning and ending amount of unrecognized tax benefits (excluding interest and penalties) is as follows (in thousands): 
Balance at December 31, 2018$7,227 
Decreases for tax positions related to prior years(48)
Increases for tax positions related to the current year495 
Decrease due to lapse of statutes of limitations(3,763)
Foreign exchange difference6 
Balance at December 31, 2019$3,917 
Increases for tax positions related to prior years2,454 
Increases for tax positions related to the current year104 
Decrease due to lapse of statutes of limitations(2,416)
Foreign exchange difference83 
Balance at December 31, 2020$4,142 
Increases for tax positions related to the current year1,067 
Decrease due to lapse of statutes of limitations(279)
Foreign exchange difference(82)
Balance at December 31, 2021$4,848 
For the year ended December 31, 2021, our net unrecognized tax benefits increased by $0.7 million resulting in a corresponding $0.7 million increase in income tax expense. The increase was primarily attributable to the increase in uncertain tax positions related to the current year in certain jurisdictions.
The unrecognized tax benefits for the tax years ended December 31, 2021, 2020 and 2019 were $4.8 million, $4.1 million and $3.9 million, respectively which include $4.6 million, $3.8 million and $3.6 million, respectively, that would impact the effective tax rate if recognized.
We expect a range from zero to $0.8 million of unrecognized tax benefit that will impact the effective tax rate in the next 12 months due to the lapse of statute of limitations provided that no taxing authority conducts a new examination.
At December 31, 2021, 2020 and 2019, we had cumulatively accrued $0.9 million, $0.5 million, and $0.4 million for estimated interest and penalties related to uncertain tax positions. We record interest and penalties related to unrecognized tax positions as a component of income tax expense (benefit), which totaled approximately $0.3 million, $0.1 million, and $(0.1) million for the years ended December 31, 2021, 2020, and 2019, respectively.
We are currently unaware of any uncertain tax positions that could result in significant additional payments, accruals, or other material deviation in this estimate over the next 12 months.
As of December 31, 2021, we are currently under U.S. federal IRS examination for tax years 2018 and 2019.
Our tax returns remain open to examination as follows: U.S. federal, 2017 through 2020; U.S. states, generally 2016 through 2020; and significant foreign jurisdictions, generally 2016 through 2020.
XML 37 R25.htm IDEA: XBRL DOCUMENT v3.22.0.1
Employee Benefit Plan
 12 Months Ended
Dec. 31, 2021
Retirement Benefits [Abstract]  
Employee Benefit Plan EMPLOYEE BENEFIT PLANWe offer pre-tax and after-tax 401(k) savings plan options under which eligible U.S. employees may elect to have a portion of their salary deferred and contributed to the plan. Employer matching contributions are determined by management and are discretionary. Employer matching contributions were $3.7 million, $3.2 million, and $3.6 million respectively, in the years ended December 31, 2021, 2020, and 2019. For new hires, employer contributions vest ratably over the first two years of employment.
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment, Customer and Geographic Information
 12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Segment, Customer and Geographic Information SEGMENT, CUSTOMER, AND GEOGRAPHIC INFORMATION
We determine our reportable segments by first identifying our operating segments, and then by assessing whether any components of these segments constitute a business for which discrete financial information is available and where segment management regularly reviews the operating results of that component. Historically, our operating segments were based on its three strategic business units. In January 2019, we announced the transition of our operating structure from three strategic business units to a single, unified company with globally led operational teams in Sales and Marketing, Manufacturing, Research and Development, Quality, and General and Administrative functions.
Following the reorganization, we operate as one operating segment and one reportable segment, which provides medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. Financial information is reviewed on a consolidated basis for purposes of making operating decisions and assessing financial performance. Consolidated financial information is accompanied by disaggregated information about revenues by end market and geographic region. We do not assess the performance of our end markets or geographic regions on measures of profit or loss, or asset-based metrics. We have disclosed the revenues for each end market and geographic region to provide the reader of the financial statements transparency into our operations.
The following tables present revenue and long-lived asset information by end market and geographic region. Revenue is based on the destination of the shipments and long-lived assets are based on the physical location of the assets (in thousands):
 
 Years Ended December 31,
 202120202019
Consolidated Revenue:
United States$285,979 $252,496 $292,400 
Foreign countries187,459 163,188 202,775 
$473,438 $415,684 $495,175 
Revenue by End Market:
Neuro
Devices and Systems$220,929 $179,464 $220,306 
Supplies63,838 56,275 66,059 
Services— — 871 
Total Neuro Revenue$284,767 $235,739 $287,236 
Newborn Care
Devices and Systems$55,174 $52,284 $53,465 
Supplies33,710 36,174 38,264 
Services16,139 16,566 19,183 
Total Newborn Care Revenue$105,023 $105,024 $110,912 
Hearing & Balance
Devices and Systems$78,652 $70,738 $92,050 
Supplies4,996 4,183 4,977 
Total Hearing & Balance Revenue$83,648 $74,921 $97,027 
Total Revenue$473,438 $415,684 $495,175 
Long-lived asset information by geographic region is as follows (in thousands):
Years Ended December 31,
20212020
Property and equipment, net:
United States$9,642 $10,998 
Ireland6,223 6,716 
Canada3,594 3,775 
Denmark1,262 1,787 
Other foreign countries1,062 1,240 
$21,783 $24,516 
During the years ended December 31, 2021, 2020 and 2019, no single customer or foreign country contributed to more than 10% of revenue.
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.22.0.1
Commitments And Contingencies
 12 Months Ended
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
Commitments And Contingencies COMMITMENTS AND CONTINGENCIES
Purchase commitments—We have various purchase obligations for goods or services totaling $178.4 million at December 31, 2021, which are expected to be paid $136.5 million in 2022 and $41.9 million thereafter.
Legal matters—We currently are, and may from time to time become, a party to various legal proceedings or claims that arise in the ordinary course of business. Our managements reviews these matters if and when they arise and believes that the resolution of any such matters currently known will not have a material effect on our results of operations or financial position.
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurements
 12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Fair Value Measurements FAIR VALUE MEASUREMENTS
ASC 820 defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. Fair value is defined under ASC 820 as the exit price associated with the sale of an asset or transfer of a liability in an orderly transaction between market participants at the measurement date. ASC 820 establishes the following three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value:
Level 1—Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.
Level 2—Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets and liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3—Unobservable inputs that are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.
During the third quarter of 2021, we sold vacant land located in Canada for $1.6 million resulting in a gain of $0.7 million. Also during this period, we sold a building located in the United Kingdom for $1.1 million resulting in a gain of $0.8 million. The gain on disposal of these assets is reported in general and administrative expense in the condensed consolidated statements of operations. The book value of these assets was in other current assets on the accompanying condensed consolidated balance sheet.
The following financial instruments are not measured at fair value on the consolidated balance sheet as of December 31, 2021 and 2020, but require disclosure of fair values: cash and cash equivalents, accounts receivable, and accounts payable. The carrying value of these financial instruments approximates fair values because of the relatively short maturity.
The carrying amount of our short-term and long-term debt approximates fair value based on Level 2 inputs since the debt carries a variable interest rate that is tied to the current LIBOR rate plus a spread.
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.22.0.1
Sale of Certain Subsidiary Assets Sale of Certain Subsidiary Assets
 12 Months Ended
Dec. 31, 2021
Related Party Transactions [Abstract]  
Sale of Certain Subsidiary Assets SALE OF CERTAIN SUBSIDIARY    We divested our wholly owned subsidiary, Medix, on April 2, 2019, via a stock sale to the local managing director, a related party. In exchange for the stock, we received $2.5 thousand in cash and provided Medix with a $2.2 million limited-recourse loan secured by real estate assets of Medix. The fair market value of the loan was adjusted as necessary to reflect any changes in market environment or the value of the building. During the second quarter of 2021, we received a $0.9 million payment of which the loan receivable of $0.7 million was fully repaid and a $0.2 million gain was recognized.     The held for sale criteria under GAAP was met in the first quarter of 2019. As such, we completed an asset impairment analysis which resulted in the full impairment of all assets held for sale. We recognized an impairment loss of $24.6 million which included an accrual for the anticipated realization of deferred foreign currency related translation adjustments in accumulated other comprehensive income of $24.8 million, net of tax, and an adjustment of $4.6 million for assets with a book value in excess of their fair market value. Included in the year ended December 31, 2019, is the impact of the sale of Medix, which was completed as of June 30, 2019, and the deferred foreign currency related translation adjustments previously in accumulated other comprehensive income have been released from the balance sheet along with the held for sale accrual.
XML 42 R30.htm IDEA: XBRL DOCUMENT v3.22.0.1
Schedule II: Valuation And Qualifying Accounts
 12 Months Ended
Dec. 31, 2021
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II: of Valuation and Qualifying Accounts
SCHEDULE II: VALUATION AND QUALIFYING ACCOUNTS
For the years ended December 31, 2021, 2020 and 2019
(In thousands)
Balance at
Beginning
of Period		Additions
Charged to
Expense		DeductionsBalance
at End
of Period
Year ended December 31, 2021
Allowance for doubtful accounts$6,213 $181 $(1,123)$5,271 
Valuation allowance969 — (35)934 
Warranty reserve5,195 3,989 (3,142)6,042 
Year ended December 31, 2020
Allowance for doubtful accounts$7,384 $1,190 $(2,361)$6,213 
Valuation allowance606 363 — 969 
Warranty reserve6,404 2,009 (3,218)5,195 
Year ended December 31, 2019
Allowance for doubtful accounts$6,960 $4,262 $(3,838)$7,384 
Valuation allowance637 — (31)606 
Warranty reserve9,391 3,949 (6,936)6,404 
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.22.0.1
Organization and Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Principles of Consolidation Basis of Presentation and Principles of ConsolidationThe accompanying Consolidated Financial Statements includes our accounts and accounts of our wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Certain reclassifications to the prior periods have been made to conform to the current period presentation.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the Consolidated Financial Statements and the reported amount of revenue and expenses during the reporting period. Such estimates include allowances for potentially uncollectible accounts receivable, valuation of inventory, intangible assets, goodwill, share-based compensation, valuation of deferred income taxes, reserves for warranty obligations, and the provision for income taxes including uncertain positions. Actual results could differ from those estimates.
Revenue recognition
Revenue recognition
Revenue is recognized when obligations under the terms of a contract with a customer are satisfied; generally this occurs with the transfer of control of devices, supplies, or services. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services.
For the majority of devices and supplies, we transfer control and recognize revenue when products ship from the warehouse to the customer. We generally do not provide rights of return on devices and supplies. Freight charges billed to customers are included in revenue and freight-related expenses are charged to cost of revenue.
Depending on the terms of the arrangement, we may also defer the recognition of a portion of the consideration received because we have to satisfy a future obligation (e.g. installation). Judgment is required to determine the standalone selling price for each distinct performance obligation. Our estimate of SSP is a point estimate.  The estimate is calculated annually for each performance obligation that is not sold separately. In instances where SSP is not directly observable, such as when we do not sell the product or service separately, the SSP is determined using information that may include market conditions and other observable inputs.
We sell separately-priced service contracts that extend maintenance coverages for both medical devices and data management systems beyond the base agreements to customers. The separately priced service contracts range from 12 months to 60 months. We receive payment at the inception of the contract and recognize revenue ratably over the service period.
For products containing embedded software, we have determined that the hardware and software components function together to deliver the products' essential functionality and are considered a combined performance obligation. Revenue recognition policies for sales of these products are substantially the same as for other tangible products.
Inventory
Inventory Valuation
Inventories are carried at the lower of cost or net realizable value, with cost being determined using the first-in, first-out method. The carrying value of our inventory is reduced for any difference between cost and estimated net realizable value of the inventory. We determine net realizable value by evaluating ending inventories for excess quantities, obsolescence, and other factors that could impact our ability to consume inventory for its intended use. Our evaluation includes an analysis of historical sales by product, projections of future demand by product, and an analysis of obsolescence by product. Adjustments to the
value of inventory establish a new cost basis and are considered permanent even if circumstances later suggest that increased carrying amounts are recoverable. If demand is higher than expected, we may sell inventory that had previously been written down.
Intangible Assets
Intangible assets
We amortize intangible assets with finite lives over the estimate of their useful lives. Any future changes that would limit their useful lives or any determination that these assets are carried at amounts greater than their estimated fair value could result in acceleration of amortization over a revised useful life.
We review intangible assets with indefinite lives for impairment on an annual basis and finite lives for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Recoverability of the finite-lived intangible assets is assessed based on the estimated undiscounted future cash flows expected to result from the use and eventual disposition of the asset. If the undiscounted future cash flows are less than the carrying amount, the finite-lived intangible assets are considered to be impaired. The amount of the impairment loss, if any, is measured as the difference between the carrying amount of the asset and its fair value. We estimate the fair value of finite-lived intangible assets by using an income approach or, when available and appropriate, using a market approach.
Goodwill
Goodwill
Goodwill is not amortized but is subject to an annual impairment analysis, which is performed as of October 1st; this assessment is also performed whenever there is a change in circumstances that indicates the carrying value of goodwill may be impaired.
Goodwill is tested for impairment at the reporting unit level. Our three strategic business units, Neuro, Newborn Care and Hearing & Balance are consolidated into one unit. We have concluded that we have one operating segment and one reporting unit for purposes of goodwill impairment testing in 2021, 2020, and 2019.
In accordance with accounting standards we perform a qualitative assessment to test goodwill for impairment prior to the performing the first step of the goodwill impairment process. Qualitative factors considered in this assessment include industry and market considerations, overall financial performance and other relevant events and factors affecting the reporting unit.
Based on the qualitative assessment in 2021, 2020, and 2019, we determined the fair value of goodwill was more likely than not greater than its carrying amount, and no further analysis was needed.
Long lived assets
Long lived assets
We continually monitor events and changes in circumstances that could indicate that carrying amounts of our long-lived assets, including property and equipment, intangible assets and leases, may not be recoverable. When such events or changes in circumstances occur, we will assess the recoverability by determining whether the carrying value of an asset group will be recovered through undiscounted expected future cash flows. If the future undiscounted cash flows are less than the carrying amount of the asset group, we will recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets.
Leases
Lessee Leases
We determine if an arrangement is a lease at inception of the lease. Right-of-use (“ROU”) assets represent the right to use an underlying asset for the lease term, and lease liabilities represent an obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit borrowing rate, generally we use an incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at the lease commencement date. We use the implicit rate when readily determinable. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include options to exclude or terminate the lease when it is reasonably certain that they will exercise that option. Lease expense for lease payments are recognized on a straight-line basis over the lease term.
Operating leases are included in operating lease ROU assets, accrued liabilities, and operating lease liabilities in our consolidated balance sheet. Finance leases are included in property and equipment, accrued liabilities, and other liabilities in the consolidated balance sheet.
We have lease agreements with lease and non-lease components, which are generally accounted for based on the type of asset. For real estate and telecom leases, we account for these components separately. For equipment leases, such as office equipment and vehicles, we account for the lease and non-lease components as a single lease component.
Leases
Lessor Leases
We determine if an arrangement is a lease at inception of the lease. We entered into a five-year non-cancelable exclusive supply agreement with a customer to provide hearing screening products which commenced on January 1, 2020. The agreement includes automatic renewal options for successive three-year periods. Notice of non-renewal must be provided to Natus at least twelve months prior to the end of the current term. The agreement does not contain any purchase options or residual value guarantees.
Pricing of the exclusive supply agreement is structured on a fee per baby screened basis. The per baby fee is inclusive of all products and services to be provided under the terms of the agreement which include hearing screening hardware, consumables required to complete each screen, and related maintenance. The pricing structure also includes a guaranteed minimum payment per unit per contract year for each unit of equipment supplied.
Sales-Type Leases
The guaranteed minimum payment for each unit of equipment supplied represents the fixed transaction price and is allocated to separate performance obligations, consisting of hardware products, consumables, and maintenance, proportionally based on the standalone selling price of each performance obligation. Standalone selling price is best evidenced by the price we charge for the good or service when selling it separately in similar circumstances to similar customers. Other than for the renewal of annual support services contracts, our products and services are not generally sold separately. We use an amount discounted from the list price as a best estimated selling price.
For sales-type leases, we recognize revenues for hearing screening hardware products at the net present value of their guaranteed minimum payment standalone selling price allocation upon delivery of the hardware. We recognize consumables and maintenance revenues associated with the sales-type leases over the term of the agreement on a weighted average as actual screens are performed.
Operating Leases
Under the terms of the exclusive supply agreement, hospitals where we were previously providing hearing screening services were provided the option to transition to the exclusive supply agreement. Hospitals which chose to transition continued to use their existing Natus hardware. Based on the remaining useful life of the existing hardware and the date new hardware is supplied after the commencement of the lease, some of these leases were classified as operating leases.
For operating leases, rental income is recognized on a straight-line basis over the term of the associated lease. Leased assets classified as operating leases are carried at amortized cost net of accumulated depreciation in property and equipment, net on the condensed consolidated balance sheet. The depreciation expense of the leased assets is recognized on a straight-line basis over the useful life of the asset, and recorded in cost of revenue in the condensed consolidated statements of operations.
Liability for product warranties
Liability for product warranties
We provide a warranty for products that is generally one year in length. In some cases, regulations may require us to provide repair or remediation beyond the typical warranty period. If any products contain defects, we may be required to incur additional repair and remediation costs. Service, repair and calibration services are provided by a combination of our owned facilities and vendors on a contract basis.
We accrue estimated product warranty costs at the time of sale based on historical experience. A warranty reserve is included in accrued liabilities for the expected future costs of servicing products. Additions to the reserve are based on management’s best estimate of probable liability. We consider a combination of factors including material and labor costs, regulatory requirements, and other judgments in determining the amount of the reserve. The reserve is reduced as costs are incurred to honor existing warranty and regulatory obligations.
Share-based compensation
Share-based compensation
We recognize share-based compensation expense associated with employee stock options under the single-option straight line method over the requisite service period, which is generally a four-year vesting period and ten-year contractual term pursuant to ASC Topic 718, Compensation-Stock Compensation. See Note 15 of the Consolidated Financial Statements.
For employee stock options, the value of each option is estimated on the date of grant using the Black-Scholes option pricing model, which was developed for use in estimating the value of freely traded options. Similar to other option pricing models, the Black-Scholes method requires the input of highly subjective assumptions, including stock price volatility. Changes in the subjective input assumptions can materially affect the estimated fair value of the employee stock options.
We recognize share-based compensation associated with Restricted Stock Awards (“RSA”) and Restricted Stock Units (“RSU”). RSAs and RSUs vest ratably over a three-year period for employees. RSAs and RSUs for executives vest over a four-year period; 25% on each of the annual anniversaries. RSAs and RSUs for non-employees (Board of Directors) vest over a one-year period; 100% on the first anniversary. The value is estimated based on the market value of Natus common stock on the date of issuance pursuant to ASC Topic 718, Compensation-Stock Compensation.
We grant market stock unit (“MSU”) awards to certain employees. We estimate the fair value of MSUs at the date of grant using a Monte Carlo simulation model and amortize those fair values over the requisite service period, which is generally three years. The Monte Carlo simulation model that we use to estimate the fair value of market-based MSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the market-based MSUs, which is determined at the date of grant, must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the achievement of the specified market criteria.
We also grant performance stock unit (“PSU”) awards to our CEO and CFO. These PSUs fully vest after a performance period and have separate performance goals than MSUs. We estimate fair value of performance stock unit awards based on the share price and other pertinent factors on the grant date. Compensation expense for performance stock unit awards are recognized on a straight-line basis over the requisite service period of the award when performance condition is probable to occur. We assess the achievement probability of the performance conditions each period and adjust compensation expense if necessary. Provided that the requisite service is rendered, the shares will become vested and payout will occur based on the outcome of the performance condition. Any unrecognized compensation cost shall be recognized when the award becomes vested.
We issue new shares of common stock upon the exercise of stock options and the vesting of RSAs, RSUs, MSUs, and PSUs.
Forfeitures of employee stock options and awards are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. Share-based compensation expense is recorded net of estimated forfeitures, such that expense is recorded only for those share-based awards that are expected to vest.
Cash Equivalents Cash EquivalentsAll highly liquid investments purchased with an original maturity or remaining maturity upon purchase of three months or less are classified as cash equivalents.
Short-term Investments Cash EquivalentsAll highly liquid investments purchased with an original maturity or remaining maturity upon purchase of three months or less are classified as cash equivalents.
Allowance for Doubtful Accounts
Allowance for Doubtful Accounts
We estimate the allowance for potentially uncollectible accounts receivable based on historical collection experience within the markets in which we operate and other customer-specific information, such as bankruptcy filings or customer liquidity problems. When all internal efforts have been exhausted to collect the receivable, it is written off and relieved from the reserve.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
Financial instruments include cash and cash equivalents, accounts receivable, and accounts payable. Cash is reported at its fair value on the balance sheet dates. The recorded carrying amounts of accounts receivable and accounts payable approximate their fair values due to the short-term maturities.
Property and Equipment Property and EquipmentProperty and equipment are stated at cost less accumulated depreciation. Depreciation expense is computed using the straight-line method over estimated useful lives of the respective assets, which are three to five years for office furniture and equipment, computer software and hardware, demonstration and loaned equipment, and 30 to 40 years for buildings. Leasehold improvements are amortized over the shorter of the lease term or the estimated useful life of the improvement. Land is not depreciated. Costs associated with acquiring and installing software to be used for internal purposes are capitalized and amortized on a straight-line basis over three years.
Research & Development Costs Research & Development CostsCosts incurred in research and development are charged to operations as incurred.
Income Taxes
Income Taxes
We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statements carrying value of assets and liabilities and the tax basis of those assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.
We record net deferred tax assets to the extent it is more likely than not that the assets will be realized. In making such determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations. To the extent that previously reserved deferred tax assets are estimated to be realizable, we adjust the valuation allowance which reduces the provision for income taxes.
We recognize the tax benefit of uncertain tax positions in the financial statements as defined in ASC Topic 740, Income Tax. When the tax position is deemed more likely than not of being sustained, we recognize the largest amount of tax benefit that is greater than 50 percent likely of being ultimately realized upon settlement, as defined in ASC 740-10-05.
Foreign Currency
Foreign Currency
The functional currency of our subsidiaries outside of North America is generally the local currency of the country where the subsidiary is located. Accordingly, foreign currency translation adjustments relating to the translation of foreign subsidiary financial statements are included as a component of accumulated other comprehensive loss. We have recorded $(10.6) million, $13.2 million, and $(1.6) million of foreign currency translation gains (losses) for the years ended December 31, 2021, 2020 and 2019, respectively.
Gains and losses from transactions denominated in currencies other than the functional currencies are included in other income and expense. In 2021, 2020, and 2019, net foreign currency transaction gains (losses) were $(2.0) million, $2.0 million, and $(0.8) million, respectively. Foreign currency gains and losses result primarily from fluctuations in the exchange rate between the U.S. dollar, Canadian dollar, Euro, British pound, and Danish kroner.
Comprehensive Income
Comprehensive Income
We break out the major components and report as a single total the change in net assets during the period as defined in ASC Topic 220, Comprehensive Income. The consolidated statement of comprehensive income (loss) has been separately stated from the consolidated statements of operations. Accumulated other comprehensive loss consists of translation gains and losses on foreign subsidiary financial statements, interest rate swap designated as a cash flow hedge, reclassifications from the adoption of ASU 2018-02, and reclassification of previously recorded deferred foreign currency related translation adjustment losses upon the divestiture of Medix.
Basic and Diluted Net Income per Share
Basic and Diluted Net Income per Share
We compute net income per share as defined in ASC Topic 260, Earnings per Share. Basic net income per share is based upon the weighted average number of common shares outstanding during the period. Diluted net income per share is based upon the weighted average number of common shares outstanding and dilutive common stock equivalents outstanding during the period. Common stock equivalents are options granted, shares of restricted stock, and shares of market stock issued under the stock awards plans and are calculated under the treasury stock method. Common equivalent shares from unexercised stock options and restricted stock are excluded from the computation when there is a loss as the effect is anti-dilutive, or if the exercise price of such options is greater than the average market price of the stock for the period.
Recent Accounting Pronouncements
Recently Adopted Accounting Pronouncements
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740), Simplifying the Accounting for Income Tax. This update includes removal of certain exceptions to the general principles of ASC 740, Income taxes, and simplification in several other areas such as accounting for franchise tax (or similar tax) that is partially based on income. We early adopted the ASU in the second quarter of 2020. Upon adoption, we recorded an additional income tax benefit of $0.9 million due to the elimination of the year-to-date loss limitation rules that limited the interim tax period tax benefit.
In October 2020, the FASB issued ASU 2020-10, Codification Improvements. This update improves consistency by amending the Codification to include all disclosure guidance in appropriate disclosure sections. Also, the update clarifies application of various provisions in the Codification by amending and adding new headings, cross-referencing to other guidance, and refining or correcting terminology. ASU 2020-10 was effective for annual period starting December 15, 2020. The adoption of this ASU did not have an impact on our consolidated financial statements.
In July 2021, the FASB issued ASU 2021-05, Leases (Topic 842): Lessors-Certain Leases with Variable Lease Payments. This update addresses stakeholders' concerns by amending the lease classification requirements for lessors to align them with practice under Topic 840. Lessors should classify and account for a lease with variable lease payments that do not depend on a reference index or a rate as an operating lease if the lease would have been classified as a sales-type lease or a direct financing lease in accordance with 842-10-25-2 through 25-3 and the lessors would have otherwise recognized a day-one loss. ASU 2021-05 is effective for fiscal years beginning after December 15, 2021. We have early adopted the ASU on a prospective basis in the third quarter of the current fiscal year. The adoption of ASU 2021-05 did not have an impact on our consolidated financial statements.
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.22.0.1
Revenue (Tables)
 12 Months Ended
Dec. 31, 2021
Revenue from Contract with Customer [Abstract]  
Contract with Customer, Asset and Liability [Table Text Block]
The following table summarized the changes in the contract assets and contract liability balances for the year ended December 31, 2021 (in thousands):

Unbilled AR, December 31, 2020$1,925 
Additions58 
Transferred to Trade Receivable(1,731)
Unbilled AR, December 31, 2021$252 
Deferred Revenue, December 31, 2020$25,723 
Additions24,053 
Revenue Recognized(19,679)
Deferred Revenue, December 31, 2021$30,097 
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.22.0.1
Allowance for Doubtful Accounts (Tables)
 12 Months Ended
Dec. 31, 2021
Receivables [Abstract]  
Schedule of Activity in Allowance for Doubtful Accounts The details of activity in allowance for doubtful accounts are as follows (in thousands):
 December 31,
 20212020
Balance, beginning of period$6,213 $7,384 
Additions charged to expense181 1,190 
Write-offs charged against allowance(1,123)(2,361)
Balance, end of period$5,271 $6,213 
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.22.0.1
Inventories (Tables)
 12 Months Ended
Dec. 31, 2021
Inventory Disclosure [Abstract]  
Inventories Inventories consist of (in thousands):
 December 31,
 20212020
Raw materials and subassemblies$20,750 $22,583 
Work in process2,825 2,294 
Finished goods57,836 65,695 
Total Inventories81,411 90,572 
Less: Non-current Inventories(13,666)(14,922)
Inventories$67,745 $75,650 
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.22.0.1
Property and Equipment (Tables)
 12 Months Ended
Dec. 31, 2021
Property, Plant and Equipment [Abstract]  
Property and Equipment
Property and equipment consist of (in thousands):
 December 31,
 20212020
Land$1,782 $1,792 
Buildings7,238 7,365 
Leasehold improvements7,722 8,050 
Finance lease right-of-use assets2,356 2,555 
Office furniture and equipment20,637 22,148 
Computer software and hardware11,308 10,246 
Demonstration and loaned equipment4,050 3,086 
55,093 55,242 
Accumulated depreciation(33,310)(30,726)
Total$21,783 $24,516 
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.22.0.1
Intangible Assets (Tables)
 12 Months Ended
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Components of Gross and Net Intangible Asset Balances
The following table summarizes the components of gross and net intangible asset balances (in thousands):
 December 31, 2021December 31, 2020
 Gross
Carrying
Amount		Accumulated
Impairment		Accumulated
Amortization		Net Book
Value		Gross
Carrying
Amount		Accumulated
Impairment		Accumulated
Amortization		Net Book
Value
Intangible assets with definite lives:
Technology$99,920 (6,039)$(66,679)$27,202 $112,138 (12,480)$(64,203)$35,455 
Customer related89,794 (50)(57,133)32,611 94,526 (50)(51,247)43,229 
Trade names45,593 (3,260)(36,960)5,373 47,058 (3,677)(31,890)11,491 
Internally developed software13,281 — (12,985)296 13,281 — (12,845)436 
Patents2,705 (133)(2,572)— 2,810 (133)(2,677)— 
Service Agreements800 — (769)31 1,190 — (1,119)71 
Total definite-lived intangible assets252,093 (9,482)(177,098)65,513 271,003 (16,340)(163,981)90,682 
Intangible assets with indefinite lives:
Intellectual Property2,004 (2,004)— — 2,059 — — 2,059 
Total intangible assets254,097 (11,486)(177,098)65,513 273,062 (16,340)(163,981)92,741 
Amortization expense related to intangible assets with definite lives Amortization expense related to intangible assets with finite and indefinite lives, including impairment charges described above, was as follows (in thousands):
 Years Ended December 31,
 202120202019
Technology$6,907 $13,417 $6,906 
Customer related9,040 8,825 8,662 
Trade names5,881 6,182 6,111 
Intellectual Property2,004 — — 
Internally developed software141 239 1,438 
Patents— — 60 
Service Agreements40 40 322 
Total amortization$24,013 $28,703 $23,499 
Expected annual amortization expense related to amortizable intangible assets
Expected annual amortization expense related to amortizable intangible assets is as follows (in thousands):
2022$17,634 
202314,865 
202412,970 
202512,362 
20262,408 
Thereafter5,274 
Total expected amortization expense$65,513 
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.22.0.1
Goodwill (Tables)
 12 Months Ended
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill
The carrying amount of goodwill and the changes in those balances are as follows (in thousands):
As of December 31, 2019$146,367 
Purchase Accounting Adjustments1,207 
Foreign currency translation$3,725 
As of December 31, 2020151,299 
Foreign currency translation(2,642)
As of December 31, 2021$148,657 
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases (Tables)
 12 Months Ended
Dec. 31, 2021
Leases [Abstract]  
Lease, Cost
Components of lease cost were as follows (in thousands):
 Year Ended 
 December 31,
 20212020
Operating lease cost$6,046 $6,696 
Finance lease cost:
Amortization of right-of-use assets (principal payments)384 395 
Interest on lease liabilities34 49 
Short-term lease cost22 7 
Variable lease cost1,958 2,541 
Sublease income(81)(61)
Total lease cost$8,363 $9,627 
Supplemental cash flow information related to leases was as follows (in thousands):
 Year Ended 
 December 31,
 20212020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$12,636 $13,979 
Operating cash flows from finance leases19 32 
Financing cash flows from finance leases410 527 
Right-of-use assets obtained in exchange for lease obligations:
Operating leases3,055 3,290 
Finance leases98 337 
Assets and Liabilities, Lessee
Supplemental balance sheet information related to leases was as follows (in thousands):
 December 31, 2021December 31, 2020
Operating Leases
Operating lease right-of-use assets$9,288 $11,669 
Current portion of operating lease liabilities
$4,964 $6,779 
Operating lease liabilities6,567 8,959 
Total operating lease liabilities$11,531 $15,738 
Finance Leases
Property and equipment, gross$2,356 $2,555 
Accumulated amortization(1,906)(1,705)
Property and equipment, net$450 $850 
Accrued liabilities$231 $414 
Other liabilities230 446 
Total finance lease liabilities$461 $860 
Weighted Average Remaining Lease Term
Operating leases2.97 years3.33 years
Finance leases2.40 years2.68 years
Weighted Average Discount Rate
Operating leases5.4 %5.4 %
Finance leases5.1 %5.1 %
Finance Lease, Liability, Maturity As of December 31, 2021, future minimum lease payments included in the measurement of lease liabilities on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):
Year ending December 31, Operating LeasesFinance Leases
2022$5,440 $240 
20233,404 159 
20241,959 63 
2025957 17 
2026630 — 
Thereafter105 — 
Total lease payments12,495 479 
Less imputed interest(964)(18)
Total$11,531 $461 
Lessee, Operating Lease, Liability, Maturity As of December 31, 2021, future minimum lease payments included in the measurement of lease liabilities on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):
Year ending December 31, Operating LeasesFinance Leases
2022$5,440 $240 
20233,404 159 
20241,959 63 
2025957 17 
2026630 — 
Thereafter105 — 
Total lease payments12,495 479 
Less imputed interest(964)(18)
Total$11,531 $461 
Sales-type Lease, Lease Income The following table provides the profit recognized for sales-type leases at their commencement (net sales includes the initial allocation of fixed costs plus allocation of incremental variable fees and excludes the revenue associated with non-lease components associated with hearing screening supplies and maintenance that are recognized as revenue over the remaining lease term) (in thousands):
 Year Ended 
 December 31,
 20212020
Net Sales$10 $2,226 
Cost of Sales13 4,107 
Gross Loss$(3)$(1,881)
The following table provides lease income related to variable lease payments on our sales-type leases not included in the measurement of the lease receivable (in thousands):
 Year Ended 
 December 31,
 20212020
Variable lease income$877 $420 
Operating Lease, Lease Income The following table provides lease income on our operating leases (in thousands):
 Year Ended 
 December 31,
 20212020
Lease income on operating leases$197 $291 
Sales Type Lease, Net Investment In Lease The receivables as a result of our sales-type leases are collateralized by the underlying equipment leased and consist of the following components (in thousands):
 Year Ended 
 December 31,
 20212020
Net minimum lease payments to be received$1,209 $1,777 
Less: Unearned interest income portion— — 
Net investment in sales-type leases$1,209 $1,777 
Less: Current portion(447)(444)
Long-term net investment in sales-type leases$762 $1,333 
Sales-type Lease Receivable, Maturity
As of December 31, 2021, future minimum lease payments and the reconciliation to net investment in sales-type leases reported on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):

Year Ended December 31,Sales-Type LeasesOperating Leases
2022447 — 
2023399 — 
2024363 — 
2025— — 
2026— — 
Thereafter— — 
Total future minimum lease payments1,209 — 
Less: imputed interest— — 
Total$1,209 $— 
Operating Lease Receivable, Maturity
As of December 31, 2021, future minimum lease payments and the reconciliation to net investment in sales-type leases reported on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):

Year Ended December 31,Sales-Type LeasesOperating Leases
2022447 — 
2023399 — 
2024363 — 
2025— — 
2026— — 
Thereafter— — 
Total future minimum lease payments1,209 — 
Less: imputed interest— — 
Total$1,209 $— 
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.22.0.1
Accrued Liabilities (Tables)
 12 Months Ended
Dec. 31, 2021
Payables and Accruals [Abstract]  
Accrued Liabilities Accrued liabilities consist of (in thousands):
 December 31,
 20212020
Compensation and related benefits$22,734 $20,409 
Accrued federal, state, and local taxes
9,855 9,118 
Warranty reserve6,042 5,195 
Accrued professional fees3,573 3,699 
Accrued amounts due to customers2,597 2,743 
Self-funded insurance expense835 911 
Accrued travel794 123 
Accrued selling expenses494 311 
Other1,211 1,727 
Total$48,135 $44,236 
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.22.0.1
Long-Term Other Liabilities (Tables)
 12 Months Ended
Dec. 31, 2021
Other Liabilities Disclosure [Abstract]  
Long-Term Other Liabilities Long-term other liabilities consist of (in thousands):
 December 31,
 20212020
Long-term taxes payable$10,678 $10,949 
Non-current deferred revenue5,001 4,416 
Long-term earnout payable1,184 1,286 
Finance lease liabilities230 446 
CARES Act payroll tax payable— 1,354 
Other144 — 
Total$17,237 $18,451 
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.22.0.1
Earnings Per Share (Tables)
 12 Months Ended
Dec. 31, 2021
Earnings Per Share [Abstract]  
Components of Basic and Diluted EPS The components of basic and diluted EPS are as follows (in thousands, except per share amounts): 
 December 31,
202120202019
Net income (loss)$13,177 $(16,613)$(15,671)
Weighted average common shares33,670 33,562 33,696 
Dilutive effect of stock based awards304 — — 
Diluted Shares33,974 33,562 33,696 
Basic income (loss) per share$0.39 $(0.49)$(0.47)
Diluted income (loss) per share$0.39 $(0.49)$(0.47)
Shares excluded from calculation of diluted EPS— 66 104 
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The fair value of option grants was estimated using the Black-Scholes option pricing model with the following weighted average assumptions:
 December 31,December 31,
 20212020
Weighted-average fair value of options granted$7.50$6.54
Expected life in years5.94.5
Risk-free interest rate0.3%0.2%
Expected volatility38%38%
Dividend yieldNoneNone
Share-Based Compensation Expense Share-based compensation was recognized as follows in the consolidated statement of income (in thousands):
 December 31,
 202120202019
Cost of revenue$394 $319 $264 
Marketing and selling2,201 1,938 1,024 
Research and development1,406 1,099 800 
General and administrative10,160 6,171 6,227 
Total expense$14,161 $9,527 $8,315 
Stock Options Activity Stock Option Activity—Stock option activity under the stock awards plans for the year ended December 31, 2021 is summarized as follows:  
Number of
Shares		Weighted
Average
Exercise Price
Outstanding, December 31, 2020 (37,062 shares exercisable at a weighted average exercise price of $35.25 per share)331,585 $23.94 
Granted200,146 $20.61 
Exercised(11,787)$20.68 
Forfeited(25,387)$20.68 
Outstanding, December 31, 2021 (320,512 shares exercisable at a weighted average exercise price of $24.01 per share)494,557 $— 
Restricted Stock Awards Activity The following table summarizes the activity for restricted stock awards during the year ended December 31, 2021:  
SharesWeighted
Average
Grant
Date Fair
Value
Unvested at December 31, 2020380,089 $31.84 
Granted320,814 $22.04 
Vested(320,541)$29.54 
Forfeited(40,592)$25.54 
Unvested at December 31, 2021339,770 $26.15 
Restricted Stock Units Activity The following table summarizes restricted stock units activity, including performance and market stock units granted at the valuation date (which may be subject to additional awards or forfeitures depending on the outcome of the performance measures at the end of the performance period) for the year ended December 31, 2021:  
SharesWeighted
Average
Grant
Date Fair
Value
Outstanding at December 31, 2020212,601 $37.27 
Awarded400,005 $26.43 
Released(205,082)$31.34 
Forfeited(40,959)$36.20 
Outstanding at December 31, 2021366,565 $28.87 
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.22.0.1
Other Income (Expense), Net (Tables)
 12 Months Ended
Dec. 31, 2021
Other Income and Expenses [Abstract]  
Other income (expense), net
Other income (expense), net consists of (in thousands): 
 Years Ended December 31,
 202120202019
Interest income$87 $11 $250 
Interest expense(1,872)(3,656)(4,941)
Foreign currency gain (loss)(1,957)1,988 (765)
Other(682)(215)(135)
Total other expense, net$(4,424)$(1,872)$(5,591)
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Income (loss) before provision (benefit) for income tax
Income (loss) before provision for income tax is as follows (in thousands): 
 Years Ended December 31,
 202120202019
U.S.$18,629 $1,908 $(22,851)
Foreign726 (23,973)1,594 
Income (loss) before provision for income tax$19,355 $(22,065)$(21,257)
Summary of components of income tax expense The components of income tax expense (benefit) for the years ended December 31, 2021, 2020 and 2019 (in thousands): 
 Years Ended December 31,
 202120202019
Current
U.S. Federal$946 $(3,976)$(948)
U.S. State and local368 145 561 
Non-U.S.7,523 1,241 8,386 
Total current tax expense (benefit)8,837 (2,590)7,999 
Deferred
U.S. Federal4,583 2,049 (7,491)
U.S. State and local184 533 (816)
Non-U.S.(7,426)(5,444)(5,278)
Total deferred tax benefit(2,659)(2,862)(13,585)
Total income expense (benefit)$6,178 $(5,452)$(5,586)
Deferred tax assets and liabilities Significant components of deferred tax assets and liabilities as of December 31, 2021 and 2020 are as follows (in thousands): 
 December 31,
 20212020
Deferred tax assets:
Net operating loss carryforwards$12,439 $9,099 
Credit carryforwards1,213 5,768 
Accruals deductible in different periods15,650 15,368 
Employee benefits925 1,016 
Operating leases2,766 3,967 
Total deferred tax assets32,993 35,218 
Valuation allowance(934)(969)
Total net deferred tax assets$32,059 $34,249 
Deferred tax liabilities:
Basis difference in fixed and intangible assets(7,007)(13,214)
Operating leases(2,224)(2,970)
Foreign earnings to be repatriated(800)(800)
Total deferred tax liabilities(10,031)(16,984)
Total net deferred tax assets$22,028 $17,265 
Reconciliation of effective income tax rate The income tax expense (benefit) in the accompanying statements of income differs from the provision calculated by applying the U.S. federal statutory income tax rate of 21% in 2021, 2020, and 2019 to income before taxes due to the following: 
 Years Ended December 31,
 202120202019
Federal statutory tax expense$4,065 $(4,634)$(4,464)
State tax expense605 661 (300)
Foreign taxes at rates less than U.S. rates(609)1,050 (2,205)
Equity compensation2,581 1,161 824 
Tax credits(1,393)(1,641)(1,428)
Uncertain tax position1,553 3,002 2,910 
Lapse of statute(365)(2,718)(3,961)
Repatriation tax net of foreign tax credits— — 172 
Federal NOL Carryback(454)(1,621)— 
Tax audits97 (224)— 
Withholding taxes254 — 1,107 
Global intangible low-taxed income net of foreign tax credits— — 1,601 
Return to provision(704)(946)560 
Other548 458 (402)
Total expense (benefit)$6,178 $(5,452)$(5,586)
Uncertain Tax Positions
A reconciliation of the beginning and ending amount of unrecognized tax benefits (excluding interest and penalties) is as follows (in thousands): 
Balance at December 31, 2018$7,227 
Decreases for tax positions related to prior years(48)
Increases for tax positions related to the current year495 
Decrease due to lapse of statutes of limitations(3,763)
Foreign exchange difference6 
Balance at December 31, 2019$3,917 
Increases for tax positions related to prior years2,454 
Increases for tax positions related to the current year104 
Decrease due to lapse of statutes of limitations(2,416)
Foreign exchange difference83 
Balance at December 31, 2020$4,142 
Increases for tax positions related to the current year1,067 
Decrease due to lapse of statutes of limitations(279)
Foreign exchange difference(82)
Balance at December 31, 2021$4,848 
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment, Customer and Geographic Information (Tables)
 12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Revenue and long-lived asset information by geographic region The following tables present revenue and long-lived asset information by end market and geographic region. Revenue is based on the destination of the shipments and long-lived assets are based on the physical location of the assets (in thousands):
 
 Years Ended December 31,
 202120202019
Consolidated Revenue:
United States$285,979 $252,496 $292,400 
Foreign countries187,459 163,188 202,775 
$473,438 $415,684 $495,175 
Revenue by End Market:
Neuro
Devices and Systems$220,929 $179,464 $220,306 
Supplies63,838 56,275 66,059 
Services— — 871 
Total Neuro Revenue$284,767 $235,739 $287,236 
Newborn Care
Devices and Systems$55,174 $52,284 $53,465 
Supplies33,710 36,174 38,264 
Services16,139 16,566 19,183 
Total Newborn Care Revenue$105,023 $105,024 $110,912 
Hearing & Balance
Devices and Systems$78,652 $70,738 $92,050 
Supplies4,996 4,183 4,977 
Total Hearing & Balance Revenue$83,648 $74,921 $97,027 
Total Revenue$473,438 $415,684 $495,175 
Long-lived asset information by geographic region is as follows (in thousands):
Years Ended December 31,
20212020
Property and equipment, net:
United States$9,642 $10,998 
Ireland6,223 6,716 
Canada3,594 3,775 
Denmark1,262 1,787 
Other foreign countries1,062 1,240 
$21,783 $24,516 
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.22.0.1
Organization and Significant Accounting Policies - Narrative (Details)
$ in Thousands
 3 Months Ended 12 Months Ended
Jun. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
reporting_unit
operating_segment
Dec. 31, 2020
USD ($)
operating_segment
reporting_unit
Dec. 31, 2019
USD ($)
strategicBusinessUnit
reporting_unit
operating_segment
Jan. 01, 2020
Dec. 31, 2018
USD ($)
Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items]            
Number of strategic business units | strategicBusinessUnit       3    
Number of operating segments | operating_segment   1 1 1    
Number of reporting units | reporting_unit   1 1 1    
Lessor, lease term         5 years  
Lessor, renewal term         3 years  
Lessor, notice of termination         12 months  
Warranty, term   1 year        
Foreign currency translation adjustment   $ (10,640) $ 13,205 $ (1,576)    
Net foreign currency transaction gains (losses)   (1,957) 1,988 (765)    
Operating lease right-of-use assets   9,288 11,669      
Total   11,531 15,738      
Stockholders' Equity Attributable to Parent   (424,750) (411,094) (416,123)   $ (398,444)
Provision (benefit) for income tax   $ (6,178) 5,452 5,586    
Cumulative Effect, Period of Adoption, Adjustment            
Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items]            
Provision (benefit) for income tax $ 900          
Minimum            
Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items]            
Contract with customer, service period   12 months        
Maximum            
Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items]            
Contract with customer, service period   60 months        
Office furniture and equipment [Member] | Minimum            
Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items]            
Estimated useful lives of property and equipment   3 years        
Office furniture and equipment [Member] | Maximum            
Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items]            
Estimated useful lives of property and equipment   5 years        
Computer software and hardware [Member]            
Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items]            
Estimated useful lives of property and equipment   3 years        
Buildings [Member] | Minimum            
Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items]            
Estimated useful lives of property and equipment   30 years        
Buildings [Member] | Maximum            
Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items]            
Estimated useful lives of property and equipment   40 years        
Share-based Payment Arrangement, Option [Member]            
Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items]            
Vesting period   4 years        
Share based compensation, expiration period   10 years        
Share-based Payment Arrangement, Option [Member] | Director [Member]            
Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items]            
Vesting period   4 years        
Share based compensation, expiration period   6 years        
Restricted Stock Awards [Member] | Employees [Member]            
Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items]            
Vesting period   3 years        
Restricted Stock Awards [Member] | Executives RSAs and RSUs [Member]            
Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items]            
Vesting period   4 years        
Restricted Stock Awards [Member] | Executives RSAs and RSUs [Member] | On each of the third and fourth anniversaries of the vesting date[Member]            
Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items]            
Vesting percentage   25.00%        
Restricted Stock Awards [Member] | Director [Member] | On each of the third and fourth anniversaries of the vesting date[Member]            
Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items]            
Vesting period   1 year        
Vesting percentage   100.00%        
Market Stock Unit | Employees [Member]            
Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items]            
Vesting period   3 years        
Retained Earnings            
Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items]            
Stockholders' Equity Attributable to Parent   $ (84,486) (71,309) (87,922)   (102,261)
Accumulated Other Comprehensive Loss            
Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items]            
Stockholders' Equity Attributable to Parent   $ 13,473 $ 3,043 $ 16,275   $ 38,032
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.22.0.1
Revenue - Narrative (Details)
$ in Millions
Dec. 31, 2021
USD ($)
Revenue from Contract with Customer [Abstract]  
Contract with Customer, Liability, Current $ 25.1
Contract with Customer, Liability, Noncurrent 5.0
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-01-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue, Remaining Performance Obligation, Amount $ 25.0
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-01-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue, Remaining Performance Obligation, Amount $ 2.7
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period 2 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue, Remaining Performance Obligation, Amount $ 1.5
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period 3 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue, Remaining Performance Obligation, Amount $ 0.5
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period 4 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue, Remaining Performance Obligation, Amount $ 0.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.22.0.1
Revenue - Unbilled AR and Deferred Revenue (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
USD ($)
Movement in Deferred Revenue [Roll Forward]  
Deferred Revenue, December 31, 2020 $ 25,723
Additions 24,053
Revenue Recognized (19,679)
Deferred Revenue, December 31, 2021 30,097
Unbilled Revenues [Member]  
Movement in Unbilled AR [Roll Forward]  
Unbilled AR, December 31, 2020 1,925
Additions 58
Transferred to Trade Receivable (1,731)
Unbilled AR, December 31, 2021 $ 252
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.22.0.1
Allowance for Doubtful Accounts (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Accounts Receivable, Allowance for Credit Loss [Roll Forward]      
Balance, beginning of period $ 6,213 $ 7,384  
Additions charged to expense 181 1,190 $ 4,262
Write-offs charged against allowance (1,123) (2,361)  
Balance, end of period $ 5,271 $ 6,213 $ 7,384
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.22.0.1
Inventories (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Inventory Disclosure [Abstract]    
Raw materials and subassemblies $ 20,750 $ 22,583
Work in process 2,825 2,294
Finished goods 57,836 65,695
Total Inventories 81,411 90,572
Less: Non-current Inventories (13,666) (14,922)
Inventories $ 67,745 $ 75,650
XML 63 R51.htm IDEA: XBRL DOCUMENT v3.22.0.1
Inventories - Narrative (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Inventory Disclosure [Abstract]    
Non-current Inventories $ 13,666 $ 14,922
XML 64 R52.htm IDEA: XBRL DOCUMENT v3.22.0.1
Property and Equipment (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Property, Plant and Equipment [Line Items]    
Property and Equipment, Gross $ 55,093 $ 55,242
Finance Lease, Right-of-Use Asset 2,356 2,555
Accumulated depreciation (33,310) (30,726)
Total $ 21,783 $ 24,516
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Total Total
Land [Member]    
Property, Plant and Equipment [Line Items]    
Property and Equipment, Gross $ 1,782 $ 1,792
Buildings [Member]    
Property, Plant and Equipment [Line Items]    
Property and Equipment, Gross 7,238 7,365
Leasehold improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property and Equipment, Gross 7,722 8,050
Office furniture and equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and Equipment, Gross 20,637 22,148
Computer software and hardware [Member]    
Property, Plant and Equipment [Line Items]    
Property and Equipment, Gross 11,308 10,246
Demonstration and loaned equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and Equipment, Gross $ 4,050 $ 3,086
XML 65 R53.htm IDEA: XBRL DOCUMENT v3.22.0.1
Property and Equipment - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Property, Plant and Equipment, Net [Abstract]      
Depreciation expense $ 6.3 $ 6.2 $ 6.6
XML 66 R54.htm IDEA: XBRL DOCUMENT v3.22.0.1
Intangible Assets - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Sep. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Acquired Finite-Lived Intangible Assets [Line Items]        
Total amortization   $ 24,013 $ 28,703 $ 23,499
Weighted average life of intangible assets   11 years    
Costs incurred for development of internal use computer software   $ 11,100    
Costs incurred for development of software to be sold   2,200    
Impairment of intangible assets $ 6,700 2,004 6,678 0
Intellectual Property        
Acquired Finite-Lived Intangible Assets [Line Items]        
Accumulated Impairment   2,004 0 0
Patents        
Acquired Finite-Lived Intangible Assets [Line Items]        
Total amortization   $ 0 0 60
Weighted average life of intangible assets   13 years    
Technology        
Acquired Finite-Lived Intangible Assets [Line Items]        
Total amortization   $ 6,907 13,417 6,906
Weighted average life of intangible assets   14 years    
Customer related        
Acquired Finite-Lived Intangible Assets [Line Items]        
Total amortization   $ 9,040 8,825 8,662
Weighted average life of intangible assets   10 years    
Trade names [Member]        
Acquired Finite-Lived Intangible Assets [Line Items]        
Total amortization   $ 5,881 6,182 6,111
Weighted average life of intangible assets   7 years    
Internally developed software [Member]        
Acquired Finite-Lived Intangible Assets [Line Items]        
Weighted average life of intangible assets   6 years    
Service Agreements        
Acquired Finite-Lived Intangible Assets [Line Items]        
Total amortization   $ 40 40 322
Weighted average life of intangible assets   2 years    
Cost of revenue        
Acquired Finite-Lived Intangible Assets [Line Items]        
Impairment of intangible assets 6,400      
Operating Expense        
Acquired Finite-Lived Intangible Assets [Line Items]        
Impairment of intangible assets $ 300      
General and administrative        
Acquired Finite-Lived Intangible Assets [Line Items]        
Total amortization   $ 100 $ 200 $ 1,300
XML 67 R55.htm IDEA: XBRL DOCUMENT v3.22.0.1
Intangible Assets - Components of Gross and Net Intangible Asset Balances (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Finite-Lived Intangible Assets, Net [Abstract]      
Gross Carrying Amount $ 252,093 $ 271,003  
Accumulated Impairment (9,482) (16,340)  
Accumulated Amortization (177,098) (163,981)  
Total expected amortization expense 65,513 90,682  
Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract]      
Gross Carrying Amount 254,097 273,062  
Accumulated Impairment (11,486) (16,340)  
Intangible assets, net 65,513 92,741  
Intellectual Property      
Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract]      
Gross Carrying Amount 2,004 2,059  
Accumulated Impairment (2,004) 0 $ 0
Net Book Value 0 2,059  
Technology      
Finite-Lived Intangible Assets, Net [Abstract]      
Gross Carrying Amount 99,920 112,138  
Accumulated Impairment (6,039) (12,480)  
Accumulated Amortization (66,679) (64,203)  
Total expected amortization expense 27,202 35,455  
Customer related      
Finite-Lived Intangible Assets, Net [Abstract]      
Gross Carrying Amount 89,794 94,526  
Accumulated Impairment (50) (50)  
Accumulated Amortization (57,133) (51,247)  
Total expected amortization expense 32,611 43,229  
Trade names      
Finite-Lived Intangible Assets, Net [Abstract]      
Gross Carrying Amount 45,593 47,058  
Accumulated Impairment (3,260) (3,677)  
Accumulated Amortization (36,960) (31,890)  
Total expected amortization expense 5,373 11,491  
Internally developed software      
Finite-Lived Intangible Assets, Net [Abstract]      
Gross Carrying Amount 13,281 13,281  
Accumulated Impairment 0 0  
Accumulated Amortization (12,985) (12,845)  
Total expected amortization expense 296 436  
Patents      
Finite-Lived Intangible Assets, Net [Abstract]      
Gross Carrying Amount 2,705 2,810  
Accumulated Impairment (133) (133)  
Accumulated Amortization (2,572) (2,677)  
Total expected amortization expense 0 0  
Service Agreements      
Finite-Lived Intangible Assets, Net [Abstract]      
Gross Carrying Amount 800 1,190  
Accumulated Impairment 0 0  
Accumulated Amortization (769) (1,119)  
Total expected amortization expense $ 31 $ 71  
XML 68 R56.htm IDEA: XBRL DOCUMENT v3.22.0.1
Intangible Assets - Schedule of Amortization Expense (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]      
Total amortization $ 24,013 $ 28,703 $ 23,499
Intellectual Property      
Finite-Lived Intangible Assets [Line Items]      
Accumulated Impairment 2,004 0 0
Technology      
Finite-Lived Intangible Assets [Line Items]      
Total amortization 6,907 13,417 6,906
Customer related      
Finite-Lived Intangible Assets [Line Items]      
Total amortization 9,040 8,825 8,662
Trade names [Member]      
Finite-Lived Intangible Assets [Line Items]      
Total amortization 5,881 6,182 6,111
Internally developed software      
Finite-Lived Intangible Assets [Line Items]      
Total amortization 141 239 1,438
Patents      
Finite-Lived Intangible Assets [Line Items]      
Total amortization 0 0 60
Service Agreements      
Finite-Lived Intangible Assets [Line Items]      
Total amortization $ 40 $ 40 $ 322
XML 69 R57.htm IDEA: XBRL DOCUMENT v3.22.0.1
Intangible Assets - Expected Annual Amortization Expense (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]    
2019 $ 17,634  
2020 14,865  
2021 12,970  
2022 12,362  
2023 2,408  
Thereafter 5,274  
Total expected amortization expense $ 65,513 $ 90,682
XML 70 R58.htm IDEA: XBRL DOCUMENT v3.22.0.1
Goodwill (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Goodwill [Roll Forward]    
Beginning Balance $ 151,299 $ 146,367
Foreign currency translation (2,642) 3,725
Purchase Accounting Adjustments   1,207
Ending Balance $ 148,657 $ 151,299
XML 71 R59.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases - Narrative (Details)
Dec. 31, 2021
Operating Leased Assets [Line Items]  
Lease renewal term 10 years
Minimum  
Operating Leased Assets [Line Items]  
Remaining lease term 1 year
Maximum  
Operating Leased Assets [Line Items]  
Remaining lease term 8 years
XML 72 R60.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases - Lease Cost (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Leases [Abstract]    
Operating lease cost $ 6,046 $ 6,696
Amortization of right-of-use assets (principal payments) 384 395
Interest on lease liabilities 34 49
Short-term lease cost 22 7
Variable lease cost 1,958 2,541
Sublease income (81) (61)
Total lease cost $ 8,363 $ 9,627
XML 73 R61.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases - Supplemental Cash Flow (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Leases [Abstract]      
Operating cash flows from operating leases $ 12,636 $ 13,979  
Operating cash flows from finance leases 19 32  
Financing cash flows from finance leases 410 527 $ 478
Right-of-use assets obtained in exchange for lease obligations: operating leases 3,055 3,290  
Right-of-use assets obtained in exchange for lease obligations: finance leases $ 98 $ 337  
XML 74 R62.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases - Supplemental Balance Sheet (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Leases [Abstract]    
Operating lease right-of-use assets $ 9,288 $ 11,669
Current portion of operating lease liabilities 4,964 6,779
Operating lease liabilities 6,567 8,959
Total operating lease liabilities 11,531 15,738
Finance Leases, property and equipment 2,356 2,555
Finance leases, accumulated amortization (1,906) (1,705)
Finance leases, property and equipment, net 450 850
Finance leases, accrued liabilities 231 414
Finance leases, other liabilities 230 446
Total finance lease liabilities $ 461 $ 860
Weighted average remaining lease term, operating leases 2 years 11 months 19 days 3 years 3 months 29 days
Weighted average remaining lease term, finance leases 2 years 4 months 24 days 2 years 8 months 4 days
Weighted average discount rate, operating leases 5.40% 5.40%
Weighted average discount rate, finance leases 5.10% 5.10%
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Accrued liabilities Accrued liabilities
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other liabilities Other liabilities
XML 75 R63.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases - Lease Maturities (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Operating Leases    
2020 $ 5,440  
2021 3,404  
2022 1,959  
2023 957  
2024 630  
Thereafter 105  
Total lease payments 12,495  
Less imputed interest (964)  
Total 11,531 $ 15,738
Finance Leases    
2020 240  
2021 159  
2022 63  
2023 17  
2024 0  
Thereafter 0  
Total lease payments 479  
Less imputed interest (18)  
Total $ 461 $ 860
XML 76 R64.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases - Lease Income (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Leases [Abstract]      
Net Sales $ 10 $ 2,226  
Cost of Sales 13 4,107  
Gross Loss (3) (1,881) $ 0
Variable lease income 877 420  
Lease income on operating leases $ 197 $ 291  
XML 77 R65.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases - Sales Type Lease Receivable (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Leases [Abstract]    
Net minimum lease payments to be received $ 1,209 $ 1,777
Less: Unearned interest income portion 0 0
Net investment in sales-type leases 1,209 1,777
Less: Current portion (447) (444)
Long-term net investment in sales-type leases $ 762 $ 1,333
XML 78 R66.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases - Lease Payments Receivable Maturity (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Sales-type and Direct Financing Leases, Lease Receivable, Fiscal Year Maturity [Abstract]    
2022 $ 447  
2023 399  
2024 363  
2025 0  
2026 0  
Thereafter 0  
Net minimum lease payments to be received 1,209 $ 1,777
Less: Unearned interest income portion 0 0
Total 1,209 $ 1,777
Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract]    
2022 0  
2023 0  
2024 0  
2025 0  
2026 0  
Thereafter 0  
Total future minimum lease payments 0  
Less: imputed interest 0  
Total $ 0  
XML 79 R67.htm IDEA: XBRL DOCUMENT v3.22.0.1
Accrued Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Payables and Accruals [Abstract]    
Compensation and related benefits $ 22,734 $ 20,409
Accrued federal, state, and local taxes 9,855 9,118
Warranty reserve 6,042 5,195
Accrued professional fees 3,573 3,699
Accrued amounts due to customers 2,597 2,743
Self-funded insurance expense 835 911
Accrued travel 794 123
Accrued selling expenses 494 311
Other 1,211 1,727
Total $ 48,135 $ 44,236
XML 80 R68.htm IDEA: XBRL DOCUMENT v3.22.0.1
Long-Term Other Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Other Liabilities Disclosure [Abstract]    
Long-term taxes payable $ 10,678 $ 10,949
Non-current deferred revenue 5,001 4,416
CARES Act payroll tax payable 0 1,354
Long-term earnout payable 1,184 1,286
Finance lease liabilities 230 446
Other 144 0
Total $ 17,237 $ 18,451
XML 81 R69.htm IDEA: XBRL DOCUMENT v3.22.0.1
Debt and Credit Arrangements - Narrative (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2019
USD ($)
Revolving credit facility [Member] | Line of Credit [Member]    
Debt Instrument [Line Items]    
Revolving credit facility with Wells Fargo Bank   $ 150
Maximum | Credit Agreement [Member] | Citibank, National Association [Member]    
Debt Instrument [Line Items]    
Ratio of Indebtedness to Net Capital 3.25  
Minimum | Credit Agreement [Member] | Citibank, National Association [Member]    
Debt Instrument [Line Items]    
Ratio of Interest Coverage 1.75  
London Interbank Offered Rate (LIBOR) [Member] | Maximum | Credit Agreement [Member] | Citibank, National Association [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Basis Spread on Variable Rate 3.50%  
London Interbank Offered Rate (LIBOR) [Member] | Minimum | Credit Agreement [Member] | Citibank, National Association [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Basis Spread on Variable Rate 2.25%  
XML 82 R70.htm IDEA: XBRL DOCUMENT v3.22.0.1
Reserve for Product Warranties (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2021
USD ($)
Product Warranties Disclosures [Abstract]  
Product warranty period 1 year
Product reserve warranty $ 6.0
XML 83 R71.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity (Details) - $ / shares
Dec. 31, 2021
Dec. 31, 2020
Equity [Abstract]    
Common Stock, shares authorized 120,000,000 120,000,000
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock authorized 10,000,000 10,000,000
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock issued 0 0
Preferred stock outstanding 0 0
XML 84 R72.htm IDEA: XBRL DOCUMENT v3.22.0.1
Earnings Per Share - Components of Basic and Diluted EPS (Detail) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Earnings Per Share [Abstract]      
Net loss $ 13,177 $ (16,613) $ (15,671)
Weighted average common shares 33,670 33,562 33,696
Dilutive effect of stock based awards 304 0 0
Diluted Shares (in dollars per share) 33,974 33,562 33,696
Basic earnings per share (in dollars per share) $ 0.39 $ (0.49) $ (0.47)
Diluted earnings per share (in dollars per share) $ 0.39 $ (0.49) $ (0.47)
Shares excluded from calculations of diluted EPS 0 66 104
XML 85 R73.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation - Share-based Compensation Expense Allocation (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Total expense $ 14,161 $ 9,527 $ 8,315
Cost of revenue      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Total expense 394 319 264
Marketing and sales [Member]      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Total expense 2,201 1,938 1,024
Research and development [Member]      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Total expense 1,406 1,099 800
General and administrative      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Total expense $ 10,160 $ 6,171 $ 6,227
XML 86 R74.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation - Narrative (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Plan modification, incremental cost $ 1,100,000    
Shares available for future awards 2,917,938    
Unrecognized compensation expense related to unvested portion of stock options $ 1,000,000    
Intrinsic value of options exercised $ 0 $ 0 $ 1,400,000
Weighted average vested options 484,507    
Weighted average exercise price of vested stock $ 22.88    
Weighted average remaining contractual term 4 years    
Weighted average exercise price (in dollars per share) $ 24.01    
Intrinsic value of options exercisable $ 800,000    
Weighted average remaining contractual term, exercisable 1 year 6 months    
Weighted average period of recognition of unrecognized compensation expense 3 years 1 month 6 days    
Compensation expense associated with the ESPP $ 100,000 200,000 200,000
Share-based Payment Arrangement, Option [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share based compensation, expiration period 10 years    
Share based compensation, vesting period 4 years    
Intrinsic value of options vested and expected to vest $ 1,300,000    
Restricted Stock Awards [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Fair value, vested in period 8,600,000 5,500,000 4,700,000
Intrinsic value of options vested and expected to vest $ 6,700,000 $ 4,800,000 $ 4,000,000
Weighted average shares exercisable 320,512    
Unrecognized compensation of unvested awards $ 5,100,000    
Weighted average period of recognition of unrecognized compensation expense 2 years 1 month 6 days    
Fair market value of outstanding awards $ 8,100,000    
Granted, Weighted - average grant date fair value $ 22.04 $ 29.74 $ 31.53
Restricted Stock Units [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Fair value, vested in period $ 5,700,000 $ 500,000 $ 1,400,000
Intrinsic value of options vested and expected to vest 4,700,000 $ 500,000 $ 1,300,000
Unrecognized compensation of unvested awards $ 8,000,000    
Weighted average period of recognition of unrecognized compensation expense 2 years 10 months 24 days    
Granted, Weighted - average grant date fair value $ 26.43 $ 35.42 $ 38.62
Aggregate intrinsic value of outstanding restricted stock units $ 8,700,000    
Employee Stock Purchase Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Employee maximum withholding rate (percent) 15.00%    
Eligible compensation of employees $ 10,625    
Purchase price for shares acquired 85.00%    
Offering price, percentage of fair market value 85.00%    
Director [Member] | Share-based Payment Arrangement, Option [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share based compensation, expiration period 6 years    
Share based compensation, vesting period 4 years    
XML 87 R75.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation - Stock Option Activity (Details) - $ / shares
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Number of Shares    
Outstanding, beginning of period (shares) 331,585  
Granted (shares) 200,146  
Exercised (shares) (11,787)  
Cancelled (shares) (25,387)  
Outstanding, end of period (shares) 494,557  
Shares exercisable (in shares) 37,062 18,531
Weighted Average Exercise Price    
Outstanding, beginning of period (in dollars per share) $ 23.94  
Granted (in dollars per share) 20.61  
Exercised (in dollars per share) 20.68  
Cancelled (in dollars per share) 20.68  
Outstanding, end of period (in dollars per share) 0  
Exercisable, weighted average price (in dollars per share) $ 35.25 $ 35.25
XML 88 R76.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation - Valuation Inputs (Details) - $ / shares
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]    
Weighted-average fair value of options granted $ 7.50 $ 6.54
Expected life in years 5 years 10 months 24 days 4 years 6 months
Risk-free interest rate 0.30% 0.20%
Expected volatility 38.00% 38.00%
Dividend yield 0.00% 0.00%
XML 89 R77.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation - Restricted Stock Award Activity (Details) - Restricted Stock Awards [Member] - $ / shares
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Shares      
Unvested, beginning of period, Shares 380,089    
Granted, Shares 320,814    
Vested, Shares (320,541)    
Forfeited, Shares (40,592)    
Unvested, end of period, Shares 339,770 380,089  
Weighted Average Grant Date Fair Value      
Unvested, beginning of period, Weighted - average grant date fair value $ 31.84    
Granted, Weighted - average grant date fair value 22.04 $ 29.74 $ 31.53
Vested, Weighted - average grant date fair value 29.54    
Forfeited, Weighted - average grant date fair value 25.54    
Unvested, end of period, Weighted - average grant date fair value $ 26.15 $ 31.84  
XML 90 R78.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation - Restricted Unit Activity (Details) - Restricted Stock Units [Member] - $ / shares
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Shares      
Unvested, beginning of period, Shares 212,601    
Awarded, units 400,005    
Release, units (205,082)    
Forfeited, units (40,959)    
Unvested, end of period, Shares 366,565    
Weighted Average Grant Date Fair Value      
Unvested, beginning of period, Weighted - average grant date fair value $ 37.27    
Granted, Weighted - average grant date fair value 26.43 $ 35.42 $ 38.62
Vested, Weighted - average grant date fair value 31.34    
Forfeited, Weighted - average grant date fair value 36.20    
Unvested, end of period, Weighted - average grant date fair value $ 28.87 $ 37.27  
XML 91 R79.htm IDEA: XBRL DOCUMENT v3.22.0.1
Other Income (Expense), Net (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Other expense, net      
Interest income $ 87 $ 11 $ 250
Interest expense (1,872) (3,656) (4,941)
Foreign currency gain (loss) (1,957) 1,988 (765)
Other (682) (215) (135)
Total other expense, net $ (4,424) $ (1,872) $ (5,591)
XML 92 R80.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes - Income Loss before Provision (Benefit) for Income Tax (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Tax Disclosure [Abstract]      
U.S. $ 18,629 $ 1,908 $ (22,851)
Foreign 726 (23,973) 1,594
Income (loss) before provision (benefit) for income tax $ 19,355 $ (22,065) $ (21,257)
XML 93 R81.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes - Component of Income Tax Expense (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Current      
U.S. Federal $ 946 $ (3,976) $ (948)
U.S. State and local 368 145 561
Non-U.S. 7,523 1,241 8,386
Total current tax expense 8,837 (2,590) 7,999
Deferred      
U.S. Federal 4,583 2,049 (7,491)
U.S. State and local 184 533 (816)
Non-U.S. (7,426) (5,444) (5,278)
Total deferred tax expense (benefit) (2,659) (2,862) (13,585)
Total expense (benefit) $ 6,178 $ (5,452) $ (5,586)
XML 94 R82.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes - Components of Deferred Tax Asset and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Deferred tax assets:    
Net operating loss carryforwards $ 12,439 $ 9,099
Credit carryforwards 1,213 5,768
Accruals deductible in different periods 15,650 15,368
Employee benefits 925 1,016
Operating leases 2,766 3,967
Total deferred tax assets 32,993 35,218
Valuation allowance (934) (969)
Total net deferred tax assets 32,059 34,249
Deferred tax liabilities:    
Basis difference in fixed and intangible assets (7,007) (13,214)
Operating leases (2,224) (2,970)
Foreign earnings to be repatriated (800) (800)
Total deferred tax liabilities (10,031) (16,984)
Deferred Tax Assets, Net $ 22,028 $ 17,265
XML 95 R83.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes - Narrative (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Schedule Of Income Taxes [Line Items]        
Statutory tax rate 21.00% 21.00% 21.00%  
Valuation allowances $ 934,000 $ 969,000    
Increase in valuation allowance 100,000      
Deferred Tax Assets, Net 22,028,000 17,265,000    
Net operating loss carryforwards 12,439,000 9,099,000    
Deferred tax liabilities related to foreign earnings 800,000 800,000    
Increase in unrecognized tax benefits 700,000      
Increases for tax positions related to the current year 1,067,000 104,000 $ 495,000  
Unrecognized tax benefits 4,848,000 4,142,000 3,917,000 $ 7,227,000
Unrecognized tax would impact effective tax rate 4,600,000 3,800,000 3,600,000  
Lapse of statutes of limitations 279,000 2,416,000 3,763,000  
Interest and penalties related to uncertain tax positions 900,000 500,000 400,000  
Total Interest and penalties related to uncertain tax positions 300,000 $ 100,000 $ (100,000)  
Income Tax Provision        
Schedule Of Income Taxes [Line Items]        
Increases for tax positions related to the current year 700,000      
Minimum        
Schedule Of Income Taxes [Line Items]        
Lapse of statutes of limitations 0      
Maximum        
Schedule Of Income Taxes [Line Items]        
Lapse of statutes of limitations 800,000      
France        
Schedule Of Income Taxes [Line Items]        
Tax net operating loss carryforwards 800,000      
Denmark        
Schedule Of Income Taxes [Line Items]        
Tax net operating loss carryforwards 8,700,000      
Canada        
Schedule Of Income Taxes [Line Items]        
Tax net operating loss carryforwards 300,000      
Germany        
Schedule Of Income Taxes [Line Items]        
Tax net operating loss carryforwards 300,000      
CHINA        
Schedule Of Income Taxes [Line Items]        
Tax net operating loss carryforwards 200,000      
State and Local Jurisdiction        
Schedule Of Income Taxes [Line Items]        
Tax net operating loss carryforwards 16,900,000      
Significant foreign jurisdictions        
Schedule Of Income Taxes [Line Items]        
Tax credits carryforwards $ 100,000      
Significant foreign jurisdictions | Minimum        
Schedule Of Income Taxes [Line Items]        
Operating Loss Carryforward, Period 6 years      
Domestic Tax Authority | Minimum        
Schedule Of Income Taxes [Line Items]        
Operating Loss Carryforward, Period 10 years      
Research Tax Credit Carryforward | State and Local Jurisdiction        
Schedule Of Income Taxes [Line Items]        
Tax credits carryforwards $ 1,300,000      
XML 96 R84.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes - Reconciliation of Income tax Expense from Continuous Operation (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Tax Disclosure [Abstract]      
Federal statutory tax expense $ 4,065 $ (4,634) $ (4,464)
State tax expense 605 661 (300)
Foreign taxes at rates less than U.S. rates (609) 1,050 (2,205)
Equity compensation 2,581 1,161 824
Tax credits (1,393) (1,641) (1,428)
Uncertain tax position 1,553 3,002 2,910
Lapse of statute (365) (2,718) (3,961)
Repatriation tax net of foreign tax credits 0 0 172
Federal NOL Carryback (454) (1,621) 0
Tax audits 97 (224) 0
Withholding taxes 254 0 1,107
Global intangible low-taxed income net of foreign tax credits 0 0 1,601
Return to provision (704) (946) 560
Other 548 458 (402)
Total expense (benefit) $ 6,178 $ (5,452) $ (5,586)
XML 97 R85.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes - Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Beginning-Unrecognized Tax Benefits $ 4,142 $ 3,917 $ 7,227
Decreases for tax positions related to prior years     48
Increases for tax positions related to prior years   (2,454)  
Increases for tax positions related to the current year 1,067 104 495
Decrease due to lapse of statutes of limitations (279) (2,416) (3,763)
Foreign exchange difference (82)   (6)
Foreign exchange difference   83  
Ending-Unrecognized Tax Benefits $ 4,848 $ 4,142 $ 3,917
XML 98 R86.htm IDEA: XBRL DOCUMENT v3.22.0.1
Employee Benefit Plan (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Retirement Benefits [Abstract]      
Employer matching contributions $ 3.7 $ 3.2 $ 3.6
Employer matching contribution, ratable vesting period 2 years    
XML 99 R87.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment, Customer and Geographic Information - Narrative (Details)
 12 Months Ended
Dec. 31, 2021
operating_segment
Segment
Dec. 31, 2020
operating_segment
Dec. 31, 2019
strategicBusinessUnit
operating_segment
Segment Reporting [Abstract]      
Number of strategic business units | strategicBusinessUnit     3
Number of operating segments | operating_segment 1 1 1
Number of reporting segments | Segment 1    
XML 100 R88.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment, Customer and Geographic Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Segment Reporting Information [Line Items]      
Revenue $ 473,438 $ 415,684 $ 495,175
Long-lived assets 21,783 24,516  
Neurology Products [Member]      
Segment Reporting Information [Line Items]      
Revenue 284,767 235,739 287,236
Neurology Products [Member] | Devices and Systems [Member]      
Segment Reporting Information [Line Items]      
Revenue 220,929 179,464 220,306
Neurology Products [Member] | Supplies [Member]      
Segment Reporting Information [Line Items]      
Revenue 63,838 56,275 66,059
Neurology Products [Member] | Services [Member]      
Segment Reporting Information [Line Items]      
Revenue 0 0 871
Newborn Care Products [Member]      
Segment Reporting Information [Line Items]      
Revenue 105,023 105,024 110,912
Newborn Care Products [Member] | Devices and Systems [Member]      
Segment Reporting Information [Line Items]      
Revenue 55,174 52,284 53,465
Newborn Care Products [Member] | Supplies [Member]      
Segment Reporting Information [Line Items]      
Revenue 33,710 36,174 38,264
Newborn Care Products [Member] | Services [Member]      
Segment Reporting Information [Line Items]      
Revenue 16,139 16,566 19,183
OtometricsProducts [Member]      
Segment Reporting Information [Line Items]      
Revenue 83,648 74,921 97,027
OtometricsProducts [Member] | Devices and Systems [Member]      
Segment Reporting Information [Line Items]      
Revenue 78,652 70,738 92,050
OtometricsProducts [Member] | Supplies [Member]      
Segment Reporting Information [Line Items]      
Revenue 4,996 4,183 4,977
United States      
Segment Reporting Information [Line Items]      
Revenue 285,979 252,496 292,400
Long-lived assets 9,642 10,998  
Foreign countries [Member]      
Segment Reporting Information [Line Items]      
Revenue 187,459 163,188 $ 202,775
Canada      
Segment Reporting Information [Line Items]      
Long-lived assets 3,594 3,775  
Ireland      
Segment Reporting Information [Line Items]      
Long-lived assets 6,223 6,716  
Denmark      
Segment Reporting Information [Line Items]      
Long-lived assets 1,262 1,787  
Other Foreign countries [Member]      
Segment Reporting Information [Line Items]      
Long-lived assets $ 1,062 $ 1,240  
XML 101 R89.htm IDEA: XBRL DOCUMENT v3.22.0.1
Commitments And Contingencies - Narrative (Details)
$ in Millions
Dec. 31, 2021
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Purchase obligation $ 178.4
Purchase obligation, to be paid, year one 136.5
Purchase Obligation, To Be Paid, After Year One $ 41.9
XML 102 R90.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurements - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Proceeds from Sale of Property, Plant, and Equipment   $ 2,674 $ 0 $ 0
Gain (Loss) on Disposition of Property Plant Equipment   $ 1,426 $ (268) $ (449)
Canada | Land [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Proceeds from Sale of Property, Plant, and Equipment $ 1,600      
Gain (Loss) on Disposition of Property Plant Equipment 700      
UNITED KINGDOM | Buildings [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Proceeds from Sale of Property, Plant, and Equipment 1,100      
Gain (Loss) on Disposition of Property Plant Equipment $ 800      
XML 103 R91.htm IDEA: XBRL DOCUMENT v3.22.0.1
Sale of Certain Subsidiary (Details) - USD ($)
 3 Months Ended
Apr. 02, 2019
Jun. 30, 2021
Dec. 31, 2021
Mar. 31, 2021
Dec. 31, 2020
Aug. 02, 2019
Related Party Transaction [Line Items]            
Gain on note receivable from related party   $ 200,000        
Accumulated other comprehensive loss     $ (13,473,000)   $ (3,043,000)  
Medix Medical Devices, SRL [Member]            
Related Party Transaction [Line Items]            
Related Party Transaction, Amounts of Transaction $ 2,500          
Notes receivable, related parties 2,200,000     $ 700,000    
Repayment of notes receivable from related party   $ 900,000        
Gain (Loss) on Sale of Assets and Asset Impairment Charges 24,600,000          
Accumulated other comprehensive loss           $ 24,800,000
Assets, Fair Value Adjustment $ 4,600,000          
XML 104 R92.htm IDEA: XBRL DOCUMENT v3.22.0.1
Schedule II: Valuation And Qualifying Accounts (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
SEC Schedule, 12-09, Allowance, Credit Loss [Member]      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period $ 6,213 $ 7,384 $ 6,960
Additions Charged to Expense 181 1,190 4,262
Deductions (1,123) (2,361) (3,838)
Balance at End of Period 5,271 6,213 7,384
SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 969 606 637
Additions Charged to Expense 0 363 0
Deductions (35) 0 (31)
Balance at End of Period 934 969 606
SEC Schedule, 12-09, Reserve, Warranty [Member]      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 5,195 6,404 9,391
Additions Charged to Expense 3,989 2,009 3,949
Deductions (3,142) (3,218) (6,936)
Balance at End of Period $ 6,042 $ 5,195 $ 6,404
XML 105 ntus-20211231_htm.xml IDEA: XBRL DOCUMENT 0000878526 2021-01-01 2021-12-31 0000878526 2021-06-30 0000878526 2022-02-18 0000878526 us-gaap:AllowanceForCreditLossMember 2020-12-31 0000878526 us-gaap:AllowanceForCreditLossMember 2021-01-01 2021-12-31 0000878526 us-gaap:AllowanceForCreditLossMember 2021-12-31 0000878526 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-12-31 0000878526 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-01-01 2021-12-31 0000878526 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-12-31 0000878526 us-gaap:WarrantyReservesMember 2020-12-31 0000878526 us-gaap:WarrantyReservesMember 2021-01-01 2021-12-31 0000878526 us-gaap:WarrantyReservesMember 2021-12-31 0000878526 us-gaap:AllowanceForCreditLossMember 2019-12-31 0000878526 us-gaap:AllowanceForCreditLossMember 2020-01-01 2020-12-31 0000878526 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-12-31 0000878526 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-01-01 2020-12-31 0000878526 us-gaap:WarrantyReservesMember 2019-12-31 0000878526 us-gaap:WarrantyReservesMember 2020-01-01 2020-12-31 0000878526 us-gaap:AllowanceForCreditLossMember 2018-12-31 0000878526 us-gaap:AllowanceForCreditLossMember 2019-01-01 2019-12-31 0000878526 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-12-31 0000878526 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-01-01 2019-12-31 0000878526 us-gaap:WarrantyReservesMember 2018-12-31 0000878526 us-gaap:WarrantyReservesMember 2019-01-01 2019-12-31 0000878526 2021-12-31 0000878526 2020-12-31 0000878526 2020-01-01 2020-12-31 0000878526 2019-01-01 2019-12-31 0000878526 us-gaap:CommonStockMember 2018-12-31 0000878526 us-gaap:RetainedEarningsMember 2018-12-31 0000878526 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000878526 2018-12-31 0000878526 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0000878526 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0000878526 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-01-01 2019-12-31 0000878526 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0000878526 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0000878526 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0000878526 us-gaap:CommonStockMember 2019-12-31 0000878526 us-gaap:RetainedEarningsMember 2019-12-31 0000878526 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000878526 2019-12-31 0000878526 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0000878526 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0000878526 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0000878526 us-gaap:CommonStockMember 2020-12-31 0000878526 us-gaap:RetainedEarningsMember 2020-12-31 0000878526 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000878526 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000878526 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0000878526 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0000878526 us-gaap:CommonStockMember 2021-12-31 0000878526 us-gaap:RetainedEarningsMember 2021-12-31 0000878526 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000878526 srt:MinimumMember 2021-01-01 2021-12-31 0000878526 srt:MaximumMember 2021-01-01 2021-12-31 0000878526 2020-01-01 0000878526 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0000878526 ntus:EmployeesMember us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0000878526 srt:ExecutiveOfficerMember us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0000878526 srt:ExecutiveOfficerMember us-gaap:RestrictedStockMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2021-01-01 2021-12-31 0000878526 srt:DirectorMember us-gaap:RestrictedStockMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2021-01-01 2021-12-31 0000878526 ntus:EmployeesMember ntus:MarketStockUnitMember 2021-01-01 2021-12-31 0000878526 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2021-01-01 2021-12-31 0000878526 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2021-01-01 2021-12-31 0000878526 srt:MinimumMember us-gaap:BuildingMember 2021-01-01 2021-12-31 0000878526 srt:MaximumMember us-gaap:BuildingMember 2021-01-01 2021-12-31 0000878526 us-gaap:ComputerEquipmentMember 2021-01-01 2021-12-31 0000878526 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2021-04-01 2021-06-30 0000878526 us-gaap:UnbilledRevenuesMember 2020-12-31 0000878526 us-gaap:UnbilledRevenuesMember 2021-01-01 2021-12-31 0000878526 us-gaap:UnbilledRevenuesMember 2021-12-31 0000878526 2019-01-01 2021-12-31 0000878526 2020-01-01 2021-12-31 0000878526 2021-01-01 2021-12-31 0000878526 2022-01-01 2021-12-31 0000878526 2023-01-01 2021-12-31 0000878526 us-gaap:LandMember 2021-12-31 0000878526 us-gaap:LandMember 2020-12-31 0000878526 us-gaap:BuildingMember 2021-12-31 0000878526 us-gaap:BuildingMember 2020-12-31 0000878526 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2021-12-31 0000878526 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2020-12-31 0000878526 us-gaap:FurnitureAndFixturesMember 2021-12-31 0000878526 us-gaap:FurnitureAndFixturesMember 2020-12-31 0000878526 us-gaap:ComputerEquipmentMember 2021-12-31 0000878526 us-gaap:ComputerEquipmentMember 2020-12-31 0000878526 ntus:DemonstrationAndLoanedEquipmentMember 2021-12-31 0000878526 ntus:DemonstrationAndLoanedEquipmentMember 2020-12-31 0000878526 us-gaap:DevelopedTechnologyRightsMember 2021-12-31 0000878526 us-gaap:DevelopedTechnologyRightsMember 2020-12-31 0000878526 us-gaap:CustomerRelationshipsMember 2021-12-31 0000878526 us-gaap:CustomerRelationshipsMember 2020-12-31 0000878526 us-gaap:TradeNamesMember 2021-12-31 0000878526 us-gaap:TradeNamesMember 2020-12-31 0000878526 us-gaap:SoftwareDevelopmentMember 2021-12-31 0000878526 us-gaap:SoftwareDevelopmentMember 2020-12-31 0000878526 us-gaap:PatentsMember 2021-12-31 0000878526 us-gaap:PatentsMember 2020-12-31 0000878526 us-gaap:ServiceAgreementsMember 2021-12-31 0000878526 us-gaap:ServiceAgreementsMember 2020-12-31 0000878526 us-gaap:IntellectualPropertyMember 2021-12-31 0000878526 us-gaap:IntellectualPropertyMember 2020-12-31 0000878526 us-gaap:DevelopedTechnologyRightsMember 2021-01-01 2021-12-31 0000878526 us-gaap:PatentsMember 2021-01-01 2021-12-31 0000878526 us-gaap:CustomerRelationshipsMember 2021-01-01 2021-12-31 0000878526 us-gaap:TradeNamesMember 2021-01-01 2021-12-31 0000878526 us-gaap:ComputerSoftwareIntangibleAssetMember 2021-01-01 2021-12-31 0000878526 us-gaap:ServiceAgreementsMember 2021-01-01 2021-12-31 0000878526 2020-07-01 2020-09-30 0000878526 us-gaap:CostOfSalesMember 2020-07-01 2020-09-30 0000878526 us-gaap:OperatingExpenseMember 2020-07-01 2020-09-30 0000878526 us-gaap:DevelopedTechnologyRightsMember 2020-01-01 2020-12-31 0000878526 us-gaap:DevelopedTechnologyRightsMember 2019-01-01 2019-12-31 0000878526 us-gaap:CustomerRelationshipsMember 2020-01-01 2020-12-31 0000878526 us-gaap:CustomerRelationshipsMember 2019-01-01 2019-12-31 0000878526 us-gaap:TradeNamesMember 2020-01-01 2020-12-31 0000878526 us-gaap:TradeNamesMember 2019-01-01 2019-12-31 0000878526 us-gaap:IntellectualPropertyMember 2019-12-31 0000878526 us-gaap:SoftwareDevelopmentMember 2021-01-01 2021-12-31 0000878526 us-gaap:SoftwareDevelopmentMember 2020-01-01 2020-12-31 0000878526 us-gaap:SoftwareDevelopmentMember 2019-01-01 2019-12-31 0000878526 us-gaap:PatentsMember 2020-01-01 2020-12-31 0000878526 us-gaap:PatentsMember 2019-01-01 2019-12-31 0000878526 us-gaap:ServiceAgreementsMember 2020-01-01 2020-12-31 0000878526 us-gaap:ServiceAgreementsMember 2019-01-01 2019-12-31 0000878526 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-12-31 0000878526 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-12-31 0000878526 us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-12-31 0000878526 srt:MinimumMember 2021-12-31 0000878526 srt:MaximumMember 2021-12-31 0000878526 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2019-12-31 0000878526 srt:MaximumMember ntus:CreditAgreementMember ntus:CitibankNationalAssociationMember 2021-12-31 0000878526 srt:MinimumMember ntus:CreditAgreementMember ntus:CitibankNationalAssociationMember 2021-12-31 0000878526 srt:MinimumMember ntus:CreditAgreementMember ntus:CitibankNationalAssociationMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-01-01 2021-12-31 0000878526 srt:MaximumMember ntus:CreditAgreementMember ntus:CitibankNationalAssociationMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-01-01 2021-12-31 0000878526 us-gaap:CostOfSalesMember 2021-01-01 2021-12-31 0000878526 us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0000878526 us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0000878526 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-12-31 0000878526 us-gaap:SellingAndMarketingExpenseMember 2020-01-01 2020-12-31 0000878526 us-gaap:SellingAndMarketingExpenseMember 2019-01-01 2019-12-31 0000878526 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-12-31 0000878526 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-12-31 0000878526 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-12-31 0000878526 srt:DirectorMember us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0000878526 us-gaap:EmployeeStockOptionMember 2021-12-31 0000878526 us-gaap:RestrictedStockMember 2021-12-31 0000878526 us-gaap:RestrictedStockMember 2020-12-31 0000878526 us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0000878526 us-gaap:RestrictedStockMember 2020-01-01 2020-12-31 0000878526 us-gaap:RestrictedStockMember 2019-01-01 2019-12-31 0000878526 us-gaap:RestrictedStockMember 2019-12-31 0000878526 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0000878526 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0000878526 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0000878526 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0000878526 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-12-31 0000878526 us-gaap:RestrictedStockUnitsRSUMember 2019-12-31 0000878526 us-gaap:EmployeeStockMember 2021-12-31 0000878526 us-gaap:EmployeeStockMember 2021-01-01 2021-12-31 0000878526 us-gaap:StateAndLocalJurisdictionMember 2021-12-31 0000878526 srt:MinimumMember us-gaap:DomesticCountryMember 2021-01-01 2021-12-31 0000878526 us-gaap:StateAndLocalJurisdictionMember us-gaap:ResearchMember 2021-12-31 0000878526 us-gaap:ForeignCountryMember 2021-12-31 0000878526 country:FR 2021-12-31 0000878526 country:DK 2021-12-31 0000878526 country:CA 2021-12-31 0000878526 country:CN 2021-12-31 0000878526 country:DE 2021-12-31 0000878526 srt:MinimumMember us-gaap:ForeignCountryMember 2021-01-01 2021-12-31 0000878526 ntus:IncomeTaxProvisionMember 2021-01-01 2021-12-31 0000878526 country:US 2021-01-01 2021-12-31 0000878526 country:US 2020-01-01 2020-12-31 0000878526 country:US 2019-01-01 2019-12-31 0000878526 us-gaap:NonUsMember 2021-01-01 2021-12-31 0000878526 us-gaap:NonUsMember 2020-01-01 2020-12-31 0000878526 us-gaap:NonUsMember 2019-01-01 2019-12-31 0000878526 ntus:DevicesAndSystemsMember ntus:NeurologyProductsMember 2021-01-01 2021-12-31 0000878526 ntus:DevicesAndSystemsMember ntus:NeurologyProductsMember 2020-01-01 2020-12-31 0000878526 ntus:DevicesAndSystemsMember ntus:NeurologyProductsMember 2019-01-01 2019-12-31 0000878526 ntus:SuppliesMember ntus:NeurologyProductsMember 2021-01-01 2021-12-31 0000878526 ntus:SuppliesMember ntus:NeurologyProductsMember 2020-01-01 2020-12-31 0000878526 ntus:SuppliesMember ntus:NeurologyProductsMember 2019-01-01 2019-12-31 0000878526 ntus:ServicesMember ntus:NeurologyProductsMember 2021-01-01 2021-12-31 0000878526 ntus:ServicesMember ntus:NeurologyProductsMember 2020-01-01 2020-12-31 0000878526 ntus:ServicesMember ntus:NeurologyProductsMember 2019-01-01 2019-12-31 0000878526 ntus:NeurologyProductsMember 2021-01-01 2021-12-31 0000878526 ntus:NeurologyProductsMember 2020-01-01 2020-12-31 0000878526 ntus:NeurologyProductsMember 2019-01-01 2019-12-31 0000878526 ntus:DevicesAndSystemsMember ntus:NewbornCareProductsMember 2021-01-01 2021-12-31 0000878526 ntus:DevicesAndSystemsMember ntus:NewbornCareProductsMember 2020-01-01 2020-12-31 0000878526 ntus:DevicesAndSystemsMember ntus:NewbornCareProductsMember 2019-01-01 2019-12-31 0000878526 ntus:SuppliesMember ntus:NewbornCareProductsMember 2021-01-01 2021-12-31 0000878526 ntus:SuppliesMember ntus:NewbornCareProductsMember 2020-01-01 2020-12-31 0000878526 ntus:SuppliesMember ntus:NewbornCareProductsMember 2019-01-01 2019-12-31 0000878526 ntus:ServicesMember ntus:NewbornCareProductsMember 2021-01-01 2021-12-31 0000878526 ntus:ServicesMember ntus:NewbornCareProductsMember 2020-01-01 2020-12-31 0000878526 ntus:ServicesMember ntus:NewbornCareProductsMember 2019-01-01 2019-12-31 0000878526 ntus:NewbornCareProductsMember 2021-01-01 2021-12-31 0000878526 ntus:NewbornCareProductsMember 2020-01-01 2020-12-31 0000878526 ntus:NewbornCareProductsMember 2019-01-01 2019-12-31 0000878526 ntus:DevicesAndSystemsMember ntus:OtometricsProductsMember 2021-01-01 2021-12-31 0000878526 ntus:DevicesAndSystemsMember ntus:OtometricsProductsMember 2020-01-01 2020-12-31 0000878526 ntus:DevicesAndSystemsMember ntus:OtometricsProductsMember 2019-01-01 2019-12-31 0000878526 ntus:SuppliesMember ntus:OtometricsProductsMember 2021-01-01 2021-12-31 0000878526 ntus:SuppliesMember ntus:OtometricsProductsMember 2020-01-01 2020-12-31 0000878526 ntus:SuppliesMember ntus:OtometricsProductsMember 2019-01-01 2019-12-31 0000878526 ntus:OtometricsProductsMember 2021-01-01 2021-12-31 0000878526 ntus:OtometricsProductsMember 2020-01-01 2020-12-31 0000878526 ntus:OtometricsProductsMember 2019-01-01 2019-12-31 0000878526 country:US 2021-12-31 0000878526 country:US 2020-12-31 0000878526 country:IE 2021-12-31 0000878526 country:IE 2020-12-31 0000878526 country:CA 2020-12-31 0000878526 country:DK 2020-12-31 0000878526 ntus:ForeignCountriesMember 2021-12-31 0000878526 ntus:ForeignCountriesMember 2020-12-31 0000878526 country:CA us-gaap:LandMember 2021-07-01 2021-09-30 0000878526 country:GB us-gaap:BuildingMember 2021-07-01 2021-09-30 0000878526 ntus:MedixMedicalDevicesSRLMember 2019-04-02 2019-04-02 0000878526 ntus:MedixMedicalDevicesSRLMember 2019-04-02 0000878526 ntus:MedixMedicalDevicesSRLMember 2021-04-01 2021-06-30 0000878526 ntus:MedixMedicalDevicesSRLMember 2021-03-31 0000878526 2021-04-01 2021-06-30 0000878526 ntus:MedixMedicalDevicesSRLMember 2019-08-02 iso4217:USD shares iso4217:USD shares ntus:strategicBusinessUnit ntus:operating_segment ntus:reporting_unit pure ntus:Segment false 2021 FY 0000878526 5271000 6213000 0.001 0.001 120000000 120000000 34225682 33911703 34225682 33911703 0.001 0.001 10000000 10000000 0 0 0 0 P3Y 25000000 2700000 1500000 500000 400000 P1Y P2Y P3Y P4Y http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentNet http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentNet P1Y http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent 18531 35.25 37062 35.25 0.21 0.21 0.21 10-K true 2021-12-31 --12-31 false 000-33001 NATUS MEDICAL INC DE 77-0154833 3150 Pleasant View Road Middleton WI 53562 608 829-8500 Common Stock, $0.001 par value per share NTUS NASDAQ Yes No Yes Yes Large Accelerated Filer false false true false 886752114 34408154 Certain portions of the Registrant's Definitive Proxy Statement for the 2022 Annual Meeting of Stockholders or an amendment to this Annual Report on Form 10-K, to be filed with the Securities and Exchange Commission, are incorporated by reference into Part III of this Annual Report on Form 10-K. KPMG LLP San Francisco, CA 185 <div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II: VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2021, 2020 and 2019 </span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions<br/>Charged to<br/>Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance<br/>at End<br/>of Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,213 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,123)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,271 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty reserve</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,195 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,989 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,142)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,042 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,384 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,190 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,361)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,213 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty reserve</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,404 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,009 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,218)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,195 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,960 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,262 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,838)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,384 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty reserve</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,391 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,949 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,936)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,404 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 6213000 181000 1123000 5271000 969000 0 35000 934000 5195000 3989000 3142000 6042000 7384000 1190000 2361000 6213000 606000 363000 0 969000 6404000 2009000 3218000 5195000 6960000 4262000 3838000 7384000 637000 0 31000 606000 9391000 3949000 6936000 6404000 75595000 82082000 111760000 93133000 67745000 75650000 22191000 20837000 277291000 271702000 21783000 24516000 9288000 11669000 65513000 92741000 148657000 151299000 23161000 27563000 18595000 20904000 564288000 600394000 36405000 23429000 0 50000000 4964000 6779000 48135000 44236000 25097000 21308000 114601000 145752000 17237000 18451000 0 5840000 6567000 8959000 1133000 10298000 139538000 189300000 353737000 342828000 0 0 84486000 71309000 -13473000 -3043000 424750000 411094000 564288000 600394000 473438000 415684000 495175000 193015000 185912000 196551000 6743000 13241000 6916000 273680000 216531000 291708000 116014000 107282000 129109000 56306000 61296000 58733000 52753000 49113000 59649000 17129000 15224000 15144000 7699000 3809000 44739000 249901000 236724000 307374000 23779000 -20193000 -15666000 -4424000 -1872000 -5591000 19355000 -22065000 -21257000 6178000 -5452000 -5586000 13177000 -16613000 -15671000 0.39 -0.49 -0.47 0.39 -0.49 -0.47 33670000 33562000 33696000 33974000 33562000 33696000 13177000 -16613000 -15671000 -10640000 13205000 -1576000 119000 27000 -180000 -91000 0 0 0 0 1332000 0 0 -24845000 -10430000 13232000 21757000 2747000 -3381000 6086000 33804379 334215000 102261000 -38032000 398444000 1332000 -1332000 0 42130 0 175833 0 53839 1354000 1354000 8315000 8315000 51784 1689000 1689000 124303 2281000 2281000 23089000 23089000 -15671000 -15671000 34148700 344476000 87922000 -16275000 416123000 14033 0 204057 0 73347 1314000 1314000 9527000 9527000 465117 10495000 10495000 63317 1994000 1994000 13232000 13232000 -16613000 -16613000 33911703 342828000 71309000 -3043000 411094000 205082 0 252064 0 28158 611000 611000 0 14161000 14161000 183112 4107000 4107000 11787 244000 244000 -10430000 -10430000 13177000 13177000 34225682 353737000 84486000 -13473000 424750000 13177000 -16613000 -15671000 181000 1190000 4262000 28091000 28115000 30722000 -3000 -1881000 0 -602000 -133000 0 1426000 -268000 -449000 2004000 6678000 0 279000 0 0 0 0 24571000 3989000 2009000 2886000 14161000 9566000 8352000 0 1353000 0 4386000 1577000 5364000 13111000 -17651000 -7139000 -4830000 -1939000 -7185000 1880000 1055000 2486000 13530000 -4523000 -1367000 -507000 -13427000 -4010000 4458000 838000 3392000 63995000 34426000 60060000 0 1997000 0 3620000 8609000 5326000 0 0 13000 2674000 0 0 1000000 2000000 0 -1946000 -12606000 -5339000 855000 1314000 3635000 410000 527000 478000 0 10495000 0 4107000 1994000 1689000 0 60000000 0 0 1175000 0 57000000 58000000 50000000 -60662000 -10877000 -48532000 -7874000 7842000 735000 -6487000 18785000 6924000 82082000 63297000 56373000 75595000 82082000 63297000 1180000 3110000 4580000 3782000 6825000 6445000 56000 -51000 69000 1167000 1303000 300000 13000 4107000 0 ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Organization</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Natus Medical Incorporated (“we”, “our”, “us”) was incorporated in California in May 1987 and reincorporated in Delaware in August 2000. We are a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, software systems for managing and tracking disorders and diseases for public health laboratories, computer-based audiological, otoneurologic and vestibular instrumentation for hearing and balance care professionals. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Consolidated Financial Statements includes our accounts and accounts of our wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Certain reclassifications to the prior periods have been made to conform to the current period presentation. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the Consolidated Financial Statements and the reported amount of revenue and expenses during the reporting period. Such estimates include allowances for potentially uncollectible accounts receivable, valuation of inventory, intangible assets, goodwill, share-based compensation, valuation of deferred income taxes, reserves for warranty obligations, and the provision for income taxes including uncertain positions. Actual results could differ from those estimates.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when obligations under the terms of a contract with a customer are satisfied; generally this occurs with the transfer of control of devices, supplies, or services. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the majority of devices and supplies, we transfer control and recognize revenue when products ship from the warehouse to the customer. We generally do not provide rights of return on devices and supplies. Freight charges billed to customers are included in revenue and freight-related expenses are charged to cost of revenue. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer the recognition of a portion of the consideration received because we have to satisfy a future obligation (e.g. installation). Judgment is required to determine the standalone selling price for each distinct performance obligation. Our estimate of SSP is a point estimate.  The estimate is calculated annually for each performance obligation that is not sold separately. In instances where SSP is not directly observable, such as when we do not sell the product or service separately, the SSP is determined using information that may include market conditions and other observable inputs. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell separately-priced service contracts that extend maintenance coverages for both medical devices and data management systems beyond the base agreements to customers. The separately priced service contracts range from 12 months to 60 months. We receive payment at the inception of the contract and recognize revenue ratably over the service period. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For products containing embedded software, we have determined that the hardware and software components function together to deliver the products' essential functionality and are considered a combined performance obligation. Revenue recognition policies for sales of these products are substantially the same as for other tangible products. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory Valuation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are carried at the lower of cost or net realizable value, with cost being determined using the first-in, first-out method. The carrying value of our inventory is reduced for any difference between cost and estimated net realizable value of the inventory. We determine net realizable value by evaluating ending inventories for excess quantities, obsolescence, and other factors that could impact our ability to consume inventory for its intended use. Our evaluation includes an analysis of historical sales by product, projections of future demand by product, and an analysis of obsolescence by product. Adjustments to the </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">value of inventory establish a new cost basis and are considered permanent even if circumstances later suggest that increased carrying amounts are recoverable. If demand is higher than expected, we may sell inventory that had previously been written down.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible assets</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We amortize intangible assets with finite lives over the estimate of their useful lives. Any future changes that would limit their useful lives or any determination that these assets are carried at amounts greater than their estimated fair value could result in acceleration of amortization over a revised useful life.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review intangible assets with indefinite lives for impairment on an annual basis and finite lives for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Recoverability of the finite-lived intangible assets is assessed based on the estimated undiscounted future cash flows expected to result from the use and eventual disposition of the asset. If the undiscounted future cash flows are less than the carrying amount, the finite-lived intangible assets are considered to be impaired. The amount of the impairment loss, if any, is measured as the difference between the carrying amount of the asset and its fair value. We estimate the fair value of finite-lived intangible assets by using an income approach or, when available and appropriate, using a market approach. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is not amortized but is subject to an annual impairment analysis, which is performed as of October 1st; this assessment is also performed whenever there is a change in circumstances that indicates the carrying value of goodwill may be impaired. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is tested for impairment at the reporting unit level. Our three strategic business units, Neuro, Newborn Care and Hearing &amp; Balance are consolidated into one unit. We have concluded that we have one operating segment and one reporting unit for purposes of goodwill impairment testing in 2021, 2020, and 2019.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with accounting standards we perform a qualitative assessment to test goodwill for impairment prior to the performing the first step of the goodwill impairment process. Qualitative factors considered in this assessment include industry and market considerations, overall financial performance and other relevant events and factors affecting the reporting unit. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the qualitative assessment in 2021, 2020, and 2019, we determined the fair value of goodwill was more likely than not greater than its carrying amount, and no further analysis was needed.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lessee Leases</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at inception of the lease. Right-of-use (“ROU”) assets represent the right to use an underlying asset for the lease term, and lease liabilities represent an obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit borrowing rate, generally we use an incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at the lease commencement date. We use the implicit rate when readily determinable. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include options to exclude or terminate the lease when it is reasonably certain that they will exercise that option. Lease expense for lease payments are recognized on a straight-line basis over the lease term.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases are included in operating lease ROU assets, accrued liabilities, and operating lease liabilities in our consolidated balance sheet. Finance leases are included in property and equipment, accrued liabilities, and other liabilities in the consolidated balance sheet.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have lease agreements with lease and non-lease components, which are generally accounted for based on the type of asset. For real estate and telecom leases, we account for these components separately. For equipment leases, such as office equipment and vehicles, we account for the lease and non-lease components as a single lease component.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lessor Leases</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at inception of the lease. We entered into a five-year non-cancelable exclusive supply agreement with a customer to provide hearing screening products which commenced on January 1, 2020. The agreement includes automatic renewal options for successive three-year periods. Notice of non-renewal must be provided to Natus at least twelve months prior to the end of the current term. The agreement does not contain any purchase options or residual value guarantees.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pricing of the exclusive supply agreement is structured on a fee per baby screened basis. The per baby fee is inclusive of all products and services to be provided under the terms of the agreement which include hearing screening hardware, consumables required to complete each screen, and related maintenance. The pricing structure also includes a guaranteed minimum payment per unit per contract year for each unit of equipment supplied. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales-Type Leases</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The guaranteed minimum payment for each unit of equipment supplied represents the fixed transaction price and is allocated to separate performance obligations, consisting of hardware products, consumables, and maintenance, proportionally based on the standalone selling price of each performance obligation. Standalone selling price is best evidenced by the price we charge for the good or service when selling it separately in similar circumstances to similar customers. Other than for the renewal of annual support services contracts, our products and services are not generally sold separately. We use an amount discounted from the list price as a best estimated selling price.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For sales-type leases, we recognize revenues for hearing screening hardware products at the net present value of their guaranteed minimum payment standalone selling price allocation upon delivery of the hardware. We recognize consumables and maintenance revenues associated with the sales-type leases over the term of the agreement on a weighted average as actual screens are performed. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the exclusive supply agreement, hospitals where we were previously providing hearing screening services were provided the option to transition to the exclusive supply agreement. Hospitals which chose to transition continued to use their existing Natus hardware. Based on the remaining useful life of the existing hardware and the date new hardware is supplied after the commencement of the lease, some of these leases were classified as operating leases.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For operating leases, rental income is recognized on a straight-line basis over the term of the associated lease. Leased assets classified as operating leases are carried at amortized cost net of accumulated depreciation in property and equipment, net on the condensed consolidated balance sheet. The depreciation expense of the leased assets is recognized on a straight-line basis over the useful life of the asset, and recorded in cost of revenue in the condensed consolidated statements of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long lived assets</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continually monitor events and changes in circumstances that could indicate that carrying amounts of our long-lived assets, including property and equipment, intangible assets and leases, may not be recoverable. When such events or changes in circumstances occur, we will assess the recoverability by determining whether the carrying value of an asset group will be recovered through undiscounted expected future cash flows. If the future undiscounted cash flows are less than the carrying amount of the asset group, we will recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liability for product warranties</span></div><div style="margin-top:5pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide a warranty for products that is generally one year in length. In some cases, regulations may require us to provide repair or remediation beyond the typical warranty period. If any products contain defects, we may be required to incur additional repair and remediation costs. Service, repair and calibration services are provided by a combination of our owned facilities and vendors on a contract basis. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue estimated product warranty costs at the time of sale based on historical experience. A warranty reserve is included in accrued liabilities for the expected future costs of servicing products. Additions to the reserve are based on management’s best estimate of probable liability. We consider a combination of factors including material and labor costs, regulatory requirements, and other judgments in determining the amount of the reserve. The reserve is reduced as costs are incurred to honor existing warranty and regulatory obligations.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-based compensation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize share-based compensation expense associated with employee stock options under the single-option straight line method over the requisite service period, which is generally a four-year vesting period and ten-year contractual term pursuant to ASC Topic 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation-Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. See Note 15 of the Consolidated Financial Statements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For employee stock options, the value of each option is estimated on the date of grant using the Black-Scholes option pricing model, which was developed for use in estimating the value of freely traded options. Similar to other option pricing models, the Black-Scholes method requires the input of highly subjective assumptions, including stock price volatility. Changes in the subjective input assumptions can materially affect the estimated fair value of the employee stock options.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize share-based compensation associated with Restricted Stock Awards (“RSA”) and Restricted Stock Units (“RSU”). RSAs and RSUs vest ratably over a three-year period for employees. RSAs and RSUs for executives vest over a four-year period; 25% on each of the annual anniversaries. RSAs and RSUs for non-employees (Board of Directors) vest over a one-year period; 100% on the first anniversary. The value is estimated based on the market value of Natus common stock on the date of issuance pursuant to ASC Topic 718, Compensation-Stock Compensation.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant market stock unit (“MSU”) awards to certain employees. We estimate the fair value of MSUs at the date of grant using a Monte Carlo simulation model and amortize those fair values over the requisite service period, which is generally three years. The Monte Carlo simulation model that we use to estimate the fair value of market-based MSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the market-based MSUs, which is determined at the date of grant, must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the achievement of the specified market criteria. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also grant performance stock unit (“PSU”) awards to our CEO and CFO. These PSUs fully vest after a performance period and have separate performance goals than MSUs. We estimate fair value of performance stock unit awards based on the share price and other pertinent factors on the grant date. Compensation expense for performance stock unit awards are recognized on a straight-line basis over the requisite service period of the award when performance condition is probable to occur. We assess the achievement probability of the performance conditions each period and adjust compensation expense if necessary. Provided that the requisite service is rendered, the shares will become vested and payout will occur based on the outcome of the performance condition. Any unrecognized compensation cost shall be recognized when the award becomes vested. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issue new shares of common stock upon the exercise of stock options and the vesting of RSAs, RSUs, MSUs, and PSUs.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeitures of employee stock options and awards are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. Share-based compensation expense is recorded net of estimated forfeitures, such that expense is recorded only for those share-based awards that are expected to vest.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All highly liquid investments purchased with an original maturity or remaining maturity upon purchase of three months or less are classified as cash equivalents. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allowance for Doubtful Accounts</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the allowance for potentially uncollectible accounts receivable based on historical collection experience within the markets in which we operate and other customer-specific information, such as bankruptcy filings or customer liquidity problems. When all internal efforts have been exhausted to collect the receivable, it is written off and relieved from the reserve.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments include cash and cash equivalents, accounts receivable, and accounts payable. Cash is reported at its fair value on the balance sheet dates. The recorded carrying amounts of accounts receivable and accounts payable approximate their fair values due to the short-term maturities.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost less accumulated depreciation. Depreciation expense is computed using the straight-line method over estimated useful lives of the respective assets, which are <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xMjQvZnJhZzpiZGQxNjg2YmJjMTA0N2Q0OWEyNGFlODRhZTg1ODdmOS90ZXh0cmVnaW9uOmJkZDE2ODZiYmMxMDQ3ZDQ5YTI0YWU4NGFlODU4N2Y5XzIxMzk2_2b6c1ed8-6ff7-40e5-9158-c59493d297f0">three</span> to five years for office furniture and equipment, computer software and hardware, demonstration and loaned equipment, and 30 to 40 years for buildings. Leasehold improvements are amortized over the shorter of the lease term or the estimated useful life of the improvement. Land is not depreciated. Costs associated with acquiring and installing software to be used for internal purposes are capitalized and amortized on a straight-line basis over three years. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research &amp; Development Costs</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred in research and development are charged to operations as incurred. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statements carrying value of assets and liabilities and the tax basis of those assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record net deferred tax assets to the extent it is more likely than not that the assets will be realized. In making such determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations. To the extent that previously reserved deferred tax assets are estimated to be realizable, we adjust the valuation allowance which reduces the provision for income taxes.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the tax benefit of uncertain tax positions in the financial statements as defined in ASC Topic 740, Income Tax. When the tax position is deemed more likely than not of being sustained, we recognize the largest amount of tax benefit that is greater than 50 percent likely of being ultimately realized upon settlement, as defined in ASC 740-10-05. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The functional currency of our subsidiaries outside of North America is generally the local currency of the country where the subsidiary is located. Accordingly, foreign currency translation adjustments relating to the translation of foreign subsidiary financial statements are included </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a component of accumulated other comprehensive loss. We have recorded $(10.6) million, $13.2 million, and $(1.6) million of foreign cur</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rency translation gains (losses) for the years ended December 31, 2021, 2020 and 2019, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and losses from transactions denominated in currencies other than the functional currencies are included in other income and expense. In 2021, 2020, and 2019, net foreign currency transaction gains (losse</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s) were $(2.0) million, $2.0 million, and $(0.8) million, r</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">espectively. Foreign currency gains and losses result primarily from fluctuations in the exchange rate between the U.S. dollar, Canadian dollar, Euro, British pound, and Danish kroner.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We divested our wholly owned subsidiary, Medix, on April 2, 2019 via a stock sale. Included in the year ended December 31, 2019 is the impact of the sale of Medix, which was completed as of June 30, 2019, and the deferred foreign currency related translation adjustments previously in accumulated other comprehensive income have been released from the balance sheet along with the held for sale accrual (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Note 22 - Sale of a Certain Subsidiary).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive Income</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We break out the major components and report as a single total the change in net assets during the period as defined in ASC Topic 220, Comprehensive Income. The consolidated statement of comprehensive income (loss) has been separately stated from the consolidated statements of operations. Accumulated other comprehensive loss consists of translation gains and losses on foreign subsidiary financial statements, interest rate swap designated as a cash flow hedge, reclassifications from the adoption of ASU 2018-02, and reclassification of previously recorded deferred foreign currency related translation adjustment losses upon the divestiture of Medix.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basic and Diluted Net Income per Share</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compute net income per share as defined in ASC Topic 260, Earnings per Share. Basic net income per share is based upon the weighted average number of common shares outstanding during the period. Diluted net income per share is based upon the weighted average number of common shares outstanding and dilutive common stock equivalents outstanding during the period. Common stock equivalents are options granted, shares of restricted stock, and shares of market stock issued under the stock awards plans and are calculated under the treasury stock method. Common equivalent shares from unexercised stock options and restricted stock are excluded from the computation when there is a loss as the effect is anti-dilutive, or if the exercise price of such options is greater than the average market price of the stock for the period.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740), Simplifying the Accounting for Income Tax. This update includes removal of certain exceptions to the general principles of ASC 740, Income taxes, and simplification in several other areas such as accounting for franchise tax (or similar tax) that is partially based on income. We early adopted the ASU in the second quarter of 2020. Upon adoption, we recorded an additional income tax benefit of $0.9 million due to the elimination of the year-to-date loss limitation rules that limited the interim tax period tax benefit. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU 2020-10, Codification Improvements. This update improves consistency by amending the Codification to include all disclosure guidance in appropriate disclosure sections. Also, the update clarifies application of various provisions in the Codification by amending and adding new headings, cross-referencing to other guidance, and refining or correcting terminology. ASU 2020-10 was effective for annual period starting December 15, 2020. The adoption of this ASU did not have an impact on our consolidated financial statements. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In July 2021, the FASB issued ASU 2021-05, Leases (Topic 842): Lessors-Certain Leases with Variable Lease Payments. This update addresses stakeholders' concerns by amending the lease classification requirements for lessors to align them with practice under Topic 840. Lessors should classify and account for a lease with variable lease payments that do not depend on a reference index or a rate as an operating lease if the lease would have been classified as a sales-type lease or a direct financing lease in accordance with 842-10-25-2 through 25-3 and the lessors would have otherwise recognized a day-one loss. ASU 2021-05 is effective for fiscal years beginning after December 15, 2021. We have early adopted the ASU on a prospective basis in the third quarter of the current fiscal year. The adoption of ASU 2021-05 did not have an impact on our consolidated financial statements.</span></div> Basis of Presentation and Principles of ConsolidationThe accompanying Consolidated Financial Statements includes our accounts and accounts of our wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Certain reclassifications to the prior periods have been made to conform to the current period presentation. <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the Consolidated Financial Statements and the reported amount of revenue and expenses during the reporting period. Such estimates include allowances for potentially uncollectible accounts receivable, valuation of inventory, intangible assets, goodwill, share-based compensation, valuation of deferred income taxes, reserves for warranty obligations, and the provision for income taxes including uncertain positions. Actual results could differ from those estimates.</span></div> <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when obligations under the terms of a contract with a customer are satisfied; generally this occurs with the transfer of control of devices, supplies, or services. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the majority of devices and supplies, we transfer control and recognize revenue when products ship from the warehouse to the customer. We generally do not provide rights of return on devices and supplies. Freight charges billed to customers are included in revenue and freight-related expenses are charged to cost of revenue. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer the recognition of a portion of the consideration received because we have to satisfy a future obligation (e.g. installation). Judgment is required to determine the standalone selling price for each distinct performance obligation. Our estimate of SSP is a point estimate.  The estimate is calculated annually for each performance obligation that is not sold separately. In instances where SSP is not directly observable, such as when we do not sell the product or service separately, the SSP is determined using information that may include market conditions and other observable inputs. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell separately-priced service contracts that extend maintenance coverages for both medical devices and data management systems beyond the base agreements to customers. The separately priced service contracts range from 12 months to 60 months. We receive payment at the inception of the contract and recognize revenue ratably over the service period. </span></div>For products containing embedded software, we have determined that the hardware and software components function together to deliver the products' essential functionality and are considered a combined performance obligation. Revenue recognition policies for sales of these products are substantially the same as for other tangible products. P12M P60M <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory Valuation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are carried at the lower of cost or net realizable value, with cost being determined using the first-in, first-out method. The carrying value of our inventory is reduced for any difference between cost and estimated net realizable value of the inventory. We determine net realizable value by evaluating ending inventories for excess quantities, obsolescence, and other factors that could impact our ability to consume inventory for its intended use. Our evaluation includes an analysis of historical sales by product, projections of future demand by product, and an analysis of obsolescence by product. Adjustments to the </span></div>value of inventory establish a new cost basis and are considered permanent even if circumstances later suggest that increased carrying amounts are recoverable. If demand is higher than expected, we may sell inventory that had previously been written down. <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible assets</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We amortize intangible assets with finite lives over the estimate of their useful lives. Any future changes that would limit their useful lives or any determination that these assets are carried at amounts greater than their estimated fair value could result in acceleration of amortization over a revised useful life.</span></div>We review intangible assets with indefinite lives for impairment on an annual basis and finite lives for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Recoverability of the finite-lived intangible assets is assessed based on the estimated undiscounted future cash flows expected to result from the use and eventual disposition of the asset. If the undiscounted future cash flows are less than the carrying amount, the finite-lived intangible assets are considered to be impaired. The amount of the impairment loss, if any, is measured as the difference between the carrying amount of the asset and its fair value. We estimate the fair value of finite-lived intangible assets by using an income approach or, when available and appropriate, using a market approach. <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is not amortized but is subject to an annual impairment analysis, which is performed as of October 1st; this assessment is also performed whenever there is a change in circumstances that indicates the carrying value of goodwill may be impaired. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is tested for impairment at the reporting unit level. Our three strategic business units, Neuro, Newborn Care and Hearing &amp; Balance are consolidated into one unit. We have concluded that we have one operating segment and one reporting unit for purposes of goodwill impairment testing in 2021, 2020, and 2019.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with accounting standards we perform a qualitative assessment to test goodwill for impairment prior to the performing the first step of the goodwill impairment process. Qualitative factors considered in this assessment include industry and market considerations, overall financial performance and other relevant events and factors affecting the reporting unit. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the qualitative assessment in 2021, 2020, and 2019, we determined the fair value of goodwill was more likely than not greater than its carrying amount, and no further analysis was needed.</span></div> 3 1 1 1 1 1 1 <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lessee Leases</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at inception of the lease. Right-of-use (“ROU”) assets represent the right to use an underlying asset for the lease term, and lease liabilities represent an obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit borrowing rate, generally we use an incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at the lease commencement date. We use the implicit rate when readily determinable. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include options to exclude or terminate the lease when it is reasonably certain that they will exercise that option. Lease expense for lease payments are recognized on a straight-line basis over the lease term.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases are included in operating lease ROU assets, accrued liabilities, and operating lease liabilities in our consolidated balance sheet. Finance leases are included in property and equipment, accrued liabilities, and other liabilities in the consolidated balance sheet.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have lease agreements with lease and non-lease components, which are generally accounted for based on the type of asset. For real estate and telecom leases, we account for these components separately. For equipment leases, such as office equipment and vehicles, we account for the lease and non-lease components as a single lease component.</span></div> <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lessor Leases</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at inception of the lease. We entered into a five-year non-cancelable exclusive supply agreement with a customer to provide hearing screening products which commenced on January 1, 2020. The agreement includes automatic renewal options for successive three-year periods. Notice of non-renewal must be provided to Natus at least twelve months prior to the end of the current term. The agreement does not contain any purchase options or residual value guarantees.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pricing of the exclusive supply agreement is structured on a fee per baby screened basis. The per baby fee is inclusive of all products and services to be provided under the terms of the agreement which include hearing screening hardware, consumables required to complete each screen, and related maintenance. The pricing structure also includes a guaranteed minimum payment per unit per contract year for each unit of equipment supplied. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales-Type Leases</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The guaranteed minimum payment for each unit of equipment supplied represents the fixed transaction price and is allocated to separate performance obligations, consisting of hardware products, consumables, and maintenance, proportionally based on the standalone selling price of each performance obligation. Standalone selling price is best evidenced by the price we charge for the good or service when selling it separately in similar circumstances to similar customers. Other than for the renewal of annual support services contracts, our products and services are not generally sold separately. We use an amount discounted from the list price as a best estimated selling price.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For sales-type leases, we recognize revenues for hearing screening hardware products at the net present value of their guaranteed minimum payment standalone selling price allocation upon delivery of the hardware. We recognize consumables and maintenance revenues associated with the sales-type leases over the term of the agreement on a weighted average as actual screens are performed. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the exclusive supply agreement, hospitals where we were previously providing hearing screening services were provided the option to transition to the exclusive supply agreement. Hospitals which chose to transition continued to use their existing Natus hardware. Based on the remaining useful life of the existing hardware and the date new hardware is supplied after the commencement of the lease, some of these leases were classified as operating leases.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For operating leases, rental income is recognized on a straight-line basis over the term of the associated lease. Leased assets classified as operating leases are carried at amortized cost net of accumulated depreciation in property and equipment, net on the condensed consolidated balance sheet. The depreciation expense of the leased assets is recognized on a straight-line basis over the useful life of the asset, and recorded in cost of revenue in the condensed consolidated statements of operations.</span></div> P5Y P3Y P12M <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long lived assets</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continually monitor events and changes in circumstances that could indicate that carrying amounts of our long-lived assets, including property and equipment, intangible assets and leases, may not be recoverable. When such events or changes in circumstances occur, we will assess the recoverability by determining whether the carrying value of an asset group will be recovered through undiscounted expected future cash flows. If the future undiscounted cash flows are less than the carrying amount of the asset group, we will recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets.</span></div> <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liability for product warranties</span></div><div style="margin-top:5pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide a warranty for products that is generally one year in length. In some cases, regulations may require us to provide repair or remediation beyond the typical warranty period. If any products contain defects, we may be required to incur additional repair and remediation costs. Service, repair and calibration services are provided by a combination of our owned facilities and vendors on a contract basis. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue estimated product warranty costs at the time of sale based on historical experience. A warranty reserve is included in accrued liabilities for the expected future costs of servicing products. Additions to the reserve are based on management’s best estimate of probable liability. We consider a combination of factors including material and labor costs, regulatory requirements, and other judgments in determining the amount of the reserve. The reserve is reduced as costs are incurred to honor existing warranty and regulatory obligations.</span></div> P1Y <div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-based compensation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize share-based compensation expense associated with employee stock options under the single-option straight line method over the requisite service period, which is generally a four-year vesting period and ten-year contractual term pursuant to ASC Topic 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation-Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. See Note 15 of the Consolidated Financial Statements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For employee stock options, the value of each option is estimated on the date of grant using the Black-Scholes option pricing model, which was developed for use in estimating the value of freely traded options. Similar to other option pricing models, the Black-Scholes method requires the input of highly subjective assumptions, including stock price volatility. Changes in the subjective input assumptions can materially affect the estimated fair value of the employee stock options.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize share-based compensation associated with Restricted Stock Awards (“RSA”) and Restricted Stock Units (“RSU”). RSAs and RSUs vest ratably over a three-year period for employees. RSAs and RSUs for executives vest over a four-year period; 25% on each of the annual anniversaries. RSAs and RSUs for non-employees (Board of Directors) vest over a one-year period; 100% on the first anniversary. The value is estimated based on the market value of Natus common stock on the date of issuance pursuant to ASC Topic 718, Compensation-Stock Compensation.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant market stock unit (“MSU”) awards to certain employees. We estimate the fair value of MSUs at the date of grant using a Monte Carlo simulation model and amortize those fair values over the requisite service period, which is generally three years. The Monte Carlo simulation model that we use to estimate the fair value of market-based MSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the market-based MSUs, which is determined at the date of grant, must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the achievement of the specified market criteria. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also grant performance stock unit (“PSU”) awards to our CEO and CFO. These PSUs fully vest after a performance period and have separate performance goals than MSUs. We estimate fair value of performance stock unit awards based on the share price and other pertinent factors on the grant date. Compensation expense for performance stock unit awards are recognized on a straight-line basis over the requisite service period of the award when performance condition is probable to occur. We assess the achievement probability of the performance conditions each period and adjust compensation expense if necessary. Provided that the requisite service is rendered, the shares will become vested and payout will occur based on the outcome of the performance condition. Any unrecognized compensation cost shall be recognized when the award becomes vested. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issue new shares of common stock upon the exercise of stock options and the vesting of RSAs, RSUs, MSUs, and PSUs.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeitures of employee stock options and awards are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. Share-based compensation expense is recorded net of estimated forfeitures, such that expense is recorded only for those share-based awards that are expected to vest.</span></div> P4Y P10Y P3Y P4Y 0.25 P1Y 1 P3Y Cash EquivalentsAll highly liquid investments purchased with an original maturity or remaining maturity upon purchase of three months or less are classified as cash equivalents. Cash EquivalentsAll highly liquid investments purchased with an original maturity or remaining maturity upon purchase of three months or less are classified as cash equivalents. <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allowance for Doubtful Accounts</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the allowance for potentially uncollectible accounts receivable based on historical collection experience within the markets in which we operate and other customer-specific information, such as bankruptcy filings or customer liquidity problems. When all internal efforts have been exhausted to collect the receivable, it is written off and relieved from the reserve.</span></div> <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments include cash and cash equivalents, accounts receivable, and accounts payable. Cash is reported at its fair value on the balance sheet dates. The recorded carrying amounts of accounts receivable and accounts payable approximate their fair values due to the short-term maturities.</span></div> Property and EquipmentProperty and equipment are stated at cost less accumulated depreciation. Depreciation expense is computed using the straight-line method over estimated useful lives of the respective assets, which are <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xMjQvZnJhZzpiZGQxNjg2YmJjMTA0N2Q0OWEyNGFlODRhZTg1ODdmOS90ZXh0cmVnaW9uOmJkZDE2ODZiYmMxMDQ3ZDQ5YTI0YWU4NGFlODU4N2Y5XzIxMzk2_2b6c1ed8-6ff7-40e5-9158-c59493d297f0">three</span> to five years for office furniture and equipment, computer software and hardware, demonstration and loaned equipment, and 30 to 40 years for buildings. Leasehold improvements are amortized over the shorter of the lease term or the estimated useful life of the improvement. Land is not depreciated. Costs associated with acquiring and installing software to be used for internal purposes are capitalized and amortized on a straight-line basis over three years. P5Y P30Y P40Y P3Y Research &amp; Development CostsCosts incurred in research and development are charged to operations as incurred. <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statements carrying value of assets and liabilities and the tax basis of those assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record net deferred tax assets to the extent it is more likely than not that the assets will be realized. In making such determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations. To the extent that previously reserved deferred tax assets are estimated to be realizable, we adjust the valuation allowance which reduces the provision for income taxes.</span></div>We recognize the tax benefit of uncertain tax positions in the financial statements as defined in ASC Topic 740, Income Tax. When the tax position is deemed more likely than not of being sustained, we recognize the largest amount of tax benefit that is greater than 50 percent likely of being ultimately realized upon settlement, as defined in ASC 740-10-05. <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The functional currency of our subsidiaries outside of North America is generally the local currency of the country where the subsidiary is located. Accordingly, foreign currency translation adjustments relating to the translation of foreign subsidiary financial statements are included </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a component of accumulated other comprehensive loss. We have recorded $(10.6) million, $13.2 million, and $(1.6) million of foreign cur</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rency translation gains (losses) for the years ended December 31, 2021, 2020 and 2019, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and losses from transactions denominated in currencies other than the functional currencies are included in other income and expense. In 2021, 2020, and 2019, net foreign currency transaction gains (losse</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s) were $(2.0) million, $2.0 million, and $(0.8) million, r</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">espectively. Foreign currency gains and losses result primarily from fluctuations in the exchange rate between the U.S. dollar, Canadian dollar, Euro, British pound, and Danish kroner.</span></div> -10600000 13200000 -1600000 -2000000.0 2000000.0 -800000 <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive Income</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We break out the major components and report as a single total the change in net assets during the period as defined in ASC Topic 220, Comprehensive Income. The consolidated statement of comprehensive income (loss) has been separately stated from the consolidated statements of operations. Accumulated other comprehensive loss consists of translation gains and losses on foreign subsidiary financial statements, interest rate swap designated as a cash flow hedge, reclassifications from the adoption of ASU 2018-02, and reclassification of previously recorded deferred foreign currency related translation adjustment losses upon the divestiture of Medix.</span></div> <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basic and Diluted Net Income per Share</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compute net income per share as defined in ASC Topic 260, Earnings per Share. Basic net income per share is based upon the weighted average number of common shares outstanding during the period. Diluted net income per share is based upon the weighted average number of common shares outstanding and dilutive common stock equivalents outstanding during the period. Common stock equivalents are options granted, shares of restricted stock, and shares of market stock issued under the stock awards plans and are calculated under the treasury stock method. Common equivalent shares from unexercised stock options and restricted stock are excluded from the computation when there is a loss as the effect is anti-dilutive, or if the exercise price of such options is greater than the average market price of the stock for the period.</span></div> <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740), Simplifying the Accounting for Income Tax. This update includes removal of certain exceptions to the general principles of ASC 740, Income taxes, and simplification in several other areas such as accounting for franchise tax (or similar tax) that is partially based on income. We early adopted the ASU in the second quarter of 2020. Upon adoption, we recorded an additional income tax benefit of $0.9 million due to the elimination of the year-to-date loss limitation rules that limited the interim tax period tax benefit. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU 2020-10, Codification Improvements. This update improves consistency by amending the Codification to include all disclosure guidance in appropriate disclosure sections. Also, the update clarifies application of various provisions in the Codification by amending and adding new headings, cross-referencing to other guidance, and refining or correcting terminology. ASU 2020-10 was effective for annual period starting December 15, 2020. The adoption of this ASU did not have an impact on our consolidated financial statements. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In July 2021, the FASB issued ASU 2021-05, Leases (Topic 842): Lessors-Certain Leases with Variable Lease Payments. This update addresses stakeholders' concerns by amending the lease classification requirements for lessors to align them with practice under Topic 840. Lessors should classify and account for a lease with variable lease payments that do not depend on a reference index or a rate as an operating lease if the lease would have been classified as a sales-type lease or a direct financing lease in accordance with 842-10-25-2 through 25-3 and the lessors would have otherwise recognized a day-one loss. ASU 2021-05 is effective for fiscal years beginning after December 15, 2021. We have early adopted the ASU on a prospective basis in the third quarter of the current fiscal year. The adoption of ASU 2021-05 did not have an impact on our consolidated financial statements.</span></div> -900000 REVENUE<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets for the periods presented primarily represent the difference between revenue recognized based on the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Deferred revenue for the periods presented was primarily related to extended service contracts, installation, and training, for which the service fees are billed up-front. The associated deferred revenue is generally recognized ratably over the extended service period or when installation and training are complete.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarized the changes in the contract assets and contract liability balances for the year ended December 31, 2021 (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.526%"><tr><td style="width:1.0%"/><td style="width:69.189%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.611%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled AR, December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,925 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transferred to Trade Receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled AR, December 31, 2021</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">252 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.526%"><tr><td style="width:1.0%"/><td style="width:69.189%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.611%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred Revenue, December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,723 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,053 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue Recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,679)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred Revenue, December 31, 2021</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,097 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, the contract assets o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f $0.3 million were inc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">luded in accounts receivable in the consolidated </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">balance sheet. At December 31, 2021, the short-term portion of the contract liability of $25.1 million an</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d the long-term portion o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f $5.0 million were included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">deferred revenue and other long-term liabilities respectively, in the consolidated balance sheet. As of December 31, 2021, we expect to recognize revenue associated with deferred revenue o</span>f approximately $25.0 million in 2022, $2.7 million in 2023, $1.5 million in 2024, $0.5 million in 2025, and $0.4 million thereafter. <div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarized the changes in the contract assets and contract liability balances for the year ended December 31, 2021 (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.526%"><tr><td style="width:1.0%"/><td style="width:69.189%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.611%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled AR, December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,925 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transferred to Trade Receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled AR, December 31, 2021</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">252 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.526%"><tr><td style="width:1.0%"/><td style="width:69.189%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.611%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred Revenue, December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,723 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,053 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue Recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,679)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred Revenue, December 31, 2021</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,097 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1925000 58000 1731000 252000 25723000 24053000 19679000 30097000 300000 25100000 5000000 25000000 2700000 1500000 500000 400000 ALLOWANCE FOR DOUBTFUL ACCOUNTS<div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the lifetime allowance for doubtful, potentially uncollectible, accounts receivable upon their inception based on historical collection experience within the markets in which we operate, customer-specific information such as bankruptcy filings or customer liquidity problems, current conditions, and reasonable and supportable forecasts about the future.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our allowance for doubtful accounts is presented as a reduction to accounts receivable on our consolidated balance sheet. When all internal efforts have been exhausted to collect the receivable, it is written off and relieved from the reserve. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The details of activity in allowance for doubtful accounts are as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:71.276%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,213 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,384 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,190 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs charged against allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,361)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, end of period</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,271 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,213 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The details of activity in allowance for doubtful accounts are as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:71.276%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,213 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,384 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,190 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs charged against allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,361)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, end of period</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,271 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,213 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 6213000 7384000 181000 1190000 1123000 2361000 5271000 6213000 INVENTORIES<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:71.276%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and subassemblies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,750 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,583 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,825 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,294 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,836 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,695 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Inventories</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,411 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,572 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Non-current Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,666)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,922)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,745 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,650 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>Non-current inventory consists of service components used to repair products held by customers pursuant to warranty obligations and extended service contracts, including service components for products that we no longer sell, inventory purchased for lifetime buys, inventory built as a last-time build, and inventory that is turning at a slow rate. We believe that these inventories will be utilized for their intended purpose. <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:71.276%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and subassemblies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,750 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,583 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,825 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,294 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,836 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,695 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Inventories</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,411 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,572 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Non-current Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,666)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,922)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,745 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,650 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 20750000 22583000 2825000 2294000 57836000 65695000 81411000 90572000 13666000 14922000 67745000 75650000 PROPERTY AND EQUIPMENT<div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consist of (in thousands):</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:71.276%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,782 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,792 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,238 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,365 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,722 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,050 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xMzkvZnJhZzo0MjdiM2JlMzk1ZjQ0YzFiODg1OTYxMDE0Yzc1ZDczNy90YWJsZTozNjFjM2JhZjFiMzg0YjU0OGIxNWRkYTNjNDNiNTQzYy90YWJsZXJhbmdlOjM2MWMzYmFmMWIzODRiNTQ4YjE1ZGRhM2M0M2I1NDNjXzUtMC0xLTEtODA1NA_83d836ab-5c25-4a15-a864-4692ae8aa2cc"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xMzkvZnJhZzo0MjdiM2JlMzk1ZjQ0YzFiODg1OTYxMDE0Yzc1ZDczNy90YWJsZTozNjFjM2JhZjFiMzg0YjU0OGIxNWRkYTNjNDNiNTQzYy90YWJsZXJhbmdlOjM2MWMzYmFmMWIzODRiNTQ4YjE1ZGRhM2M0M2I1NDNjXzUtMC0xLTEtODA1NA_d4637462-4c40-4732-ad6d-42e2094ddec9">Finance lease right-of-use assets</span></span></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,356 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,555 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,637 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,148 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software and hardware</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,308 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,246 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Demonstration and loaned equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,050 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,086 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,093 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,242 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,310)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,726)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,783 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,516 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense of property and equipmen</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t was $6.3 million, $6.2 million, and $6.6 million in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the years ending December 31, 2021, 2020 and 2019, respectively.</span></div> <div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consist of (in thousands):</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:71.276%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,782 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,792 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,238 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,365 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,722 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,050 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xMzkvZnJhZzo0MjdiM2JlMzk1ZjQ0YzFiODg1OTYxMDE0Yzc1ZDczNy90YWJsZTozNjFjM2JhZjFiMzg0YjU0OGIxNWRkYTNjNDNiNTQzYy90YWJsZXJhbmdlOjM2MWMzYmFmMWIzODRiNTQ4YjE1ZGRhM2M0M2I1NDNjXzUtMC0xLTEtODA1NA_83d836ab-5c25-4a15-a864-4692ae8aa2cc"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xMzkvZnJhZzo0MjdiM2JlMzk1ZjQ0YzFiODg1OTYxMDE0Yzc1ZDczNy90YWJsZTozNjFjM2JhZjFiMzg0YjU0OGIxNWRkYTNjNDNiNTQzYy90YWJsZXJhbmdlOjM2MWMzYmFmMWIzODRiNTQ4YjE1ZGRhM2M0M2I1NDNjXzUtMC0xLTEtODA1NA_d4637462-4c40-4732-ad6d-42e2094ddec9">Finance lease right-of-use assets</span></span></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,356 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,555 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,637 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,148 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software and hardware</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,308 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,246 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Demonstration and loaned equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,050 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,086 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,093 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,242 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,310)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,726)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,783 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,516 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1782000 1792000 7238000 7365000 7722000 8050000 2356000 2555000 20637000 22148000 11308000 10246000 4050000 3086000 55093000 55242000 33310000 30726000 21783000 24516000 6300000 6200000 6600000 INTANGIBLE ASSETS<div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of gross and net intangible asset balances (in thousands):</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:15.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.726%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Impairment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Book<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Impairment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Book<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99,920 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,039)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(66,679)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27,202 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">112,138 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,480)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(64,203)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35,455 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Customer related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89,794 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(57,133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32,611 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">94,526 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(51,247)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43,229 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">45,593 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,260)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(36,960)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,373 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47,058 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,677)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(31,890)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11,491 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Internally developed software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,281 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,985)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">296 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,281 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,845)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">436 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,705 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,572)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,810 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,677)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service Agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(769)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,190 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total definite-lived intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">252,093 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,482)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(177,098)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65,513 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">271,003 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16,340)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(163,981)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">90,682 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intangible assets with indefinite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intellectual Property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,004 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,004)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,059 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,059 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">254,097 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11,486)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(177,098)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65,513 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">273,062 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16,340)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(163,981)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">92,741 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finite lived intangible assets are amortized over their weighted average lives, which are 14 years for technology, 13 years for patents, 10 years for customer-related intangibles, 7 years for trade names, 6 years for internally developed software, 2 years for service agreements, and 11 years weighted average in total. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internally developed software consists of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $11.1 million relating to costs incurred for development of internal use computer software and $2.2 million for development</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of software to be sold.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2020 we recorded an impairment charge related to intangible assets of $6.7 million of which $6.4 million was recorded within intangibles amortization within cost of revenue and $0.3 million was recorded within intangibles amortization within operating expense on our income statement. T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he impairment related to an end of life decision for an acquired tradename and technology at which time we made the decision to discontinue sales of the related product rather than continuing to invest in the product. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021 we recorded an impairment charge related to intangible assets of $2.0 million which was recorded within intangibles amortization within operating expense on our income statement. The impairment was a management decision to abandon further development of the product using intellectual property.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to intangible assets with finite and indefinite lives, including impairment charges described above, was as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,907 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,417 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,906 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer related</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,040 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,825 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,662 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,881 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,182 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,111 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual Property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,004 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service Agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortization</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,013 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,703 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,499 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortization expense amounts shown above include internally developed software not held for sale of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $0.1 million, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.2 million, and $1.3 million for the years ended 2021, 2020, and 2019, respectively. The amortization expense for internally developed software not held for sale is recorded within our income statement as a general and administrative operating expense. The amount in the table shown above for intellectual property relates to the impairment charge recorded during the fourth quarter of 2021.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected annual amortization expense related to amortizable intangible assets is as follows (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:85.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.326%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,634 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,865 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,970 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,362 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,408 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,274 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expected amortization expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,513 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of gross and net intangible asset balances (in thousands):</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:15.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.726%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Impairment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Book<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Impairment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Book<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99,920 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,039)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(66,679)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27,202 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">112,138 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,480)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(64,203)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35,455 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Customer related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89,794 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(57,133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32,611 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">94,526 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(51,247)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43,229 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">45,593 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,260)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(36,960)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,373 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47,058 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,677)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(31,890)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11,491 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Internally developed software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,281 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,985)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">296 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,281 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,845)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">436 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,705 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,572)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,810 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,677)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service Agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(769)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,190 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total definite-lived intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">252,093 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,482)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(177,098)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65,513 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">271,003 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16,340)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(163,981)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">90,682 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intangible assets with indefinite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intellectual Property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,004 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,004)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,059 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,059 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">254,097 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11,486)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(177,098)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65,513 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">273,062 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16,340)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(163,981)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">92,741 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 99920000 6039000 66679000 27202000 112138000 12480000 64203000 35455000 89794000 50000 57133000 32611000 94526000 50000 51247000 43229000 45593000 3260000 36960000 5373000 47058000 3677000 31890000 11491000 13281000 0 12985000 296000 13281000 0 12845000 436000 2705000 133000 2572000 0 2810000 133000 2677000 0 800000 0 769000 31000 1190000 0 1119000 71000 252093000 9482000 177098000 65513000 271003000 16340000 163981000 90682000 2004000 2004000 0 2059000 0 2059000 254097000 11486000 177098000 65513000 273062000 16340000 163981000 92741000 P14Y P13Y P10Y P7Y P6Y P2Y P11Y 11100000 2200000 6700000 6400000 300000 2000000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to intangible assets with finite and indefinite lives, including impairment charges described above, was as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,907 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,417 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,906 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer related</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,040 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,825 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,662 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,881 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,182 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,111 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual Property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,004 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service Agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortization</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,013 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,703 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,499 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 6907000 13417000 6906000 9040000 8825000 8662000 5881000 6182000 6111000 2004000 0 0 141000 239000 1438000 0 0 60000 40000 40000 322000 24013000 28703000 23499000 100000 200000 1300000 <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected annual amortization expense related to amortizable intangible assets is as follows (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:85.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.326%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,634 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,865 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,970 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,362 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,408 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,274 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expected amortization expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,513 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 17634000 14865000 12970000 12362000 2408000 5274000 65513000 GOODWILL<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of goodwill and the changes in those balances are as follows (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"/><td style="width:85.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.580%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2019</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,367 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Accounting Adjustments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,725 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2020</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,299 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,642)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2021</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,657 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of goodwill and the changes in those balances are as follows (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"/><td style="width:85.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.580%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2019</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,367 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Accounting Adjustments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,725 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2020</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,299 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,642)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2021</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,657 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 146367000 1207000 3725000 151299000 -2642000 148657000 LEASES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lessee Leases</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operating and finance leases for offices, warehouses, and certain equipment. The leases have remaining lease terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xNDgvZnJhZzpiNDFhMjc0NmJkMGM0MGZlYmRiOGZlMWFmMDhhN2VjNC90ZXh0cmVnaW9uOmI0MWEyNzQ2YmQwYzQwZmViZGI4ZmUxYWYwOGE3ZWM0XzE1Nw_12427527-a2f5-404b-b9eb-8c597fcfb0f4">one</span> to eight years, some of which include options to extend the leases for up to ten years. Our leases do not have any residual value guarantees or any restrictions or covenants imposed by leases. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of lease cost were as follows (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.233%"><tr><td style="width:1.0%"/><td style="width:56.018%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.656%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,046 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,696 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets (principal payments)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,958 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,541 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,363 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,627 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:60.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,636 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,979 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,055 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,290 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.678%"><tr><td style="width:1.0%"/><td style="width:53.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.104%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,288 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,669 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities<br/></span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,964 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,779 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,567 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,959 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,531 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,738 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,356 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,555 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,906)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,705)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xNDgvZnJhZzpiNDFhMjc0NmJkMGM0MGZlYmRiOGZlMWFmMDhhN2VjNC90YWJsZTo1NGRmOWE4MWZhMWU0ZjQ2YWY2N2MxM2IyNzQ3YWY4ZS90YWJsZXJhbmdlOjU0ZGY5YTgxZmExZTRmNDZhZjY3YzEzYjI3NDdhZjhlXzEzLTAtMS0xLTgwNTQ_048f6a01-36f3-49fb-9806-f0422121908e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xNDgvZnJhZzpiNDFhMjc0NmJkMGM0MGZlYmRiOGZlMWFmMDhhN2VjNC90YWJsZTo1NGRmOWE4MWZhMWU0ZjQ2YWY2N2MxM2IyNzQ3YWY4ZS90YWJsZXJhbmdlOjU0ZGY5YTgxZmExZTRmNDZhZjY3YzEzYjI3NDdhZjhlXzEzLTAtMS0xLTgwNTQ_cd461ffd-2b29-4015-97af-dc6daa8e20a3">Accrued liabilities</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xNDgvZnJhZzpiNDFhMjc0NmJkMGM0MGZlYmRiOGZlMWFmMDhhN2VjNC90YWJsZTo1NGRmOWE4MWZhMWU0ZjQ2YWY2N2MxM2IyNzQ3YWY4ZS90YWJsZXJhbmdlOjU0ZGY5YTgxZmExZTRmNDZhZjY3YzEzYjI3NDdhZjhlXzE0LTAtMS0xLTgwNTQ_ba1f7c16-e5ab-469d-bcc1-b523e88332f5"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xNDgvZnJhZzpiNDFhMjc0NmJkMGM0MGZlYmRiOGZlMWFmMDhhN2VjNC90YWJsZTo1NGRmOWE4MWZhMWU0ZjQ2YWY2N2MxM2IyNzQ3YWY4ZS90YWJsZXJhbmdlOjU0ZGY5YTgxZmExZTRmNDZhZjY3YzEzYjI3NDdhZjhlXzE0LTAtMS0xLTgwNTQ_dbe855d9-ba5a-45e0-a4c6-564d29edd6ff">Other liabilities</span></span></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.97 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.68 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, future minimum lease payments included in the measurement of lease liabilities on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):</span></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.239%"><tr><td style="width:1.0%"/><td style="width:53.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.224%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.722%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31, </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,440 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,404 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,495 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(964)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,531 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lessor Leases</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pricing of our exclusive hearing screening supply agreement is structured on a fee per baby screened basis and includes a guaranteed minimum payment per unit per contract year for each unit of equipment supplied. We recognize revenues for the hardware products upon commencement of each lease at the net present value of their guaranteed minimum payment standalone selling price allocation. The remaining variable fees are recognized as revenue over the remaining lease term. The following table provides the profit recognized for sales-type leases at their commencement (net sales includes the initial allocation of fixed costs plus allocation of incremental variable fees and excludes the revenue associated with non-lease components associated with hearing screening supplies and maintenance that are recognized as revenue over the remaining lease term) (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:60.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,226 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,107 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,881)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides lease income related to variable lease payments on our sales-type leases not included in the measurement of the lease receivable (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:60.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides lease income on our operating leases (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:60.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease income on operating leases</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The receivables as a result of our sales-type leases are collateralized by the underlying equipment leased and consist of the following components (in thousands):</span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:60.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net minimum lease payments to be received</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,777 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unearned interest income portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,777 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term net investment in sales-type leases</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,333 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, future minimum lease payments and the reconciliation to net investment in sales-type leases reported on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.239%"><tr><td style="width:1.0%"/><td style="width:53.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.224%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.722%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sales-Type Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> LEASES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lessee Leases</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operating and finance leases for offices, warehouses, and certain equipment. The leases have remaining lease terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xNDgvZnJhZzpiNDFhMjc0NmJkMGM0MGZlYmRiOGZlMWFmMDhhN2VjNC90ZXh0cmVnaW9uOmI0MWEyNzQ2YmQwYzQwZmViZGI4ZmUxYWYwOGE3ZWM0XzE1Nw_12427527-a2f5-404b-b9eb-8c597fcfb0f4">one</span> to eight years, some of which include options to extend the leases for up to ten years. Our leases do not have any residual value guarantees or any restrictions or covenants imposed by leases. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of lease cost were as follows (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.233%"><tr><td style="width:1.0%"/><td style="width:56.018%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.656%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,046 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,696 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets (principal payments)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,958 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,541 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,363 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,627 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:60.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,636 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,979 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,055 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,290 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.678%"><tr><td style="width:1.0%"/><td style="width:53.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.104%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,288 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,669 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities<br/></span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,964 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,779 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,567 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,959 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,531 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,738 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,356 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,555 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,906)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,705)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xNDgvZnJhZzpiNDFhMjc0NmJkMGM0MGZlYmRiOGZlMWFmMDhhN2VjNC90YWJsZTo1NGRmOWE4MWZhMWU0ZjQ2YWY2N2MxM2IyNzQ3YWY4ZS90YWJsZXJhbmdlOjU0ZGY5YTgxZmExZTRmNDZhZjY3YzEzYjI3NDdhZjhlXzEzLTAtMS0xLTgwNTQ_048f6a01-36f3-49fb-9806-f0422121908e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xNDgvZnJhZzpiNDFhMjc0NmJkMGM0MGZlYmRiOGZlMWFmMDhhN2VjNC90YWJsZTo1NGRmOWE4MWZhMWU0ZjQ2YWY2N2MxM2IyNzQ3YWY4ZS90YWJsZXJhbmdlOjU0ZGY5YTgxZmExZTRmNDZhZjY3YzEzYjI3NDdhZjhlXzEzLTAtMS0xLTgwNTQ_cd461ffd-2b29-4015-97af-dc6daa8e20a3">Accrued liabilities</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xNDgvZnJhZzpiNDFhMjc0NmJkMGM0MGZlYmRiOGZlMWFmMDhhN2VjNC90YWJsZTo1NGRmOWE4MWZhMWU0ZjQ2YWY2N2MxM2IyNzQ3YWY4ZS90YWJsZXJhbmdlOjU0ZGY5YTgxZmExZTRmNDZhZjY3YzEzYjI3NDdhZjhlXzE0LTAtMS0xLTgwNTQ_ba1f7c16-e5ab-469d-bcc1-b523e88332f5"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xNDgvZnJhZzpiNDFhMjc0NmJkMGM0MGZlYmRiOGZlMWFmMDhhN2VjNC90YWJsZTo1NGRmOWE4MWZhMWU0ZjQ2YWY2N2MxM2IyNzQ3YWY4ZS90YWJsZXJhbmdlOjU0ZGY5YTgxZmExZTRmNDZhZjY3YzEzYjI3NDdhZjhlXzE0LTAtMS0xLTgwNTQ_dbe855d9-ba5a-45e0-a4c6-564d29edd6ff">Other liabilities</span></span></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.97 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.68 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, future minimum lease payments included in the measurement of lease liabilities on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):</span></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.239%"><tr><td style="width:1.0%"/><td style="width:53.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.224%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.722%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31, </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,440 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,404 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,495 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(964)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,531 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lessor Leases</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pricing of our exclusive hearing screening supply agreement is structured on a fee per baby screened basis and includes a guaranteed minimum payment per unit per contract year for each unit of equipment supplied. We recognize revenues for the hardware products upon commencement of each lease at the net present value of their guaranteed minimum payment standalone selling price allocation. The remaining variable fees are recognized as revenue over the remaining lease term. The following table provides the profit recognized for sales-type leases at their commencement (net sales includes the initial allocation of fixed costs plus allocation of incremental variable fees and excludes the revenue associated with non-lease components associated with hearing screening supplies and maintenance that are recognized as revenue over the remaining lease term) (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:60.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,226 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,107 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,881)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides lease income related to variable lease payments on our sales-type leases not included in the measurement of the lease receivable (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:60.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides lease income on our operating leases (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:60.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease income on operating leases</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The receivables as a result of our sales-type leases are collateralized by the underlying equipment leased and consist of the following components (in thousands):</span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:60.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net minimum lease payments to be received</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,777 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unearned interest income portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,777 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term net investment in sales-type leases</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,333 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, future minimum lease payments and the reconciliation to net investment in sales-type leases reported on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.239%"><tr><td style="width:1.0%"/><td style="width:53.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.224%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.722%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sales-Type Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> LEASES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lessee Leases</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operating and finance leases for offices, warehouses, and certain equipment. The leases have remaining lease terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xNDgvZnJhZzpiNDFhMjc0NmJkMGM0MGZlYmRiOGZlMWFmMDhhN2VjNC90ZXh0cmVnaW9uOmI0MWEyNzQ2YmQwYzQwZmViZGI4ZmUxYWYwOGE3ZWM0XzE1Nw_12427527-a2f5-404b-b9eb-8c597fcfb0f4">one</span> to eight years, some of which include options to extend the leases for up to ten years. Our leases do not have any residual value guarantees or any restrictions or covenants imposed by leases. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of lease cost were as follows (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.233%"><tr><td style="width:1.0%"/><td style="width:56.018%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.656%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,046 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,696 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets (principal payments)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,958 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,541 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,363 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,627 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:60.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,636 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,979 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,055 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,290 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.678%"><tr><td style="width:1.0%"/><td style="width:53.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.104%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,288 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,669 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities<br/></span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,964 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,779 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,567 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,959 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,531 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,738 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,356 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,555 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,906)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,705)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xNDgvZnJhZzpiNDFhMjc0NmJkMGM0MGZlYmRiOGZlMWFmMDhhN2VjNC90YWJsZTo1NGRmOWE4MWZhMWU0ZjQ2YWY2N2MxM2IyNzQ3YWY4ZS90YWJsZXJhbmdlOjU0ZGY5YTgxZmExZTRmNDZhZjY3YzEzYjI3NDdhZjhlXzEzLTAtMS0xLTgwNTQ_048f6a01-36f3-49fb-9806-f0422121908e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xNDgvZnJhZzpiNDFhMjc0NmJkMGM0MGZlYmRiOGZlMWFmMDhhN2VjNC90YWJsZTo1NGRmOWE4MWZhMWU0ZjQ2YWY2N2MxM2IyNzQ3YWY4ZS90YWJsZXJhbmdlOjU0ZGY5YTgxZmExZTRmNDZhZjY3YzEzYjI3NDdhZjhlXzEzLTAtMS0xLTgwNTQ_cd461ffd-2b29-4015-97af-dc6daa8e20a3">Accrued liabilities</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xNDgvZnJhZzpiNDFhMjc0NmJkMGM0MGZlYmRiOGZlMWFmMDhhN2VjNC90YWJsZTo1NGRmOWE4MWZhMWU0ZjQ2YWY2N2MxM2IyNzQ3YWY4ZS90YWJsZXJhbmdlOjU0ZGY5YTgxZmExZTRmNDZhZjY3YzEzYjI3NDdhZjhlXzE0LTAtMS0xLTgwNTQ_ba1f7c16-e5ab-469d-bcc1-b523e88332f5"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xNDgvZnJhZzpiNDFhMjc0NmJkMGM0MGZlYmRiOGZlMWFmMDhhN2VjNC90YWJsZTo1NGRmOWE4MWZhMWU0ZjQ2YWY2N2MxM2IyNzQ3YWY4ZS90YWJsZXJhbmdlOjU0ZGY5YTgxZmExZTRmNDZhZjY3YzEzYjI3NDdhZjhlXzE0LTAtMS0xLTgwNTQ_dbe855d9-ba5a-45e0-a4c6-564d29edd6ff">Other liabilities</span></span></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.97 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.68 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, future minimum lease payments included in the measurement of lease liabilities on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):</span></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.239%"><tr><td style="width:1.0%"/><td style="width:53.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.224%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.722%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31, </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,440 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,404 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,495 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(964)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,531 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lessor Leases</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pricing of our exclusive hearing screening supply agreement is structured on a fee per baby screened basis and includes a guaranteed minimum payment per unit per contract year for each unit of equipment supplied. We recognize revenues for the hardware products upon commencement of each lease at the net present value of their guaranteed minimum payment standalone selling price allocation. The remaining variable fees are recognized as revenue over the remaining lease term. The following table provides the profit recognized for sales-type leases at their commencement (net sales includes the initial allocation of fixed costs plus allocation of incremental variable fees and excludes the revenue associated with non-lease components associated with hearing screening supplies and maintenance that are recognized as revenue over the remaining lease term) (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:60.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,226 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,107 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,881)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides lease income related to variable lease payments on our sales-type leases not included in the measurement of the lease receivable (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:60.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides lease income on our operating leases (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:60.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease income on operating leases</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The receivables as a result of our sales-type leases are collateralized by the underlying equipment leased and consist of the following components (in thousands):</span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:60.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net minimum lease payments to be received</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,777 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unearned interest income portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,777 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term net investment in sales-type leases</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,333 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, future minimum lease payments and the reconciliation to net investment in sales-type leases reported on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.239%"><tr><td style="width:1.0%"/><td style="width:53.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.224%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.722%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sales-Type Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> P8Y P10Y <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of lease cost were as follows (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.233%"><tr><td style="width:1.0%"/><td style="width:56.018%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.656%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,046 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,696 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets (principal payments)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,958 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,541 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,363 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,627 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows (in thousands):</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:60.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,636 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,979 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,055 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,290 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 6046000 6696000 384000 395000 34000 49000 22000 7000 1958000 2541000 81000 61000 8363000 9627000 12636000 13979000 19000 32000 410000 527000 3055000 3290000 98000 337000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.678%"><tr><td style="width:1.0%"/><td style="width:53.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.104%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,288 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,669 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities<br/></span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,964 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,779 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,567 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,959 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,531 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,738 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,356 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,555 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,906)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,705)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xNDgvZnJhZzpiNDFhMjc0NmJkMGM0MGZlYmRiOGZlMWFmMDhhN2VjNC90YWJsZTo1NGRmOWE4MWZhMWU0ZjQ2YWY2N2MxM2IyNzQ3YWY4ZS90YWJsZXJhbmdlOjU0ZGY5YTgxZmExZTRmNDZhZjY3YzEzYjI3NDdhZjhlXzEzLTAtMS0xLTgwNTQ_048f6a01-36f3-49fb-9806-f0422121908e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xNDgvZnJhZzpiNDFhMjc0NmJkMGM0MGZlYmRiOGZlMWFmMDhhN2VjNC90YWJsZTo1NGRmOWE4MWZhMWU0ZjQ2YWY2N2MxM2IyNzQ3YWY4ZS90YWJsZXJhbmdlOjU0ZGY5YTgxZmExZTRmNDZhZjY3YzEzYjI3NDdhZjhlXzEzLTAtMS0xLTgwNTQ_cd461ffd-2b29-4015-97af-dc6daa8e20a3">Accrued liabilities</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xNDgvZnJhZzpiNDFhMjc0NmJkMGM0MGZlYmRiOGZlMWFmMDhhN2VjNC90YWJsZTo1NGRmOWE4MWZhMWU0ZjQ2YWY2N2MxM2IyNzQ3YWY4ZS90YWJsZXJhbmdlOjU0ZGY5YTgxZmExZTRmNDZhZjY3YzEzYjI3NDdhZjhlXzE0LTAtMS0xLTgwNTQ_ba1f7c16-e5ab-469d-bcc1-b523e88332f5"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVlNWFkZjM1MTBlZTQ3NDU5OGI5MDlhMjVhOTllMDkyL3NlYzplZTVhZGYzNTEwZWU0NzQ1OThiOTA5YTI1YTk5ZTA5Ml8xNDgvZnJhZzpiNDFhMjc0NmJkMGM0MGZlYmRiOGZlMWFmMDhhN2VjNC90YWJsZTo1NGRmOWE4MWZhMWU0ZjQ2YWY2N2MxM2IyNzQ3YWY4ZS90YWJsZXJhbmdlOjU0ZGY5YTgxZmExZTRmNDZhZjY3YzEzYjI3NDdhZjhlXzE0LTAtMS0xLTgwNTQ_dbe855d9-ba5a-45e0-a4c6-564d29edd6ff">Other liabilities</span></span></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.97 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.68 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 9288000 11669000 4964000 6779000 6567000 8959000 11531000 15738000 2356000 2555000 1906000 1705000 450000 850000 231000 414000 230000 446000 461000 860000 P2Y11M19D P3Y3M29D P2Y4M24D P2Y8M4D 0.054 0.054 0.051 0.051 As of December 31, 2021, future minimum lease payments included in the measurement of lease liabilities on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.239%"><tr><td style="width:1.0%"/><td style="width:53.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.224%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.722%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31, </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,440 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,404 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,495 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(964)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,531 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> As of December 31, 2021, future minimum lease payments included in the measurement of lease liabilities on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.239%"><tr><td style="width:1.0%"/><td style="width:53.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.224%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.722%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31, </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,440 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,404 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,495 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(964)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,531 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 5440000 240000 3404000 159000 1959000 63000 957000 17000 630000 0 105000 0 12495000 479000 964000 18000 11531000 461000 The following table provides the profit recognized for sales-type leases at their commencement (net sales includes the initial allocation of fixed costs plus allocation of incremental variable fees and excludes the revenue associated with non-lease components associated with hearing screening supplies and maintenance that are recognized as revenue over the remaining lease term) (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:60.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,226 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,107 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,881)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides lease income related to variable lease payments on our sales-type leases not included in the measurement of the lease receivable (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:60.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 10000 2226000 13000 4107000 -3000 -1881000 877000 420000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides lease income on our operating leases (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:60.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease income on operating leases</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 197000 291000 The receivables as a result of our sales-type leases are collateralized by the underlying equipment leased and consist of the following components (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:60.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/> December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net minimum lease payments to be received</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,777 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unearned interest income portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,777 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term net investment in sales-type leases</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,333 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 1209000 1777000 0 0 1209000 1777000 447000 444000 762000 1333000 <div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, future minimum lease payments and the reconciliation to net investment in sales-type leases reported on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.239%"><tr><td style="width:1.0%"/><td style="width:53.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.224%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.722%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sales-Type Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, future minimum lease payments and the reconciliation to net investment in sales-type leases reported on the consolidated balance sheet, for the following five fiscal years and thereafter, were as follows (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.239%"><tr><td style="width:1.0%"/><td style="width:53.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.224%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.722%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sales-Type Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 447000 0 399000 0 363000 0 0 0 0 0 0 0 1209000 0 0 0 1209000 0 ACCRUED LIABILITIES<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:71.276%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and related benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,734 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,409 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued federal, state, and local taxes<br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,855 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,118 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,042 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,195 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,573 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,699 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued amounts due to customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,597 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,743 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Self-funded insurance expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued travel</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued selling expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,211 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,727 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,135 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,236 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:71.276%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and related benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,734 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,409 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued federal, state, and local taxes<br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,855 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,118 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,042 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,195 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,573 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,699 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued amounts due to customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,597 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,743 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Self-funded insurance expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued travel</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued selling expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,211 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,727 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,135 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,236 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 22734000 20409000 9855000 9118000 6042000 5195000 3573000 3699000 2597000 2743000 835000 911000 794000 123000 494000 311000 1211000 1727000 48135000 44236000 LONG-TERM OTHER LIABILITIES<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term other liabilities consist of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:71.276%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term taxes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,678 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,949 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,001 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,416 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term earnout payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,286 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CARES Act payroll tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,237 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,451 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term other liabilities consist of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:71.276%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term taxes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,678 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,949 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,001 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,416 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term earnout payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,286 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CARES Act payroll tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,237 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,451 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 10678000 10949000 5001000 4416000 1184000 1286000 230000 446000 0 1354000 144000 0 17237000 18451000 DEBT AND CREDIT ARRANGEMENTS<div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a Credit Agreement with JP Morgan Chase Bank ("JP Morgan"), Citibank, NA (“Citibank”), and Wells Fargo Bank, National Association (“Wells Fargo”). During the third quarter of 2020 we amended the terms of the Credit Agreement to extend the maturity date of the original agreement, reduce the aggregate value of the revolving facility, and amend certain covenants. The amended Credit Agreement provides for an aggregate $150 million of secured revolving credit facility. The Credit Agreement contains covenants, including covenants relating to maintenance of books and records, financial reporting and notification, compliance with laws, maintenance of properties and insurance, and limitations on guaranties, investments, issuance of debt, lease obligations and capital expenditures, and is secured by virtually all of our assets. The Credit Agreement provides for events of default, including failure to pay any principal or interest when due, failure to perform or observe covenants, bankruptcy or insolvency events and the occurrence of the event has a material adverse effect. We have no other significant credit facilities. As of December 31, 2021, no amounts were outstanding under the Credit Agreement. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the customary restrictive covenants listed above, the Credit Agreement also contains financial covenants that require us to maintain a certain leverage ratio and fixed charge coverage ratio, each as defined in the Credit Agreement:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Leverage Ratio, as defined, to be no higher than 3.25 to 1.00.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Interest Coverage Ratio, as defined, to be at least 1.75 to 1.00 at all times.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the Credit Agreement, the outstanding principal balance will bear interest at either (a) a fluctuating rate per annum equal to the Applicable Rate, as defined in the Credit Agreement, depending on our leverage ratio plus the higher of (i) the federal funds rate plus one-half of one percent per annum; (ii) the prime rate in effect on such a day; and (iii) the LIBOR rate plus one percent, or (b) a fluctuating rate per annum of LIBOR Rate plus the Applicable Rate, which ranges between 2.25% to 3.50%. The Credit Agreement matures on September 25, 2023, at which time all principal amounts outstanding under the Credit Agreement will be due and payable.</span></div>As of June 30, 2021, we have discontinued our interest rate swap derivative. There are no amounts outstanding under our Credit Agreement and the termination date of the hedge was September 23, 2021. Upon the discontinuation of the hedge relationship, we have reclassified the unrealized gains or losses recorded in accumulated other comprehensive income (“AOCI”) to earnings. 150000000 3.25 1.75 0.0225 0.0350 RESERVE FOR PRODUCT WARRANTIES<div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide a warranty for products that is generally one year in length and in some cases, regulations may require us to provide repair or remediation beyond the typical warranty period. If any of the products contain defects, we may be required to incur additional repair and remediation costs. Service, repair and calibration services are provided by a combination of our owned facilities and vendors on a contract basis. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A warranty reserve is included in accrued liabilities for the expected future costs of servicing products. Additions to the reserve are based on management's best estimate of probable liability. We consider a combination of factors including material and labor costs, regulatory requirements, and other judgments in determining the amount of reserve. The reserve is reduced as costs are incurred to honor existing warranty and regulatory obligations. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we have acc</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rued $6.0 million for pr</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">oduct related warranties. The estimates we use in projecting future product warranty costs may prove to be incorrect. Any future determination that product warranty reserves are understated could result in increases to cost of sales and reductions in operating profits and results of operations.</span></div> P1Y 6000000 STOCKHOLDERS’ EQUITY<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—We have 120,000,000 shares of common stock authorized at a par value or $0.001 per share.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span>Preferred Stock—We have 10,000,000 shares of preferred stock authorized at a par value of $0.001 per share. In accordance with the terms of the amended and restated certificate of incorporation, the Board of Directors is authorized to provide for the issuance of one or more series of preferred stock, including increases or decreases to the series. The Board of Directors has the authority to set the rights, preferences, and terms of such shares. As of December 31, 2021, no shares of preferred stock were issued and outstanding. 120000000 0.001 10000000 0.001 0 0 EARNINGS PER SHARE<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of basic and diluted EPS are as follows (in thousands, except per share amounts):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,177 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,613)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,671)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,670 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,562 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,696 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,974 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,562 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,696 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic income (loss) per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted income (loss) per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares excluded from calculation of diluted EPS</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of basic and diluted EPS are as follows (in thousands, except per share amounts):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,177 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,613)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,671)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,670 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,562 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,696 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,974 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,562 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,696 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic income (loss) per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted income (loss) per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares excluded from calculation of diluted EPS</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 13177000 -16613000 -15671000 33670000 33562000 33696000 304000 0 0 33974000 33562000 33696000 0.39 -0.49 -0.47 0.39 -0.49 -0.47 0 66000 104000 SHARE-BASED COMPENSATION<div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—We account for share-based compensation in accordance with ASC Topic 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation—Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Share-based compensation was recognized as follows in the consolidated statement of income (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing and selling</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,201 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,938 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,406 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,160 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,171 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,227 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,161 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,527 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,315 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant modification impacted stock compensation expense related to the CEO transition in late December 2021. As part of the separation agreement, the former CEO received the benefit of immediate accelerated vesting for all forms of unvested stock (stock options, restricted stock awards, restricted stock units, performance-based stock and market-based stock).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accelerated vesting was not subject to any future service conditions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 718, the stock options, restricted stock awards and restricted stock units service periods were modified to end on the separation date. The acceleration was contemplated in the CEO's original employment agreement, which resulted in compensation cost recognized at the grant date fair value of the original grants. The performance-based and market-based units were treated as a Type III modification (from improbable to probable) as the stock would be forfeited if the full vesting period was not achieved due to separation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As such, the terms and conditions of the performance-based and market-based units were modified to change the vesting conditions where two measurements were computed, and the net impact of truing up the cumulative compensation expense to the fair value of the modified award was recorded in the income statement, resulting in a $1.1 million net benefit in compensation cost, classified as restructuring expense in the consolidated statements of operations, for the year ended December 31, 2021. </span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Awards Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Natus' 2021 Stock Awards Plan (the “Plan”) provides for the granting of the following:</span></div><div style="margin-bottom:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Incentive stock options to employees;</span></div><div style="margin-bottom:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Non-statutory stock options to employees, directors and consultants;</span></div><div style="margin-bottom:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restricted stock awards and restricted stock units;</span></div><div style="margin-bottom:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Market stock units;</span></div><div style="margin-bottom:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Performance stock units;</span></div><div style="margin-bottom:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Stock bonuses; and</span></div><div style="margin-bottom:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Stock appreciation rights.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, there were 2,917,938 shares available for future awards under the plan.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Plan, stock options may be issued at not less than the fair market value of the common stock on the date of grant, as determined by the Board of Directors. Options issued under the Plan become exercisable as determined by the Board of Directors and expire no more than six years after the date of grant. Most options vest ratably over four years.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Option Activity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Stock option activity under the stock awards plans for the year ended December 31, 2021 is summarized as follows: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, December 31, 2020 (37,062 shares exercisable at a weighted average exercise price of $35.25 per share)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331,585 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.94 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,146 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.61 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,787)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.68 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,387)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.68 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, December 31, 2021 (320,512 shares exercisable at a weighted average exercise price of $24.01 per share)</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494,557 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, unrecognized compensation related to the unvested portion of stock options was approximately $1.0 million, which is expected to be recognized over a weighted average period of 3.1 years. The intrinsic value of options exercised, representing the difference between the closing stock price of common stock on the date of the exercise and the exercise price, in the years ended December 31, 2021, 2020 and 2019 was $0.0 million, $0.0 million, and $1.4 million, respectively. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, there were: (i) 484,507 options vested and expected to vest with a weighted average exercise price of $22.88, an intrinsic value of $1.3 million, and a weighted average remaining contractual term of 4.0 years; and (ii) 320,512 options exercisable with a weighted average exercise price of $24.01, an intrinsic value of $0.8 million, and a weighted average remaining contractual term of 1.5 years.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Black-Scholes Inputs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The fair value of option grants was estimated using the Black-Scholes option pricing model with the following weighted average assumptions:</span></div><div style="margin-bottom:6pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.157%"><tr><td style="width:1.0%"/><td style="width:58.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.420%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.115%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average fair value of options granted</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7.50</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6.54</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life in years</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not grant any stock options during December 31, 2019.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected life of options is based primarily on historical share option exercise experience of the employees for options granted. All options are treated as a single group in the determination of expected life, as we do not currently expect substantially different exercise or post-vesting termination behavior among the employee population. The risk-free interest rate is based on the U.S. Treasury yield for a term consistent with the expected life of the awards in effect at the time of grant. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility is based primarily on historical volatility data of our common stock. We have no history or expectation of paying dividends on common stock.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense associated with options is based on awards ultimately expected to vest. At the time of an option grant, we estimate the expected future rate of forfeitures based on historical experience. These estimates are revised, if necessary, in subsequent periods if actual forfeiture rates differ from those estimates. If the actual forfeiture rate is lower than estimated we will record additional expense and if the actual forfeiture is higher than estimated we will record a recovery of prior expense.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock Awards Activity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The following table summarizes the activity for restricted stock awards during the year ended December 31, 2021: </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:71.276%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant<br/>Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380,089 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.84 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,814 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.04 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(320,541)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,592)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.54 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,770 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, unrecognized compensation related to the unvested portion of stock awards was $5.1 million, which is expected to be recognized over a weighted average period of 2.1 years. The fair market value of outstanding restricted stock awards at December 31, 2021 was $8.1 million. For the restricted stock awards granted during the years ended December 31, 2021, 2020, 2019, the weighted average grant date fair values were $22.04, $29.74, and $31.53, respectively. The total grant date fair value of restricted stock awards vested during fiscal year 2021, 2020, and 2019 was $8.6 million, $5.5 million, and $4.7 million, respectively. For the restricted stock awards that vested during the years ended December 31, 2021, 2020, and 2019, the total intrinsic value was $6.7 million, $4.8 million, and $4.0 million, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock Units Activity</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The following table summarizes restricted stock units activity, including performance and market stock units granted at the valuation date (which may be subject to additional awards or forfeitures depending on the outcome of the performance measures at the end of the performance period)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the year ended December 31, 2021: </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:71.276%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant<br/>Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,601 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awarded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,005 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.43 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205,082)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,959)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.20 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366,565 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.87 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, unrecognized compensation related to the unvested portion of stock units was $8.0 million, which is expected to be recognized over a weighted average period of 2.9 years. The aggregate intrinsic value of outstanding restricted stock units at December 31, 2021 was $8.7 million. For the restricted stock units granted during the years December 31, 2021, 2020, 2019, the weighted average grant date fair values were $26.43, $35.42, and $38.62, respectively. The total grant date fair value of restricted stock units vested during fiscal year 2021, 2020, and 2019 was $5.7 million, $0.5 million, and $1.4 million, respectively. For the restricted stock units that vested during the years ended December 31, 2021, 2020, and 2019, the total intrinsic value was $4.7 million, $0.5 million, and $1.3 million, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Under Natus' 2011 Employee Stock Purchase Plan (the “ESPP”), U.S. employees can elect to have salary withholdings of up to 15% of eligible compensation to a maximum of $10,625 per offering period, to purchase shares of common stock on April 30 and October 31 of each year. The purchase price for shares acquired under the </span></div>ESPP is 85% of the fair market value on the last day of the offering period. As of December 31, 2021, there are no shares reserved for future issuance under the ESPP. Because the ESPP does not have a “look back” feature, the compensation expense associated with the Plan is not measured by the use of the Black-Scholes pricing model, but rather by measuring the difference between the fair market value of common stock on the last day of the offering period and the purchase price for the offering period, which is 85% of the fair market value. Compensation expense associated with the ESPP for the years ended December 31, 2021, 2020 and 2019, respectively, was $0.1 million, $0.2 million, and $0.2 million. Share-based compensation was recognized as follows in the consolidated statement of income (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing and selling</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,201 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,938 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,406 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,160 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,171 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,227 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,161 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,527 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,315 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 394000 319000 264000 2201000 1938000 1024000 1406000 1099000 800000 10160000 6171000 6227000 14161000 9527000 8315000 1100000 2917938 P6Y P4Y <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Option Activity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Stock option activity under the stock awards plans for the year ended December 31, 2021 is summarized as follows: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, December 31, 2020 (37,062 shares exercisable at a weighted average exercise price of $35.25 per share)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331,585 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.94 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,146 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.61 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,787)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.68 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,387)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.68 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, December 31, 2021 (320,512 shares exercisable at a weighted average exercise price of $24.01 per share)</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494,557 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 331585 23.94 200146 20.61 11787 20.68 25387 20.68 494557 0 1000000 P3Y1M6D 0 0 1400000 484507 22.88 1300000 P4Y 320512 24.01 800000 P1Y6M The fair value of option grants was estimated using the Black-Scholes option pricing model with the following weighted average assumptions:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.157%"><tr><td style="width:1.0%"/><td style="width:58.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.420%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.115%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average fair value of options granted</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7.50</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6.54</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life in years</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr></table> 7.50 6.54 P5Y10M24D P4Y6M 0.003 0.002 0.38 0.38 0 0 The following table summarizes the activity for restricted stock awards during the year ended December 31, 2021: <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:71.276%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant<br/>Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380,089 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.84 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,814 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.04 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(320,541)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,592)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.54 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,770 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 380089 31.84 320814 22.04 320541 29.54 40592 25.54 339770 26.15 5100000 P2Y1M6D 8100000 22.04 29.74 31.53 8600000 5500000 4700000 6700000 4800000 4000000 The following table summarizes restricted stock units activity, including performance and market stock units granted at the valuation date (which may be subject to additional awards or forfeitures depending on the outcome of the performance measures at the end of the performance period) for the year ended December 31, 2021: <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:71.276%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant<br/>Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,601 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awarded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,005 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.43 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205,082)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,959)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.20 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366,565 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.87 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 212601 37.27 400005 26.43 205082 31.34 40959 36.20 366565 28.87 8000000 P2Y10M24D 8700000 26.43 35.42 38.62 5700000 500000 1400000 4700000 500000 1300000 0.15 10625 0.85 0.85 100000 200000 200000 OTHER INCOME (EXPENSE), NET<div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net consists of (in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,872)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,656)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,941)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,957)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,988 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(765)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(682)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,424)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,872)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,591)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net consists of (in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,872)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,656)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,941)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,957)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,988 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(765)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(682)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,424)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,872)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,591)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 87000 11000 250000 1872000 3656000 4941000 -1957000 1988000 -765000 -682000 -215000 -135000 -4424000 -1872000 -5591000 INCOME TAXES<div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before provision for income tax is as follows (in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,629 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,851)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,973)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,594 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before provision for income tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,355 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,065)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,257)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of income tax expense (benefit) for the years ended December 31, 2021, 2020 and 2019 (in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:57.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,976)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(948)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. State and local</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,523 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,386 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,837 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,590)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,999 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,583 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,491)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. State and local</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(816)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,426)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax benefit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,659)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,862)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,585)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income expense (benefit)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,178 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,452)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,586)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of deferred tax assets and liabilities as of December 31, 2021 and 2020 are as follows (in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,439 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,099 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,768 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals deductible in different periods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,650 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,368 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,766 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,967 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,993 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,218 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(934)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(969)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net deferred tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,059 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,249 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="9" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basis difference in fixed and intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,007)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,224)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,970)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign earnings to be repatriated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,031)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,984)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,028 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,265 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax expense (benefit) in the accompanying statements of income differs from the provision calculated by applying the U.S. federal statutory income tax rate of 21% in 2021, 2020, and 2019 to income before taxes due to the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal statutory tax expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,065 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,634)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,464)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign taxes at rates less than U.S. rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(609)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,205)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,581 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,161 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,393)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,641)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,428)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax position</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,553 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,002 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lapse of statute</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(365)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,718)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,961)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repatriation tax net of foreign tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal NOL Carryback</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(454)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,621)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax audits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Withholding taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,107 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global intangible low-taxed income net of foreign tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,601 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(704)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(946)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expense (benefit)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,178 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,452)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,586)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, we had U.S. state net operating loss carryforwards of $16.9 million, of which immaterial portions will begin to expire in 2022 and the majority have long carryforward periods ranging primarily from 10 years to indefinite. At December 31, 2021, we had U.S. state R&amp;D credit carryforwards of $1.3 million, which will begin to expire in 2022. At December 31, 2021, we had $0.1 million of U.S. foreign tax credit carryforwards that can be used to offset future U.S. tax liabilities related to foreign source taxable income. The foreign tax credits will start to expire in 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, certain foreign subsidiaries had deferred tax assets attributable to net operating loss carryforwards as follows: $0.8 million in France, $8.7 million in Denmark, $0.3 million in Canada, $0.2 million in China, and $0.3 million in Germany. These foreign net operating loss carryforwards, ranging from 6 years utilization period to indefinite utilization period, if not utilized to offset taxable income in future periods, will begin to expire in various amounts beginning in 2026. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. Accordingly, valuation allowances of $0.9 million and $1.0 million were recorded at December 31, 2021 and 2020, respectively. The decrease of $0.1 million in valuation allowance was primarily due to a valuation allowance recorded against certain U.S. state credits, which are expected to expire before fully utilized, and release of prior Canadian valuation allowances. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The realizability of the deferred tax assets is primarily dependent on our ability to generate sufficient taxable income in future periods. We record net deferred tax assets to the extent it is more likely than not that the assets will be realized. In making such determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations. To the extent that previously reserved deferred tax assets are estimated to be realizable, we adjust the valuation allowance which reduces the provision for income taxes. Weighing all of the positive and negative evidence, we have recorded a valuation allowance related primarily to net operating losses in certain foreign jurisdictions where it is more likely than not that the tax benefit of the net operating losses will not be realized. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no changes to the position on our permanent reinvestment of earnings from foreign operations. As of December 31, 2021, we intend to distribute all of the earnings from Excel-Tech and Natus Ireland in excess of their operational needs. We intend to permanently reinvest the earnings of remaining foreign subsidiaries. The other remaining foreign subsidiaries have both the intent and ability to indefinitely reinvest its undistributed earnings. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Uncertain Tax Positions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits (excluding interest and penalties) is as follows (in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:85.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.326%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,227 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases for tax positions related to prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases for tax positions related to the current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to lapse of statutes of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,763)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange difference</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,917 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases for tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,454 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases for tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to lapse of statutes of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,416)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange difference</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,142 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases for tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to lapse of statutes of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange difference</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,848 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2021, our net unrecognized tax benefits increased by $0.7 million resulting in a corresponding $0.7 million increase in income tax expense. The increase was primarily attributable to the increase in uncertain tax positions related to the current year in certain jurisdictions. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unrecognized tax benefits for the tax years ended December 31, 2021, 2020 and 2019 were $4.8 million, $4.1 million and $3.9 million, respectively which include $4.6 million, $3.8 million and $3.6 million, respectively, that would impact the effective tax rate if recognized.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect a range from zero to $0.8 million of unrecognized tax benefit that will impact the effective tax rate in the next 12 months due to the lapse of statute of limitations provided that no taxing authority conducts a new examination.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, 2020 and 2019, we had cumulatively accrued $0.9 million, $0.5 million, and $0.4 million for estimated interest and penalties related to uncertain tax positions. We record interest and penalties related to unrecognized tax positions as a component of income tax expense (benefit), which totaled approximately $0.3 million, $0.1 million, and $(0.1) million for the years ended December 31, 2021, 2020, and 2019, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently unaware of any uncertain tax positions that could result in significant additional payments, accruals, or other material deviation in this estimate over the next 12 months.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we are currently under U.S. federal IRS examination for tax years 2018 and 2019.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tax returns remain open to examination as follows: U.S. federal, 2017 through 2020; U.S. states, generally 2016 through 2020; and significant foreign jurisdictions, generally 2016 through 2020.</span></div> <div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before provision for income tax is as follows (in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,629 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,851)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,973)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,594 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before provision for income tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,355 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,065)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,257)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 18629000 1908000 -22851000 726000 -23973000 1594000 19355000 -22065000 -21257000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of income tax expense (benefit) for the years ended December 31, 2021, 2020 and 2019 (in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:57.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,976)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(948)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. State and local</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,523 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,386 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,837 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,590)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,999 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,583 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,491)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. State and local</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(816)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,426)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax benefit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,659)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,862)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,585)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income expense (benefit)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,178 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,452)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,586)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 946000 -3976000 -948000 368000 145000 561000 7523000 1241000 8386000 8837000 -2590000 7999000 4583000 2049000 -7491000 184000 533000 -816000 -7426000 -5444000 -5278000 -2659000 -2862000 -13585000 6178000 -5452000 -5586000 Significant components of deferred tax assets and liabilities as of December 31, 2021 and 2020 are as follows (in thousands): <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,439 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,099 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,768 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals deductible in different periods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,650 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,368 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,766 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,967 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,993 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,218 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(934)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(969)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net deferred tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,059 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,249 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="9" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basis difference in fixed and intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,007)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,224)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,970)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign earnings to be repatriated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,031)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,984)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,028 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,265 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 12439000 9099000 1213000 5768000 15650000 15368000 925000 1016000 2766000 3967000 32993000 35218000 934000 969000 32059000 34249000 7007000 13214000 2224000 2970000 800000 800000 10031000 16984000 22028000 17265000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax expense (benefit) in the accompanying statements of income differs from the provision calculated by applying the U.S. federal statutory income tax rate of 21% in 2021, 2020, and 2019 to income before taxes due to the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal statutory tax expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,065 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,634)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,464)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign taxes at rates less than U.S. rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(609)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,205)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,581 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,161 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,393)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,641)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,428)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax position</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,553 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,002 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lapse of statute</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(365)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,718)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,961)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repatriation tax net of foreign tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal NOL Carryback</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(454)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,621)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax audits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Withholding taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,107 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global intangible low-taxed income net of foreign tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,601 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(704)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(946)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expense (benefit)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,178 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,452)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,586)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 0.21 4065000 -4634000 -4464000 605000 661000 -300000 -609000 1050000 -2205000 2581000 1161000 824000 1393000 1641000 1428000 1553000 3002000 2910000 -365000 -2718000 -3961000 0 0 172000 -454000 -1621000 0 97000 -224000 0 254000 0 1107000 0 0 1601000 -704000 -946000 560000 548000 458000 -402000 6178000 -5452000 -5586000 16900000 P10Y 1300000 100000 800000 8700000 300000 200000 300000 P6Y 900000 1000000 100000 <div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits (excluding interest and penalties) is as follows (in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:85.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.326%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,227 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases for tax positions related to prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases for tax positions related to the current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to lapse of statutes of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,763)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange difference</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,917 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases for tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,454 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases for tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to lapse of statutes of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,416)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange difference</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,142 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases for tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to lapse of statutes of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange difference</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,848 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 7227000 48000 495000 3763000 6000 3917000 2454000 104000 2416000 83000 4142000 1067000 279000 82000 4848000 700000 700000 4800000 4100000 3900000 4600000 3800000 3600000 0 800000 900000 500000 400000 -300000 -100000 100000 EMPLOYEE BENEFIT PLAN<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer pre-tax and after-tax 401(k) savings plan options under which eligible U.S. employees may elect to have a portion of their salary deferred and contributed to the plan. Employer matching contributions are determined by management and are discretionary. Employer matching contributions we</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">re $3.7 million, $3.2 million, and $3.6 million respectively, in the years ended December 31, 2021, 2020, and 2019. For new hires, employe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r contributions vest ratably over the first two years of employment.</span> 3700000 3200000 3600000 P2Y SEGMENT, CUSTOMER, AND GEOGRAPHIC INFORMATION<div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine our reportable segments by first identifying our operating segments, and then by assessing whether any components of these segments constitute a business for which discrete financial information is available and where segment management regularly reviews the operating results of that component. Historically, our operating segments were based on its three strategic business units. In January 2019, we announced the transition of our operating structure from three strategic business units to a single, unified company with globally led operational teams in Sales and Marketing, Manufacturing, Research and Development, Quality, and General and Administrative functions.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the reorganization, we operate as one operating segment and one reportable segment, which provides medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. Financial information is reviewed on a consolidated basis for purposes of making operating decisions and assessing financial performance. Consolidated financial information is accompanied by disaggregated information about revenues by end market and geographic region. We do not assess the performance of our end markets or geographic regions on measures of profit or loss, or asset-based metrics. We have disclosed the revenues for each end market and geographic region to provide the reader of the financial statements transparency into our operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present revenue and long-lived asset information by end market and geographic region. Revenue is based on the destination of the shipments and long-lived assets are based on the physical location of the assets (in thousands):</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Revenue:</span></td><td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,979 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,496 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,400 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,459 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,188 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,775 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,438 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415,684 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,175 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue by End Market:</span></td><td colspan="15" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuro</span></td><td colspan="15" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Devices and Systems</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,929 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,464 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,306 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,838 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,275 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,059 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Neuro Revenue</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284,767 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,739 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,236 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Newborn Care</span></td><td colspan="15" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Devices and Systems</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,174 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,284 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,465 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,710 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,174 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,264 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,139 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,566 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,183 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Newborn Care Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,023 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,024 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,912 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hearing &amp; Balance</span></td><td colspan="15" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Devices and Systems</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,738 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,050 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,996 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,183 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,977 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Hearing &amp; Balance Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,648 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,921 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,027 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,438 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415,684 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,175 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived asset information by geographic region is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.807%"><tr><td style="width:1.0%"/><td style="width:68.177%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.804%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.559%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,642 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,998 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,223 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,716 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,594 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,775 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denmark</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other foreign countries</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,240 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,783 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,516 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2021, 2020 and 2019, no single customer or foreign country contributed to more than 10% of revenue.</span></div> 3 1 1 The following tables present revenue and long-lived asset information by end market and geographic region. Revenue is based on the destination of the shipments and long-lived assets are based on the physical location of the assets (in thousands):<div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Revenue:</span></td><td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,979 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,496 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,400 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,459 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,188 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,775 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,438 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415,684 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,175 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue by End Market:</span></td><td colspan="15" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuro</span></td><td colspan="15" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Devices and Systems</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,929 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,464 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,306 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,838 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,275 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,059 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Neuro Revenue</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284,767 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,739 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,236 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Newborn Care</span></td><td colspan="15" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Devices and Systems</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,174 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,284 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,465 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,710 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,174 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,264 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,139 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,566 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,183 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Newborn Care Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,023 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,024 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,912 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hearing &amp; Balance</span></td><td colspan="15" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Devices and Systems</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,738 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,050 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,996 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,183 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,977 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Hearing &amp; Balance Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,648 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,921 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,027 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,438 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415,684 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,175 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived asset information by geographic region is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.807%"><tr><td style="width:1.0%"/><td style="width:68.177%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.804%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.559%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,642 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,998 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,223 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,716 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,594 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,775 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denmark</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other foreign countries</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,240 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,783 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,516 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 285979000 252496000 292400000 187459000 163188000 202775000 473438000 415684000 495175000 220929000 179464000 220306000 63838000 56275000 66059000 0 0 871000 284767000 235739000 287236000 55174000 52284000 53465000 33710000 36174000 38264000 16139000 16566000 19183000 105023000 105024000 110912000 78652000 70738000 92050000 4996000 4183000 4977000 83648000 74921000 97027000 473438000 415684000 495175000 9642000 10998000 6223000 6716000 3594000 3775000 1262000 1787000 1062000 1240000 21783000 24516000 COMMITMENTS AND CONTINGENCIES<div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchase commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—We have various purchase obligations for goods or s</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ervices totaling $178.4 million at December 31, 2021, which are expected to be paid $136.5 million in 2022 and $41.9 million ther</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">eafter. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—We currently are, and may from time to time become, a party to various legal proceedings or claims that arise in the ordinary course of business. Our managements reviews these matters if and when they arise and believes that the resolution of any such matters currently known will not have a material effect on our results of operations or financial position.</span></div> 178400000 136500000 41900000 FAIR VALUE MEASUREMENTS<div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 820 defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. Fair value is defined under ASC 820 as the exit price associated with the sale of an asset or transfer of a liability in an orderly transaction between market participants at the measurement date. ASC 820 establishes the following three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets and liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Unobservable inputs that are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, we sold vacant land located in Canada for $1.6 million resulting in a gain of $0.7 million. Also during this period, we sold a building located in the United Kingdom for $1.1 million resulting in a gain of $0.8 million. The gain on disposal of these assets is reported in general and administrative expense in the condensed consolidated statements of operations. The book value of these assets was in other current assets on the accompanying condensed consolidated balance sheet. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following financial instruments are not measured at fair value on the consolidated balance sheet as of December 31, 2021 and 2020, but require disclosure of fair values: cash and cash equivalents, accounts receivable, and accounts payable. The carrying value of these financial instruments approximates fair values because of the relatively short maturity. </span></div><div style="margin-bottom:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of our short-term and long-term debt approximates fair value based on Level 2 inputs since the debt carries a variable interest rate that is tied to the current LIBOR rate plus a spread.</span></div> 1600000 700000 1100000 800000 SALE OF CERTAIN SUBSIDIARY    We divested our wholly owned subsidiary, Medix, on April 2, 2019, via a stock sale to the local managing director, a related party. In exchange for the stock, we received $2.5 thousand in cash and provided Medix with a $2.2 million limited-recourse loan secured by real estate assets of Medix. The fair market value of the loan was adjusted as necessary to reflect any changes in market environment or the value of the building. During the second quarter of 2021, we received a $0.9 million payment of which the loan receivable of $0.7 million was fully repaid and a $0.2 million gain was recognized.     The held for sale criteria under GAAP was met in the first quarter of 2019. As such, we completed an asset impairment analysis which resulted in the full impairment of all assets held for sale. We recognized an impairment loss of $24.6 million which included an accrual for the anticipated realization of deferred foreign currency related translation adjustments in accumulated other comprehensive income of $24.8 million, net of tax, and an adjustment of $4.6 million for assets with a book value in excess of their fair market value. Included in the year ended December 31, 2019, is the impact of the sale of Medix, which was completed as of June 30, 2019, and the deferred foreign currency related translation adjustments previously in accumulated other comprehensive income have been released from the balance sheet along with the held for sale accrual. 2500 2200000 900000 700000 200000 24600000 24800000 4600000 EXCEL 106 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 107 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 108 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 109 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.0.1 html 227 585 1 false 66 0 false 8 false false R1.htm 0001001 - Document - Document and Entity Information Sheet http://www.natus.com/role/DocumentandEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001002 - Statement - Consolidated Balance Sheets Sheet http://www.natus.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 1002003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.natus.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1003004 - Statement - Consolidated Statements of Operations Sheet http://www.natus.com/role/ConsolidatedStatementsofOperations Consolidated Statements of Operations Statements 4 false false R5.htm 1004005 - Statement - Consolidated Statements of Comprehensive Income (Loss) Consolidated Statement of Comprehensive Income (Loss) Sheet http://www.natus.com/role/ConsolidatedStatementsofComprehensiveIncomeLossConsolidatedStatementofComprehensiveIncomeLoss Consolidated Statements of Comprehensive Income (Loss) Consolidated Statement of Comprehensive Income (Loss) Statements 5 false false R6.htm 1005006 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 6 false false R7.htm 1006007 - Statement - Consolidated Statements of Cash Flows Sheet http://www.natus.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 2101101 - Disclosure - Organization and Significant Accounting Policies Sheet http://www.natus.com/role/OrganizationandSignificantAccountingPolicies Organization and Significant Accounting Policies Notes 8 false false R9.htm 2104102 - Disclosure - Revenue Sheet http://www.natus.com/role/Revenue Revenue Notes 9 false false R10.htm 2108103 - Disclosure - Allowance for Doubtful Accounts Sheet http://www.natus.com/role/AllowanceforDoubtfulAccounts Allowance for Doubtful Accounts Notes 10 false false R11.htm 2111104 - Disclosure - Inventories Sheet http://www.natus.com/role/Inventories Inventories Notes 11 false false R12.htm 2115105 - Disclosure - Property and Equipment Sheet http://www.natus.com/role/PropertyandEquipment Property and Equipment Notes 12 false false R13.htm 2119106 - Disclosure - Intangible Assets Sheet http://www.natus.com/role/IntangibleAssets Intangible Assets Notes 13 false false R14.htm 2125107 - Disclosure - Goodwill Sheet http://www.natus.com/role/Goodwill Goodwill Notes 14 false false R15.htm 2128108 - Disclosure - Leases Sheet http://www.natus.com/role/Leases Leases Notes 15 false false R16.htm 2138109 - Disclosure - Accrued Liabilities Sheet http://www.natus.com/role/AccruedLiabilities Accrued Liabilities Notes 16 false false R17.htm 2141110 - Disclosure - Long-Term Other Liabilities Sheet http://www.natus.com/role/LongTermOtherLiabilities Long-Term Other Liabilities Notes 17 false false R18.htm 2144111 - Disclosure - Debt and Credit Arrangements Sheet http://www.natus.com/role/DebtandCreditArrangements Debt and Credit Arrangements Notes 18 false false R19.htm 2146112 - Disclosure - Reserve for Product Warranties Sheet http://www.natus.com/role/ReserveforProductWarranties Reserve for Product Warranties Notes 19 false false R20.htm 2148113 - Disclosure - Stockholders' Equity Sheet http://www.natus.com/role/StockholdersEquity Stockholders' Equity Notes 20 false false R21.htm 2150114 - Disclosure - Earnings Per Share Sheet http://www.natus.com/role/EarningsPerShare Earnings Per Share Notes 21 false false R22.htm 2153115 - Disclosure - Share-Based Compensation Sheet http://www.natus.com/role/ShareBasedCompensation Share-Based Compensation Notes 22 false false R23.htm 2161116 - Disclosure - Other Income (Expense), Net Sheet http://www.natus.com/role/OtherIncomeExpenseNet Other Income (Expense), Net Notes 23 false false R24.htm 2164117 - Disclosure - Income Taxes Sheet http://www.natus.com/role/IncomeTaxes Income Taxes Notes 24 false false R25.htm 2172118 - Disclosure - Employee Benefit Plan Sheet http://www.natus.com/role/EmployeeBenefitPlan Employee Benefit Plan Notes 25 false false R26.htm 2174119 - Disclosure - Segment, Customer and Geographic Information Sheet http://www.natus.com/role/SegmentCustomerandGeographicInformation Segment, Customer and Geographic Information Notes 26 false false R27.htm 2178120 - Disclosure - Commitments And Contingencies Sheet http://www.natus.com/role/CommitmentsAndContingencies Commitments And Contingencies Notes 27 false false R28.htm 2180121 - Disclosure - Fair Value Measurements Sheet http://www.natus.com/role/FairValueMeasurements Fair Value Measurements Notes 28 false false R29.htm 2182122 - Disclosure - Sale of Certain Subsidiary Assets Sale of Certain Subsidiary Assets Sheet http://www.natus.com/role/SaleofCertainSubsidiaryAssetsSaleofCertainSubsidiaryAssets Sale of Certain Subsidiary Assets Sale of Certain Subsidiary Assets Notes 29 false false R30.htm 2184123 - Disclosure - Schedule II: Valuation And Qualifying Accounts Sheet http://www.natus.com/role/ScheduleIIValuationAndQualifyingAccounts Schedule II: Valuation And Qualifying Accounts Notes 30 false false R31.htm 2202201 - Disclosure - Organization and Significant Accounting Policies (Policies) Sheet http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies Organization and Significant Accounting Policies (Policies) Policies http://www.natus.com/role/OrganizationandSignificantAccountingPolicies 31 false false R32.htm 2305301 - Disclosure - Revenue (Tables) Sheet http://www.natus.com/role/RevenueTables Revenue (Tables) Tables http://www.natus.com/role/Revenue 32 false false R33.htm 2309302 - Disclosure - Allowance for Doubtful Accounts (Tables) Sheet http://www.natus.com/role/AllowanceforDoubtfulAccountsTables Allowance for Doubtful Accounts (Tables) Tables http://www.natus.com/role/AllowanceforDoubtfulAccounts 33 false false R34.htm 2312303 - Disclosure - Inventories (Tables) Sheet http://www.natus.com/role/InventoriesTables Inventories (Tables) Tables http://www.natus.com/role/Inventories 34 false false R35.htm 2316304 - Disclosure - Property and Equipment (Tables) Sheet http://www.natus.com/role/PropertyandEquipmentTables Property and Equipment (Tables) Tables http://www.natus.com/role/PropertyandEquipment 35 false false R36.htm 2320305 - Disclosure - Intangible Assets (Tables) Sheet http://www.natus.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://www.natus.com/role/IntangibleAssets 36 false false R37.htm 2326306 - Disclosure - Goodwill (Tables) Sheet http://www.natus.com/role/GoodwillTables Goodwill (Tables) Tables http://www.natus.com/role/Goodwill 37 false false R38.htm 2329307 - Disclosure - Leases (Tables) Sheet http://www.natus.com/role/LeasesTables Leases (Tables) Tables http://www.natus.com/role/Leases 38 false false R39.htm 2339308 - Disclosure - Accrued Liabilities (Tables) Sheet http://www.natus.com/role/AccruedLiabilitiesTables Accrued Liabilities (Tables) Tables http://www.natus.com/role/AccruedLiabilities 39 false false R40.htm 2342309 - Disclosure - Long-Term Other Liabilities (Tables) Sheet http://www.natus.com/role/LongTermOtherLiabilitiesTables Long-Term Other Liabilities (Tables) Tables http://www.natus.com/role/LongTermOtherLiabilities 40 false false R41.htm 2351310 - Disclosure - Earnings Per Share (Tables) Sheet http://www.natus.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.natus.com/role/EarningsPerShare 41 false false R42.htm 2354311 - Disclosure - Share-Based Compensation (Tables) Sheet http://www.natus.com/role/ShareBasedCompensationTables Share-Based Compensation (Tables) Tables http://www.natus.com/role/ShareBasedCompensation 42 false false R43.htm 2362312 - Disclosure - Other Income (Expense), Net (Tables) Sheet http://www.natus.com/role/OtherIncomeExpenseNetTables Other Income (Expense), Net (Tables) Tables http://www.natus.com/role/OtherIncomeExpenseNet 43 false false R44.htm 2365313 - Disclosure - Income Taxes (Tables) Sheet http://www.natus.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.natus.com/role/IncomeTaxes 44 false false R45.htm 2375314 - Disclosure - Segment, Customer and Geographic Information (Tables) Sheet http://www.natus.com/role/SegmentCustomerandGeographicInformationTables Segment, Customer and Geographic Information (Tables) Tables http://www.natus.com/role/SegmentCustomerandGeographicInformation 45 false false R46.htm 2403401 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details) Sheet http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails Organization and Significant Accounting Policies - Narrative (Details) Details http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies 46 false false R47.htm 2406402 - Disclosure - Revenue - Narrative (Details) Sheet http://www.natus.com/role/RevenueNarrativeDetails Revenue - Narrative (Details) Details 47 false false R48.htm 2407403 - Disclosure - Revenue - Unbilled AR and Deferred Revenue (Details) Sheet http://www.natus.com/role/RevenueUnbilledARandDeferredRevenueDetails Revenue - Unbilled AR and Deferred Revenue (Details) Details 48 false false R49.htm 2410404 - Disclosure - Allowance for Doubtful Accounts (Details) Sheet http://www.natus.com/role/AllowanceforDoubtfulAccountsDetails Allowance for Doubtful Accounts (Details) Details http://www.natus.com/role/AllowanceforDoubtfulAccountsTables 49 false false R50.htm 2413405 - Disclosure - Inventories (Details) Sheet http://www.natus.com/role/InventoriesDetails Inventories (Details) Details http://www.natus.com/role/InventoriesTables 50 false false R51.htm 2414406 - Disclosure - Inventories - Narrative (Details) Sheet http://www.natus.com/role/InventoriesNarrativeDetails Inventories - Narrative (Details) Details 51 false false R52.htm 2417407 - Disclosure - Property and Equipment (Details) Sheet http://www.natus.com/role/PropertyandEquipmentDetails Property and Equipment (Details) Details http://www.natus.com/role/PropertyandEquipmentTables 52 false false R53.htm 2418408 - Disclosure - Property and Equipment - Narrative (Details) Sheet http://www.natus.com/role/PropertyandEquipmentNarrativeDetails Property and Equipment - Narrative (Details) Details 53 false false R54.htm 2421409 - Disclosure - Intangible Assets - Narrative (Details) Sheet http://www.natus.com/role/IntangibleAssetsNarrativeDetails Intangible Assets - Narrative (Details) Details 54 false false R55.htm 2422410 - Disclosure - Intangible Assets - Components of Gross and Net Intangible Asset Balances (Details) Sheet http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails Intangible Assets - Components of Gross and Net Intangible Asset Balances (Details) Details 55 false false R56.htm 2423411 - Disclosure - Intangible Assets - Schedule of Amortization Expense (Details) Sheet http://www.natus.com/role/IntangibleAssetsScheduleofAmortizationExpenseDetails Intangible Assets - Schedule of Amortization Expense (Details) Details 56 false false R57.htm 2424412 - Disclosure - Intangible Assets - Expected Annual Amortization Expense (Details) Sheet http://www.natus.com/role/IntangibleAssetsExpectedAnnualAmortizationExpenseDetails Intangible Assets - Expected Annual Amortization Expense (Details) Details 57 false false R58.htm 2427413 - Disclosure - Goodwill (Details) Sheet http://www.natus.com/role/GoodwillDetails Goodwill (Details) Details http://www.natus.com/role/GoodwillTables 58 false false R59.htm 2430414 - Disclosure - Leases - Narrative (Details) Sheet http://www.natus.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 59 false false R60.htm 2431415 - Disclosure - Leases - Lease Cost (Details) Sheet http://www.natus.com/role/LeasesLeaseCostDetails Leases - Lease Cost (Details) Details 60 false false R61.htm 2432416 - Disclosure - Leases - Supplemental Cash Flow (Details) Sheet http://www.natus.com/role/LeasesSupplementalCashFlowDetails Leases - Supplemental Cash Flow (Details) Details 61 false false R62.htm 2433417 - Disclosure - Leases - Supplemental Balance Sheet (Details) Sheet http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails Leases - Supplemental Balance Sheet (Details) Details 62 false false R63.htm 2434418 - Disclosure - Leases - Lease Maturities (Details) Sheet http://www.natus.com/role/LeasesLeaseMaturitiesDetails Leases - Lease Maturities (Details) Details 63 false false R64.htm 2435419 - Disclosure - Leases - Lease Income (Details) Sheet http://www.natus.com/role/LeasesLeaseIncomeDetails Leases - Lease Income (Details) Details 64 false false R65.htm 2436420 - Disclosure - Leases - Sales Type Lease Receivable (Details) Sheet http://www.natus.com/role/LeasesSalesTypeLeaseReceivableDetails Leases - Sales Type Lease Receivable (Details) Details 65 false false R66.htm 2437421 - Disclosure - Leases - Lease Payments Receivable Maturity (Details) Sheet http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails Leases - Lease Payments Receivable Maturity (Details) Details 66 false false R67.htm 2440422 - Disclosure - Accrued Liabilities (Details) Sheet http://www.natus.com/role/AccruedLiabilitiesDetails Accrued Liabilities (Details) Details http://www.natus.com/role/AccruedLiabilitiesTables 67 false false R68.htm 2443423 - Disclosure - Long-Term Other Liabilities (Details) Sheet http://www.natus.com/role/LongTermOtherLiabilitiesDetails Long-Term Other Liabilities (Details) Details http://www.natus.com/role/LongTermOtherLiabilitiesTables 68 false false R69.htm 2445424 - Disclosure - Debt and Credit Arrangements - Narrative (Details) Sheet http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails Debt and Credit Arrangements - Narrative (Details) Details 69 false false R70.htm 2447425 - Disclosure - Reserve for Product Warranties (Details) Sheet http://www.natus.com/role/ReserveforProductWarrantiesDetails Reserve for Product Warranties (Details) Details http://www.natus.com/role/ReserveforProductWarranties 70 false false R71.htm 2449426 - Disclosure - Stockholders' Equity (Details) Sheet http://www.natus.com/role/StockholdersEquityDetails Stockholders' Equity (Details) Details http://www.natus.com/role/StockholdersEquity 71 false false R72.htm 2452427 - Disclosure - Earnings Per Share - Components of Basic and Diluted EPS (Detail) Sheet http://www.natus.com/role/EarningsPerShareComponentsofBasicandDilutedEPSDetail Earnings Per Share - Components of Basic and Diluted EPS (Detail) Details 72 false false R73.htm 2455428 - Disclosure - Share-Based Compensation - Share-based Compensation Expense Allocation (Details) Sheet http://www.natus.com/role/ShareBasedCompensationSharebasedCompensationExpenseAllocationDetails Share-Based Compensation - Share-based Compensation Expense Allocation (Details) Details 73 false false R74.htm 2456429 - Disclosure - Share-Based Compensation - Narrative (Details) Sheet http://www.natus.com/role/ShareBasedCompensationNarrativeDetails Share-Based Compensation - Narrative (Details) Details 74 false false R75.htm 2457430 - Disclosure - Share-Based Compensation - Stock Option Activity (Details) Sheet http://www.natus.com/role/ShareBasedCompensationStockOptionActivityDetails Share-Based Compensation - Stock Option Activity (Details) Details 75 false false R76.htm 2458431 - Disclosure - Share-Based Compensation - Valuation Inputs (Details) Sheet http://www.natus.com/role/ShareBasedCompensationValuationInputsDetails Share-Based Compensation - Valuation Inputs (Details) Details 76 false false R77.htm 2459432 - Disclosure - Share-Based Compensation - Restricted Stock Award Activity (Details) Sheet http://www.natus.com/role/ShareBasedCompensationRestrictedStockAwardActivityDetails Share-Based Compensation - Restricted Stock Award Activity (Details) Details 77 false false R78.htm 2460433 - Disclosure - Share-Based Compensation - Restricted Unit Activity (Details) Sheet http://www.natus.com/role/ShareBasedCompensationRestrictedUnitActivityDetails Share-Based Compensation - Restricted Unit Activity (Details) Details 78 false false R79.htm 2463434 - Disclosure - Other Income (Expense), Net (Details) Sheet http://www.natus.com/role/OtherIncomeExpenseNetDetails Other Income (Expense), Net (Details) Details http://www.natus.com/role/OtherIncomeExpenseNetTables 79 false false R80.htm 2466435 - Disclosure - Income Taxes - Income Loss before Provision (Benefit) for Income Tax (Details) Sheet http://www.natus.com/role/IncomeTaxesIncomeLossbeforeProvisionBenefitforIncomeTaxDetails Income Taxes - Income Loss before Provision (Benefit) for Income Tax (Details) Details 80 false false R81.htm 2467436 - Disclosure - Income Taxes - Component of Income Tax Expense (Details) Sheet http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails Income Taxes - Component of Income Tax Expense (Details) Details 81 false false R82.htm 2468437 - Disclosure - Income Taxes - Components of Deferred Tax Asset and Liabilities (Details) Sheet http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails Income Taxes - Components of Deferred Tax Asset and Liabilities (Details) Details 82 false false R83.htm 2469438 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.natus.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 83 false false R84.htm 2470439 - Disclosure - Income Taxes - Reconciliation of Income tax Expense from Continuous Operation (Details) Sheet http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails Income Taxes - Reconciliation of Income tax Expense from Continuous Operation (Details) Details 84 false false R85.htm 2471440 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details) Sheet http://www.natus.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails Income Taxes - Unrecognized Tax Benefits (Details) Details 85 false false R86.htm 2473441 - Disclosure - Employee Benefit Plan (Details) Sheet http://www.natus.com/role/EmployeeBenefitPlanDetails Employee Benefit Plan (Details) Details http://www.natus.com/role/EmployeeBenefitPlan 86 false false R87.htm 2476442 - Disclosure - Segment, Customer and Geographic Information - Narrative (Details) Sheet http://www.natus.com/role/SegmentCustomerandGeographicInformationNarrativeDetails Segment, Customer and Geographic Information - Narrative (Details) Details 87 false false R88.htm 2477443 - Disclosure - Segment, Customer and Geographic Information (Details) Sheet http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails Segment, Customer and Geographic Information (Details) Details http://www.natus.com/role/SegmentCustomerandGeographicInformationTables 88 false false R89.htm 2479444 - Disclosure - Commitments And Contingencies - Narrative (Details) Sheet http://www.natus.com/role/CommitmentsAndContingenciesNarrativeDetails Commitments And Contingencies - Narrative (Details) Details 89 false false R90.htm 2481445 - Disclosure - Fair Value Measurements - Narrative (Details) Sheet http://www.natus.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements - Narrative (Details) Details 90 false false R91.htm 2483446 - Disclosure - Sale of Certain Subsidiary (Details) Sheet http://www.natus.com/role/SaleofCertainSubsidiaryDetails Sale of Certain Subsidiary (Details) Details http://www.natus.com/role/SaleofCertainSubsidiaryAssetsSaleofCertainSubsidiaryAssets 91 false false R92.htm 2485447 - Disclosure - Schedule II: Valuation And Qualifying Accounts (Details) Sheet http://www.natus.com/role/ScheduleIIValuationAndQualifyingAccountsDetails Schedule II: Valuation And Qualifying Accounts (Details) Details http://www.natus.com/role/ScheduleIIValuationAndQualifyingAccounts 92 false false All Reports Book All Reports ntus-20211231.htm exhibit211123121.htm exhibit231123121.htm exhibit311123121.htm exhibit312123121.htm exhibit321123121.htm ntus-20211231.xsd ntus-20211231_cal.xml ntus-20211231_def.xml ntus-20211231_lab.xml ntus-20211231_pre.xml ntus-20211231_g1.jpg http://fasb.org/srt/2021-01-31 http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true JSON 112 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ntus-20211231.htm": { "axisCustom": 0, "axisStandard": 24, "contextCount": 227, "dts": { "calculationLink": { "local": [ "ntus-20211231_cal.xml" ] }, "definitionLink": { "local": [ "ntus-20211231_def.xml" ] }, "inline": { "local": [ "ntus-20211231.htm" ] }, "labelLink": { "local": [ "ntus-20211231_lab.xml" ] }, "presentationLink": { "local": [ "ntus-20211231_pre.xml" ] }, "schema": { "local": [ "ntus-20211231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 715, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 43, "http://xbrl.sec.gov/dei/2021q4": 4, "total": 47 }, "keyCustom": 47, "keyStandard": 538, "memberCustom": 14, "memberStandard": 52, "nsprefix": "ntus", "nsuri": "http://www.natus.com/20211231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Document and Entity Information", "role": "http://www.natus.com/role/DocumentandEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForCreditLossesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2108103 - Disclosure - Allowance for Doubtful Accounts", "role": "http://www.natus.com/role/AllowanceforDoubtfulAccounts", "shortName": "Allowance for Doubtful Accounts", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForCreditLossesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2111104 - Disclosure - Inventories", "role": "http://www.natus.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2115105 - Disclosure - Property and Equipment", "role": "http://www.natus.com/role/PropertyandEquipment", "shortName": "Property and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2119106 - Disclosure - Intangible Assets", "role": "http://www.natus.com/role/IntangibleAssets", "shortName": "Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2125107 - Disclosure - Goodwill", "role": "http://www.natus.com/role/Goodwill", "shortName": "Goodwill", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "us-gaap:LessorSalesTypeLeasesTextBlock", "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2128108 - Disclosure - Leases", "role": "http://www.natus.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "us-gaap:LessorSalesTypeLeasesTextBlock", "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2138109 - Disclosure - Accrued Liabilities", "role": "http://www.natus.com/role/AccruedLiabilities", "shortName": "Accrued Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2141110 - Disclosure - Long-Term Other Liabilities", "role": "http://www.natus.com/role/LongTermOtherLiabilities", "shortName": "Long-Term Other Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2144111 - Disclosure - Debt and Credit Arrangements", "role": "http://www.natus.com/role/DebtandCreditArrangements", "shortName": "Debt and Credit Arrangements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2146112 - Disclosure - Reserve for Product Warranties", "role": "http://www.natus.com/role/ReserveforProductWarranties", "shortName": "Reserve for Product Warranties", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001002 - Statement - Consolidated Balance Sheets", "role": "http://www.natus.com/role/ConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2148113 - Disclosure - Stockholders' Equity", "role": "http://www.natus.com/role/StockholdersEquity", "shortName": "Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2150114 - Disclosure - Earnings Per Share", "role": "http://www.natus.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2153115 - Disclosure - Share-Based Compensation", "role": "http://www.natus.com/role/ShareBasedCompensation", "shortName": "Share-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2161116 - Disclosure - Other Income (Expense), Net", "role": "http://www.natus.com/role/OtherIncomeExpenseNet", "shortName": "Other Income (Expense), Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2164117 - Disclosure - Income Taxes", "role": "http://www.natus.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2172118 - Disclosure - Employee Benefit Plan", "role": "http://www.natus.com/role/EmployeeBenefitPlan", "shortName": "Employee Benefit Plan", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2174119 - Disclosure - Segment, Customer and Geographic Information", "role": "http://www.natus.com/role/SegmentCustomerandGeographicInformation", "shortName": "Segment, Customer and Geographic Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2178120 - Disclosure - Commitments And Contingencies", "role": "http://www.natus.com/role/CommitmentsAndContingencies", "shortName": "Commitments And Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2180121 - Disclosure - Fair Value Measurements", "role": "http://www.natus.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2182122 - Disclosure - Sale of Certain Subsidiary Assets Sale of Certain Subsidiary Assets", "role": "http://www.natus.com/role/SaleofCertainSubsidiaryAssetsSaleofCertainSubsidiaryAssets", "shortName": "Sale of Certain Subsidiary Assets Sale of Certain Subsidiary Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002003 - Statement - Consolidated Balance Sheets (Parenthetical)", "role": "http://www.natus.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R30": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2184123 - Disclosure - Schedule II: Valuation And Qualifying Accounts", "role": "http://www.natus.com/role/ScheduleIIValuationAndQualifyingAccounts", "shortName": "Schedule II: Valuation And Qualifying Accounts", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2202201 - Disclosure - Organization and Significant Accounting Policies (Policies)", "role": "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies", "shortName": "Organization and Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2305301 - Disclosure - Revenue (Tables)", "role": "http://www.natus.com/role/RevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2309302 - Disclosure - Allowance for Doubtful Accounts (Tables)", "role": "http://www.natus.com/role/AllowanceforDoubtfulAccountsTables", "shortName": "Allowance for Doubtful Accounts (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2312303 - Disclosure - Inventories (Tables)", "role": "http://www.natus.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2316304 - Disclosure - Property and Equipment (Tables)", "role": "http://www.natus.com/role/PropertyandEquipmentTables", "shortName": "Property and Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ntus:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2320305 - Disclosure - Intangible Assets (Tables)", "role": "http://www.natus.com/role/IntangibleAssetsTables", "shortName": "Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ntus:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2326306 - Disclosure - Goodwill (Tables)", "role": "http://www.natus.com/role/GoodwillTables", "shortName": "Goodwill (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2329307 - Disclosure - Leases (Tables)", "role": "http://www.natus.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2339308 - Disclosure - Accrued Liabilities (Tables)", "role": "http://www.natus.com/role/AccruedLiabilitiesTables", "shortName": "Accrued Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003004 - Statement - Consolidated Statements of Operations", "role": "http://www.natus.com/role/ConsolidatedStatementsofOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CostsAndExpenses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2342309 - Disclosure - Long-Term Other Liabilities (Tables)", "role": "http://www.natus.com/role/LongTermOtherLiabilitiesTables", "shortName": "Long-Term Other Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2351310 - Disclosure - Earnings Per Share (Tables)", "role": "http://www.natus.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2354311 - Disclosure - Share-Based Compensation (Tables)", "role": "http://www.natus.com/role/ShareBasedCompensationTables", "shortName": "Share-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2362312 - Disclosure - Other Income (Expense), Net (Tables)", "role": "http://www.natus.com/role/OtherIncomeExpenseNetTables", "shortName": "Other Income (Expense), Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2365313 - Disclosure - Income Taxes (Tables)", "role": "http://www.natus.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2375314 - Disclosure - Segment, Customer and Geographic Information (Tables)", "role": "http://www.natus.com/role/SegmentCustomerandGeographicInformationTables", "shortName": "Segment, Customer and Geographic Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "iff69f95bcf8b4240bbfb8682718623cc_D20190101-20191231", "decimals": "0", "first": true, "lang": "en-US", "name": "ntus:NumberOfStrategicBusinessUnits", "reportCount": 1, "unitRef": "strategicbusinessunit", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403401 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)", "role": "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails", "shortName": "Organization and Significant Accounting Policies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:NumberOfReportingUnits", "us-gaap:NumberOfReportingUnits", "span", "div", "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "0", "lang": "en-US", "name": "us-gaap:NumberOfReportingUnits", "reportCount": 1, "unique": true, "unitRef": "reporting_unit", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406402 - Disclosure - Revenue - Narrative (Details)", "role": "http://www.natus.com/role/RevenueNarrativeDetails", "shortName": "Revenue - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i98f1778ae90c459b97a0e16660d606a8_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407403 - Disclosure - Revenue - Unbilled AR and Deferred Revenue (Details)", "role": "http://www.natus.com/role/RevenueUnbilledARandDeferredRevenueDetails", "shortName": "Revenue - Unbilled AR and Deferred Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i98f1778ae90c459b97a0e16660d606a8_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i98f1778ae90c459b97a0e16660d606a8_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410404 - Disclosure - Allowance for Doubtful Accounts (Details)", "role": "http://www.natus.com/role/AllowanceforDoubtfulAccountsDetails", "shortName": "Allowance for Doubtful Accounts (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004005 - Statement - Consolidated Statements of Comprehensive Income (Loss) Consolidated Statement of Comprehensive Income (Loss)", "role": "http://www.natus.com/role/ConsolidatedStatementsofComprehensiveIncomeLossConsolidatedStatementofComprehensiveIncomeLoss", "shortName": "Consolidated Statements of Comprehensive Income (Loss) Consolidated Statement of Comprehensive Income (Loss)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413405 - Disclosure - Inventories (Details)", "role": "http://www.natus.com/role/InventoriesDetails", "shortName": "Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryNoncurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414406 - Disclosure - Inventories - Narrative (Details)", "role": "http://www.natus.com/role/InventoriesNarrativeDetails", "shortName": "Inventories - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417407 - Disclosure - Property and Equipment (Details)", "role": "http://www.natus.com/role/PropertyandEquipmentDetails", "shortName": "Property and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418408 - Disclosure - Property and Equipment - Narrative (Details)", "role": "http://www.natus.com/role/PropertyandEquipmentNarrativeDetails", "shortName": "Property and Equipment - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "ntus:AmortizationofIntangibleAssetsProductionandNonproduction", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421409 - Disclosure - Intangible Assets - Narrative (Details)", "role": "http://www.natus.com/role/IntangibleAssetsNarrativeDetails", "shortName": "Intangible Assets - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ntus:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2422410 - Disclosure - Intangible Assets - Components of Gross and Net Intangible Asset Balances (Details)", "role": "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails", "shortName": "Intangible Assets - Components of Gross and Net Intangible Asset Balances (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ntus:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "ntus:AmortizationofIntangibleAssetsProductionandNonproduction", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2423411 - Disclosure - Intangible Assets - Schedule of Amortization Expense (Details)", "role": "http://www.natus.com/role/IntangibleAssetsScheduleofAmortizationExpenseDetails", "shortName": "Intangible Assets - Schedule of Amortization Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i9a4726c7bbd149faa4a61525bba83e24_D20210101-20211231", "decimals": "-3", "lang": "en-US", "name": "ntus:AmortizationofIntangibleAssetsProductionandNonproduction", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2424412 - Disclosure - Intangible Assets - Expected Annual Amortization Expense (Details)", "role": "http://www.natus.com/role/IntangibleAssetsExpectedAnnualAmortizationExpenseDetails", "shortName": "Intangible Assets - Expected Annual Amortization Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i98f1778ae90c459b97a0e16660d606a8_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2427413 - Disclosure - Goodwill (Details)", "role": "http://www.natus.com/role/GoodwillDetails", "shortName": "Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i7accc2cbcfc54c15aa016680d5046d4b_I20191231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseRenewalTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2430414 - Disclosure - Leases - Narrative (Details)", "role": "http://www.natus.com/role/LeasesNarrativeDetails", "shortName": "Leases - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseRenewalTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i24bfe95fa4f8473ca9bd214c7dfa284b_D20190101-20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005006 - Statement - Consolidated Statements of Stockholders' Equity", "role": "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity", "shortName": "Consolidated Statements of Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i24bfe95fa4f8473ca9bd214c7dfa284b_D20190101-20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2431415 - Disclosure - Leases - Lease Cost (Details)", "role": "http://www.natus.com/role/LeasesLeaseCostDetails", "shortName": "Leases - Lease Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2432416 - Disclosure - Leases - Supplemental Cash Flow (Details)", "role": "http://www.natus.com/role/LeasesSupplementalCashFlowDetails", "shortName": "Leases - Supplemental Cash Flow (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2433417 - Disclosure - Leases - Supplemental Balance Sheet (Details)", "role": "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails", "shortName": "Leases - Supplemental Balance Sheet (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ntus:AssetsandLiabilitiesLesseeTableTextBlock", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "lang": "en-US", "name": "ntus:FinanceLeaseRightOfUseAssetGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2434418 - Disclosure - Leases - Lease Maturities (Details)", "role": "http://www.natus.com/role/LeasesLeaseMaturitiesDetails", "shortName": "Leases - Lease Maturities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:SalesTypeLeaseLeaseIncome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2435419 - Disclosure - Leases - Lease Income (Details)", "role": "http://www.natus.com/role/LeasesLeaseIncomeDetails", "shortName": "Leases - Lease Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:SalesTypeLeaseLeaseIncome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2436420 - Disclosure - Leases - Sales Type Lease Receivable (Details)", "role": "http://www.natus.com/role/LeasesSalesTypeLeaseReceivableDetails", "shortName": "Leases - Sales Type Lease Receivable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:NetInvestmentInLeaseCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2437421 - Disclosure - Leases - Lease Payments Receivable Maturity (Details)", "role": "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails", "shortName": "Leases - Lease Payments Receivable Maturity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2440422 - Disclosure - Accrued Liabilities (Details)", "role": "http://www.natus.com/role/AccruedLiabilitiesDetails", "shortName": "Accrued Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LiabilityForUncertainTaxPositionsNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2443423 - Disclosure - Long-Term Other Liabilities (Details)", "role": "http://www.natus.com/role/LongTermOtherLiabilitiesDetails", "shortName": "Long-Term Other Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LiabilityForUncertainTaxPositionsNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i04f2f382082d45498898fac29eebda3a_I20191231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2445424 - Disclosure - Debt and Credit Arrangements - Narrative (Details)", "role": "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails", "shortName": "Debt and Credit Arrangements - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i04f2f382082d45498898fac29eebda3a_I20191231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006007 - Statement - Consolidated Statements of Cash Flows", "role": "http://www.natus.com/role/ConsolidatedStatementsofCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ntus:StandardProductWarrantyPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2447425 - Disclosure - Reserve for Product Warranties (Details)", "role": "http://www.natus.com/role/ReserveforProductWarrantiesDetails", "shortName": "Reserve for Product Warranties (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ntus:StandardProductWarrantyPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2449426 - Disclosure - Stockholders' Equity (Details)", "role": "http://www.natus.com/role/StockholdersEquityDetails", "shortName": "Stockholders' Equity (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R72": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2452427 - Disclosure - Earnings Per Share - Components of Basic and Diluted EPS (Detail)", "role": "http://www.natus.com/role/EarningsPerShareComponentsofBasicandDilutedEPSDetail", "shortName": "Earnings Per Share - Components of Basic and Diluted EPS (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2455428 - Disclosure - Share-Based Compensation - Share-based Compensation Expense Allocation (Details)", "role": "http://www.natus.com/role/ShareBasedCompensationSharebasedCompensationExpenseAllocationDetails", "shortName": "Share-Based Compensation - Share-based Compensation Expense Allocation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2456429 - Disclosure - Share-Based Compensation - Narrative (Details)", "role": "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails", "shortName": "Share-Based Compensation - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i98f1778ae90c459b97a0e16660d606a8_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2457430 - Disclosure - Share-Based Compensation - Stock Option Activity (Details)", "role": "http://www.natus.com/role/ShareBasedCompensationStockOptionActivityDetails", "shortName": "Share-Based Compensation - Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i98f1778ae90c459b97a0e16660d606a8_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2458431 - Disclosure - Share-Based Compensation - Valuation Inputs (Details)", "role": "http://www.natus.com/role/ShareBasedCompensationValuationInputsDetails", "shortName": "Share-Based Compensation - Valuation Inputs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4d3a964e3cde4fb38fc29ea0b3276c58_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2459432 - Disclosure - Share-Based Compensation - Restricted Stock Award Activity (Details)", "role": "http://www.natus.com/role/ShareBasedCompensationRestrictedStockAwardActivityDetails", "shortName": "Share-Based Compensation - Restricted Stock Award Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "ia2fc410147364d44ab83b757a0601aab_D20210101-20211231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i5cee6d5a4acf4bc28a87c59182844162_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2460433 - Disclosure - Share-Based Compensation - Restricted Unit Activity (Details)", "role": "http://www.natus.com/role/ShareBasedCompensationRestrictedUnitActivityDetails", "shortName": "Share-Based Compensation - Restricted Unit Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i5cee6d5a4acf4bc28a87c59182844162_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InvestmentIncomeInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2463434 - Disclosure - Other Income (Expense), Net (Details)", "role": "http://www.natus.com/role/OtherIncomeExpenseNetDetails", "shortName": "Other Income (Expense), Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InvestmentIncomeInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101101 - Disclosure - Organization and Significant Accounting Policies", "role": "http://www.natus.com/role/OrganizationandSignificantAccountingPolicies", "shortName": "Organization and Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2466435 - Disclosure - Income Taxes - Income Loss before Provision (Benefit) for Income Tax (Details)", "role": "http://www.natus.com/role/IncomeTaxesIncomeLossbeforeProvisionBenefitforIncomeTaxDetails", "shortName": "Income Taxes - Income Loss before Provision (Benefit) for Income Tax (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2467436 - Disclosure - Income Taxes - Component of Income Tax Expense (Details)", "role": "http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails", "shortName": "Income Taxes - Component of Income Tax Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2468437 - Disclosure - Income Taxes - Components of Deferred Tax Asset and Liabilities (Details)", "role": "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails", "shortName": "Income Taxes - Components of Deferred Tax Asset and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsTaxCreditCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2469438 - Disclosure - Income Taxes - Narrative (Details)", "role": "http://www.natus.com/role/IncomeTaxesNarrativeDetails", "shortName": "Income Taxes - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2470439 - Disclosure - Income Taxes - Reconciliation of Income tax Expense from Continuous Operation (Details)", "role": "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails", "shortName": "Income Taxes - Reconciliation of Income tax Expense from Continuous Operation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i98f1778ae90c459b97a0e16660d606a8_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2471440 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)", "role": "http://www.natus.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails", "shortName": "Income Taxes - Unrecognized Tax Benefits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "iff69f95bcf8b4240bbfb8682718623cc_D20190101-20191231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2473441 - Disclosure - Employee Benefit Plan (Details)", "role": "http://www.natus.com/role/EmployeeBenefitPlanDetails", "shortName": "Employee Benefit Plan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "iff69f95bcf8b4240bbfb8682718623cc_D20190101-20191231", "decimals": "0", "first": true, "lang": "en-US", "name": "ntus:NumberOfStrategicBusinessUnits", "reportCount": 1, "unitRef": "strategicbusinessunit", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2476442 - Disclosure - Segment, Customer and Geographic Information - Narrative (Details)", "role": "http://www.natus.com/role/SegmentCustomerandGeographicInformationNarrativeDetails", "shortName": "Segment, Customer and Geographic Information - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2477443 - Disclosure - Segment, Customer and Geographic Information (Details)", "role": "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails", "shortName": "Segment, Customer and Geographic Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:NoncurrentAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:PurchaseObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2479444 - Disclosure - Commitments And Contingencies - Narrative (Details)", "role": "http://www.natus.com/role/CommitmentsAndContingenciesNarrativeDetails", "shortName": "Commitments And Contingencies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i343a6ed332ff4701be70332781477743_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:PurchaseObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2104102 - Disclosure - Revenue", "role": "http://www.natus.com/role/Revenue", "shortName": "Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i4914f1b18be84ab0b0f56bd357693aa7_D20210101-20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2481445 - Disclosure - Fair Value Measurements - Narrative (Details)", "role": "http://www.natus.com/role/FairValueMeasurementsNarrativeDetails", "shortName": "Fair Value Measurements - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i538d48ad4bfd4fe1add576e94f65d990_D20210701-20210930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i33f42de6c4174bec9c09e99d2fdc99db_D20210401-20210630", "decimals": "-5", "first": true, "lang": "en-US", "name": "ntus:GainOnNotesReceivableFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2483446 - Disclosure - Sale of Certain Subsidiary (Details)", "role": "http://www.natus.com/role/SaleofCertainSubsidiaryDetails", "shortName": "Sale of Certain Subsidiary (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i33f42de6c4174bec9c09e99d2fdc99db_D20210401-20210630", "decimals": "-5", "first": true, "lang": "en-US", "name": "ntus:GainOnNotesReceivableFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i9e41ae22e1d14b06bc8399966e24614f_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2485447 - Disclosure - Schedule II: Valuation And Qualifying Accounts (Details)", "role": "http://www.natus.com/role/ScheduleIIValuationAndQualifyingAccountsDetails", "shortName": "Schedule II: Valuation And Qualifying Accounts (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "body", "html" ], "baseRef": "ntus-20211231.htm", "contextRef": "i478ada7cd19544de969016b83cd96d02_I20181231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } } }, "segmentCount": 66, "tag": { "country_CA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CANADA", "terseLabel": "Canada" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.natus.com/role/FairValueMeasurementsNarrativeDetails", "http://www.natus.com/role/IncomeTaxesNarrativeDetails", "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "domainItemType" }, "country_CN": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CHINA", "terseLabel": "CHINA" } } }, "localname": "CN", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "country_DE": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "GERMANY", "terseLabel": "Germany" } } }, "localname": "DE", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "country_DK": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DENMARK", "terseLabel": "Denmark", "verboseLabel": "Denmark" } } }, "localname": "DK", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails", "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "domainItemType" }, "country_FR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FRANCE", "terseLabel": "France" } } }, "localname": "FR", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "country_GB": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED KINGDOM", "terseLabel": "UNITED KINGDOM" } } }, "localname": "GB", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.natus.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "country_IE": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IRELAND", "terseLabel": "Ireland" } } }, "localname": "IE", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails", "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r703", "r704", "r705" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r703", "r704", "r705" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r703", "r704", "r705" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r703", "r704", "r705" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r706" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r701" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r707" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r719" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r703", "r704", "r705" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r699" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r702" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.natus.com/role/DocumentandEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "ntus_AccruedPayrollTaxesNoncurrentCARESAct": { "auth_ref": [], "calculation": { "http://www.natus.com/role/LongTermOtherLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Payroll Taxes, Noncurrent, CARES Act", "label": "Accrued Payroll Taxes, Noncurrent, CARES Act", "terseLabel": "CARES Act payroll tax payable" } } }, "localname": "AccruedPayrollTaxesNoncurrentCARESAct", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/LongTermOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ntus_AccruedSellingExpenseCurrent": { "auth_ref": [], "calculation": { "http://www.natus.com/role/AccruedLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Selling Expense, Current", "label": "Accrued Selling Expense, Current", "terseLabel": "Accrued selling expenses" } } }, "localname": "AccruedSellingExpenseCurrent", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/AccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ntus_AccruedTravelCurrent": { "auth_ref": [], "calculation": { "http://www.natus.com/role/AccruedLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Travel, Current", "label": "Accrued Travel, Current", "terseLabel": "Accrued travel" } } }, "localname": "AccruedTravelCurrent", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/AccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ntus_AccumulatedImpairmentOfIntangibleAssetsExcludingGoodwill": { "auth_ref": [], "calculation": { "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails": { "order": 3.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated Impairment of Intangible Assets (excluding Goodwill)", "label": "Accumulated Impairment of Intangible Assets (excluding Goodwill)", "negatedTerseLabel": "Accumulated Impairment" } } }, "localname": "AccumulatedImpairmentOfIntangibleAssetsExcludingGoodwill", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails" ], "xbrltype": "monetaryItemType" }, "ntus_AmortizationofIntangibleAssetsProductionandNonproduction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization of Intangible Assets, Production and Nonproduction", "label": "Amortization of Intangible Assets, Production and Nonproduction", "terseLabel": "Total amortization" } } }, "localname": "AmortizationofIntangibleAssetsProductionandNonproduction", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/IntangibleAssetsNarrativeDetails", "http://www.natus.com/role/IntangibleAssetsScheduleofAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "ntus_AssetsandLiabilitiesLesseeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets and Liabilities, Lessee [Table Text Block]", "label": "Assets and Liabilities, Lessee [Table Text Block]", "terseLabel": "Assets and Liabilities, Lessee" } } }, "localname": "AssetsandLiabilitiesLesseeTableTextBlock", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "ntus_CapitalExpendituresIncurredButNotYetPaidPrepaymentsForCapitalExpenditures": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Capital Expenditures Incurred But Not Yet Paid (Prepayments For Capital Expenditures)", "label": "Capital Expenditures Incurred But Not Yet Paid (Prepayments For Capital Expenditures)", "terseLabel": "Property and equipment included in accounts payable" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaidPrepaymentsForCapitalExpenditures", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "ntus_CitibankNationalAssociationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Citibank, National Association [Member]", "label": "Citibank, National Association [Member]", "terseLabel": "Citibank, National Association [Member]" } } }, "localname": "CitibankNationalAssociationMember", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "ntus_ContractWithCustomerAssetIncreaseFromPerformanceObligationSatisfied": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Contract With Customer, Asset, Increase From Performance Obligation Satisfied", "label": "Contract With Customer, Asset, Increase From Performance Obligation Satisfied", "terseLabel": "Additions" } } }, "localname": "ContractWithCustomerAssetIncreaseFromPerformanceObligationSatisfied", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/RevenueUnbilledARandDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "ntus_ContractWithCustomerLiabilityIncreaseFromCashReceipts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Contract With Customer, Liability, Increase From Cash Receipts", "label": "Contract With Customer, Liability, Increase From Cash Receipts", "terseLabel": "Additions" } } }, "localname": "ContractWithCustomerLiabilityIncreaseFromCashReceipts", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/RevenueUnbilledARandDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "ntus_ContractWithCustomerServicePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contract With Customer, Service Period", "label": "Contract With Customer, Service Period", "terseLabel": "Contract with customer, service period" } } }, "localname": "ContractWithCustomerServicePeriod", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "ntus_CostsIncurredForDevelopmentOfInternalUseComputerSoftware": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Costs incurred for development of internal use computer software.", "label": "Costs Incurred for Development of Internal Use Computer Software", "terseLabel": "Costs incurred for development of internal use computer software" } } }, "localname": "CostsIncurredForDevelopmentOfInternalUseComputerSoftware", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/IntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ntus_CreditAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit Agreement [Member]", "label": "Credit Agreement [Member]", "terseLabel": "Credit Agreement [Member]" } } }, "localname": "CreditAgreementMember", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "ntus_DeferredTaxAssetsLeaseLiabilities": { "auth_ref": [], "calculation": { "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Lease Liabilities", "label": "Deferred Tax Assets, Lease Liabilities", "terseLabel": "Operating leases" } } }, "localname": "DeferredTaxAssetsLeaseLiabilities", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ntus_DeferredTaxLiabilitiesBasisDifferenceInFixedAndIntangibleAssets": { "auth_ref": [], "calculation": { "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred tax liabilities basis difference in fixed and intangible assets.", "label": "Deferred Tax Liabilities Basis Difference In Fixed And Intangible Assets", "negatedLabel": "Basis difference in fixed and intangible assets" } } }, "localname": "DeferredTaxLiabilitiesBasisDifferenceInFixedAndIntangibleAssets", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ntus_DeferredTaxLiabilitiesRightOfUseAssets": { "auth_ref": [], "calculation": { "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Liabilities, Right-Of-Use Assets", "label": "Deferred Tax Liabilities, Right-Of-Use Assets", "negatedTerseLabel": "Operating leases" } } }, "localname": "DeferredTaxLiabilitiesRightOfUseAssets", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ntus_DefinedContributionPlanEmployerMatchingContributionRatableVestingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Contribution Plan, Employer Matching Contribution, Ratable Vesting Period", "label": "Defined Contribution Plan, Employer Matching Contribution, Ratable Vesting Period", "terseLabel": "Employer matching contribution, ratable vesting period" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionRatableVestingPeriod", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/EmployeeBenefitPlanDetails" ], "xbrltype": "durationItemType" }, "ntus_DemonstrationAndLoanedEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Demonstration and loaned equipment.", "label": "Demonstration and Loaned Equipment [Member]", "terseLabel": "Demonstration and loaned equipment [Member]" } } }, "localname": "DemonstrationAndLoanedEquipmentMember", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/PropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "ntus_DevicesAndSystemsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Devices and systems.", "label": "Devices and Systems [Member]", "terseLabel": "Devices and Systems [Member]" } } }, "localname": "DevicesAndSystemsMember", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "domainItemType" }, "ntus_EarnoutLiabilityNoncurrent": { "auth_ref": [], "calculation": { "http://www.natus.com/role/LongTermOtherLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Earnout Liability, Noncurrent", "label": "Earnout Liability, Noncurrent", "terseLabel": "Long-term earnout payable" } } }, "localname": "EarnoutLiabilityNoncurrent", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/LongTermOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ntus_EffectiveIncomeTaxRateReconciliationFederalNetOperatingLossCarrybackAmount": { "auth_ref": [], "calculation": { "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails": { "order": 11.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Federal Net Operating Loss Carryback, Amount", "label": "Effective Income Tax Rate Reconciliation, Federal Net Operating Loss Carryback, Amount", "terseLabel": "Federal NOL Carryback" } } }, "localname": "EffectiveIncomeTaxRateReconciliationFederalNetOperatingLossCarrybackAmount", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails" ], "xbrltype": "monetaryItemType" }, "ntus_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeNetofForeignTaxCreditsAmount": { "auth_ref": [], "calculation": { "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails": { "order": 6.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Global Intangible Low-Taxed Income Net of Foreign Tax Credits, Amount", "label": "Effective Income Tax Rate Reconciliation, Global Intangible Low-Taxed Income Net of Foreign Tax Credits, Amount", "terseLabel": "Global intangible low-taxed income net of foreign tax credits" } } }, "localname": "EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeNetofForeignTaxCreditsAmount", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails" ], "xbrltype": "monetaryItemType" }, "ntus_EffectiveIncomeTaxRateReconciliationReturnToProvision": { "auth_ref": [], "calculation": { "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails": { "order": 8.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Return To Provision", "label": "Effective Income Tax Rate Reconciliation, Return To Provision", "terseLabel": "Return to provision" } } }, "localname": "EffectiveIncomeTaxRateReconciliationReturnToProvision", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails" ], "xbrltype": "monetaryItemType" }, "ntus_EffectiveIncomeTaxRateReconciliationTaxAudit": { "auth_ref": [], "calculation": { "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails": { "order": 13.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Tax Audit", "label": "Effective Income Tax Rate Reconciliation, Tax Audit", "terseLabel": "Tax audits" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxAudit", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails" ], "xbrltype": "monetaryItemType" }, "ntus_EmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employees [Member]", "label": "Employees [Member]", "terseLabel": "Employees [Member]" } } }, "localname": "EmployeesMember", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ntus_FinanceLeaseRightOfUseAssetAccumulatedDepreciation": { "auth_ref": [], "calculation": { "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails": { "order": 2.0, "parentTag": "ntus_FinanceLeaseRightofUseAssetNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Finance Lease, Right-Of-Use Asset, Accumulated Depreciation", "label": "Finance Lease, Right-Of-Use Asset, Accumulated Depreciation", "negatedTerseLabel": "Finance leases, accumulated amortization" } } }, "localname": "FinanceLeaseRightOfUseAssetAccumulatedDepreciation", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "ntus_FinanceLeaseRightOfUseAssetGross": { "auth_ref": [], "calculation": { "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails": { "order": 1.0, "parentTag": "ntus_FinanceLeaseRightofUseAssetNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finance Lease, Right-Of-Use Asset, Gross", "label": "Finance Lease, Right-Of-Use Asset, Gross", "terseLabel": "Finance Leases, property and equipment" } } }, "localname": "FinanceLeaseRightOfUseAssetGross", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "ntus_FinanceLeaseRightofUseAssetNet": { "auth_ref": [], "calculation": { "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finance Lease, Right-of-Use Asset, Net", "label": "Finance Lease, Right-of-Use Asset, Net", "totalLabel": "Finance leases, property and equipment, net" } } }, "localname": "FinanceLeaseRightofUseAssetNet", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "ntus_ForeignCountriesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign countries.", "label": "Foreign Countries [Member]", "terseLabel": "Other Foreign countries [Member]" } } }, "localname": "ForeignCountriesMember", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "domainItemType" }, "ntus_GainOnNotesReceivableFromRelatedParties": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gain On Notes Receivable From Related Parties", "label": "Gain On Notes Receivable From Related Parties", "terseLabel": "Gain on note receivable from related party" } } }, "localname": "GainOnNotesReceivableFromRelatedParties", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/SaleofCertainSubsidiaryDetails" ], "xbrltype": "monetaryItemType" }, "ntus_ImpairmentOfIntangibleAssetsIndefinedLivedExcludingGoodwill": { "auth_ref": [], "calculation": { "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails": { "order": 2.0, "parentTag": "ntus_IndefiniteLivedIntangibleAssetsExcludingGoodwillNetOfImpairments", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Impairment of Intangible Assets Indefined Lived (excluding Goodwill)", "label": "Impairment of Intangible Assets Indefined Lived (excluding Goodwill)", "negatedTerseLabel": "Accumulated Impairment", "terseLabel": "Accumulated Impairment" } } }, "localname": "ImpairmentOfIntangibleAssetsIndefinedLivedExcludingGoodwill", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails", "http://www.natus.com/role/IntangibleAssetsNarrativeDetails", "http://www.natus.com/role/IntangibleAssetsScheduleofAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "ntus_ImpairmentofIntangibleAssetsDefinedLivedexcludingGoodwill": { "auth_ref": [], "calculation": { "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Impairment of Intangible Assets Defined Lived (excluding Goodwill)", "label": "Impairment of Intangible Assets Defined Lived (excluding Goodwill)", "negatedTerseLabel": "Accumulated Impairment" } } }, "localname": "ImpairmentofIntangibleAssetsDefinedLivedexcludingGoodwill", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails" ], "xbrltype": "monetaryItemType" }, "ntus_IncomeTaxProvisionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income Tax Provision [Member]", "label": "Income Tax Provision [Member]", "terseLabel": "Income Tax Provision" } } }, "localname": "IncomeTaxProvisionMember", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ntus_IncomeTaxReconciliationLapseOfStatuteAndAuditSettlementOnUncertainTaxPosition": { "auth_ref": [], "calculation": { "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails": { "order": 9.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income tax reconciliation lapse of statute and audit settlement on uncertain tax position.", "label": "Income Tax Reconciliation Lapse Of Statute And Audit Settlement On Uncertain Tax Position", "terseLabel": "Lapse of statute" } } }, "localname": "IncomeTaxReconciliationLapseOfStatuteAndAuditSettlementOnUncertainTaxPosition", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails" ], "xbrltype": "monetaryItemType" }, "ntus_IndefiniteLivedIntangibleAssetsExcludingGoodwillNetOfImpairments": { "auth_ref": [], "calculation": { "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Indefinite Lived Intangible Assets (Excluding Goodwill), Net of Impairments", "label": "Indefinite Lived Intangible Assets (Excluding Goodwill), Net of Impairments", "totalLabel": "Net Book Value" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillNetOfImpairments", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails" ], "xbrltype": "monetaryItemType" }, "ntus_InventoryCurrentAndNoncurrent": { "auth_ref": [], "calculation": { "http://www.natus.com/role/InventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Inventory current and noncurrent.", "label": "Inventory Current and Noncurrent", "totalLabel": "Total Inventories" } } }, "localname": "InventoryCurrentAndNoncurrent", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "ntus_LessorOperatingLeaseImputedInterest": { "auth_ref": [], "calculation": { "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails_1": { "order": 2.0, "parentTag": "ntus_LessorOperatingLeasePaymentsToBeReceivedBeforeImputedInterest", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lessor, Operating Lease, Imputed Interest", "label": "Lessor, Operating Lease, Imputed Interest", "negatedTerseLabel": "Less: imputed interest" } } }, "localname": "LessorOperatingLeaseImputedInterest", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "ntus_LessorOperatingLeaseNoticeOfTermination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessor, Operating Lease, Notice of Termination", "label": "Lessor, Operating Lease, Notice of Termination", "terseLabel": "Lessor, notice of termination" } } }, "localname": "LessorOperatingLeaseNoticeOfTermination", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "ntus_LessorOperatingLeasePaymentsToBeReceivedBeforeImputedInterest": { "auth_ref": [], "calculation": { "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Lessor, Operating Lease, Payments To Be Received Before Imputed Interest", "label": "Lessor, Operating Lease, Payments To Be Received Before Imputed Interest", "totalLabel": "Total future minimum lease payments" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedBeforeImputedInterest", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "ntus_MarketStockUnitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market Stock Unit", "label": "Market Stock Unit [Member]", "terseLabel": "Market Stock Unit" } } }, "localname": "MarketStockUnitMember", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ntus_MaximumEligibleCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Maximum eligible compensation.", "label": "Maximum Eligible Compensation", "terseLabel": "Eligible compensation of employees" } } }, "localname": "MaximumEligibleCompensation", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ntus_MedixMedicalDevicesSRLMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Medix Medical Devices, SRL [Member]", "label": "Medix Medical Devices, SRL [Member]", "terseLabel": "Medix Medical Devices, SRL [Member]" } } }, "localname": "MedixMedicalDevicesSRLMember", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/SaleofCertainSubsidiaryDetails" ], "xbrltype": "domainItemType" }, "ntus_MovementinUnbilledReceivablesRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Movement in Unbilled Receivables [Roll Forward]", "label": "Movement in Unbilled Receivables [Roll Forward]", "terseLabel": "Movement in Unbilled AR [Roll Forward]" } } }, "localname": "MovementinUnbilledReceivablesRollForward", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/RevenueUnbilledARandDeferredRevenueDetails" ], "xbrltype": "stringItemType" }, "ntus_NeurologyProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Neurology Products [Member]", "label": "Neurology Products [Member]", "terseLabel": "Neurology Products [Member]" } } }, "localname": "NeurologyProductsMember", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "domainItemType" }, "ntus_NewbornCareProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Newborn Care Products [Member]", "label": "Newborn Care Products [Member]", "terseLabel": "Newborn Care Products [Member]" } } }, "localname": "NewbornCareProductsMember", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "domainItemType" }, "ntus_NoncashLeaseExpense": { "auth_ref": [], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Noncash Lease Expense", "label": "Noncash Lease Expense", "terseLabel": "Non cash lease expense" } } }, "localname": "NoncashLeaseExpense", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "ntus_NumberOfStrategicBusinessUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Strategic Business Units", "label": "Number Of Strategic Business Units", "terseLabel": "Number of strategic business units" } } }, "localname": "NumberOfStrategicBusinessUnits", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails", "http://www.natus.com/role/SegmentCustomerandGeographicInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "ntus_OperatingLossCarryforwardPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating Loss Carryforward, Period", "label": "Operating Loss Carryforward, Period", "terseLabel": "Operating Loss Carryforward, Period" } } }, "localname": "OperatingLossCarryforwardPeriod", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "durationItemType" }, "ntus_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items]", "label": "Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items]", "terseLabel": "Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Line Items]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesLineItems", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "ntus_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Table]", "label": "Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Table]", "terseLabel": "Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Table]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTable", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "ntus_OtherComprehensiveIncomeLossNetOfTaxAndASUAdoptionImpact": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other Comprehensive Income (Loss), Net Of Tax And ASU Adoption Impact", "label": "Other Comprehensive Income (Loss), Net Of Tax And ASU Adoption Impact", "terseLabel": "Other comprehensive income, net of ASU adoption impact" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxAndASUAdoptionImpact", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "ntus_OtometricsProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "OtometricsProducts [Member]", "label": "OtometricsProducts [Member]", "terseLabel": "OtometricsProducts [Member]" } } }, "localname": "OtometricsProductsMember", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "domainItemType" }, "ntus_PurchaseObligationToBePaidAfterYearOne": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Purchase Obligation, To Be Paid, After Year One", "label": "Purchase Obligation, To Be Paid, After Year One", "terseLabel": "Purchase Obligation, To Be Paid, After Year One" } } }, "localname": "PurchaseObligationToBePaidAfterYearOne", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ntus_RatioofInterestCoverage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ratio of Interest Coverage", "label": "Ratio of Interest Coverage", "terseLabel": "Ratio of Interest Coverage" } } }, "localname": "RatioofInterestCoverage", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails" ], "xbrltype": "pureItemType" }, "ntus_SalesTypeLeaseNetInvestmentInLeaseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sales Type Lease, Net Investment In Lease", "label": "Sales Type Lease, Net Investment In Lease [Table Text Block]", "terseLabel": "Sales Type Lease, Net Investment In Lease" } } }, "localname": "SalesTypeLeaseNetInvestmentInLeaseTableTextBlock", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "ntus_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of finite and indefinite lived intangible assets.", "label": "Schedule of Finite and Indefinite Lived Intangible Assets [Table Text Block]", "terseLabel": "Components of Gross and Net Intangible Asset Balances" } } }, "localname": "ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "ntus_ScheduleOfIncomeTaxesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Income Taxes [Line Items]", "label": "Schedule Of Income Taxes [Line Items]", "terseLabel": "Schedule Of Income Taxes [Line Items]" } } }, "localname": "ScheduleOfIncomeTaxesLineItems", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "ntus_ScheduleOfIncomeTaxesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Income Taxes [Table]", "label": "Schedule Of Income Taxes [Table]", "terseLabel": "Schedule Of Income Taxes [Table]" } } }, "localname": "ScheduleOfIncomeTaxesTable", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "ntus_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsActivityTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Activity [Table]", "label": "Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Activity [Table]", "terseLabel": "Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Activity [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsActivityTable", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationRestrictedStockAwardActivityDetails", "http://www.natus.com/role/ShareBasedCompensationRestrictedUnitActivityDetails" ], "xbrltype": "stringItemType" }, "ntus_ServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Services [Member]", "label": "Services [Member]", "terseLabel": "Services [Member]" } } }, "localname": "ServicesMember", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "domainItemType" }, "ntus_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsOutstandingFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Fair Value", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Fair Value", "terseLabel": "Fair market value of outstanding awards" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsOutstandingFairValue", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ntus_StandardProductWarrantyPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Standard product warranty period.", "label": "Standard Product Warranty Period", "terseLabel": "Product warranty period" } } }, "localname": "StandardProductWarrantyPeriod", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/ReserveforProductWarrantiesDetails" ], "xbrltype": "durationItemType" }, "ntus_StandardProductWarrantyTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Standard Product Warranty, Term", "label": "Standard Product Warranty, Term", "terseLabel": "Warranty, term" } } }, "localname": "StandardProductWarrantyTerm", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "ntus_SuppliesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Supplies [Member]", "label": "Supplies [Member]", "terseLabel": "Supplies [Member]" } } }, "localname": "SuppliesMember", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "domainItemType" }, "ntus_TransferOfLeasedAssetsToSalesTypeLeases": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transfer Of Leased Assets To Sales-Type Leases", "label": "Transfer Of Leased Assets To Sales-Type Leases", "terseLabel": "Transfer of leased assets to sales-type leases" } } }, "localname": "TransferOfLeasedAssetsToSalesTypeLeases", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "ntus_VestingOfRestrictedStockUnits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Vesting of restricted stock units.", "label": "Vesting Of Restricted Stock Units", "terseLabel": "Vesting of restricted stock units" } } }, "localname": "VestingOfRestrictedStockUnits", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "ntus_VestingOfRestrictedStockUnitsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vesting of restricted stock units shares.", "label": "Vesting Of Restricted Stock Units Shares", "terseLabel": "Vesting of restricted stock units (shares)" } } }, "localname": "VestingOfRestrictedStockUnitsShares", "nsuri": "http://www.natus.com/20211231", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r0", "r151", "r157", "r164", "r237", "r445", "r446", "r447", "r487", "r488", "r519", "r521", "r522", "r523", "r720" ], "lang": { "en-us": { "role": { "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]", "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r0", "r151", "r157", "r164", "r237", "r445", "r446", "r447", "r487", "r488", "r519", "r521", "r522", "r523", "r720" ], "lang": { "en-us": { "role": { "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption [Axis]", "terseLabel": "Cumulative Effect, Period of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r0", "r151", "r157", "r164", "r237", "r445", "r446", "r447", "r487", "r488", "r519", "r521", "r522", "r523", "r720" ], "lang": { "en-us": { "role": { "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption [Domain]", "terseLabel": "Cumulative Effect, Period of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_DirectorMember": { "auth_ref": [ "r226" ], "lang": { "en-us": { "role": { "documentation": "Person serving on board of directors.", "label": "Director [Member]", "terseLabel": "Director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails", "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ExecutiveOfficerMember": { "auth_ref": [ "r226" ], "lang": { "en-us": { "role": { "documentation": "Person with designation of executive officer.", "label": "Executive Officer [Member]", "terseLabel": "Executives RSAs and RSUs [Member]" } } }, "localname": "ExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r321", "r353", "r403", "r404", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r667", "r670", "r695", "r696" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails", "http://www.natus.com/role/IncomeTaxesNarrativeDetails", "http://www.natus.com/role/LeasesNarrativeDetails", "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r321", "r353", "r403", "r404", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r667", "r670", "r695", "r696" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails", "http://www.natus.com/role/IncomeTaxesNarrativeDetails", "http://www.natus.com/role/LeasesNarrativeDetails", "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r220", "r386", "r390", "r614", "r666", "r668" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r220", "r386", "r390", "r614", "r666", "r668" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r321", "r353", "r401", "r403", "r404", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r667", "r670", "r695", "r696" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails", "http://www.natus.com/role/IncomeTaxesNarrativeDetails", "http://www.natus.com/role/LeasesNarrativeDetails", "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r321", "r353", "r401", "r403", "r404", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r667", "r670", "r695", "r696" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails", "http://www.natus.com/role/IncomeTaxesNarrativeDetails", "http://www.natus.com/role/LeasesNarrativeDetails", "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r1", "r148", "r149", "r150", "r152", "r153", "r154", "r155", "r156", "r157", "r159", "r160", "r161", "r162", "r163", "r164", "r175", "r238", "r239", "r448", "r488", "r520", "r522", "r523", "r524", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r721", "r722" ], "lang": { "en-us": { "role": { "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.", "label": "Revision of Prior Period [Axis]", "terseLabel": "Restatement [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r1", "r148", "r149", "r150", "r152", "r153", "r154", "r155", "r156", "r157", "r159", "r160", "r161", "r162", "r163", "r164", "r175", "r238", "r239", "r448", "r488", "r520", "r522", "r523", "r524", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r721", "r722" ], "lang": { "en-us": { "role": { "documentation": "Adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.", "label": "Revision of Prior Period [Domain]", "terseLabel": "Restatement [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": { "auth_ref": [ "r146", "r718" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]", "terseLabel": "Schedule II: of Valuation and Qualifying Accounts" } } }, "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.natus.com/role/ScheduleIIValuationAndQualifyingAccounts" ], "xbrltype": "textBlockItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r221", "r222", "r386", "r391", "r669", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r708", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717" ], "lang": { "en-us": { "role": { "documentation": "Geographical area.", "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]", "verboseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.natus.com/role/FairValueMeasurementsNarrativeDetails", "http://www.natus.com/role/IncomeTaxesNarrativeDetails", "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r221", "r222", "r386", "r391", "r669", "r681", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r708", "r709" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.natus.com/role/FairValueMeasurementsNarrativeDetails", "http://www.natus.com/role/IncomeTaxesNarrativeDetails", "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r226", "r598" ], "lang": { "en-us": { "role": { "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Axis]", "terseLabel": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails", "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Domain]", "terseLabel": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails", "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ValuationAndQualifyingAccountsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]" } } }, "localname": "ValuationAndQualifyingAccountsAbstract", "nsuri": "http://fasb.org/srt/2021-01-31", "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureLineItems", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.natus.com/role/ScheduleIIValuationAndQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureTable": { "auth_ref": [ "r140", "r141", "r142", "r144", "r145", "r718" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureTable", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.natus.com/role/ScheduleIIValuationAndQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis": { "auth_ref": [ "r62" ], "lang": { "en-us": { "role": { "documentation": "Information by billing status of receivables.", "label": "Billing Status, Type [Axis]", "terseLabel": "Billing Status, Type [Axis]" } } }, "localname": "AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/RevenueUnbilledARandDeferredRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "terseLabel": "Accrued Liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/AccruedLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r50", "r604" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": { "auth_ref": [ "r245" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]", "terseLabel": "Schedule of Activity in Allowance for Doubtful Accounts" } } }, "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/AllowanceforDoubtfulAccountsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r7", "r26", "r227", "r228" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net of allowance for doubtful accounts of $5,271 and $6,213" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r55" ], "calculation": { "http://www.natus.com/role/AccruedLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued liabilities", "totalLabel": "Total" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/AccruedLiabilitiesDetails", "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r10", "r11", "r55" ], "calculation": { "http://www.natus.com/role/AccruedLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees, Current", "terseLabel": "Accrued professional fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/AccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r47", "r281" ], "calculation": { "http://www.natus.com/role/PropertyandEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/PropertyandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r28", "r70", "r72", "r73", "r653", "r676", "r680" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets", "http://www.natus.com/role/SaleofCertainSubsidiaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r69", "r73", "r84", "r85", "r86", "r148", "r149", "r150", "r511", "r671", "r672", "r722" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Acquired Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails", "http://www.natus.com/role/IntangibleAssetsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by operating activities:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation", "negatedLabel": "Taxes paid related to net share settlement of equity awards" } } }, "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r407", "r440", "r450" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Total expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationSharebasedCompensationExpenseAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForCreditLossMember": { "auth_ref": [ "r140", "r141", "r142", "r144", "r145" ], "lang": { "en-us": { "role": { "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]", "terseLabel": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]" } } }, "localname": "AllowanceForCreditLossMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ScheduleIIValuationAndQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AllowanceForCreditLossesTextBlock": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for allowance for credit losses.", "label": "Allowance for Credit Losses [Text Block]", "terseLabel": "Allowance for Doubtful Accounts" } } }, "localname": "AllowanceForCreditLossesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/AllowanceforDoubtfulAccounts" ], "xbrltype": "textBlockItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r229", "r240", "r241", "r244" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss", "periodEndLabel": "Balance, end of period", "periodStartLabel": "Balance, beginning of period" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/AllowanceforDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r32", "r229", "r240" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]", "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableRollforward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/AllowanceforDoubtfulAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "auth_ref": [ "r243" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.", "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "negatedTerseLabel": "Write-offs charged against allowance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/AllowanceforDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r121", "r259", "r267" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Intangibles amortization" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r172" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Shares excluded from calculations of diluted EPS" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/EarningsPerShareComponentsofBasicandDilutedEPSDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_Assets": { "auth_ref": [ "r133", "r202", "r209", "r216", "r236", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r508", "r512", "r532", "r602", "r604", "r631", "r651" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r8", "r9", "r66", "r133", "r236", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r508", "r512", "r532", "r602", "r604" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueAdjustment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of addition (reduction) to the amount at which an asset could be incurred (settled) in a current transaction between willing parties.", "label": "Assets, Fair Value Adjustment", "terseLabel": "Assets, Fair Value Adjustment" } } }, "localname": "AssetsFairValueAdjustment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/SaleofCertainSubsidiaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r409", "r443" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails", "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails", "http://www.natus.com/role/ShareBasedCompensationRestrictedStockAwardActivityDetails", "http://www.natus.com/role/ShareBasedCompensationRestrictedUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r280" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Buildings [Member]" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/FairValueMeasurementsNarrativeDetails", "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails", "http://www.natus.com/role/PropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers": { "auth_ref": [ "r17", "r630", "r650", "r697" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unamortized costs incurred for development of computer software, which is to be sold, leased or otherwise marketed, after establishing technological feasibility through to the general release of the software products. Excludes capitalized costs of developing software for internal use.", "label": "Capitalized Software Development Costs for Software Sold to Customers", "terseLabel": "Costs incurred for development of software to be sold" } } }, "localname": "CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r5", "r44", "r123" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash and cash equivalents, end of year", "periodStartLabel": "Cash and cash equivalents, beginning of year", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets", "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r14", "r124" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r116", "r539" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r60", "r297", "r638", "r657" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 20)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r294", "r295", "r296", "r298", "r682" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments And Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r148", "r149", "r522" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.natus.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common Stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.natus.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common Stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r25", "r365" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common Stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r25", "r604" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.001 par value; 120,000,000 shares authorized; shares issued and outstanding 34,225,682 in 2021 and 33,911,703 in 2020" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "auth_ref": [ "r399", "r400", "r405", "r452" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.", "label": "Compensation and Employee Benefit Plans [Text Block]", "terseLabel": "Employee Benefit Plan" } } }, "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/EmployeeBenefitPlan" ], "xbrltype": "textBlockItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r79", "r81", "r82", "r93", "r642", "r662" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofComprehensiveIncomeLossConsolidatedStatementofComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income (loss)" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofComprehensiveIncomeLossConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income, Policy [Policy Text Block]", "terseLabel": "Comprehensive Income" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computer software and hardware [Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails", "http://www.natus.com/role/PropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ComputerSoftwareIntangibleAssetMember": { "auth_ref": [ "r260", "r265", "r505" ], "lang": { "en-us": { "role": { "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.", "label": "Computer Software, Intangible Asset [Member]", "terseLabel": "Internally developed software [Member]" } } }, "localname": "ComputerSoftwareIntangibleAssetMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r126", "r510" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r376" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "terseLabel": "Contract with Customer, Asset and Liability [Table Text Block]" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetNet": { "auth_ref": [ "r372", "r374", "r387" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss", "periodEndLabel": "Unbilled AR, December 31, 2021", "periodStartLabel": "Unbilled AR, December 31, 2020" } } }, "localname": "ContractWithCustomerAssetNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/RevenueUnbilledARandDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetReclassifiedToReceivable": { "auth_ref": [ "r375" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time from transfer to receivable due to right to consideration becoming unconditional.", "label": "Contract with Customer, Asset, Reclassified to Receivable", "negatedTerseLabel": "Transferred to Trade Receivable" } } }, "localname": "ContractWithCustomerAssetReclassifiedToReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/RevenueUnbilledARandDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r372", "r373", "r387" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "periodEndLabel": "Deferred Revenue, December 31, 2021", "periodStartLabel": "Deferred Revenue, December 31, 2020" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/RevenueUnbilledARandDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r372", "r373", "r387" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Contract with Customer, Liability, Current" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r372", "r373", "r387" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Contract with Customer, Liability, Noncurrent", "terseLabel": "Contract with Customer, Liability, Noncurrent" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r388" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "negatedTerseLabel": "Revenue Recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/RevenueUnbilledARandDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSoldAmortization": { "auth_ref": [ "r97" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofOperations": { "order": 3.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.", "label": "Cost, Amortization", "terseLabel": "Intangibles amortization" } } }, "localname": "CostOfGoodsAndServicesSoldAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsSoldSalesTypeLease": { "auth_ref": [ "r179", "r589" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of goods sold for sales-type financing lease.", "label": "Cost of Goods Sold, Sales-type Lease", "terseLabel": "Cost of Sales" } } }, "localname": "CostOfGoodsSoldSalesTypeLease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of revenue" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsNarrativeDetails", "http://www.natus.com/role/ShareBasedCompensationSharebasedCompensationExpenseAllocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r98" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "terseLabel": "Cost of revenue" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r134", "r483", "r491" ], "calculation": { "http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Federal Tax Expense (Benefit)", "verboseLabel": "U.S. Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r134", "r483" ], "calculation": { "http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense (Benefit)", "verboseLabel": "Non-U.S." } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r134", "r483", "r491", "r493" ], "calculation": { "http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "totalLabel": "Total current tax expense" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Current" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r134", "r483", "r491" ], "calculation": { "http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current State and Local Tax Expense (Benefit)", "terseLabel": "U.S. State and local" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerRefundLiabilityCurrent": { "auth_ref": [], "calculation": { "http://www.natus.com/role/AccruedLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Current regulatory liabilities generally represent obligations to make refunds to customers for various reasons including overpayment.", "label": "Customer Refund Liability, Current", "terseLabel": "Accrued amounts due to customers" } } }, "localname": "CustomerRefundLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/AccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer related" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails", "http://www.natus.com/role/IntangibleAssetsNarrativeDetails", "http://www.natus.com/role/IntangibleAssetsScheduleofAmortizationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r130", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r335", "r342", "r343", "r345", "r350" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt and Credit Arrangements" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangements" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r18", "r19", "r20", "r132", "r139", "r318", "r319", "r320", "r321", "r322", "r323", "r325", "r331", "r332", "r333", "r334", "r336", "r337", "r338", "r339", "r340", "r341", "r346", "r347", "r348", "r349", "r554", "r632", "r635", "r649" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Debt Instrument, Basis Spread on Variable Rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r58", "r132", "r139", "r318", "r319", "r320", "r321", "r322", "r323", "r325", "r331", "r332", "r333", "r334", "r336", "r337", "r338", "r339", "r340", "r341", "r346", "r347", "r348", "r349", "r554" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r58", "r132", "r139", "r318", "r319", "r320", "r321", "r322", "r323", "r325", "r331", "r332", "r333", "r334", "r336", "r337", "r338", "r339", "r340", "r341", "r344", "r346", "r347", "r348", "r349", "r366", "r367", "r368", "r369", "r551", "r552", "r554", "r555", "r647" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r134", "r484", "r491" ], "calculation": { "http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal Income Tax Expense (Benefit)", "terseLabel": "U.S. Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r134", "r484", "r491" ], "calculation": { "http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense (Benefit)", "terseLabel": "Non-U.S." } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r458", "r459" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred income tax" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r121", "r134", "r484", "r491", "r492", "r493" ], "calculation": { "http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "totalLabel": "Total deferred tax expense (benefit)" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Deferred" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r22", "r23", "r473", "r633", "r648" ], "calculation": { "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r458", "r459" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred income tax" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r34" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueNoncurrent": { "auth_ref": [ "r34" ], "calculation": { "http://www.natus.com/role/LongTermOtherLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Deferred Revenue, Noncurrent", "terseLabel": "Non-current deferred revenue" } } }, "localname": "DeferredRevenueNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LongTermOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r134", "r484", "r491" ], "calculation": { "http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "terseLabel": "U.S. State and local" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetDomain": { "auth_ref": [ "r475" ], "lang": { "en-us": { "role": { "documentation": "Identification of the deferred tax asset for which a valuation reserve exists.", "label": "Deferred Tax Asset [Domain]", "terseLabel": "Deferred Tax Asset [Domain]" } } }, "localname": "DeferredTaxAssetDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r474" ], "calculation": { "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Total deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r476" ], "calculation": { "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "terseLabel": "Deferred Tax Assets, Net", "totalLabel": "Deferred Tax Assets, Net" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails", "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r476" ], "calculation": { "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Total net deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net [Abstract]", "terseLabel": "Deferred tax assets:" } } }, "localname": "DeferredTaxAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r481", "r482" ], "calculation": { "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails", "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "auth_ref": [ "r479", "r481", "r482" ], "calculation": { "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards", "terseLabel": "Credit carryforwards" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits": { "auth_ref": [ "r481", "r482" ], "calculation": { "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from employee benefits, classified as other.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits", "terseLabel": "Employee benefits" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": { "auth_ref": [ "r481", "r482" ], "calculation": { "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals", "terseLabel": "Accruals deductible in different periods" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r475" ], "calculation": { "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance", "terseLabel": "Valuation allowances" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails", "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Gross [Abstract]", "terseLabel": "Deferred tax liabilities:" } } }, "localname": "DeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": { "auth_ref": [ "r481" ], "calculation": { "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.", "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings", "negatedTerseLabel": "Foreign earnings to be repatriated", "terseLabel": "Deferred tax liabilities related to foreign earnings" } } }, "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesComponentsofDeferredTaxAssetandLiabilitiesDetails", "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.", "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount", "terseLabel": "Employer matching contributions" } } }, "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/EmployeeBenefitPlanDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r121", "r279" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/PropertyandEquipmentNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r121", "r197" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r506" ], "lang": { "en-us": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "terseLabel": "Technology" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails", "http://www.natus.com/role/IntangibleAssetsNarrativeDetails", "http://www.natus.com/role/IntangibleAssetsScheduleofAmortizationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/RevenueUnbilledARandDeferredRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r386", "r390", "r391", "r392", "r393", "r394", "r395", "r396" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/RevenueUnbilledARandDeferredRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "Share-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement [Abstract]", "terseLabel": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]", "terseLabel": "Domestic Tax Authority" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Net income (loss) per share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r94", "r154", "r155", "r157", "r158", "r159", "r165", "r167", "r169", "r170", "r171", "r175", "r176", "r523", "r524", "r643", "r663" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic", "verboseLabel": "Basic earnings per share (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations", "http://www.natus.com/role/EarningsPerShareComponentsofBasicandDilutedEPSDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r94", "r154", "r155", "r157", "r158", "r159", "r167", "r169", "r170", "r171", "r175", "r176", "r523", "r524", "r643", "r663" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted (in dollars per share)", "verboseLabel": "Diluted earnings per share (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations", "http://www.natus.com/role/EarningsPerShareComponentsofBasicandDilutedEPSDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r172", "r173" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Basic and Diluted Net Income per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r172", "r173", "r174", "r177" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": { "auth_ref": [ "r539" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.", "label": "Effect of Exchange Rate on Cash and Cash Equivalents", "terseLabel": "Exchange rate effect on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r136", "r461", "r495" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Statutory tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r55" ], "calculation": { "http://www.natus.com/role/AccruedLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Compensation and related benefits" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/AccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationSharebasedCompensationExpenseAllocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r442" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted average period of recognition of unrecognized compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [ "r442" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized compensation of unvested awards" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r442" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized compensation expense related to unvested portion of stock options" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "Employee Stock Purchase Plan [Member]" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Share-based Payment Arrangement, Option [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails", "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense": { "auth_ref": [ "r451" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of plan compensation cost recognized during the period.", "label": "Employee Stock Ownership Plan (ESOP), Compensation Expense", "terseLabel": "Compensation expense associated with the ESPP" } } }, "localname": "EmployeeStockOwnershipPlanESOPCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r84", "r85", "r86", "r148", "r149", "r150", "r153", "r160", "r163", "r180", "r237", "r365", "r370", "r445", "r446", "r447", "r487", "r488", "r522", "r542", "r543", "r544", "r545", "r546", "r548", "r671", "r672", "r673", "r722" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r525", "r526", "r527", "r529" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r530", "r531" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeaseInterestExpense": { "auth_ref": [ "r559", "r566", "r577" ], "calculation": { "http://www.natus.com/role/LeasesLeaseCostDetails": { "order": 3.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense on finance lease liability.", "label": "Finance Lease, Interest Expense", "terseLabel": "Interest on lease liabilities" } } }, "localname": "FinanceLeaseInterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseInterestPaymentOnLiability": { "auth_ref": [ "r561", "r571" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest paid on finance lease liability.", "label": "Finance Lease, Interest Payment on Liability", "terseLabel": "Operating cash flows from finance leases" } } }, "localname": "FinanceLeaseInterestPaymentOnLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesSupplementalCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Payment, Due [Abstract]", "terseLabel": "Finance Leases" } } }, "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseMaturitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r557", "r576" ], "calculation": { "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease, Liability", "terseLabel": "Total", "totalLabel": "Total finance lease liabilities" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseMaturitiesDetails", "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r557" ], "calculation": { "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails": { "order": 1.0, "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Finance Lease, Liability, Current", "terseLabel": "Finance leases, accrued liabilities" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r558" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.", "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r576" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.", "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Finance Lease, Liability, Maturity" } } }, "localname": "FinanceLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r557" ], "calculation": { "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails": { "order": 2.0, "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0 }, "http://www.natus.com/role/LongTermOtherLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Finance Lease, Liability, Noncurrent", "terseLabel": "Finance lease liabilities", "verboseLabel": "Finance leases, other liabilities" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails", "http://www.natus.com/role/LongTermOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r558" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability.", "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r576" ], "calculation": { "http://www.natus.com/role/LeasesLeaseMaturitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Payment, Due", "totalLabel": "Total lease payments" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r576" ], "calculation": { "http://www.natus.com/role/LeasesLeaseMaturitiesDetails": { "order": 6.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r576" ], "calculation": { "http://www.natus.com/role/LeasesLeaseMaturitiesDetails": { "order": 1.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year One", "terseLabel": "2020" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r576" ], "calculation": { "http://www.natus.com/role/LeasesLeaseMaturitiesDetails": { "order": 5.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Five", "terseLabel": "2024" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r576" ], "calculation": { "http://www.natus.com/role/LeasesLeaseMaturitiesDetails": { "order": 4.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Four", "terseLabel": "2023" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r576" ], "calculation": { "http://www.natus.com/role/LeasesLeaseMaturitiesDetails": { "order": 3.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Three", "terseLabel": "2022" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r576" ], "calculation": { "http://www.natus.com/role/LeasesLeaseMaturitiesDetails": { "order": 2.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Two", "terseLabel": "2021" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r576" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Less imputed interest" } } }, "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [ "r560", "r571" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "Finance Lease, Principal Payments", "negatedTerseLabel": "Finance Lease, Principal Payments", "terseLabel": "Financing cash flows from finance leases" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows", "http://www.natus.com/role/LeasesSupplementalCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAsset": { "auth_ref": [ "r556" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization", "terseLabel": "Finance Lease, Right-of-Use Asset" } } }, "localname": "FinanceLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/PropertyandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "auth_ref": [ "r559", "r566", "r577" ], "calculation": { "http://www.natus.com/role/LeasesLeaseCostDetails": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, Amortization", "terseLabel": "Amortization of right-of-use assets (principal payments)" } } }, "localname": "FinanceLeaseRightOfUseAssetAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r558" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.", "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/PropertyandEquipmentDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r574", "r577" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for finance lease calculated at point in time.", "label": "Finance Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate, finance leases" } } }, "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails" ], "xbrltype": "percentItemType" }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r573", "r577" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Finance Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term, finance leases" } } }, "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Weighted average life of intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r266" ], "calculation": { "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://www.natus.com/role/IntangibleAssetsExpectedAnnualAmortizationExpenseDetails": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsExpectedAnnualAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r268" ], "calculation": { "http://www.natus.com/role/IntangibleAssetsExpectedAnnualAmortizationExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2019" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsExpectedAnnualAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r268" ], "calculation": { "http://www.natus.com/role/IntangibleAssetsExpectedAnnualAmortizationExpenseDetails": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsExpectedAnnualAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r268" ], "calculation": { "http://www.natus.com/role/IntangibleAssetsExpectedAnnualAmortizationExpenseDetails": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsExpectedAnnualAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r268" ], "calculation": { "http://www.natus.com/role/IntangibleAssetsExpectedAnnualAmortizationExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2021" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsExpectedAnnualAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r268" ], "calculation": { "http://www.natus.com/role/IntangibleAssetsExpectedAnnualAmortizationExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2020" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsExpectedAnnualAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r260", "r262", "r266", "r270", "r615", "r616" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails", "http://www.natus.com/role/IntangibleAssetsNarrativeDetails", "http://www.natus.com/role/IntangibleAssetsScheduleofAmortizationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]", "terseLabel": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r266", "r616" ], "calculation": { "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Gross Carrying Amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsScheduleofAmortizationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r260", "r265" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails", "http://www.natus.com/role/IntangibleAssetsNarrativeDetails", "http://www.natus.com/role/IntangibleAssetsScheduleofAmortizationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r266", "r615" ], "calculation": { "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.natus.com/role/IntangibleAssetsExpectedAnnualAmortizationExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Total expected amortization expense" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails", "http://www.natus.com/role/IntangibleAssetsExpectedAnnualAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net [Abstract]", "terseLabel": "Finite-Lived Intangible Assets, Net [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]", "terseLabel": "Significant foreign jurisdictions" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r533", "r535", "r537", "r538" ], "calculation": { "http://www.natus.com/role/OtherIncomeExpenseNetDetails": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "terseLabel": "Net foreign currency transaction gains (losses)", "verboseLabel": "Foreign currency gain (loss)" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails", "http://www.natus.com/role/OtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r549" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Office furniture and equipment [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails", "http://www.natus.com/role/PropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r121" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedLabel": "(Gain) Loss on disposal of property and equipment", "terseLabel": "Gain (Loss) on Disposition of Property Plant Equipment" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows", "http://www.natus.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges": { "auth_ref": [ "r121" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.", "label": "Gain (Loss) on Sale of Assets and Asset Impairment Charges", "terseLabel": "Gain (Loss) on Sale of Assets and Asset Impairment Charges" } } }, "localname": "GainLossOnSalesOfAssetsAndAssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/SaleofCertainSubsidiaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r101" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r95" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsNarrativeDetails", "http://www.natus.com/role/ShareBasedCompensationSharebasedCompensationExpenseAllocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r251", "r252", "r604", "r629" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets", "http://www.natus.com/role/GoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.", "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r255", "r263" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillDisclosureTextBlock": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill.", "label": "Goodwill Disclosure [Text Block]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/Goodwill" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r253" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign currency translation" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/GoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/GoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": { "auth_ref": [ "r253", "r254", "r501" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Translation and Purchase Accounting Adjustments", "terseLabel": "Purchase Accounting Adjustments" } } }, "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/GoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r100", "r133", "r202", "r208", "r212", "r215", "r218", "r236", "r307", "r308", "r309", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r532" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentChargeOnReclassifiedAssets": { "auth_ref": [ "r276", "r278" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For the asset that is reclassified back to held and used from held-for-sale, the amount of impairment charge that is recognized on the reclassification date.", "label": "Impairment Charge on Reclassified Assets", "terseLabel": "Impairment charge for sale of entity" } } }, "localname": "ImpairmentChargeOnReclassifiedAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": { "auth_ref": [ "r121", "r271" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.", "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)", "verboseLabel": "Impairment of intangible assets" } } }, "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows", "http://www.natus.com/role/IntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "auth_ref": [ "r121", "r277", "r283" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).", "label": "Impairment, Long-Lived Asset, Held-for-Use", "terseLabel": "Impairment, Long-Lived Asset, Held-for-Use" } } }, "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r275", "r286" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "terseLabel": "Long lived assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r135", "r494" ], "calculation": { "http://www.natus.com/role/IncomeTaxesIncomeLossbeforeProvisionBenefitforIncomeTaxDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "terseLabel": "U.S." } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesIncomeLossbeforeProvisionBenefitforIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r135", "r494" ], "calculation": { "http://www.natus.com/role/IncomeTaxesIncomeLossbeforeProvisionBenefitforIncomeTaxDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "terseLabel": "Foreign" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesIncomeLossbeforeProvisionBenefitforIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r202", "r208", "r212", "r215", "r218" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 }, "http://www.natus.com/role/IncomeTaxesIncomeLossbeforeProvisionBenefitforIncomeTaxDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "totalLabel": "Income (loss) before provision (benefit) for income tax" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations", "http://www.natus.com/role/IncomeTaxesIncomeLossbeforeProvisionBenefitforIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r90", "r121", "r199", "r234", "r639", "r659" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "negatedTerseLabel": "Loss on equity method investment adjustment" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r284", "r289" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails", "http://www.natus.com/role/IntangibleAssetsNarrativeDetails", "http://www.natus.com/role/ShareBasedCompensationSharebasedCompensationExpenseAllocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r289" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails", "http://www.natus.com/role/IntangibleAssetsNarrativeDetails", "http://www.natus.com/role/ShareBasedCompensationSharebasedCompensationExpenseAllocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r136", "r462", "r471", "r478", "r489", "r496", "r498", "r499", "r500" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r137", "r162", "r163", "r200", "r460", "r490", "r497", "r665" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 }, "http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedTerseLabel": "Provision (benefit) for income tax", "terseLabel": "Provision (benefit) for income tax", "totalLabel": "Total expense (benefit)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations", "http://www.natus.com/role/IncomeTaxesComponentofIncomeTaxExpenseDetails", "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails", "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r83", "r456", "r457", "r471", "r472", "r477", "r485" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r461" ], "calculation": { "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails": { "order": 7.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount", "terseLabel": "Foreign taxes at rates less than U.S. rates" } } }, "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r461" ], "calculation": { "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "terseLabel": "Federal statutory tax expense" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": { "auth_ref": [ "r461" ], "calculation": { "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails": { "order": 12.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount", "terseLabel": "Equity compensation" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "auth_ref": [ "r461" ], "calculation": { "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount", "terseLabel": "Withholding taxes" } } }, "localname": "IncomeTaxReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": { "auth_ref": [ "r461" ], "calculation": { "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails": { "order": 4.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount", "terseLabel": "Other" } } }, "localname": "IncomeTaxReconciliationOtherReconcilingItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings": { "auth_ref": [ "r461" ], "calculation": { "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails": { "order": 5.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to repatriation of foreign earnings.", "label": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount", "terseLabel": "Repatriation tax net of foreign tax credits" } } }, "localname": "IncomeTaxReconciliationRepatriationOfForeignEarnings", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r461" ], "calculation": { "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount", "terseLabel": "State tax expense" } } }, "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxContingencies": { "auth_ref": [ "r461" ], "calculation": { "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails": { "order": 14.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.", "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Amount", "terseLabel": "Uncertain tax position" } } }, "localname": "IncomeTaxReconciliationTaxContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxCredits": { "auth_ref": [ "r461" ], "calculation": { "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails": { "order": 10.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Amount", "negatedLabel": "Tax credits" } } }, "localname": "IncomeTaxReconciliationTaxCredits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesReconciliationofIncometaxExpensefromContinuousOperationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r118", "r125" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r120" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r120" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r120" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": { "auth_ref": [ "r120" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.", "label": "Increase (Decrease) in Deferred Income Taxes", "negatedLabel": "Deferred taxes" } } }, "localname": "IncreaseDecreaseInDeferredIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r120" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r120" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "verboseLabel": "Changes in operating assets and liabilities, net of assets and liabilities acquired in acquisitions:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r120" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r261", "r269" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails", "http://www.natus.com/role/IntangibleAssetsNarrativeDetails", "http://www.natus.com/role/IntangibleAssetsScheduleofAmortizationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r269" ], "calculation": { "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails": { "order": 1.0, "parentTag": "ntus_IndefiniteLivedIntangibleAssetsExcludingGoodwillNetOfImpairments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)", "terseLabel": "Gross Carrying Amount" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract]", "terseLabel": "Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract]" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r261", "r269" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails", "http://www.natus.com/role/IntangibleAssetsNarrativeDetails", "http://www.natus.com/role/IntangibleAssetsScheduleofAmortizationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]", "terseLabel": "Intangible Assets" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [], "calculation": { "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "terseLabel": "Gross Carrying Amount" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r258", "r264" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net", "totalLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets", "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntellectualPropertyMember": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.", "label": "Intellectual Property [Member]", "terseLabel": "Intellectual Property" } } }, "localname": "IntellectualPropertyMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails", "http://www.natus.com/role/IntangibleAssetsNarrativeDetails", "http://www.natus.com/role/IntangibleAssetsScheduleofAmortizationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r88", "r196", "r550", "r553", "r644" ], "calculation": { "http://www.natus.com/role/OtherIncomeExpenseNetDetails": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r115", "r117", "r125" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]", "terseLabel": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r35", "r249" ], "calculation": { "http://www.natus.com/role/InventoriesDetails": { "order": 3.0, "parentTag": "ntus_InventoryCurrentAndNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r6", "r63", "r604" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets", "http://www.natus.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNoncurrent": { "auth_ref": [ "r65" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.", "label": "Inventory, Noncurrent", "negatedLabel": "Less: Non-current Inventories", "terseLabel": "Non-current Inventories" } } }, "localname": "InventoryNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/InventoriesDetails", "http://www.natus.com/role/InventoriesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r13", "r64", "r127", "r178", "r247", "r248", "r250", "r612" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventory" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": { "auth_ref": [ "r37", "r38", "r249" ], "calculation": { "http://www.natus.com/role/InventoriesDetails": { "order": 1.0, "parentTag": "ntus_InventoryCurrentAndNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.", "label": "Inventory, Raw Materials and Supplies, Net of Reserves", "terseLabel": "Raw materials and subassemblies" } } }, "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r36", "r249" ], "calculation": { "http://www.natus.com/role/InventoriesDetails": { "order": 2.0, "parentTag": "ntus_InventoryCurrentAndNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r102", "r195" ], "calculation": { "http://www.natus.com/role/OtherIncomeExpenseNetDetails": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r235", "r664" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Short-term Investments" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]", "terseLabel": "Land [Member]" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/FairValueMeasurementsNarrativeDetails", "http://www.natus.com/role/PropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r575", "r577" ], "calculation": { "http://www.natus.com/role/LeasesLeaseCostDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r575" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Lease, Cost" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdsAndLeaseholdImprovementsMember": { "auth_ref": [ "r280" ], "lang": { "en-us": { "role": { "documentation": "Assets held by a lessee under a capital lease and any addition or improvement to assets held under a lease arrangement (including addition or improvement to assets held by lessee under an operating lease arrangement).", "label": "Leaseholds and Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements [Member]" } } }, "localname": "LeaseholdsAndLeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/PropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_LesseeFinanceLeasesTextBlock": { "auth_ref": [ "r578" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.", "label": "Lessee, Finance Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeFinanceLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r563" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r576" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Lessee, Operating Lease, Liability, Maturity" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r576" ], "calculation": { "http://www.natus.com/role/LeasesLeaseMaturitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r576" ], "calculation": { "http://www.natus.com/role/LeasesLeaseMaturitiesDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r576" ], "calculation": { "http://www.natus.com/role/LeasesLeaseMaturitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2020" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r576" ], "calculation": { "http://www.natus.com/role/LeasesLeaseMaturitiesDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r576" ], "calculation": { "http://www.natus.com/role/LeasesLeaseMaturitiesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r576" ], "calculation": { "http://www.natus.com/role/LeasesLeaseMaturitiesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r576" ], "calculation": { "http://www.natus.com/role/LeasesLeaseMaturitiesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r576" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Less imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "auth_ref": [ "r564" ], "lang": { "en-us": { "role": { "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Remaining Lease Term", "terseLabel": "Remaining lease term" } } }, "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Renewal Term", "terseLabel": "Lease renewal term" } } }, "localname": "LesseeOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r578" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorLeasesPolicyTextBlock": { "auth_ref": [ "r582", "r585", "r587", "r588" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangements entered into by lessor.", "label": "Lessor, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LessorLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract]", "terseLabel": "Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract]" } } }, "localname": "LessorOperatingLeasePaymentsFiscalYearMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceived": { "auth_ref": [ "r584" ], "calculation": { "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails_1": { "order": 1.0, "parentTag": "ntus_LessorOperatingLeasePaymentsToBeReceivedBeforeImputedInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payments to be received by lessor for operating lease.", "label": "Lessor, Operating Lease, Payments to be Received", "terseLabel": "Total" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceived", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears": { "auth_ref": [ "r584" ], "calculation": { "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails": { "order": 5.0, "parentTag": "ntus_LessorOperatingLeasePaymentsToBeReceivedBeforeImputedInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Five", "terseLabel": "2026" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedFiveYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears": { "auth_ref": [ "r584" ], "calculation": { "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails": { "order": 4.0, "parentTag": "ntus_LessorOperatingLeasePaymentsToBeReceivedBeforeImputedInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Four", "terseLabel": "2025" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedFourYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock": { "auth_ref": [ "r584" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.", "label": "Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Operating Lease Receivable, Maturity" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths": { "auth_ref": [ "r584" ], "calculation": { "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails": { "order": 6.0, "parentTag": "ntus_LessorOperatingLeasePaymentsToBeReceivedBeforeImputedInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year One", "terseLabel": "2022" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter": { "auth_ref": [ "r584" ], "calculation": { "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails": { "order": 2.0, "parentTag": "ntus_LessorOperatingLeasePaymentsToBeReceivedBeforeImputedInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedThereafter", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears": { "auth_ref": [ "r584" ], "calculation": { "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails": { "order": 3.0, "parentTag": "ntus_LessorOperatingLeasePaymentsToBeReceivedBeforeImputedInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Three", "terseLabel": "2024" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedThreeYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears": { "auth_ref": [ "r584" ], "calculation": { "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails": { "order": 1.0, "parentTag": "ntus_LessorOperatingLeasePaymentsToBeReceivedBeforeImputedInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Two", "terseLabel": "2023" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedTwoYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeaseRenewalTerm": { "auth_ref": [ "r586" ], "lang": { "en-us": { "role": { "documentation": "Term of lessor's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessor, Operating Lease, Renewal Term", "terseLabel": "Lessor, renewal term" } } }, "localname": "LessorOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LessorOperatingLeaseTermOfContract": { "auth_ref": [ "r586" ], "lang": { "en-us": { "role": { "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessor, Operating Lease, Term of Contract", "terseLabel": "Lessor, lease term" } } }, "localname": "LessorOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LessorSalesTypeLeasesTextBlock": { "auth_ref": [ "r592" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of lessor's sales-type leases.", "label": "Lessor, Sales-type Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LessorSalesTypeLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r54", "r133", "r210", "r236", "r307", "r308", "r309", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r509", "r512", "r513", "r532", "r602", "r603" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r31", "r133", "r236", "r532", "r604", "r636", "r655" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r57", "r133", "r236", "r307", "r308", "r309", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r509", "r512", "r513", "r532", "r602", "r603", "r604" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent [Abstract]", "terseLabel": "Long-term liabilities:" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": { "auth_ref": [ "r59" ], "calculation": { "http://www.natus.com/role/LongTermOtherLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.", "label": "Liability for Uncertainty in Income Taxes, Noncurrent", "terseLabel": "Long-term taxes payable" } } }, "localname": "LiabilityForUncertainTaxPositionsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LongTermOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r52", "r132" ], "lang": { "en-us": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Lender Name [Axis]", "terseLabel": "Lender Name [Axis]" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r52", "r132" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.", "label": "Line of Credit Facility, Lender [Domain]", "terseLabel": "Line of Credit Facility, Lender [Domain]" } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r52" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "verboseLabel": "Revolving credit facility with Wells Fargo Bank" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of Credit [Member]" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "London Interbank Offered Rate (LIBOR) [Member]" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r53" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Current Maturities", "verboseLabel": "Current portion of long-term debt" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r58" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r58" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r58", "r306" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MovementInDeferredRevenueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Movement in Deferred Revenue [Roll Forward]", "terseLabel": "Movement in Deferred Revenue [Roll Forward]" } } }, "localname": "MovementInDeferredRevenueRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/RevenueUnbilledARandDeferredRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MovementInValuationAllowancesAndReservesRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]", "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]" } } }, "localname": "MovementInValuationAllowancesAndReservesRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ScheduleIIValuationAndQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r116" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r116" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r116", "r119", "r122" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r3", "r77", "r80", "r86", "r91", "r122", "r133", "r152", "r154", "r155", "r157", "r158", "r162", "r163", "r168", "r202", "r208", "r212", "r215", "r218", "r236", "r307", "r308", "r309", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r524", "r532", "r640", "r660" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.natus.com/role/ConsolidatedStatementsofComprehensiveIncomeLossConsolidatedStatementofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://www.natus.com/role/ConsolidatedStatementsofOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows", "http://www.natus.com/role/ConsolidatedStatementsofComprehensiveIncomeLossConsolidatedStatementofComprehensiveIncomeLoss", "http://www.natus.com/role/ConsolidatedStatementsofOperations", "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.natus.com/role/EarningsPerShareComponentsofBasicandDilutedEPSDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentInLease": { "auth_ref": [ "r230", "r240", "r246", "r579" ], "calculation": { "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails_1": { "order": 1.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 }, "http://www.natus.com/role/LeasesSalesTypeLeaseReceivableDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.natus.com/role/LeasesSalesTypeLeaseReceivableDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of net investment in sales-type and direct financing leases.", "label": "Net Investment in Lease, before Allowance for Credit Loss", "totalLabel": "Net investment in sales-type leases", "verboseLabel": "Total" } } }, "localname": "NetInvestmentInLease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails", "http://www.natus.com/role/LeasesSalesTypeLeaseReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentInLeaseCurrent": { "auth_ref": [ "r240", "r579", "r580" ], "calculation": { "http://www.natus.com/role/LeasesSalesTypeLeaseReceivableDetails_1": { "order": 1.0, "parentTag": "us-gaap_NetInvestmentInLease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of net investment in sales-type and direct financing leases, classified as current.", "label": "Net Investment in Lease, before Allowance for Credit Loss, Current", "negatedTerseLabel": "Less: Current portion" } } }, "localname": "NetInvestmentInLeaseCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesSalesTypeLeaseReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentInLeaseNoncurrent": { "auth_ref": [ "r240", "r579", "r580" ], "calculation": { "http://www.natus.com/role/LeasesSalesTypeLeaseReceivableDetails_1": { "order": 2.0, "parentTag": "us-gaap_NetInvestmentInLease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of net investment in sales-type and direct financing leases, classified as noncurrent.", "label": "Net Investment in Lease, before Allowance for Credit Loss, Noncurrent", "terseLabel": "Long-term net investment in sales-type leases" } } }, "localname": "NetInvestmentInLeaseNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesSalesTypeLeaseReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Countries excluding the United States of America (US).", "label": "Non-US [Member]", "terseLabel": "Foreign countries [Member]" } } }, "localname": "NonUsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NoncurrentAssets": { "auth_ref": [ "r222" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.", "label": "Long-Lived Assets", "terseLabel": "Long-lived assets" } } }, "localname": "NoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r103" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 }, "http://www.natus.com/role/OtherIncomeExpenseNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "terseLabel": "Other expense, net", "totalLabel": "Total other expense, net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations", "http://www.natus.com/role/OtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other expense, net" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OtherIncomeExpenseNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NotesReceivableRelatedParties": { "auth_ref": [ "r138", "r596", "r658" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amounts due from parties associated with the reporting entity as evidenced by a written promise to pay.", "label": "Notes Receivable, Related Parties", "terseLabel": "Notes receivable, related parties" } } }, "localname": "NotesReceivableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/SaleofCertainSubsidiaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails", "http://www.natus.com/role/SegmentCustomerandGeographicInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reporting segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/SegmentCustomerandGeographicInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportingUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.", "label": "Number of Reporting Units", "terseLabel": "Number of reporting units" } } }, "localname": "NumberOfReportingUnits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpenseMember": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing expenses associated with normal operations.", "label": "Operating Expense [Member]", "terseLabel": "Operating Expense" } } }, "localname": "OperatingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r202", "r208", "r212", "r215", "r218" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Income (loss) from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r567", "r577" ], "calculation": { "http://www.natus.com/role/LeasesLeaseCostDetails": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLeaseIncome": { "auth_ref": [ "r179", "r581", "r591" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.", "label": "Operating Lease, Lease Income", "terseLabel": "Lease income on operating leases" } } }, "localname": "OperatingLeaseLeaseIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLeaseIncomeTableTextBlock": { "auth_ref": [ "r179", "r591" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of components of income from operating lease.", "label": "Operating Lease, Lease Income [Table Text Block]", "terseLabel": "Operating Lease, Lease Income" } } }, "localname": "OperatingLeaseLeaseIncomeTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]", "terseLabel": "Operating Leases" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseMaturitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r557" ], "calculation": { "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Total", "totalLabel": "Total operating lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseMaturitiesDetails", "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails", "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r557" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Current portion of operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets", "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r557" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets", "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r562", "r571" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Operating cash flows from operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesSupplementalCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r556" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets", "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails", "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r574", "r577" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate, operating leases" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r573", "r577" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "verboseLabel": "Weighted average remaining lease term, operating leases" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesSupplementalBalanceSheetDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Leased Assets [Line Items]", "terseLabel": "Operating Leased Assets [Line Items]" } } }, "localname": "OperatingLeasedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r479" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Tax net operating loss carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r4", "r147", "r188", "r514" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]", "terseLabel": "Organization and Significant Accounting Policies" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r10", "r11", "r12", "r55" ], "calculation": { "http://www.natus.com/role/AccruedLiabilitiesDetails": { "order": 9.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/AccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r49" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r67", "r70", "r534", "r536", "r541" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofComprehensiveIncomeLossConsolidatedStatementofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "terseLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofComprehensiveIncomeLossConsolidatedStatementofComprehensiveIncomeLoss", "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r68", "r70", "r515", "r516", "r518" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofComprehensiveIncomeLossConsolidatedStatementofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofComprehensiveIncomeLossConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": { "auth_ref": [ "r70", "r74" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofComprehensiveIncomeLossConsolidatedStatementofComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax", "terseLabel": "Interest rate swap designated as a cash flow hedge" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofComprehensiveIncomeLossConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax": { "auth_ref": [ "r70", "r74", "r75", "r76", "r540" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofComprehensiveIncomeLossConsolidatedStatementofComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax", "terseLabel": "Reclassification of deferred foreign currency related adjustments related to the sale of Medix (See FN 22)" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofComprehensiveIncomeLossConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r78", "r81", "r84", "r85", "r87", "r92", "r365", "r542", "r547", "r548", "r641", "r661" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofComprehensiveIncomeLossConsolidatedStatementofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Total other comprehensive income (loss)", "verboseLabel": "Other comprehensive income" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofComprehensiveIncomeLossConsolidatedStatementofComprehensiveIncomeLoss", "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income and Expenses [Abstract]", "terseLabel": "Other Income and Expenses [Abstract]" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": { "auth_ref": [ "r398", "r453" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.", "label": "Other Income and Other Expense Disclosure [Text Block]", "terseLabel": "Other Income (Expense), Net" } } }, "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OtherIncomeExpenseNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLiabilitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities Disclosure [Abstract]", "terseLabel": "Other Liabilities Disclosure [Abstract]" } } }, "localname": "OtherLiabilitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other liabilities.", "label": "Other Liabilities Disclosure [Text Block]", "terseLabel": "Long-Term Other Liabilities" } } }, "localname": "OtherLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LongTermOtherLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r59" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.natus.com/role/LongTermOtherLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other liabilities", "totalLabel": "Total" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets", "http://www.natus.com/role/LongTermOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Noncash Investing and Financing Items [Abstract]", "terseLabel": "Non-cash investing activities:" } } }, "localname": "OtherNoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Table Text Block]", "terseLabel": "Long-Term Other Liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LongTermOtherLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r104" ], "calculation": { "http://www.natus.com/role/OtherIncomeExpenseNetDetails": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSundryLiabilitiesNoncurrent": { "auth_ref": [ "r21", "r634", "r652" ], "calculation": { "http://www.natus.com/role/LongTermOtherLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.", "label": "Other Sundry Liabilities, Noncurrent", "terseLabel": "Other" } } }, "localname": "OtherSundryLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LongTermOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PatentsMember": { "auth_ref": [ "r506" ], "lang": { "en-us": { "role": { "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.", "label": "Patents [Member]", "terseLabel": "Patents" } } }, "localname": "PatentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails", "http://www.natus.com/role/IntangibleAssetsNarrativeDetails", "http://www.natus.com/role/IntangibleAssetsScheduleofAmortizationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]", "terseLabel": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r112" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchase of company stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r114" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedTerseLabel": "Deferred debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r112" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-based Payment Arrangement", "negatedLabel": "Taxes paid related to net share settlement of equity awards" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r107" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Acquisition of businesses, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r108" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Acquisition of intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r109" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "negatedTerseLabel": "Purchases of equity investments" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r108" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Acquisition of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r24", "r351" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "verboseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.natus.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock authorized", "verboseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.natus.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r24", "r351" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock issued", "verboseLabel": "Preferred stock, issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.natus.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock outstanding", "verboseLabel": "Preferred stock, outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.natus.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r24", "r604" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding in 2021 and in 2020" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r8", "r42", "r43" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r111" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-term Debt", "terseLabel": "Proceeds from long-term borrowings" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": { "auth_ref": [ "r110", "r444" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.", "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised", "terseLabel": "Proceeds from stock option exercises and ESPP" } } }, "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r106" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from Sale of Property, Plant, and Equipment", "terseLabel": "Proceeds from Sale of Property, Plant, and Equipment" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows", "http://www.natus.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantiesDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Product Warranties Disclosures [Abstract]", "terseLabel": "Product Warranties Disclosures [Abstract]" } } }, "localname": "ProductWarrantiesDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_ProductWarrantyAccrual": { "auth_ref": [ "r303", "r304", "r637" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.", "label": "Standard and Extended Product Warranty Accrual", "terseLabel": "Product reserve warranty" } } }, "localname": "ProductWarrantyAccrual", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ReserveforProductWarrantiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "auth_ref": [ "r55", "r299", "r300" ], "calculation": { "http://www.natus.com/role/AccruedLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Product Warranty Accrual, Current", "terseLabel": "Accrued federal, state, and local taxes" } } }, "localname": "ProductWarrantyAccrualClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/AccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyDisclosureTextBlock": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.", "label": "Product Warranty Disclosure [Text Block]", "terseLabel": "Reserve for Product Warranties" } } }, "localname": "ProductWarrantyDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ReserveforProductWarranties" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProductWarrantyExpense": { "auth_ref": [ "r120", "r301" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The expense charged against earnings for the period pertaining to standard and extended warranties on the entity's goods and services granted to customers.", "label": "Product Warranty Expense", "terseLabel": "Warranty reserve" } } }, "localname": "ProductWarrantyExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]", "terseLabel": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r47", "r282" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/FairValueMeasurementsNarrativeDetails", "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails", "http://www.natus.com/role/PropertyandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r287", "r683", "r684", "r685" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/PropertyandEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r46", "r280" ], "calculation": { "http://www.natus.com/role/PropertyandEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property and Equipment, Gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/PropertyandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Gross, Period Increase (Decrease)", "terseLabel": "Inventory transferred to property and equipment" } } }, "localname": "PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/PropertyandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r15", "r16", "r282", "r604", "r646", "r656" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.natus.com/role/PropertyandEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net", "totalLabel": "Total" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets", "http://www.natus.com/role/PropertyandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Net [Abstract]", "terseLabel": "Property, Plant and Equipment, Net [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r45", "r282", "r683", "r684" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r15", "r282" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/PropertyandEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r15", "r280" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/FairValueMeasurementsNarrativeDetails", "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails", "http://www.natus.com/role/PropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Estimated useful lives of property and equipment" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r96", "r242" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Provision for losses on accounts receivable", "verboseLabel": "Additions charged to expense" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/AllowanceforDoubtfulAccountsDetails", "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PurchaseObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.", "label": "Purchase Obligation", "terseLabel": "Purchase obligation" } } }, "localname": "PurchaseObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PurchaseObligationDueInNextTwelveMonths": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Purchase Obligation, to be Paid, Year One", "terseLabel": "Purchase obligation, to be paid, year one" } } }, "localname": "PurchaseObligationDueInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RatioOfIndebtednessToNetCapital1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indebtedness divided by net capital.", "label": "Ratio of Indebtedness to Net Capital", "terseLabel": "Ratio of Indebtedness to Net Capital" } } }, "localname": "RatioOfIndebtednessToNetCapital1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails" ], "xbrltype": "pureItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_ReceivablesBillingStatusDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amounts due from customers (or dealers) within the next year (or operating cycle, if longer) for goods or services that have been delivered or used, but not yet paid.", "label": "Receivables Billing Status [Domain]", "terseLabel": "Receivables Billing Status [Domain]" } } }, "localname": "ReceivablesBillingStatusDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/RevenueUnbilledARandDeferredRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": { "auth_ref": [ "r33", "r231" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.", "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]", "terseLabel": "Allowance for Doubtful Accounts" } } }, "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": { "auth_ref": [ "r73", "r87" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofComprehensiveIncomeLossConsolidatedStatementofComprehensiveIncomeLoss": { "order": 5.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.", "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent", "terseLabel": "Reclassification of stranded tax effects upon adoption of ASU 2018-02" } } }, "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofComprehensiveIncomeLossConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]" } } }, "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r402", "r595", "r596" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/SaleofCertainSubsidiaryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r595", "r599" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related Party Transaction, Amounts of Transaction", "terseLabel": "Related Party Transaction, Amounts of Transaction" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/SaleofCertainSubsidiaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/SaleofCertainSubsidiaryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]", "terseLabel": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r402", "r595", "r599", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/SaleofCertainSubsidiaryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r593", "r594", "r596", "r600", "r601" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Sale of Certain Subsidiary Assets" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/SaleofCertainSubsidiaryAssetsSaleofCertainSubsidiaryAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentOfNotesReceivableFromRelatedParties": { "auth_ref": [ "r105" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a loan, supported by a promissory note, granted to related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.", "label": "Repayment of Notes Receivable from Related Parties", "terseLabel": "Repayment of notes receivable from related party" } } }, "localname": "RepaymentOfNotesReceivableFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/SaleofCertainSubsidiaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r113" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "negatedLabel": "Payments on borrowings" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r454", "r613", "r698" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "terseLabel": "Research and development [Member]" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationSharebasedCompensationExpenseAllocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": { "auth_ref": [ "r48", "r272", "r273", "r698" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.", "label": "Research, Development, and Computer Software, Policy [Policy Text Block]", "terseLabel": "Research & Development Costs" } } }, "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchMember": { "auth_ref": [ "r480" ], "lang": { "en-us": { "role": { "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.", "label": "Research Tax Credit Carryforward [Member]", "terseLabel": "Research Tax Credit Carryforward" } } }, "localname": "ResearchMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r172" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted Stock Awards [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails", "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails", "http://www.natus.com/role/ShareBasedCompensationRestrictedStockAwardActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock Units [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails", "http://www.natus.com/role/ShareBasedCompensationRestrictedUnitActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r121", "r288", "r291", "r292" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Charges", "terseLabel": "Restructuring" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r27", "r370", "r448", "r604", "r654", "r675", "r680" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r148", "r149", "r150", "r153", "r160", "r163", "r237", "r445", "r446", "r447", "r487", "r488", "r522", "r671", "r673" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]", "terseLabel": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r376", "r377", "r378", "r379", "r380", "r381", "r384", "r385", "r389", "r397" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/Revenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r128", "r129" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r382" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Revenue, Remaining Performance Obligation, Amount" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r383" ], "lang": { "en-us": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/RevenueNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r383" ], "lang": { "en-us": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r89", "r133", "r193", "r194", "r207", "r213", "r214", "r220", "r221", "r224", "r236", "r307", "r308", "r309", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r532", "r645" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations", "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving credit facility [Member]" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": { "auth_ref": [ "r572", "r577" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability", "terseLabel": "Right-of-use assets obtained in exchange for lease obligations: finance leases" } } }, "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesSupplementalCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r572", "r577" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Right-of-use assets obtained in exchange for lease obligations: operating leases" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesSupplementalCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableFiscalYearMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sales-type and Direct Financing Leases, Lease Receivable, Fiscal Year Maturity [Abstract]", "terseLabel": "Sales-type and Direct Financing Leases, Lease Receivable, Fiscal Year Maturity [Abstract]" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivableFiscalYearMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock": { "auth_ref": [ "r583" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received on annual basis for sales-type and direct financing leases receivable. Includes, but is not limited to, reconciliation to lease receivable recognized in statement of financial position.", "label": "Sales-type and Direct Financing Leases, Lease Receivable, Maturity [Table Text Block]", "terseLabel": "Sales-type Lease Receivable, Maturity" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived": { "auth_ref": [ "r583" ], "calculation": { "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.natus.com/role/LeasesSalesTypeLeaseReceivableDetails": { "order": 1.0, "parentTag": "us-gaap_NetInvestmentInLease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases.", "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received", "terseLabel": "Net minimum lease payments to be received", "totalLabel": "Net minimum lease payments to be received" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails", "http://www.natus.com/role/LeasesSalesTypeLeaseReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFiveYears": { "auth_ref": [ "r583" ], "calculation": { "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails": { "order": 2.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Five", "terseLabel": "2026" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFiveYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears": { "auth_ref": [ "r583" ], "calculation": { "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails": { "order": 5.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Four", "terseLabel": "2025" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths": { "auth_ref": [ "r583" ], "calculation": { "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails": { "order": 4.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year One", "terseLabel": "2022" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThereafter": { "auth_ref": [ "r583" ], "calculation": { "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails": { "order": 1.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThereafter", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears": { "auth_ref": [ "r583" ], "calculation": { "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails": { "order": 3.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Three", "terseLabel": "2024" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears": { "auth_ref": [ "r583" ], "calculation": { "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails": { "order": 6.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Two", "terseLabel": "2023" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount": { "auth_ref": [ "r583" ], "calculation": { "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails_1": { "order": 2.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 }, "http://www.natus.com/role/LeasesSalesTypeLeaseReceivableDetails": { "order": 2.0, "parentTag": "us-gaap_NetInvestmentInLease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undiscounted lease receivable in excess of discounted receivable for sales-type and direct financing leases.", "label": "Sales-type and Direct Financing Leases, Lease Receivable, Undiscounted Excess Amount", "negatedTerseLabel": "Less: Unearned interest income portion" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeasePaymentsReceivableMaturityDetails", "http://www.natus.com/role/LeasesSalesTypeLeaseReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeLeaseLeaseIncome": { "auth_ref": [ "r179", "r581", "r591" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lease income from variable lease payments, interest income from net investment on sales-type lease, and profit (loss) recognized at commencement.", "label": "Sales-type Lease, Lease Income", "terseLabel": "Net Sales" } } }, "localname": "SalesTypeLeaseLeaseIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock": { "auth_ref": [ "r179", "r591" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of components of income from sales-type lease.", "label": "Sales-type Lease, Lease Income [Table Text Block]", "terseLabel": "Sales-type Lease, Lease Income" } } }, "localname": "SalesTypeLeaseLeaseIncomeTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SalesTypeLeaseSellingProfitLoss": { "auth_ref": [ "r179", "r589" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of profit (loss) recognized at commencement from sales-type lease.", "label": "Sales-type Lease, Selling Profit (Loss)", "negatedTerseLabel": "Sales-type Lease, Selling Profit (Loss)", "terseLabel": "Gross Loss" } } }, "localname": "SalesTypeLeaseSellingProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows", "http://www.natus.com/role/LeasesLeaseIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeLeaseVariableLeaseIncome": { "auth_ref": [ "r179", "r590" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sales-type lease income from variable lease payments paid and payable to lessor, excluding amount included in measurement of lease receivable.", "label": "Sales-type Lease, Variable Lease Income", "terseLabel": "Variable lease income" } } }, "localname": "SalesTypeLeaseVariableLeaseIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Accrued Liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/AccruedLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.", "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]", "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]" } } }, "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails", "http://www.natus.com/role/IntangibleAssetsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r485" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Summary of components of income tax expense" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r476" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Deferred tax assets and liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r171" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Components of Basic and Diluted EPS" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r461" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Reconciliation of effective income tax rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r407", "r439", "r450" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails", "http://www.natus.com/role/ShareBasedCompensationSharebasedCompensationExpenseAllocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r407", "r439", "r450" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Share-Based Compensation Expense" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r260", "r265", "r615" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsScheduleofAmortizationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r260", "r265" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Amortization expense related to intangible assets with definite lives" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r255", "r256" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/GoodwillTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r134" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "terseLabel": "Income (loss) before provision (benefit) for income tax" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r13", "r39", "r40", "r41" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOperatingLeasedAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Schedule of Operating Leased Assets [Table]", "terseLabel": "Schedule of Operating Leased Assets [Table]" } } }, "localname": "ScheduleOfOperatingLeasedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.", "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]", "terseLabel": "Other income (expense), net" } } }, "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OtherIncomeExpenseNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r47", "r282" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/PropertyandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r597", "r599" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/SaleofCertainSubsidiaryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": { "auth_ref": [ "r99", "r223" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]", "terseLabel": "Revenue and long-lived asset information by geographic region" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/SegmentCustomerandGeographicInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r202", "r205", "r211", "r255" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r415" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Restricted Stock Units Activity" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r415", "r427", "r430" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Stock Options Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Restricted Stock Awards Activity" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [ "r470", "r486" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits.", "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]", "terseLabel": "Uncertain Tax Positions" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Expected annual amortization expense related to amortizable intangible assets" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r189", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r207", "r208", "r209", "r210", "r212", "r213", "r214", "r215", "r216", "r218", "r224", "r290", "r293", "r666" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r189", "r191", "r192", "r202", "r206", "r212", "r216", "r217", "r218", "r219", "r220", "r223", "r224", "r225" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment, Customer and Geographic Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/SegmentCustomerandGeographicInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SelfInsuranceReserveCurrent": { "auth_ref": [], "calculation": { "http://www.natus.com/role/AccruedLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property that are expected to be paid within one year (or the normal operating cycle, if longer).", "label": "Self Insurance Reserve, Current", "terseLabel": "Self-funded insurance expense" } } }, "localname": "SelfInsuranceReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/AccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Marketing and selling" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [ "r95" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling and marketing expense.", "label": "Selling and Marketing Expense [Member]", "terseLabel": "Marketing and sales [Member]" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationSharebasedCompensationExpenseAllocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ServiceAgreementsMember": { "auth_ref": [ "r504" ], "lang": { "en-us": { "role": { "documentation": "Limited duration contract between, for example, an electricity transmission customer and an electricity transmission provider for service.", "label": "Service Agreements [Member]", "terseLabel": "Service Agreements" } } }, "localname": "ServiceAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails", "http://www.natus.com/role/IntangibleAssetsNarrativeDetails", "http://www.natus.com/role/IntangibleAssetsScheduleofAmortizationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r120" ], "calculation": { "http://www.natus.com/role/ConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r410" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Share based compensation, vesting period", "verboseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails", "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate": { "auth_ref": [ "r443" ], "lang": { "en-us": { "role": { "documentation": "Discount rate from fair value on purchase date that participants pay for shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date", "terseLabel": "Offering price, percentage of fair market value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Forfeited, Shares", "negatedTerseLabel": "Forfeited, units" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationRestrictedStockAwardActivityDetails", "http://www.natus.com/role/ShareBasedCompensationRestrictedUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r425" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited, Weighted - average grant date fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationRestrictedStockAwardActivityDetails", "http://www.natus.com/role/ShareBasedCompensationRestrictedUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r423" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Awarded, units", "verboseLabel": "Granted, Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationRestrictedStockAwardActivityDetails", "http://www.natus.com/role/ShareBasedCompensationRestrictedUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r423" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted, Weighted - average grant date fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails", "http://www.natus.com/role/ShareBasedCompensationRestrictedStockAwardActivityDetails", "http://www.natus.com/role/ShareBasedCompensationRestrictedUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r422" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Unvested, end of period, Shares", "periodStartLabel": "Unvested, beginning of period, Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationRestrictedStockAwardActivityDetails", "http://www.natus.com/role/ShareBasedCompensationRestrictedUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationRestrictedStockAwardActivityDetails", "http://www.natus.com/role/ShareBasedCompensationRestrictedUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r422" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Unvested, end of period, Weighted - average grant date fair value", "periodStartLabel": "Unvested, beginning of period, Weighted - average grant date fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationRestrictedStockAwardActivityDetails", "http://www.natus.com/role/ShareBasedCompensationRestrictedUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted Average Grant Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationRestrictedStockAwardActivityDetails", "http://www.natus.com/role/ShareBasedCompensationRestrictedUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r424" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Release, units", "negatedTerseLabel": "Vested, Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationRestrictedStockAwardActivityDetails", "http://www.natus.com/role/ShareBasedCompensationRestrictedUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "auth_ref": [ "r429" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "terseLabel": "Fair value, vested in period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r424" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested, Weighted - average grant date fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationRestrictedStockAwardActivityDetails", "http://www.natus.com/role/ShareBasedCompensationRestrictedUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationValuationInputsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r435" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationValuationInputsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r437" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationValuationInputsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails", "http://www.natus.com/role/ShareBasedCompensationRestrictedStockAwardActivityDetails", "http://www.natus.com/role/ShareBasedCompensationRestrictedUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": { "auth_ref": [ "r443" ], "lang": { "en-us": { "role": { "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate", "terseLabel": "Employee maximum withholding rate (percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r416", "r418" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "periodStartLabel": "Unvested, beginning of period, Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationRestrictedUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r412" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Shares available for future awards" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "verboseLabel": "Weighted average shares exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "verboseLabel": "Weighted average exercise price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r429" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value", "terseLabel": "Intrinsic value of options exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Cancelled (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Granted (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted-average fair value of options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationValuationInputsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r417", "r443" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding, end of period (shares)", "periodStartLabel": "Outstanding, beginning of period (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Number of Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Outstanding, end of period (in dollars per share)", "periodStartLabel": "Outstanding, beginning of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted Average Exercise\u00a0Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": { "auth_ref": [ "r432" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value", "terseLabel": "Intrinsic value of options exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [ "r430" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "terseLabel": "Intrinsic value of options vested and expected to vest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "auth_ref": [ "r431" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "terseLabel": "Weighted average vested options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r431" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price of vested stock" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": { "auth_ref": [ "r441" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification.", "label": "Share-based Payment Arrangement, Plan Modification, Incremental Cost", "terseLabel": "Plan modification, incremental cost" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r406", "r413" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails", "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails", "http://www.natus.com/role/ShareBasedCompensationRestrictedStockAwardActivityDetails", "http://www.natus.com/role/ShareBasedCompensationRestrictedUnitActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Cancelled (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-based Payment Arrangement, Tranche Two [Member]", "terseLabel": "On each of the third and fourth anniversaries of the vesting date[Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheTwoMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r409", "r414" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-based Payment Arrangement [Policy Text Block]", "terseLabel": "Share-based compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable", "terseLabel": "Shares exercisable (in shares)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r410" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Vesting percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding", "terseLabel": "Aggregate intrinsic value of outstanding restricted stock units" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period", "terseLabel": "Share based compensation, expiration period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails", "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r434", "r449" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected life in years" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationValuationInputsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r432" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted average remaining contractual term, exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r431" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted average remaining contractual term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent", "terseLabel": "Purchase price for shares acquired" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price", "terseLabel": "Exercisable, weighted average price (in dollars per share)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "periodEndLabel": "Ending balance (shares)", "periodStartLabel": "Beginning balance (shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation", "negatedLabel": "Taxes paid related to net share settlement of equity awards (shares)" } } }, "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r568", "r577" ], "calculation": { "http://www.natus.com/role/LeasesLeaseCostDetails": { "order": 4.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-term Lease, Cost", "terseLabel": "Short-term lease cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SoftwareDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Internally developed software for sale, licensing or long-term internal use.", "label": "Software Development [Member]", "terseLabel": "Internally developed software" } } }, "localname": "SoftwareDevelopmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails", "http://www.natus.com/role/IntangibleAssetsScheduleofAmortizationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StandardProductWarrantyPolicy": { "auth_ref": [ "r302" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.", "label": "Standard Product Warranty, Policy [Policy Text Block]", "terseLabel": "Liability for product warranties" } } }, "localname": "StandardProductWarrantyPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State and Local Jurisdiction [Member]", "terseLabel": "State and Local Jurisdiction" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r2", "r189", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r207", "r208", "r209", "r210", "r212", "r213", "r214", "r215", "r216", "r218", "r224", "r255", "r285", "r290", "r293", "r666" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/SegmentCustomerandGeographicInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r61", "r84", "r85", "r86", "r148", "r149", "r150", "r153", "r160", "r163", "r180", "r237", "r365", "r370", "r445", "r446", "r447", "r487", "r488", "r522", "r542", "r543", "r544", "r545", "r546", "r548", "r671", "r672", "r673", "r722" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations", "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r148", "r149", "r150", "r180", "r614" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations", "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r24", "r25", "r365", "r370" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "terseLabel": "Employee stock purchase plan (shares)" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r24", "r25", "r365", "r370" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Net issuance of restricted stock awards (shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r24", "r25", "r365", "r370" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation expense (shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r24", "r25", "r365", "r370", "r420" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedLabel": "Exercised (shares)", "terseLabel": "Exercise of stock options (shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.natus.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r24", "r25", "r365", "r370" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "terseLabel": "Employee stock purchase plan" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r365", "r370" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Net issuance of restricted stock awards" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r24", "r25", "r370", "r408", "r428" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation expense" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r61", "r365", "r370" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r24", "r25", "r365", "r370" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "negatedLabel": "Repurchase of company stock (shares)" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r24", "r25", "r365", "r370" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedLabel": "Repurchase of company stock" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r25", "r29", "r30", "r133", "r232", "r236", "r532", "r604" ], "calculation": { "http://www.natus.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "negatedTerseLabel": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets", "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r131", "r352", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r370", "r371" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stockholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubleaseIncome": { "auth_ref": [ "r570", "r577" ], "calculation": { "http://www.natus.com/role/LeasesLeaseCostDetails": { "order": 6.0, "parentTag": "us-gaap_LeaseCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sublease income excluding finance and operating lease expense.", "label": "Sublease Income", "negatedTerseLabel": "Sublease income" } } }, "localname": "SubleaseIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosure of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardAmount": { "auth_ref": [ "r479" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Tax Credit Carryforward, Amount", "terseLabel": "Tax credits carryforwards" } } }, "localname": "TaxCreditCarryforwardAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCreditCarryforwardAxis": { "auth_ref": [ "r480" ], "lang": { "en-us": { "role": { "documentation": "Information by specific tax credit related to an unused tax credit.", "label": "Tax Credit Carryforward [Axis]", "terseLabel": "Tax Credit Carryforward [Axis]" } } }, "localname": "TaxCreditCarryforwardAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardNameDomain": { "auth_ref": [ "r480" ], "lang": { "en-us": { "role": { "documentation": "The name of the tax credit carryforward.", "label": "Tax Credit Carryforward, Name [Domain]", "terseLabel": "Tax Credit Carryforward, Name [Domain]" } } }, "localname": "TaxCreditCarryforwardNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect": { "auth_ref": [ "r71", "r85" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in accumulated other comprehensive income (AOCI) for reclassification to retained earnings of tax effect from remeasurement of deferred tax pursuant to Tax Cuts and Jobs Act.", "label": "Tax Cuts and Jobs Act, Reclassification from AOCI to Retained Earnings, Tax Effect", "terseLabel": "Tax Cuts and Jobs Act, Reclassification from AOCI to Retained Earnings, Tax Effect" } } }, "localname": "TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r53" ], "calculation": { "http://www.natus.com/role/AccruedLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Taxes Payable, Current", "terseLabel": "Warranty reserve" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/AccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r502" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Trade names", "verboseLabel": "Trade names [Member]" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IntangibleAssetsComponentsofGrossandNetIntangibleAssetBalancesDetails", "http://www.natus.com/role/IntangibleAssetsNarrativeDetails", "http://www.natus.com/role/IntangibleAssetsScheduleofAmortizationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnbilledRevenuesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unbilled amounts due for services rendered or products shipped. This element is distinct from unbilled contracts receivables because this is based on noncontract transactions.", "label": "Unbilled Revenues [Member]", "terseLabel": "Unbilled Revenues [Member]" } } }, "localname": "UnbilledRevenuesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/RevenueUnbilledARandDeferredRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r455", "r465" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Ending-Unrecognized Tax Benefits", "periodStartLabel": "Beginning-Unrecognized Tax Benefits", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails", "http://www.natus.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation": { "auth_ref": [ "r465" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from foreign currency translation.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation", "negatedTerseLabel": "Foreign exchange difference" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r466" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "terseLabel": "Decreases for tax positions related to prior years" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r463" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Interest and penalties related to uncertain tax positions" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": { "auth_ref": [ "r463" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense", "negatedTerseLabel": "Total Interest and penalties related to uncertain tax positions" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r467" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "terseLabel": "Increases for tax positions related to the current year" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails", "http://www.natus.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation": { "auth_ref": [ "r465" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from foreign currency translation.", "label": "Unrecognized Tax Benefits, Increase Resulting from Foreign Currency Translation", "terseLabel": "Foreign exchange difference" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r466" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions", "negatedTerseLabel": "Increases for tax positions related to prior years" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": { "auth_ref": [ "r465" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.", "label": "Unrecognized Tax Benefits, Period Increase (Decrease)", "terseLabel": "Increase in unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [ "r468" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.", "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations", "negatedLabel": "Decrease due to lapse of statutes of limitations", "terseLabel": "Lapse of statutes of limitations" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails", "http://www.natus.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "auth_ref": [ "r469" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate", "terseLabel": "Unrecognized tax would impact effective tax rate" } } }, "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r181", "r182", "r183", "r184", "r185", "r186", "r187" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceByDeferredTaxAssetAxis": { "auth_ref": [ "r475" ], "lang": { "en-us": { "role": { "documentation": "Information by type of deferred tax consequences attributable to deductible temporary differences.", "label": "Valuation Allowance by Deferred Tax Asset [Axis]", "terseLabel": "Valuation Allowance by Deferred Tax Asset [Axis]" } } }, "localname": "ValuationAllowanceByDeferredTaxAssetAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r476" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "terseLabel": "Increase in valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": { "auth_ref": [ "r140", "r141", "r142", "r144", "r145" ], "lang": { "en-us": { "role": { "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.", "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]" } } }, "localname": "ValuationAllowanceOfDeferredTaxAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ScheduleIIValuationAndQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesBalance": { "auth_ref": [ "r140", "r145" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount", "periodEndLabel": "Balance at End of Period", "periodStartLabel": "Balance at Beginning of Period" } } }, "localname": "ValuationAllowancesAndReservesBalance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ScheduleIIValuationAndQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": { "auth_ref": [ "r143" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense", "terseLabel": "Additions Charged to Expense" } } }, "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ScheduleIIValuationAndQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDeductions": { "auth_ref": [ "r144" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction", "negatedTerseLabel": "Deductions" } } }, "localname": "ValuationAllowancesAndReservesDeductions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ScheduleIIValuationAndQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDomain": { "auth_ref": [ "r140", "r141", "r142", "r144", "r145" ], "lang": { "en-us": { "role": { "documentation": "Valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]" } } }, "localname": "ValuationAllowancesAndReservesDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ScheduleIIValuationAndQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesTypeAxis": { "auth_ref": [ "r140", "r141", "r142", "r144", "r145" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]" } } }, "localname": "ValuationAllowancesAndReservesTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ScheduleIIValuationAndQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableLeaseCost": { "auth_ref": [ "r569", "r577" ], "calculation": { "http://www.natus.com/role/LeasesLeaseCostDetails": { "order": 5.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.", "label": "Variable Lease, Cost", "terseLabel": "Variable lease cost" } } }, "localname": "VariableLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/LeasesLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/DebtandCreditArrangementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r443" ], "lang": { "en-us": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]", "terseLabel": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r443" ], "lang": { "en-us": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Domain]", "terseLabel": "Vesting [Domain]" } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantyReservesMember": { "auth_ref": [ "r140", "r141", "r142", "r144", "r145" ], "lang": { "en-us": { "role": { "documentation": "Reserve for expected cost from warranty provided on specific product or service.", "label": "SEC Schedule, 12-09, Reserve, Warranty [Member]", "terseLabel": "SEC Schedule, 12-09, Reserve, Warranty [Member]" } } }, "localname": "WarrantyReservesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ScheduleIIValuationAndQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "auth_ref": [ "r171" ], "calculation": { "http://www.natus.com/role/EarningsPerShareComponentsofBasicandDilutedEPSDetail": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.", "label": "Weighted Average Number Diluted Shares Outstanding Adjustment", "terseLabel": "Dilutive effect of stock based awards" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/EarningsPerShareComponentsofBasicandDilutedEPSDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r166", "r171" ], "calculation": { "http://www.natus.com/role/EarningsPerShareComponentsofBasicandDilutedEPSDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (shares)", "totalLabel": "Diluted Shares (in dollars per share)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations", "http://www.natus.com/role/EarningsPerShareComponentsofBasicandDilutedEPSDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted average shares used in the calculation of net income (loss) per share:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r165", "r171" ], "calculation": { "http://www.natus.com/role/EarningsPerShareComponentsofBasicandDilutedEPSDetail": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic (shares)", "verboseLabel": "Weighted average common shares" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.natus.com/role/ConsolidatedStatementsofOperations", "http://www.natus.com/role/EarningsPerShareComponentsofBasicandDilutedEPSDetail" ], "xbrltype": "sharesItemType" } }, "unitCount": 8 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column B))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column D))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column E))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r147": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r177": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=124502072&loc=SL77927221-108306" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r188": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r225": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r233": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "310", "URI": "http://asc.fasb.org/topic&trid=2196771" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r257": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/subtopic&trid=2144439" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "40", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=16397303&loc=d3e19347-109286" }, "r274": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "44", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=29634951&loc=d3e1756-110224" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2459-110228" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r287": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r296": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r298": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123377177&loc=d3e11281-110244" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12524-110249" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3,4))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(5)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r305": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "460", "URI": "http://asc.fasb.org/topic&trid=2155896" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r371": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r397": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r398": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "610", "URI": "http://asc.fasb.org/topic&trid=49130413" }, "r399": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "710", "URI": "http://asc.fasb.org/topic&trid=2127225" }, "r4": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "712", "URI": "http://asc.fasb.org/topic&trid=2197446" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r405": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929" }, "r452": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r453": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "720", "URI": "http://asc.fasb.org/topic&trid=2122503" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.15)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "44", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5558-128473" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r514": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "40", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=116633155&loc=d3e31531-110899" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r549": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20,24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r578": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123420820&loc=SL77919306-209978" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123420820&loc=SL77919308-209978" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123420820&loc=SL77919311-209978" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919352-209981" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919391-209981" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL119206284-209981" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919359-209981" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981" }, "r592": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888252" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r601": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(d))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.3)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(b))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a-c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r699": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r700": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r701": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r702": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r703": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r704": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r705": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r706": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r707": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r708": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r709": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL116659650-108580" }, "r710": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r711": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column C", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r712": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column D", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r713": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column E", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r714": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column F", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r715": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column G", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r716": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column H", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r717": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column I", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r718": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "09" }, "r719": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e709-108580" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(2))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" } }, "version": "2.1" } ZIP 113 0000878526-22-000026-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000878526-22-000026-xbrl.zip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�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end

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�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